nct_id,title,phase,condition,endpoint_1,endpoint_2,endpoint_3
NCT02087176,A Placebo Controlled Study Comparing AZD1775+ Docetaxel Versus Placebo+Docetaxel to Treat Lung Cancer,PHASE2,Previously Treated Non Small Cell Lung Cancer,,,
NCT05512676,Trabectedin/Caelyx vs Cisplatin Hypersensitivity in Relapsed Ovarian Cancer Patients Allergic to Platinum,,Ovarian Neoplasm,,,
NCT03146117,PET-DECT for Staging and Imaged Based Radiotherapy Planning in Lung Cancer,,PET CT,,,
NCT03272217,Atezolizumab With Bevacizumab in Previously Untreated Metastatic/Unresectable Urothelial Cancer,PHASE2,Urothelial Carcinoma,,,
NCT06706076,A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations,PHASE1,NSCLC (Advanced Non-small Cell Lung Cancer),,,
NCT01865617,"Laboratory Treated T Cells in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, or Acute Lymphoblastic Leukemia",PHASE1,CD19-Positive Neoplastic Cells Present,,,
NCT04473040,Managed Access Program to Provide Access to Alpelisib for Patients With Advanced Breast Cancer,,"HR+, HER2-, Advanced Breast Cancer",,,
NCT07037589,Women With isoLated acUte cyStitis and Macroscopic Hematuria. Is Further Investigation Needed?,,Hematuria,is to identify low-risk patients where invasive investigations may be safely avoided,,
NCT02404389,"Safety, Tolerability, and Efficacy Study of LFX453 in Actinic Keratosis Patients",PHASE2,Actinic Keratosis,,,
NCT04666168,A Multicenter Clinical Study on the Safety and Efficacy of CAR-T in the Treatment of Relapsed / Refractory Non Hodgkin's Lymphoma,NA,Non-hodgkin's Lymphoma,,,
NCT04013568,Exercise Post-Diagnosis of Breast Cancer,NA,Breast Cancer,if there are body composition changes after a 12-week exercise program in breast cancer patients and determine what factors contribute to sustained physical activity after the 12-week exercise program intervention,,
NCT06766591,Ivonescimab Combined With Chemotherapy for the Treatment of Leptomeningeal Metastases Failed to EGFR-TKIs,NA,NSCLC,* iPFS (intracranial progression free survival),Main purpose Exploring the real-world effectiveness of Ivonescimab combined with chemotherapy for EGFR mutant NSCLC with leptomeningeal metastasis after EGFR-TKIs resistance,
NCT01535391,"Nilotinib in PH+, BCR-, ABL+ CML Patients",PHASE3,Chronic Myeloid Leukemia,"of the trial is to evaluate the efficacy of nilotinib, 300 mg twice daily with dose increase to 400 mg twice daily in case of suboptimal response or failure (excluding patients who will fail for progression to ABP), in a population of patients with Ph-positive, BCR-ABL positive CML in early CP","the efficacy of nilotinib, 300 mg twice daily with dose increase to 400 mg twice daily in case of suboptimal response or failure (excluding patients who will fail for progression to ABP), in a population of patients with Ph-positive, BCR-ABL positive CML in early CP","nilotinib, 300 mg twice daily with dose increase to 400 mg twice daily in case of suboptimal response or failure (excluding patients who will fail for progression to ABP), in a population of patients with Ph-positive, BCR-ABL positive CML in early CP"
NCT00042991,Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas,PHASE1,Untreated Childhood Anaplastic Astrocytoma,,,
NCT00931918,Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients,PHASE2,Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL),,,
NCT07066813,Staging Strategies and Their Association With Prognosis and Therapy in Lung Cancer With Cystic Airspaces (STAGE),,Lung Cancer Associated With Cystic Airspaces,the most accurate tumor size measurement method for T-staging and prognostic assessment in lung cancer with cystic airspaces (LCCA),,
NCT00457860,"Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease",PHASE1,Leukemia,"the maximum tolerated dose of CAT-8015 immunotoxin in treating patients who have chronic lymphocytic leukemia, prolymphocytic leukemia or small lymphocytic lymphoma that has not responded to treatment",,
NCT02693860,Neoadjuvant J591 Treatment for Prostate Cancer,PHASE1,Prostate Cancer,,,
NCT01398982,TAP Block in DIEP or Free MS-TRAM Donor Site: A RCT,PHASE4,Transversus Abdominis Plane (TAP) Block Catheter,a TAP block in reducing postoperative abdominal pain following abdominal tissue breast reconstruction,,
NCT01309282,An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Sero-Positive Rheumatoid Arthritis Who Are Non-Responders or Intolerant to a Single TNF-Inhibitor (PORTSMAB),,Rheumatoid Arthritis,the long-term efficacy and safety of MabThera/Rituxan in routine clinical practice in patients with sero-positive rheumatoid arthritis who are non-responders or intolerant to a single tumour necrosis factor (TNF) inhibitor,,
NCT00506324,Oropharyngeal Function After Radiotherapy With IMRT,,Head and Neck Neoplasms,are: 1) define the physiologic effects of chemoradiotherapy with IMRT to various sites in the upper aerodigestive/vocal tract including the cervical esophagus and the rate at which patients return to oral intake,laryngeal elevation,
NCT04687423,Study of FCN-011 in Patients With Advanced Solid Tumor（Phase I）and NTRK Fusion Positive Advanced Solid Tumor （Phase II）,PHASE1,Advanced Solid Tumor,"the safety, tolerability, pharmacokinetic characteristics, and primary antitumor activity of FCN-011 in patients with advanced solid tumor (phase I) and NTRK fusion positive advanced solid tumor (phase II)",,
NCT02716623,The Feasibility of a Diet and Exercise Intervention in Diabetics During Treatment for Non-muscle Invasive Bladder Cancer,NA,Bladder Cancer,,,
NCT05373823,MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors,NA,Melanoma,1 will focus on enhancing the previous version of MSS by collaborating with multi-level stakeholders in qualitative interviews and usability testing,,
NCT04431024,"Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome",,Familial Cancer,To see if researchers can improve how people who have or are suspected to have a BAP1 mutation are monitored over time,,
NCT01902823,Effect of Cancer Nurse Navigators on Patient Outcomes,PHASE2,Lung Cancer,1,the feasibility of studying the impact of Aurora CNN Program,
NCT00806923,A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer (NSCLC),PHASE3,Non-Squamous Non-Small Cell Lung Cancer,,,
NCT01721759,Study of Nivolumab (BMS-936558) in Patients With Advanced or Metastatic Squamous Cell Nonsmall-cell Lung Cancer Who Have Received At Least 2 Prior Systemic Regimens,PHASE2,Squamous Cell Non-small Cell Lung Cancer,response rate (change in tumor size from baseline) in patients with advanced or metastatic squamous cell nonsmall-cell lung cancer treated with Nivolumab (BMS-936558) after failure of 2 prior systemic regimens,the objective response rate (change in tumor size from baseline) in patients with advanced or metastatic squamous cell nonsmall-cell lung cancer treated with Nivolumab (BMS-936558) after failure of 2 prior systemic regimens,
NCT01881659,Cervical Cancer Screening With Human Papillomavirus Testing,,CIN3,,,
NCT06391879,Establishment of a Multidimensional Prediction Model for the Natural Course of VHL Disease-related Renal Cell Carcinoma,,VHL Syndrome,to retrospectively and prospectively analyze the factors related to the natural course of VHL-related RCC,,
NCT01804179,"Colorectal Cancer Awareness, Research, Education and Screening (CARES)",NA,Colorectal Cancer,,,
NCT02962596,EURAD MRI Classification of US Indeterminate Adnexa Lesions,,Ovarian Tumor,,,
NCT06272162,Locally Advanced Pancreatic Cancer After Systemic Therapy: Ablative MR-guided Radiotherapy,NA,Locally Advanced Pancreatic Adenocarcinoma,,,
NCT02376296,Observational Study of Docetaxel Exposure in Metastatic Prostate Cancer Patients,,Prostate Cancer,,,
NCT01870596,Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia,PHASE2,Adult Acute Megakaryoblastic Leukemia,,,
NCT05906862,AMT-253 in Patients With Selected Advanced Solid Tumours,PHASE1,Advanced Solid Tumor,,,
NCT03336762,Injured Spinal Cord Pressure Evaluation Study - Transverse Myelitis,,Transverse Myelitis,cord perfusion and metabolism in patients with severe spinal cord damage from transverse myelitis,,
NCT06376162,Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia,PHASE1,Relapsed/Refractory KMT2A-r Acute Leukemia,"of the study is to determine the recommended phase 2 dose (RP2D) of ziftomenib in combination with chemotherapy (FLA) in children with relapsed or refractory KMT2A-r, NUP98-r, or NPM1-m acute leukemia based on safety and pharmacokinetics (PK)","the recommended phase 2 dose (RP2D) of ziftomenib in combination with chemotherapy (FLA) in children with relapsed or refractory KMT2A-r, NUP98-r, or NPM1-m acute leukemia based on safety and pharmacokinetics (PK)",
NCT03904862,Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery,PHASE1,"Medulloblastoma, Childhood",,,
NCT01085396,Use of Fiber-optic Probe for Non-invasive Diagnosis of Melanoma and Assessment of Impact of Ultraviolet (UV) Exposure on Skin,,Melanoma,,,
NCT00458796,Comparison of Two Schedules of Zoledronic Acid in Treating Patients With Breast Cancer That Has Spread to the Bone,NA,Breast Cancer,,,
NCT02638896,Dose Reduction of Etanercept in Patients With Ankylosing Spondylitis,PHASE4,Ankylosing Spondylitis,of this study is to evaluate the efficacy of safety of etanercept dose reduction combined with sulfasalazine in ankylosing spondylitis (AS) patients who have achieved a significant clinical response,the efficacy of safety of etanercept dose reduction combined with sulfasalazine in ankylosing spondylitis (AS) patients who have achieved a significant clinical response,safety of etanercept dose reduction combined with sulfasalazine in ankylosing spondylitis (AS) patients who have achieved a significant clinical response
NCT03949062,Study Evaluating the Safety and Efficacy of iR2 in Untreated and Unfit Elderly Patients With DLBCL,PHASE2,Diffuse Large B Cell Lymphoma,,,
NCT07063888,A Prospective Phase II Study of Postoperative Concurrent Chemoradiotherapy in Patients With Intrahepatic Cholangiocarcinoma,PHASE2,Intrahepatic Cholangiocarcinoma (Icc),is 2-year recurrence-free survival,,
NCT06276088,Plasma and Tissue SAA1 Levels in Cancer Patients to Predict Hyperprogression of Immunotherapy,,Immunotherapy,,,
NCT00536588,A Safety and Tolerability Study of SCH 721015 in Patients With Transitional Cell Carcinoma of the Bladder (Study P03816),PHASE1,Bladder Neoplasms,the safety and tolerability of SCH 721015 in subjects with transitional cell carcinoma of the bladder,,
NCT00355888,Safety Study of MBP-426 (Liposomal Oxaliplatin Suspension for Injection) to Treat Advanced or Metastatic Solid Tumors,PHASE1,Cancer,whether MBP-426 (liposomal oxaliplatin suspension for injection) is safe and effective in the treatment of advanced or metastatic solid tumors,,
NCT05104788,A Study of Icotinib With Chemotherapy as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung Cancer,PHASE2,Non-Small Cell Lung Cancer,,,
NCT06621303,Autonomous Regulatory Monocytes (OPM Cells) for the Treatment of Diabetic Foot in a Single-arm Open-label Clinical Study,EARLY_PHASE1,Diabetic Foot Ulcer,"： As a clinical study initiated by researchers, this study aims to explore the safety and preliminary efficacy of OPM cells in reducing complications in diabetic foot patients",the safety and preliminary efficacy of OPM cells in the treatment of diabetic ulcers,OPM cells in the treatment of diabetic ulcers
NCT02491827,Confocal Laser Endomicroscopy (CLE) During Medically Induced Neurosurgery in Craniobasal and Glioma Tumours,,Cerebral Tumors,,,
NCT00001827,p53 Vaccine for Ovarian Cancer,PHASE2,Ovarian Neoplasm,,,
NCT03401827,The Effect of Gemcitabine Plus Nab-paclitaxel as Secondary Chemotherapy in Advanced Pancreatic Cancer,PHASE4,Pancreatic Adenocarcinoma,of this study was to evaluate the efficacy of GnP as a second-line treatment after failed FOLFIRINOX treatment for locally advanced or metastatic pancreatic ductal adenocarcinoma,the efficacy of GnP as a second-line treatment after failed FOLFIRINOX treatment for locally advanced or metastatic pancreatic ductal adenocarcinoma,GnP as a second-line treatment after failed FOLFIRINOX treatment for locally advanced or metastatic pancreatic ductal adenocarcinoma
NCT07173127,The Impact of a Novel GnRH Antagonist With Add-back Therapy for Treatment of Uterine Fibroids and Endometriosis on Hemostasis Parameters,NA,Uterine Fibroid,of this study is to document the effects of Ryeqo® on hemostasis parameters in order to estimate the risk of VTE associated with its employ,,
NCT03349827,HIPEC and Systemic Chemotherapy Combined With Apatinib in Unresectable Peritoneal Metastases From Gastric Cancer,NA,Peritoneal Metastases From Gastric Cancer,,,
NCT01394861,Endoscopic Submucosal Dissection (ESD)- Master Slave Robotic System - Human Study,EARLY_PHASE1,Endoscopic Submucosal Dissection,"the feasibility, ease and safety of flexible endoscopic robotic system to treat early gastric cancer in humans",,
NCT01983761,Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation,PHASE1,Blood And Marrow Transplantation,,,
NCT05215561,"Special Drug Use-results Survey to Evaluate Safety and Efficacy of Cosentyx in Pediatric Patients With PsV, PsA, or GPP",,Psoriasis Vulgaris,,,
NCT00965861,SCRI Tissue Testing Registry,,Melanoma,,,
NCT04035642,Phase II Study of Single-Dose Image-Guided Radiotherapy (SDRT) for Prostate Cancer,NA,Prostate Cancer,,,
NCT04940442,Outreach and Choice in Colorectal Cancer Screening,NA,Colorectal Cancer Screening,"of this clinical trial will be to compare overall colorectal cancer (CRC) screening participation between an active choice (fecal immunochemical test \[FIT\] or colonoscopy) and a sequential choice (FIT offered first, then colonoscoscopy offered in those still unscreened) arm",,
NCT01130142,A Study Evaluating IPI-926 in Combination With Gemcitabine in Patients With Metastatic Pancreatic Cancer,PHASE1,Metastatic Pancreatic Cancer,IPI 926 in combination with gemcitabine in patients with previously untreated metastatic pancreatic cancer,,
NCT00192842,Gemcitabine With Curcumin for Pancreatic Cancer,PHASE2,Pancreatic Cancer,the standard chemotherapy gemcitabine in patients with advanced pancreatic cancer,,
NCT02731742,Dose Evaluation of MK-1966 in Combination With SD-101 in Participants With Advanced Malignancies (MK-1966-001),PHASE1,"Neoplasms, Advanced",the maximum tolerated dose (MTD)/maximum administered dose (MAD) by evaluating Dose Limiting Toxicities (DLTs) of four dose combinations of MK-1966 and SD-101,,
NCT04164186,Fully Automated Pipeline for the Detection and Segmentation of Non-Small Cell Lung Cancer (NSCLC) on CT Images,,Detection,"to develop an automated pipeline that can produce swift, accurate and reproducible lung tumor segmentations",,
NCT02775786,Prospective Evaluation of MRI Biomarkers in Pancreatic Ductal Adenocarcinoma,NA,Pancreatic Adenocarcinoma,,,
NCT04430270,Perceptions of Orthopedic Prespecialists on Patient-Specific 3D Models.,,Educational Problems,the perceptions of fellows in orthopaedic surgeon training,,
NCT04019470,Immunomodulation Analysis of Radiation Therapy in Pediatric Malignant Brain Tumors,,"Brain Tumor, Pediatric",,,
NCT05725070,Phase 0/1 Study of 212Pb-NG001 in mCRPC,EARLY_PHASE1,Metastatic Castration-resistant Prostate Cancer,the imaging feasibility and safety of 212Pb-NG001,,
NCT07093073,Clinical Study of U01（ssCART-19） in Patients With B-Cell Lymphoma,PHASE1,B Cell Lymphoma,,,
NCT01298869,"The Study of Immunogenicity of Quadrivalent Vaccine Against Human Papilloma Virus (HPV) Types 6, 11, 16, and 18 (HPV-6/11/16/18) in Chronic Kidney Disease (CKD) Patients",,"Chronic Kidney Disease, Stage IV (Severe)",to investigate the immunogenicity of quadrivalent HPV-6/11/16/18 vaccination (Gardasil,HPV-6/11/16/18 vaccination (Gardasil,
NCT04319783,Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA,PHASE2,Advanced Prostate Carcinoma,,,
NCT00906841,Study of 90Y-DOTA-hLL2 as a Consolidation Therapy After R-CHOP in Patients With Diffuse Large B-cell Lymphoma,PHASE2,B-cell Lymphoma,,,
NCT03158441,DTi Diffusion Findings in Breast MRI Screening and Diagnostic,,Breast Cancer,the correlation between the DTI analysis of breast MRI and the results of conventional contrast enhanced breast MRI,,
NCT02292641,Beyond TME Origins,NA,Neoplasms,,,
NCT05633641,Peripheral Blood Neoantigen Specific T Cells Predict the Efficacy of Immunotherapy for Esophageal Squamous Cell Carcinoma,,Esophageal Squamous Cell Carcinoma,,,
NCT07194954,Dietary Fiber and Probiotics in Advanced Colorectal Cancer,NA,Colorectal Cancer (MSI-H),"the efficacy of a 12-week combined dietary fiber and probiotic supplementation on gut microbiota, immune function, nutritional status, and survival outcomes in malnourished patients with advanced colorectal cancer undergoing conventional therapy, compared to standard nutritional support alone","a 12-week combined dietary fiber and probiotic supplementation on gut microbiota, immune function, nutritional status, and survival outcomes in malnourished patients with advanced colorectal cancer undergoing conventional therapy, compared to standard nutritional support alone",
NCT07071454,Preventing Early-Onset Colorectal Cancer in the VA,NA,Colorectal Neoplasms,2 is the focus of the trial,,
NCT00779454,Combined Biological Treatment and Chemotherapy for Patients With Inoperable Cholangiocarcinoma,PHASE2,Cholangiocarcinoma,,,
NCT02406105,An Effectiveness and Toxicity of CyberKnife Based Radiosurgery for Parkinson Disease,PHASE2,Parkinson Disease,of the study is estimation of effectiveness and safety of Cyber Knife based functional radiosurgery for Parkinson disease patients suffering from tremor,,
NCT04003805,Biomarkers of Exposure and Effect in Standardized Research E-cigarette (SREC) Users,PHASE1,"Smoking, Cigarette",ed at evaluating the value and limitations of e-cigarettes as tobacco risk reduction tools,,
NCT03043105,"TCP Regimen in Newly Diagnosed MCD:a Prospective, Single-center, Single-arm, Phase-II Pilot Trial",PHASE2,Multicentric Castleman Disease,,,
NCT01783054,"Pilot, Neoadjuvant Gemcitabine and Abraxane Chemotherapy Followed by Surgery, Adenocarcinoma of the Pancreas",EARLY_PHASE1,Adenocarcinoma Pancreas,the safety and effectiveness of the drugs Gemcitabine and Abraxane in the treatment of adenocarcinoma of the pancreas before surgery,if he or she is eligible to participate in this study,
NCT06817668,Evaluating Tolerability of ePUHRT With Brachytherapy Boost,NA,Prostate Cancer,"the tolerability and toxicity of combining two radiation therapy methods for prostate cancer: Elective Pelvic Ultra Hypofractionated Irradiation Treatment (ePUHRT), which is an external beam radiotherapy with High Dose Rate Brachytherapy Boost (form of internal radiation where a cancer doctor implants a small plastic tube or balloon (catheter) in the tumor)",,
NCT00005591,"Cetuximab Plus Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Pancreas",PHASE2,Pancreatic Cancer,,,
NCT02716974,A Study of Definitive Therapy to Treat Prostate Cancer,PHASE2,Prostate Cancer,"the safety of treating men with oligometastatic prostate cancer with the following therapy: (1st) Systemic chemo-hormonal therapy with up to 6-months (\~24 weeks) of neoadjuvant androgen deprivation and up to 6 cycles of chemotherapy, (2nd) definitive local tumor control with prostatectomy +/- adjuvant radiation therapy, and (3rd) consolidative stereotactic radiation to oligometastatic lesions",,
NCT00074074,Infliximab in Treating Patients With Myelodysplastic Syndrome,PHASE2,Myelodysplastic Syndromes,,,
NCT03026374,"Effect of a Mentor-based, Supportive-expressive Program on Survival in Metastatic Breast Cancer",NA,Metastatic Breastcancer,,,
NCT06404918,Preemptive Erector Spinae Plane Block Versus Serratus Anterior Plane Block in MRM,NA,Modified Radical Mastectomy,,,
NCT04707118,Ntraperitoneal Thermal Perfusion Combined With Chemotherapy Versus Chemotherapy,PHASE1,Advanced Pancreatic Cancer,"abdominal albumin hot perfusion chemotherapy combined control of ascites and taxol in improving patients' quality of life, survival, exploring the feasibility of celiac hot perfusion chemotherapy combined albumin paclitaxel and side effects",,
NCT02316197,"Clinical Phase I Study Investigating MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Advanced Solid Tumors or Chronic Lymphocytic Leukemia",PHASE1,Advanced Solid Tumors,the highest dose that does not cause unacceptable side effects,,
NCT04905810,Azacitidine or Decitabine With Venetoclax for Acute Myeloid Leukemia With Prior Hypomethylating Agent Failure,PHASE2,Acute Myeloid Leukemia,,,
NCT03679910,Evaluation of CEMIP in Pancreatic Cancer,,Pancreas Cancer,"the clinical utility of serum CEMIP, CA19-9 and CEA in pancreatic cancer patients in comparison with healthy controls and their relation to cancer staging and histopathological types",,
NCT03286413,Comparison of Microwave Ablation With Cryoablation for Breast Tumor,NA,Breast Tumor,,,
NCT06435013,Lenvatinib vs Bevacizumab Plus ICIs and HAIC in Unresectable HCC,,Hepatocellular Carcinoma,,,
NCT03322813,ExAblate Blood Brain Barrier Disruption (BBBD) for Planned Surgery in Suspected Infiltrating Glioma,NA,Glioma,"the safety and feasibility of using the ExAblate, Type 2 to temporarily disrupt the blood brain barrier in non-enhancing suspected infiltrating glioma",,
NCT06394713,A Study to Evaluate the Efficacy and Safety of QLF31907 Combination Therapy in Patients With Advanced Malignant Tumors,PHASE1,Advanced Malignant Neoplasm,the safety and efficacy of QLF31907 combination therapy in advanced malignant tumors,QLF31907 combination therapy in advanced malignant tumors,
NCT00368082,"Autologous/Allogeneic TGFbeta-resistant LMP-specific CTL, Lymphoma (TGF-beta)",PHASE1,Lymphoma,,,
NCT05821582,Study SBX-01-101: A Stool Collection Study in Colorectal Cancer (CRC) Patients Treated With Irinotecan-Based Regimens,,Colorectal Cancer,of the study is to determine whether there is a correlation between the intestinal side effects of chemotherapy treatment and the expression/activity profiles of glucuronidase enzymes in the stool microbiome of the target patient population,whether there is a correlation between the intestinal side effects of chemotherapy treatment and the expression/activity profiles of glucuronidase enzymes in the stool microbiome of the target patient population,
NCT02620423,Study of Pembrolizumab With REOLYSIN® and Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma,PHASE1,Pancreatic Adenocarcinoma,,,
NCT05830123,ARTEMIS-002: HS-20093 in Patients With Relapsed or Refractory Osteosarcoma and Other Sarcomas,PHASE2,Osteosarcoma,"the efficacy, safety, pharmacokinetics (PK) and immunogenicity of HS-20093 as a monotherapy in patients with relapsed or refractory osteosarcoma and other sarcomas",,
NCT05605223,Study of Acute Autoimmune Encephalitis With Positive Antibodies in Eastern France,,Acute Autoimmune Encephalitis,,,
NCT02781259,Selective Lymph Node Dissection Using Fluorescent Dye in Node-positive Breast Cancer,PHASE4,Breast Neoplasms,,,
NCT00068523,Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies,NA,Chronic Myeloproliferative Disorders,,,
NCT06553859,Evaluation of ADM(SC Derm® Recon) in Breast Reconstruction,,Breast Cancer Female,,,
NCT00551759,"Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer",PHASE2,Esophageal Cancer,,,
NCT03748680,IMPROVE Intervention Trial Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer,PHASE2,Colorectal Cancer,,,
NCT03892980,Robotic-Assisted da Vinci System Prophylactic Nipple-Sparing Mastectomy,NA,Nipple Sparing Mastectomy,,,
NCT00093080,"Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED)",PHASE2,Leiomyosarcoma,the efficacy of ridaforolimus when administered once daily for 5 consecutive days (QDx5) every two weeks in participants with advanced sarcoma,ridaforolimus when administered once daily for 5 consecutive days (QDx5) every two weeks in participants with advanced sarcoma,
NCT02980679,A Study to Compare the Safety and Imaging Pattern of Cyclotron-produced Technetium (CTC) vs. Generator-produced Technetium (G-PERT) in People With Thyroid Disorders Who Need Surgery,PHASE3,Thyroid Gland Diseases,of this study is to confirm that CTC is safe and can be used interchangeably with G-PERT,thyroid uptake,
NCT00670579,Study About Complications of Totally Implanted Venous Access Devices (TIVADs) in People With Cystic Fibrosis (CF),,Cystic Fibrosis,,,
NCT00001079,A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss,PHASE2,HIV Infections,,,
NCT05011279,"Move Together Boston Feasibility Pilot (Sit Less, Move More App for Black Breast Cancer Survivors & At-Risk Relatives)",NA,Breast Cancer Survivor,,,
NCT02391662,"Nab-paclitaxel and Gemcitabine, in Elderly Patients Untreated Metastatic Pancreatic Adenocarcinoma",PHASE2,Pancreatic Carcinoma Metastatic,of this study is to investigate whether the clinical benefit of nab-paclitaxel associated with gemcitabine can be extended to elderly patients with pancreatic cancer,,
NCT06579196,Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed Advanced NSCLC and Positive PD-L1,PHASE1,Non-small Cell Lung Cancer,the combination therapy in adults with certain types of Non-Small Cell Lung Cancer,,
NCT05698888,"Study of VP301 in Patients With Multiple Myeloma, Lymphoma, or Solid Tumors",PHASE1,"Solid Tumors, Adult",,,
NCT05771103,Stellate Ganglion Destruction With Alcohol Versus Thermal Ablation for Chronic Post Mastectomy Pain,NA,Post-mastectomy Pain Syndrome,,,
NCT04654403,Study of First-line Camrelizumab With or Without Chemotherapy for Advanced Esophageal Squamous Cell Cancer,NA,Esophageal Cancer,"the efficacy and safety of Camrelizumab or Camrelizumab plus chemotherapy in patients with untreated, advanced ESCC with PD-L1 CPS≥10 ,who have been achieved PR and CR after treated with Camrelizumab",,
NCT05438303,"Study to Assess the Effect of Co-Administration of AZD9833 on the Pharmacokinetics of Midazolam, of Omeprazole, of Celecoxib and of Dabigatran Etexilate in Healthy Postmenopausal Female Volunteers",PHASE1,Healthy Volunteers,,,
NCT06712927,"Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain Metastases",PHASE2,Melanoma,,,
NCT03561727,Risk Factors for Development of Incisional Hernia in Transverse Incisions,NA,Incisional Hernia,"The aim of this planned study is to evaluate factors, with particular reference to surgical technique of abdominal closure, accumulation of advanced glycation end products, and collagen content in the transversalis fascia, that are associated with the development of incisional hernias after transverse epigastric incisions in patients operated due to malignant tumors","factors, with particular reference to surgical technique of abdominal closure, accumulation of advanced glycation end products, and collagen content in the transversalis fascia, that are associated with the development of incisional hernias after transverse epigastric incisions in patients operated due to malignant tumors",
NCT03162627,Selumetinib and Olaparib in Solid Tumors,PHASE1,Malignant Neoplasm of Breast,,,
NCT02500927,A Study of ASP8273 in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-Naïve Patients With Non-Small Cell Lung Cancer Harboring EGFR Mutations,PHASE2,EGFR-TKI-naïve Patients With NSCLC Harboring EGFR Activating Mutations,"the safety, the antitumor activity and the pharmacokinetics of ASP8273 in EGFR tyrosine kinase inhibitor (EGFR-TKI)-naïve patients with non-small cell lung cancer (NSCLC) harboring EGFR activating mutations",,
NCT04372927,ADMIRAL Trial: Adaptive Mediastinal Radiation With Chemo-Immunotherapy,PHASE2,Locally Advanced Lung Non-Small Cell Carcinoma,,,
NCT05206942,Serial Ultrasound of Solid Tumor Lesions to Detect Early Response to Cancer Immunotherapy,NA,Solid Tumor,"are to evaluate if there is an optimal ultrasound imaging modality (CEUS or conventional power Doppler or LEAD ultrasound) or optimal time point to predict initial objective response and to assess the correlation of tumor perfusion parameters with change in overall tumor burden, change in diameter on a per-lesion basis, and with 12-month progression-free survival (PFS)","the correlation of tumor perfusion parameters with change in overall tumor burden, change in diameter on a per-lesion basis, and with 12-month progression-free survival (PFS)","if there is an optimal ultrasound imaging modality (CEUS or conventional power Doppler or LEAD ultrasound) or optimal time point to predict initial objective response and to assess the correlation of tumor perfusion parameters with change in overall tumor burden, change in diameter on a per-lesion basis, and with 12-month progression-free survival (PFS)"
NCT04714086,Expanded Access Program for Avapritinib,,Solid Tumors,,,
NCT06840886,A Study of PHST001 in Advanced Solid Tumors,PHASE1,Advanced Solid Tumors,the safety and tolerability of PHST001 and determine the RP2D (Recommended Phase 2 dose) of PHST001,,
NCT00782886,Evaluation of Image-Guided Liver Surgical System for Resection of Liver Cancer,,Liver Cancer,,,
NCT06160570,"IMRT Versus 3DCRT for Locally Advanced Rectal Cancer, Prospective Phase II Study.",NA,Rectal Cancer,"whether personalized planning-based nCRT for LARC would indeed decrease small bowel dose, and whether selected plans, specifically prioritizing lower dose to small bowel, would result in lower rates of acute GI toxicity compared with previously reported rates",,
NCT00003470,Antineoplaston Therapy in Treating Patients With Anaplastic Astrocytoma,PHASE2,Anaplastic Astrocytoma,the effects (good and bad) that Antineoplaston therapy has on adults with anaplastic astrocytomas that have not responded to standard therapy,,
NCT00751270,Phase 1b Study of AdV-tk + Valacyclovir Combined With Radiation Therapy for Malignant Gliomas,PHASE1,Malignant Glioma,"the safety and feasibility of delivering an experimental approach called GliAtak which uses AdV-tk, an adenoviral vector containing the Herpes Simplex thymidine kinase gene, plus an oral anti-herpetic prodrug, valacyclovir, in combination with standard of care radiation",,
NCT00772083,Caring for Those Who Share: Improving the Health of Wisconsin Blood Donors,NA,Anemia,,,
NCT01403883,Psychological and Enterostomal Therapy Care,NA,Cancer of Rectum,"of the study was to assess the benefit of an optimal care, i","the benefit of an optimal care, i",
NCT04093141,Chemotherapy Followed by Irreversible Electroporation in Patients With Unresectable Locally Advanced Pancreatic Cancer,NA,Unresectable Pancreatic Cancer,of the study is to evaluate the efficacy of IRE in this patient group,the efficacy of IRE in this patient group,IRE in this patient group
NCT04410341,The DPP-4 Inhibitor Vildagliptin as Adjunct in Major Depressive Disorder Patients,PHASE1,Major Depressive Disorder,,,
NCT06949254,PRospective Observational Study of STereotactic Body rAdiation Therapy With Androgen Deprivation Therapy for Organ-confined High-risk Prostate Cancer: the PROSTAR Trial,,High Risk Prostate Cancer,of the study was to demonstrate that SBRT (42,the safety and efficacy of SBRT (40 Gy in 5 fractions every other day) coupled with ADT (relugolix 18-24 monthsaccording to clinical care) in patients with localized high-risk PCa,SBRT in combination with ADT for patients with unfavorable intermediate and high-risk PCa and will recruit 1182 patients who will be randomized to receive either hypofractionated RT (60 Gy in 20 fractions) or SBRT delivered with 36
NCT03530605,Use of Optune TTF With Radiation as an Alternative for Elderly Patients With Primary CNS Lymphoma,NA,"Central Nervous System Neoplasms, Primary",,,
NCT06225505,Early Detection of Triple Negative Breast Cancer Relapse,NA,Triple Negative Breast Cancer,the clinical utility of ctDNA monitoring combined with 68Ga-FAPI-46-PET-CT imaging upon ctDNA detection for the surveillance of patients with a non-metastatic TNBC at high risk of relapse,,
NCT05125354,A Retrospective Analysis to Evaluate Long Term Outcomes of SCC Patients Previously Treated With Alpha DaRT,,Squamous Cell Carcinoma,,,
NCT06066905,A Study of Chidamide With AZA in MRD Positive AML After Transplant,NA,"AML, Adult",,,
NCT02059850,NY-ESO-1 Specific T Cells After Cyclophosphamide in Treating Patients With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma,PHASE1,Adult Synovial Sarcoma,,,
NCT02252250,Transanal Total Mesorectal Excision Versus Laparoscopic TME for Rectal Cancer,NA,Rectal Neoplasms,,,
NCT00028691,Chlorambucil Compared With Radiation Therapy in Treating Patients With Previously Untreated Stage III or Stage IV Follicular Lymphoma,PHASE3,Lymphoma,,,
NCT05876091,Effects of Tobacco Flavoring and Liquid Composition on Vaping Topography,NA,Tobacco-Related Carcinoma,,,
NCT06151574,Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment,PHASE3,"Lung Cancer, Non-squamous, Non-small Cell",,,
NCT03262818,Transvaginal Ultrasound and Photoacoustic Imaging of the Ovary,PHASE1,Oophorectomy,,,
NCT05413018,An Efficacy and Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy in Chinese Participants With Acute Myeloid Leukemia in Complete Remission,PHASE2,"Leukemia, Myeloid, Acute",the efficacy and safety of Oral Azacitidine (CC-486) in Chinese participants with acute myeloid leukemia in complete remission,,
NCT04036318,Evaluation of Presumptive Periodic Treatment (PPT) of Sexually Transmitted Infections (STIs),,"Sexually Transmitted Diseases, Bacterial",,,
NCT06133218,Patient Reported Outcomes Using Mepitel Film During Radiotherapy,NA,Radiodermatitis,of this study is patient-reported symptoms and patient-reported experiences with the prophylactic use of Mepitel Film compared to standard cream treatment,,
NCT06824818,Study to Assess the Feasibility of Stopping Prostate Cancer Treatment Early in Elderly Patients,NA,Elderly,,,
NCT00510718,A Phase 1 Study of MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate Cancer,PHASE1,Prostate Cancer,,,
NCT00749697,Radioiodine Dosimetry Protocol for Thyroid Cancer Metastases,NA,Thyroid Carcinoma,,,
NCT01952210,Effectiveness of a Nutritional Consultation and Exercise Program in Esophageal Cancer Patient,NA,Esophageal Cancer,the effects of nutritional and exercise intervention in locally advanced esophageal cancer patients undergoing neoadjuvant chemoradiation,,
NCT03067610,Involved Field Elective Volume De-Intensification Radiation Therapy for Head and Neck Cancer,PHASE2,Head and Neck Cancer,,,
NCT00374660,Study of Irofulven in Combination With Oxaliplatin in Patients With Advanced Solid Tumors,PHASE1,Liver Cancer,"the maximum tolerated dose (MTD) and to investigate the efficacy, safety and pharmacokinetics of irofulven combined with oxaliplatin in patients with advanced solid tumors",,
NCT04607460,"EMG Biofeedback Treatment for Chronic Low Back Pain, Cancer Pain and Migraines",NA,Chronic Low-back Pain,of this study are to examine the impact of EMG-BF on pain and QST and the impact of EMG-BF on psychosocial function,,
NCT03242460,The Safety and Efficacy of Pomalidomide in Combination With Cyclophosphamide and Dexamethasone (PCD) in the Transplant-ineligible Patients With Relapsed and/or Refractory Multiple Myeloma (MM),PHASE2,Relapsed and/or refractorY Multiple Myeloma,,,
NCT04968860,Oral Health Condition and Quality of Life in Children With Leukemia,,"Leukemia, Lymphoblastic","To identify the clinical characteristics of the oral condition, types of microorganisms of the oral microbiota, and quality of life in children/adolescents with acute lymphoid leukemia and acute myeloid leukemia before and during antineoplastic treatment, and compare them with healthy children/adolescent individuals",,
NCT02827682,The Effect of IoC on Analgesia for Elderly Patients With Postoperative Effectiveness,NA,Colorectal Cancer,,,
NCT02934724,Impact of HPV Vaccine On The Prevalence Of HPV In Norway,,Cervical Intraepithelial Neoplasia,of the study is to assess the effect of school-based Human Papillomavirus (HPV) vaccination by comparing type-specific HPV prevalence between vaccinated and non-vaccinated women born in 1997,the effect of school-based Human Papillomavirus (HPV) vaccination by comparing type-specific HPV prevalence between vaccinated and non-vaccinated women born in 1997,
NCT05334823,A Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents,PHASE2,Acute Lymphoblastic Leukemia,the safety and efficacy of pCAR-19 B cell autologous infusion preparation in the treatment of CD19-positive relapsed/refractory B-cell acute lymphoblastic leukemia,pCAR-19 B cell autologous infusion preparation in the treatment of CD19-positive relapsed/refractory B-cell acute lymphoblastic leukemia,
NCT01135823,Symptom Assessment With Patient Surveys,,Carcinomas,,,
NCT00002823,Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer,PHASE3,Lung Cancer,,,
NCT05969223,Study to Assess the Safety and Efficacy of Subcutaneously Injected Risankizumab in Adult Participants With Genital or Scalp Psoriasis,PHASE4,Genital Psoriasis,how safe and effective risankizumab is in adult participants with moderate to severe genital psoriasis or moderate to severe scalp psoriasis,,
NCT05498623,MR Fingerprinting for Diagnostic of Prostate Cancer,,Prostate Cancer,is to conduct a clinical pilot study in which patients will be scanned using the newly refined MRF sequence in addition to the conventional scanning protocols,,
NCT05650723,Zanubrutinib and Venetoclax as Initial Therapy for Chronic Lymphocytic Leukemia (CLL) With Response-based Obinutuzumab,PHASE2,"Leukemia, Lymphocytic, Chronic, B-Cell",,,
NCT02724280,Linked Color Imaging to Differentiate H. Pylori Associated Gastritis and Gastric Atrophy,NA,Gastritis,,,
NCT04929080,The Safety and Efficacy of Multiple-dose of JS004 in Subject With HNC,PHASE1,Head and Neck Squamous Cell Carcinom,"the safety, tolerability, PK, immunogenicity, antitumor activity and biomarkers of JS004, define the RP2D",,
NCT02969096,Clinical Study of Targeted Cryoablation Therapy in the Treatment of Hepatic Carcinoma,PHASE2,Liver Neoplasms,the safety and efficacy of targeted cryoablation therapy for hepatic carcinoma,targeted cryoablation therapy for hepatic carcinoma,
NCT00839696,"Total Xenoestrogen Body Burden in Relation to Mammographic Density, a Marker of Breast Cancer Rlisk",,Breast Cancer Risk,,,
NCT05019196,fMRI Study of Functional Reorganization in Glioma Patients,,Glioma,,,
NCT00910546,Image Guided and Breathing Adapted Radiotherapy of Early Stage Lung Cancer,NA,Lung Cancer,,,
NCT00004262,Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme,PHASE1,Adult Giant Cell Glioblastoma,,,
NCT00385788,Allogeneic Blood Stem Cell Transplantation and Adoptive Immunotherapy for Hodgkin's Disease,PHASE2,Hodgkin's Disease,,,
NCT02995603,Patient Experience and Acceptance of Horizontal Rotation,NA,Cancer,,,
NCT06668961,A Study of SI-B001+SI-B003 Combined With Platinum-based Chemotherapy as First-line Treatment in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma,PHASE2,Head and Neck Squamous Cell Carcinoma,,,
NCT02845986,Study on Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Advanced Gastric Cancer,PHASE2,Stomach Neoplasms,,,
NCT01670786,Safety Profile of Iodopovidone as an Agent for Pleurodesis in Malignant Pleural Effusion,PHASE4,"Pleural Effusion, Malignant",,,
NCT01363986,A Study of Herceptin (Trastuzumab) in Combination With Whole Brain Radiotherapy in Patients With HER-2 Positive Breast Cancer,PHASE2,Breast Cancer,,,
NCT02179086,Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma,PHASE2,Glioblastoma,,,
NCT04285086,Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance,PHASE3,Essential Thrombocythemia,,,
NCT05537870,The Effectiveness of Nurse Navigators in Cancer Care,NA,Neoplasms,,,
NCT06746870,"A Phase II Clinical Study to Evaluate the Safety, Pharmacokinetic Profile, and Preliminary Efficacy of IMM2510 in Combination with Chemotherapy As First-line Treatment in Subjects with Non-small Cell Lung Cancer or Triple-negative Breast Cancer",PHASE2,NSCLC,the dose for the combination treatment,,
NCT06787170,Prediction of Platinum Resistance and Prognosis of High-grade Serous Ovarian Cancer,,High-grade Serous Ovarian Cancer (HGSOC),to perform habitat imaging on multi-functional MRI such as multi b-value DWI and DCE-MRI and to train WSI-based multi-instance learning to construct pathological signature,,
NCT02005770,Anesthesia and Circulating Tumor Cells in Breast Cancer,PHASE4,Female Breast Carcinoma,the effect of anesthesia on this tumor marker,,
NCT00537173,Predicting Response and Toxicity in Patients Receiving Paclitaxel and Avastin for Breast Cancer,,Breast Cancer,,,
NCT03194373,Phase II Trial Evaluating the Efficacy of Palbociclib in Combination With Carboplatin for the Treatment of Unresectable Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma,PHASE2,Squamous Cell Carcinoma of the Head and Neck,,,
NCT05210283,CORRECT Study of Minimal Residual Disease Detection in Colorectal Cancer,,Colorectal Cancer,,,
NCT00091741,Safety and Efficacy Study of Etanercept (Enbrel) on the Response Rate of HIV-infected Subjects,PHASE1,HIV Infection,the safety and efficacy of etanercept (Enbrel) on the response rate in HIV-infected subjects who have failed to respond to conventional antiretroviral (HAART) therapy and for whom no alternative therapy exists,etanercept (Enbrel) on the response rate in HIV-infected subjects who have failed to respond to conventional antiretroviral (HAART) therapy and for whom no alternative therapy exists,
NCT01954641,Accountability for Cancer Care Through Undoing Racism and Equity,NA,Breast Cancer,,,
NCT01168505,Iron Supplement in the Prevention of Anemia in Female Breast Cancer Patients,PHASE2,Breast Cancer,the efficacy of intravenous iron supplementation in the prevention of anemia in patients receiving (neo)adjuvant breast cancer regimens,intravenous iron supplementation in the prevention of anemia in patients receiving (neo)adjuvant breast cancer regimens,
NCT02233205,Safety Study of Combining Ultrasound Microbubbles and Chemotherapy to Treat Malignant Neoplasms of Digestive System,PHASE1,Gastrointestinal Neoplasms,,,
NCT05969405,"Comparison of Prognosis in Endometrial Cancer Treated With Different Surgical Methods: Laparoscopy, Robotic-assisted Laparoscopy and Laparotomy",,Endometrial Cancer,"：To compare the clinical outcomes of endometrial cancer patients who received surgerical treatments: Comparisons of robotic-assisted laparoscopic, laparoscopic and laparotomic methods",,
NCT02734966,Efficacy and Safety Study of Magnesium Isoglycyrrhizinate Injection in Subjects With Acute Drug-induced Liver Injury,PHASE2,Drug-Induced Liver Injury,,,
NCT00014066,Photodynamic Therapy Plus Brachytherapy in Treating Patients With Lung Cancer,PHASE1,Lung Cancer,,,
NCT01309256,Multi-institutional Study on the Assessment of Robotic Surgery for Gastric Cancer,,Gastric Cancer,"of this study is to analyze the surgical outcomes of the robotic gastrectomy focusing on the learning curve, cost-effectiveness, quality of life, and acute-inflammatory reaction in comparison with laparoscopic gastrectomy",,
NCT05768256,Treatment Efficacy of Mindfulness-based Cognitive Therapy for Distress in Advanced Cancer Patients,NA,Cancer Pain,to explore whether mindfulness-based cognitive-behavioral therapy for cancer patients is effective in relieving distress and to discover neurophysiological factors that contribute to relieving distress,"a mindfulness-based cognitive behavioral therapy program for distress of patients with advanced cancer through an in-depth and multifaceted integrated approach, and to understand the related neurophysiological mechanisms",
NCT00227656,Capecitabine and Pegylated Interferon Alfa-2a in Treating Patients With Recurrent or Progressive Brain Metastases Due to Breast Cancer,PHASE2,Breast Cancer,,,
NCT00005956,Biological Therapy in Treating Patients With Advanced Cancer,NA,Breast Cancer,,,
NCT03619356,Investigation of Hemoglobin Oxygenation With Third Harmonic Generation Microscopy,,Hypoxia,of the project are performing a pre-clinical study on a human model and evaluating the oxygenation and other status of human erythrocytes by spectrally-resolved third harmonic generation (srTHG) microscopy,,
NCT01419860,Evaluation of Microcirculation in Colon Wall and Bowel Anastomosis by Laser Induced Fluorescence Video Angiography,NA,Colon Cancer,"of the study is to describe utility of dynamic fluorescence videoangiography of indocyanine green (ICG) in gastrointestinal surgery, for evaluation of microcirculation in colon wall and anastomosis before and after surgical resection",,
NCT05383482,Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1,PHASE1,Solid Tumor,"RP2D, safety, tolerability and anti-tumor activity of Sintilimab + afuresertib + nab-paclitaxel or docetaxel administered as a combination therapy",clinical efficacy and safety of the combination therapy in phase II,
NCT01738724,Study of the Efficacy of Dienogest in the Treatment of Uterine Leiomyomas When Compared to Desogestrel and Goserelin,PHASE4,Uterine Leiomyoma,is to assess whether the progestagen dienogest reduces leiomyoma volume and its associated symptoms to the same extent as gonadotropin releasing hormone (GnRH) analogs or the progestagen desogestrel or whether it is inferior to other drugs already in use,whether the progestagen dienogest reduces leiomyoma volume and its associated symptoms to the same extent as gonadotropin releasing hormone (GnRH) analogs or the progestagen desogestrel or whether it is inferior to other drugs already in use,
NCT00298324,Myfortic - Treatment for Extensive cGvHD,PHASE3,Graft vs Host Disease,"whether the response to treatment for extensive chronic Graft versus Host Disease (cGvHD)is improved with the addition of myfortic alongside cyclosporine A and prednisone, compared to the reference treatment of cyclosporine A and prednisone alone",,
NCT01053624,Concomitant Tracheostomy and Lung Resection,PHASE3,Lung Cancer,if tracheostomy performed immediately after lung operation (i,,
NCT05090124,Experimental Medicine Studies of the Brain in Patients With Rheumatoid Arthritis REALISE,NA,Rheumatoid Arthritis,,,
NCT03500380,A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases,PHASE2,Breast Neoplasms,,,
NCT07188480,The Role of DNA and RNA in NGS Analyses for Advaced Stage NSCLC Patients,NA,Non Small Cell Lung Cancer NSCLC,of identifying driver gene mutations that may be targeted by specific therapies,its feasibility in NGS analyses,the technical feasibility of NGS analysis on EV-DNA/RNA derived from bronchoalveolar lavage in patients with advanced NSCLC
NCT05081180,Study of Avelumab in Combination With Lenvatinib for Children With Primary CNS Tumors,PHASE1,Central Nervous System Tumors,the efficacy of Avelumab in combination with Lenvatinib by Progression-free Survival in participants with pre-defined primary central nervous system (CNS) tumors,Avelumab in combination with Lenvatinib by Progression-free Survival in participants with pre-defined primary central nervous system (CNS) tumors,
NCT03052179,The Clinical and Biological Effects Of The Use Of Probiotic VSL#3 In Patients With Oral Lichen Planus,NA,Oral Lichen Planus,the clinical effects between groups of active VSL #3 and placebo and the results will analyze by statistician,,
NCT06645496,Evaluation of Technology Acceptance and Electronic Health (Ehealth) Literacy of Patients Undergoing Radiotherapy,NA,eHealth Literacy,,,
NCT01692262,"Investigating Safety, Tolerability and Efficacy of AZD5363 in Prostate Cancer.",PHASE1,"Metastatic Castrate-Resistant Prostate Cancer (mCRPC),",,,
NCT01199562,Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant,,Hematopoietic/Lymphoid Cancer,,,
NCT05831488,"Assessing the Accuracy of Seismofit® as an Estimate of VO2 Peak in Patients With Hepato-pancreato-biliary, Colorectal, and Gastro-oesophageal Cancer",,Hepato-Biliary Carcinoma in Situ Nos,to assess the relationship between the Seismofit® derived VO2 peak estimate and CPET-measured VO2 peak in patients who are having CPET as part of their preoperative workup,the relationship between the Seismofit® derived VO2 peak estimate and CPET-measured VO2 peak in patients who are having CPET as part of their preoperative workup,
NCT01221688,Sentinel Lymph Node Detection After Neoadjuvant Chemotherapy for Large Operable Breast Cancer,NA,Breast Cancer,the risk of axillary relapse without lymphadenectomy,"two groups of patients : group 1 (pN+) : patients with proven involved axillary nodes and group 2, patients without proven axillary involved nodes (cN0)",
NCT06980103,Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyroid Cancer,NA,Thyroid Cancer,to answer are: - Does the decision aid help participants understand the risks and benefits of RAI treatment? - Does it help participants make choices that reflect what matters most to them? - How does the decision aid compare to usual care in supporting patients through this decision? Participants who have been recently diagnosed with intermediate-risk differentiated thyroid cancer (DTC) will be randomly assigned to one of two groups,,
NCT06276803,The LINFU® U.S. Registry for the in the General Population Without Risk Factors,,Pancreatic Cancer,,,
NCT00002003,Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas,PHASE2,"Lymphoma, Non-Hodgkin",the efficacy and toxicity of the combination of mitoxantrone hydrochloride ( Novantrone ) and etoposide in the treatment of patients with HIV associated lymphomas,,
NCT04281303,Endoscopic Bariatric Therapy in NASH Cirrhosis,,Non-alcoholic Steatohepatitis (NASH),of the investigators study is to evaluate the safety and efficacy of endoscopic gastroplasty in improving metabolic factors and liver histology in patients with obesity with or without metabolic syndrome and NASH-compensated cirrhosis,the safety and efficacy of endoscopic gastroplasty in improving metabolic factors and liver histology in patients with obesity with or without metabolic syndrome and NASH-compensated cirrhosis,endoscopic gastroplasty in improving metabolic factors and liver histology in patients with obesity with or without metabolic syndrome and NASH-compensated cirrhosis
NCT00859027,Effect Of Risedronate On Bone Mass In Older Men Receiving Neoadjuvant Therapy For Prostate Cancer,PHASE4,Prostate Cancer,,,
NCT06361927,A Phase II Study of SSGJ-707 Monotherapy in First-line PD-L1 Positive Advanced NSCLC Patients,PHASE2,NSCLC,,,
NCT00929461,Impact of Omega-3 Fatty Acids on Lactate,NA,Gastric Surgery,,,
NCT03533361,Expanded Access Program With Lenvatinib for the Treatment of Differentiated Thyroid Cancer in Brazil,,Thyroid Cancer,,,
NCT02025361,Impact of Local Anesthesia Type on Cancer Detection Rate in Transrectal Ultrasound Guided Prostate Biopsy,PHASE4,Adenocarcinoma of Prostate,,,
NCT03116542,18F-FLT (PET/CT) in Prefibrotic/Early Primary Myelofibrosis and Essential Thrombocythemia,NA,Essential Thrombocythemia,"to examine the association of FLT-PET uptake patterns with different genetic makeup (JAK2 (Janus kinase 2), CALR (Calreticulin), MPL (myeloproliferative leukemia protein), or Triple negative disease) or allele burden in cases of Pre-PMF and ET",,
NCT05076942,Groningen International Study on Sentinel Nodes in Vulvar Cancer-III,PHASE2,Vulvar Cancer,,,
NCT00130442,Trial of PI-88 With Dacarbazine in Patients With Metastatic Melanoma,PHASE2,Melanoma,"of the study is to compare the safety and effectiveness of a new drug called PI-88, when used in combination with an approved chemotherapy drug called dacarbazine, in the treatment of metastatic melanoma",,
NCT00686842,PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma,PHASE1,Kaposi's Sarcoma,,,
NCT03627442,Post-op Outcomes of Enhanced Energy Delivery Dissection for Mastectomy With Immediate Breast Reconstruction,NA,Breast Cancer,Determine if post-op flap viability differs between women getting mastectomy flap creation using PB vs Bovie Determine if post-op site drainage measures differs between two devices Determine if post-op pain measures differ when using PB vs Bovie Determine if time to mastectomy flap creation differs between using Bovie and PB,,
NCT05951842,"Anesthesia, TIVA, Balanced Anesthesia, NK Cell",NA,Colorectal Cancer,"the effect of propofol, inhalation agent, and opioid on tumor genesis, recurrence, NK cell activity, cytokine response, and postoperative outcome",,
NCT04904042,Study of Safety and Efficiency of the Use of Neutral Argon Plasma in Cyto-reduction of Miliary Implants in the Peritoneal Surface.,NA,Peritoneal Carcinomatosis,is to evaluate the effectiveness and safety of neutral argon plasma on peritoneal implants with different dosimetry in vivo and ex vivo,the effectiveness and safety of neutral argon plasma on peritoneal implants with different dosimetry in vivo and ex vivo,
NCT05134142,Quality of Life and Function of Patients With Pelvic Tumors After Undergoing Hemipelvectomy,,Malignant Primary Pelvic Neoplasm,to determine the functional outcomes of patients who underwent internal hemipelvectomy with or without reconstruction or external hemipelvectomy for pelvic tumors,the functional outcomes of patients who underwent internal hemipelvectomy with or without reconstruction or external hemipelvectomy for pelvic tumors,
NCT00543842,"Bevacizumab, Erlotinib, and Capecitabine for Locally Advanced Rectal Cancer",PHASE1,Rectal Cancer,"the maximal tolerated dose (MTD) of concurrent capecitabine, bevacizumab and erlotinib with preoperative radiation therapy (RT) for rectal cancer",,
NCT02122042,Hyperbaric Oxygen Therapy Can Improve Cognitive Deficits Post Low Grade Glioma Removal Surgery,PHASE1,Post Low Grade Glioma Surgery,"of the current study is to evaluate, in a prospective cross-over, randomized study, the effect of hyperbaric oxygen therapy (HBOT) on patients with chronic impairment after low grade glioma tumor removal surgery",,
NCT06694142,Feasibility of Addressing Sexual Dysfunction in Women with Breast and Gynecologic Cancers with a Novel Mobile Application,NA,Sexual Dysfunction,,,
NCT06453642,Evaluation of a Simple-Prep Controlled Embolic,NA,Embolization,"of this study is to evaluate the safety and effectiveness of the GPX® Embolic Device when used as indicated for embolization requiring distal vessel penetration in 114 subjects in up to 25 investigational sites in the USA, New Zealand, and Canada","the safety and effectiveness of the GPX® Embolic Device when used as indicated for embolization requiring distal vessel penetration in 114 subjects in up to 25 investigational sites in the USA, New Zealand, and Canada",
NCT00153842,A Study of Paclitaxel and Carboplatin in Combination With Bexarotene Oral Capsules in Patients With Advanced Lung Cancer,PHASE1,"Carcinoma, Non-small-cell Lung","is to evaluate the safety (Phase I components) of administering bexarotene (Targretin®, LGD1069) oral capsules in combination with two Taxol® and carboplatin (Paraplatin®) schedules to patients with stage IIIB and IV non-small cell lung cancer","the safety (Phase I components) of administering bexarotene (Targretin®, LGD1069) oral capsules in combination with two Taxol® and carboplatin (Paraplatin®) schedules to patients with stage IIIB and IV non-small cell lung cancer",
NCT04696042,Asian Investigation of Lanreotide Autogel® in the Management of GEP-NETs,,Neuroendocrine Tumors,,,
NCT04327986,Immune Checkpoint Inhibitor M7824 and the Immunocytokine M9241 in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Advanced Pancreas Cancer,PHASE1,Histologically or Cytologically Confirmed Pancreatic Cancer,"To find a safe combined dose of Bintrafusp Alfa (M7824), NHS-IL12 (M9241, and radiation and to see if it causes pancreas cancer tumors to shrink",,
NCT03094286,Durvalumab in HIV-1 Patients With Solid Tumors,PHASE2,HIV,the feasibility of durvalumab (MEDI4736) in HIV-1-infected individuals with solid tumors,,
NCT04716686,Niraparib Monotherapy as Maintain and Recurrent Treatment of Endometrial Serous Carcinoma,PHASE2,Endometrial Carcinoma,,,
NCT03975270,Sintilimab in Combination With Nab-paclitaxel in Patients With HNSCC (Head and Neck Squamous Cell Carcinoma ),PHASE2,Head and Neck Squamous Cell Cancer,of this study is to observe and evaluate the efficacy and safety of Sintilimab combined with paclitaxel-albumin-binding for injection in patients with advanced recurrent and metastatic HNSCC who fail to receive first-line or more treatment,,
NCT06082570,A Study to Observe and Evaluate the Safety and Efficacy of c610 Injection for Treatment of Advanced Solid Tumor Patients,PHASE1,Advanced Solid Tumors,c610 injection in the treatment of patients with advanced solid tumors,,
NCT02857270,A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer,PHASE1,Advanced Cancer,the safety of an extracellular signal regulated kinase (ERK1/2) inhibitor LY3214996 administered alone or in combination with other agents in participants with advanced cancer,,
NCT04870970,The Effect of Tobacco Products on Wound Healing,,Smoking,"the effect of various tobacco products (including but not limited to combustible cigarettes, medicinal nicotine, electronic cigarettes, and smokeless tobacco) on cutaneous wound healing",,
NCT03549273,Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial Lesions,PHASE2,Carcinoma,,,
NCT03674073,A Study Combining Personalized Neoantigen-based Dendritic Cell Vaccine With Microwave Ablation for the Treatment of Hepatocellular Carcinoma,PHASE1,Hepatocellular Carcinoma,,,
NCT05120973,Multispectral Fluorescence as a Tool to Separate Healthy and Disease Related Lymphatic Anatomies in Prostate Cancer.,,Prostate Cancer,technical feasibility to differentiate these patterns and in the future reduce the amount of complications that result from damage to lymphatic structures,,
NCT03492073,Effectiveness of an Individual Mindfulness-based Intervention for Cancer Patients in a Advanced Stage of the Disease and Their Relatives,NA,Cancer,"of the study was to analyze the differential effect between two Emotional Support programs, one of them based on Mindfulness, and the other one Emotional Support as usual, on advanced cancer patients (stage III \& IV) admitted to a Madrid Community Hospital La Paz and their relatives",,
NCT01833273,Dose Evaluation Safety STudy IN Individuals With Astrocytoma Taking PolyMVA,PHASE1,Glioblastoma Multiform (Grade IV Astrocytoma),ed at determining whether grade IV astrocytoma patients who receive PolyMVA achieve a better quality of life during their chemo-therapeutic regimens versus grade IV astrocytoma patients who do not receive PolyMVA,,
NCT04291469,Antipsychotic Effects of Probiotics and Prebiotics on Patients With Schizophrenia,NA,Schizophrenia,,,
NCT03901469,A Study of ZEN003694 and Talazoparib in Patients With Triple Negative Breast Cancer,PHASE2,Triple Negative Breast Cancer,,,
NCT01373983,Intrathecal Bolus Doses of Ziconotide,PHASE4,Peripheral Neuropathy,if the effect of ziconotide can be tested by intrathecal bolus doses,,
NCT00049283,"Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer",PHASE1,Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma,,,
NCT05142241,"Testing the Combination of Anti-Cancer Drugs Talazoparib and Temozolomide in Patients With Advanced Stage Rare Cancers, RARE 2 Trial",PHASE2,Adrenal Gland Pheochromocytoma,,,
NCT00176241,Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck Cancer,PHASE1,Head and Neck Cancer,,,
NCT06022341,MultiOmic characteriZation of Acute Myeloid Leukemia Evolving From myelopRoliferative Neoplasm to Identify New Targeted Therapeutic Strategies,NA,Myeloproliferative Neoplasm,is to identify new targeted therapeutic approaches in post-MPN AML through in-depth characterization of the dysregulated pathways,,
NCT01941641,Colon Neoadjuvant FOLFOXIRI Study,PHASE2,Rectal Cancer,tumour response rate to FOLFOXIRI to pre-operative therapy,,
NCT05781841,Gene Expression Of Suppressor Of Cytokines in In Cutaneous Warts,,Warts,,,
NCT02797041,Bortezomib as First Salvage Therapy for Myeloma Patients Previously Exposed to Bortezomib as Initial Treatment.,,Multiple Myeloma,,,
NCT04199741,PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56,PHASE1,Small Cell Lung Cancer,,,
NCT03849105,131I-IPA and Concurrent XRT in Recurrent GBM,PHASE1,Glioblastoma Multiforme,"safety, tolerability, dosing schedule, and preliminary efficacy of carrier-added 4-L-\[131I\]iodo-phenylalanine (131I-IPA), administered as single or repetitive injections in patients with recurrent glioblastoma multiforme (GBM), concomitantly to 2nd line external radiation therapy (XRT) - IPAX-1","carrier-added 4-L-\[131I\]iodo-phenylalanine (131I-IPA), administered as single or repetitive injections in patients with recurrent glioblastoma multiforme (GBM), concomitantly to 2nd line external radiation therapy (XRT) - IPAX-1",
NCT01884454,SLEEP AND OSA ON REPRODUCTIVE FUNCTION IN MEN,,Obstructive Sleep Apnea,to evaluate the effects of the OSA or sleep deprivation (total or selective REM sleep for 48h) on reproductive function in adult men with normal body mass index,the effects of the OSA or sleep deprivation (total or selective REM sleep for 48h) on reproductive function in adult men with normal body mass index,
NCT00002854,High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer,PHASE1,Cancer,,,
NCT04321954,Lenvatinib in Locally Advanced Invasive Thyroid Cancer,PHASE2,Differentiated Thyroid Cancer,the safety and efficacy of neoadjuvant lenvatinib on surgical outcomes of patients with invasive extrathyroidal differentiated thyroid cancer (DTC),neoadjuvant lenvatinib on surgical outcomes of patients with invasive extrathyroidal differentiated thyroid cancer (DTC),
NCT02682394,Evaluation of Pancreatic Steatosis in Patients With Cancer of Pancreas,,Cancer of Pancreas,,,
NCT00772694,Sorafenib Monotherapy in Inoperable/Recurrent Germ Cell Carcinoma Refractory to Chemotherapy,PHASE2,Testicular Cancer,if multiple-relapsed chemorefractory pts may benefit from sorafenib monotherapy,,
NCT00416494,"Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer",PHASE2,Colorectal Cancer,,,
NCT05498766,Effect and Safety of Huaier Granule Versus SOX Regimen in Gastric Cancer Patients,PHASE4,Gastric Cancer,the efficacy and safety of Huaier Granule versus SOX regimen in the postoperative adjuvant treatment of resectable stage II-III gastric cancer,,
NCT00172666,Decoy Receptor 3 (DcR3) Polymorphisms in Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE),,Rheumatoid Arthritis,"to establish the possible correlation between DcR3 genetic polymorphisms, DcR3 expressions, and autoimmune phenotypes, the investigators offer this proposal",,
NCT03897556,Effect of High-Dose Guarana And Cancer-Related Fatigue,NA,Cancer-related Fatigue,,,
NCT00124956,Doxorubicin Pharmacokinetic (PK) Study,PHASE1,Cancer,,,
NCT00121056,REKinDLE: Registry With Enbrel® or Kineret® in a Database Using Longitudinal Evaluations,,Rheumatoid Arthritis,if Enbrel® or Kineret® will have a positive effect on subject functionality as measured by the Health Assessment Questionnaire Disability Index (HAQDI),,
NCT02167256,"A Phase IIa Multi-Center Study of 18F-FDG PET, Safety, and Tolerability of AZD0530 in Mild Alzheimer's Disease",PHASE2,Alzheimer's Disease,,,
NCT00568022,A Phase I Study of Ixabepilone in Combination With Capecitabine in Japanese Patients With Metastatic Breast Cancer,PHASE1,Breast Cancer,"the dose-limiting toxicity (DLT), maximum tolerated dose (MTD) and recommended Phase II dose of ixabepilone in combination with capecitabine in Japanese participants with metastatic breast cancer",,
NCT02178722,"Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers",PHASE1,Microsatellite-instability (MSI) High Colorectal Cancer (CRC),"the safety, tolerability, and efficacy when combining MK-3475 and INCB024360 in participants with certain cancers",,
NCT04002622,Study of TQB2450 Injection in Subjects With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma,PHASE2,Relapsed or Refractory Primary Mediastinal B-cell Lymphoma (rrPMBCL),,,
NCT01994382,"Phase 1/2a Dose Escalation Study in Participants With CLL, SLL, or NHL",PHASE1,Follicular Lymphoma (FL/Indolent NHL),,,
NCT06860282,A Study of CX2101A Enteric-Coated Tablets in Healthy Chinese Adult Subjects,PHASE1,COVID-19,,,
NCT04068623,Correlation Between TILs and Blood Cell Counts in Triple Negative Breast Cancer Patients,,Triple Negative Breast Cancer,"to assess the correlation between blood cell counts (Leucocytes, Neutrophils, Lymphocytes, Platelets, NLR (Neutrophil-to-Lymphocyte Ratio) and PLR (Platelet-to-Lymphocyte Ratio)) and Tumor Infiltrating Lymphocytes (TILs), at baseline and after surgery, for patients diagnosed with triple negative breast cancer","the correlation between blood cell counts (Leucocytes, Neutrophils, Lymphocytes, Platelets, NLR (Neutrophil-to-Lymphocyte Ratio) and PLR (Platelet-to-Lymphocyte Ratio)) and Tumor Infiltrating Lymphocytes (TILs), at baseline and after surgery, for patients diagnosed with triple negative breast cancer",
NCT04001023,Overcoming Chemoresistance in Advanced Ovarian Cancer Via Targeting Hypoxia,NA,Epithelial Ovarian Cancer,,,
NCT00591123,Study of Erlotinib and Chemotherapy for Unresectable or Metastatic Cancer of the Esophagus and Gastric Cardia,PHASE2,Unresectable Adenocarcinoma of the Esophagus,,,
NCT04038359,A Phase 2 Study Comparing 2 Intermittent Dosing Schedules of Duvelisib in Participants With Indolent Non-Hodgkin Lymphoma,PHASE2,Indolent Non-Hodgkin Lymphoma,,,
NCT03585959,superDimension™ Navigation System Version 7.2 With Fluoroscopic Navigation Technology,NA,Lung Cancer,,,
NCT01716780,Pain: Screen and Treat,PHASE3,Head and Neck Cancer,,,
NCT07064980,ERCP Versus PTBD for Severe Acute Cholangitis Caused by Bile Duct Stones,NA,Severe Acute Cholangitis,"which emergency drainage procedure leads to faster patient recovery, specifically by evaluating the length of hospital stay, without increasing complication rates",,
NCT01372579,Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients,PHASE2,Estrogen Receptor-negative Breast Cancer,,,
NCT00808379,Concurrent Chemo-Radiotherapy Versus Radiotherapy With Boost in Locally Advanced Unresectable Rectal Cancers,PHASE2,Rectal Cancer,,,
NCT00644579,"bLAC - Treatment of Cutaneous Warts in Immune Suppressed, Kidney Transplanted Patients",PHASE2,Cutaneous Warts,"of first clinical trial with bLAC is to show proof of concept in treatment of cutaneous wart lesions on hands and/or feet after local administration of bLAC in two dose groups to immune suppressed, kidney transplanted patients",,
NCT05215496,[18F]Fluoro-PEG-folate PET/CT Imaging in Epithelial Ovarian Cancer,PHASE1,Epithelial Ovarian Cancer,"to evaluate the safety and tolerability, and pharmacokinetics of the \[18F\]fluoro-PEG-folate PET tracer and to assess the sensitivity and specificity of a \[18F\]fluoro-PEG-folate PET/CT scan for the preoperative detection of intra-abdominal metastatic lesions in patients with advanced stage epithelial ovarian cancer",the sensitivity and specificity of a \[18F\]fluoro-PEG-folate PET/CT scan for the preoperative detection of intra-abdominal metastatic lesions in patients with advanced stage epithelial ovarian cancer,"the safety and tolerability, and pharmacokinetics of the \[18F\]fluoro-PEG-folate PET tracer and to assess the sensitivity and specificity of a \[18F\]fluoro-PEG-folate PET/CT scan for the preoperative detection of intra-abdominal metastatic lesions in patients with advanced stage epithelial ovarian cancer"
NCT00006096,"Radiation Therapy With or Without Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Cancer of the Vulva",PHASE3,Vulvar Cancer,"the effectiveness of radiation therapy with or without cisplatin in treating patients who have stage I, stage II, or stage III cancer of the vulva",,
NCT01851096,Safety and Pharmacology Study of SNX-5422 in Subjects With Resistant Lung Adenocarcinoma,PHASE1,Cancer,,,
NCT01954862,"Comparison of Methods to Distend the Colon During Insertion: CO2, Air Insufflation, Water-aided Colonoscopy",NA,Pain,to test the respective peculiarities of each method,,
NCT03646162,Study of VERU-944 to Ameliorate Hot Flashes in Men With Advanced Prostate Cancer,PHASE2,Prostate Cancer Metastatic,,,
NCT02737046,Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma,PHASE2,Adult T-cell Leukemia-Lymphoma,,,
NCT04716946,Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy,PHASE2,NSCLC,,,
NCT05935579,Durvalumab and Lenvatinib With or Without Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer,PHASE2,Biliary Tract Neoplasms,,,
NCT00817479,Tumor Gene Expression in Women With Ovarian Cancer,PHASE4,Ovarian Cancer,is to compare changes in expression of glucocorticoid-induced genes that may be involved in cell survival signaling in the tumors of ovarian cancer patients before and after an intraoperative dose of 20mg dexamethasone,,
NCT01728779,Stereotactic Body Radiation With Nelfinavir for Oligometastases,PHASE2,Oligometastases,,,
NCT05700396,Breast Cancer Survivor Educational Intervention,NA,Breast Cancer,,,
NCT03498196,A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer,PHASE1,Bladder Cancer,,,
NCT02149862,FIRBladd - Use of Infrared Spectroscopy in the Diagnosis of Bladder Tumors,NA,Bladder Cancer,,,
NCT06478862,Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After Therapy,PHASE2,Cancer of Ovary,"the safety, tolerability, and efficacy of Promitil in patients with recurrent ovarian cancer and inoperable, locally advanced or metastatic pancreatic cancer, which bears deleterious germline or somatic mutations in BRCA1, BRCA2, or HRD (homologous recombination deficiency) -related genes","Promitil in patients with recurrent ovarian cancer and inoperable, locally advanced or metastatic pancreatic cancer, which bears deleterious germline or somatic mutations in BRCA1, BRCA2, or HRD (homologous recombination deficiency) -related genes",
NCT03101488,Phase I Study of KN035 in Chinese Subjects With Advanced Solid Tumors,PHASE1,Solid Tumors,and characterize the tolerability and safety profile of single agent KN035 in Chinese adult subjects with unresectable advanced carcinoma,,
NCT00910988,Healthy Volunteers Study of the Effects of Olanzapine and Ziprasidone,NA,Hyperglycemia,"To test the acute effects of olanzapine or ziprasidone administration, in comparison to placebo, on insulin sensitivity in antipsychotic-naïve healthy young men, measured as whole-body dextrose infusion rates (mg/kg/min), hepatic glucose production (glucose rate of appearance \[Ra\]), primarily muscle glucose utilization (glucose rate of disappearance \[Rd\]), and adipose tissue related free fatty acid production (glycerol rate of appearance \[Ra\])",,
NCT02590588,Idelalisib for Immunoglobulin M (IgM)-Associated Primary (AL) Amyloidosis,PHASE2,Amyloidosis,,,
NCT06941688,"Evaluating the Effectiveness of Decitabine With Gemcitabine, Oxaliplatin for Relapsed/Refractory Peripheral T-cell Lymphoma",PHASE2,Peripheral T-cell Lymphoma (PTCL),"the efficacy of a multidrug combination regimen comprising decitabine, gemcitabine, and oxaliplatin as a second-line or later treatment","a multidrug combination regimen comprising decitabine, gemcitabine, and oxaliplatin as a second-line or later treatment",
NCT00294203,Pilot Study of Epoetin Alfa for Patients Having Abdominal or Pelvic Surgery for Cancer,PHASE1,Anemia,,,
NCT06698003,A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1,PHASE2,"T-Cell Leukemia/Lymphoma, Adult",,,
NCT06083103,Contribution of PET/MRI in Locally Advanced Cervical Cancer (ATICC),,Cervical Cancer,,,
NCT00580203,"Collection Of Tissue, Blood, and Other Specimens From Patients With Head and Neck Tumors To Study the Causes, Diagnosis, Prevention and Treatment of Cancers",,Head and Neck Cancers,,,
NCT02000427,Blinatumomab in Adults With Relapsed/Refractory Philadelphia Positive B-precursor Acute Lymphoblastic Leukemia,PHASE2,Relapsed/Refractory Philadelphia Positive B-precursor ALL,is to evaluate the rate of complete remission/complete remission with partial hematological recovery (CRh\*) in adults with relapsed/refractory Philadelphia chromosome positive (Ph+) B-precursor acute lymphoblastic leukemia (ALL) who receive blinatumomab,the rate of complete remission/complete remission with partial hematological recovery (CRh\*) in adults with relapsed/refractory Philadelphia chromosome positive (Ph+) B-precursor acute lymphoblastic leukemia (ALL) who receive blinatumomab,
NCT02473861,EXercise Influence on Taxane Side Effects (EXIT) Study,NA,Breast Neoplasms,,,
NCT00928161,Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation Therapy,NA,Head and Neck Cancer,"Determine if radiation induced xerostomia (RIX) increases the frequency or duration of acid-reflux when re-measured approximately 6-12 weeks after RT (measured by # episodes, their duration, and Reflux Area Index (RAI)",if radiation induced hyposalivation is associated with more reflux events and symptoms,
NCT02541461,Body Composition After Laparoscopic Gastrectomy for Gastric Cancer,NA,Gastric Cancer,,,
NCT00063427,Study Evaluating MAC-321 in Colorectal Cancer,PHASE2,Colorectal Neoplasms,response (complete plus partial responses),,
NCT02130427,"A Volume, Motion, and Anatomically Adaptive Approach to Photon and Proton Beam Radiotherapy",NA,Biopsy Proven Non Small Cell Lung Cancer,,,
NCT02678442,Endoscopic Ultrasound Guided Fine Needle Biopsy (EUS-FNB-SC) Using a Novel Fork Needle,NA,Pancreatic Cancer,,,
NCT01742442,Cancer in the Elderly: Prevalence and Impact of Age Related Problems,,Cancer,"is to describe the frequency of age related problems in a cohort of Norwegian cancer patients \> 70 years of age, to investigate the predictive/prognostic impact of these indicators on cancer and treatment related morbidity and mortality, and to investigate the association between clinical frailty indicators, sarcopenia (severe loss of muscle mass) and inflammatory response",,
NCT02608073,A Study of Capecitabine (Xeloda) as First-Line Chemotherapy in Participants With Metastatic Nasopharyngeal Cancer,PHASE2,Nasopharyngeal Cancer,,,
NCT04282473,Peristomal Hernia Rate 5 Years After a Terminal Colostomy With the Parietex ™ TCM Parietal Prosthesis Versus Without Mesh,,Colostomy Stoma,,,
NCT05478473,Clinical Study of Chidamide Combined With Toripalimab in the Treatment of Advanced Melanoma,NA,Melanoma,the efficacy and safety of Chidamide combined with Toripalimab,,
NCT00665873,Antibiotic Therapy is Not Necessary to Implant Totally Implantable Venous Access Devices: Randomized Prospective Study,PHASE4,Infections,of this study is to evaluate the role of the antibiotic in the prevention of the infection of the surgical site and the TIVAD until 30 days after the implant,the role of the antibiotic in the prevention of the infection of the surgical site and the TIVAD until 30 days after the implant,
NCT00910273,"Effects of Etanercept on the Heart, Veins and Thickness of Certain Major Arteries In Ankylosing Spondylitis Patients",PHASE4,Ankylosing Spondylitis,"whether etanercept therapy is able to increase flow-mediated vasodilatation in AS, and whether etanercept can modify the intima-media thickness (IMT) in these patients",,
NCT05975073,A Phase 1/2 Study of AMG 193 in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid Tumors,PHASE1,MTAP-null Non-Small-Cell Lung Cancer,"of this study are to evaluate the safety and tolerability, and to determine the maximum tolerated dose (MTD) or the recommended combination dose of AMG 193 in combination with IDE397 in adult participants with metastatic or locally advanced MTAP-null solid tumors, and to evaluate the preliminary anti-tumor activity of AMG 193 in combination with IDE397 in adult participants with metastatic or locally advanced MTAP-null Non-Small-Cell Lung Cancer (NSCLC)","the safety and tolerability, and to determine the maximum tolerated dose (MTD) or the recommended combination dose of AMG 193 in combination with IDE397 in adult participants with metastatic or locally advanced MTAP-null solid tumors, and to evaluate the preliminary anti-tumor activity of AMG 193 in combination with IDE397 in adult participants with metastatic or locally advanced MTAP-null Non-Small-Cell Lung Cancer (NSCLC)","the maximum tolerated dose (MTD) or the recommended combination dose of AMG 193 in combination with IDE397 in adult participants with metastatic or locally advanced MTAP-null solid tumors, and to evaluate the preliminary anti-tumor activity of AMG 193 in combination with IDE397 in adult participants with metastatic or locally advanced MTAP-null Non-Small-Cell Lung Cancer (NSCLC)"
NCT00216073,"Capecitabine, Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast Cancer",PHASE2,Metastatic Breast Cancer,response rates ranging from 27-34% in two studies of patients with prior chemotherapy,trastuzumab combined with chemotherapy in patients with HER2 overexpressing metastatic breast cancer,
NCT06881173,The Effectiveness of Bu Zhong Yi Qi Tang in Patients with Myasthenia Gravis,NA,Myasthenia Gravis,,,
NCT06829173,Concurrent XRD-0394 With Radiation Therapy for High Grade Gliomas,EARLY_PHASE1,High-Grade Glioma,,,
NCT06479473,Radiotherapy to All Residual Lesions After Chemoimmunotherapy,PHASE1,Extensive-stage Small Cell Lung Cancer,,,
NCT02938273,Bioimmunoradiotherapy (Cetuximab/RT/Avelumab),PHASE1,"Carcinoma, Squamous Cell of Head and Neck",,,
NCT06562673,Intra-arterial Cisplatin Plus Rh-endostatin Combined With Systematic Chemotherapy in Osteosarcoma,PHASE1,Osteosarcoma,,,
NCT04524273,Myasthenia Gravis Inebilizumab Trial,PHASE3,Myasthenia Gravis,,,
NCT04632173,Head and Neck cancERs International cOviD-19 collabOraTion,,Head and Neck Cancer,,,
NCT06528769,Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma,PHASE2,Leiomyosarcoma,all-trans retinoic acid (ATRA) and Cemiplimab in patients with metastatic/locally advanced - unresectable leiomyosarcoma (LMS) who have progressed standard-of-care therapy,,
NCT03336983,Luteinizing Hormone-releasing Hormone Analogue and Enzalutamide +/- Zoledronic Acid in Prostate Cancer Patients,PHASE2,Prostate Cancer,bone response in metastatic prostate cancer patients treated with Enzalutamide with or without Zoledronic Acid in combination with luteinizing hormone-releasing hormone (LHRH) analogue with the use of Whole Boby (WB) DW-MRI,,
NCT05268783,Patient-reported Outcomes in Neuroendocrine Neoplasms: a Prospective Quality of Life and Quality of Care Study Within NETwerk,NA,Quality of Life,of this study is to map the quality of life of NET patients within NETwerk in order to optimize the quality of care,,
NCT03755141,Efficacy and Safety of Trastuzumab Biosimilar (Herzuma®) Plus Treatment of Physician's Choice (TPC) in Patients With HER-2 Positive Metastatic Breast Cancer,PHASE2,HER2-positive Breast Cancer,their second use beyond progression with other chemotherapeutic agents has not been tested yet,,
NCT05003141,"PSB202 in Patients With Previously Treated-, Relapsed-, Indolent B-Cell Malignancies",PHASE1,Follicular Lymphoma,,,
NCT00444041,Pre- and Postoperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal Cancer,PHASE1,Metastatic Colorectal Cancer,in this trial,"RFS and OS, the trial will last for approx",
NCT01407341,Beta-Tricalcium Phosphate Bone Graft in Treating Patients Undergoing Surgery For Metastatic Spine Cancer,PHASE1,Adult Spinal Cord Neoplasm,,,
NCT02997241,Colon Cancer Treatment Decisions and Recurrence Predicting,NA,Colonic Neoplasms,the relationship between change of gene copies and recurrence，and the overall survival at 5 years after chemotherapy based on clinical prognosis compared to Oncocare detection prognosis,,
NCT00068341,Docetaxel and Carboplatin With or Without Trastuzumab Before Surgery in Treating Women With Locally Advanced Breast Cancer,PHASE2,Breast Cancer,,,
NCT07171554,Evaluation of a Diagnostic Test to Identify the Best Drugs for Treatment of Metastatic Colorectal Cancer,NA,Metastatic Colorectal Cancer (mCRC),,,
NCT05629494,Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test,PHASE4,Prostate Cancer,,,
NCT06377566,A Study of BV-AVD in People With Bulky Hodgkin Lymphoma,PHASE2,Hodgkin Lymphoma,,,
NCT01134666,An Observational Study to Evaluate the Safety and Efficacy of FOLFIRI / FOLFOX Plus Cetuximab as First-line Therapy in Patients With KRAS Wild-type Metastatic Colorectal Cancer,,Colorectal Neoplasms,,,
NCT06367556,Emotion and Symptom-Focused Engagement (EASE) for Caregivers,NA,Trauma and Stressor Related Disorders,"analysis, area under the curve will be calculated for each participant",the effectiveness of a novel psychotherapeutic intervention called Emotion and Symptom-focused Engagement (EASE) in parents caring for a child or adolescent with cancer,
NCT06666582,Real-world Data of Paclitaxel and Ramucirumab Compared to Other Treatment Regimens in Advanced Gastric Cancer,,Gastric Cancer Stage IV,was to evaluate whether second-line treatment with paclitaxel and ramucirumab was associated with improved clinical outcomes compared to other available therapies,whether second-line treatment with paclitaxel and ramucirumab was associated with improved clinical outcomes compared to other available therapies,"therapeutic combinations, administered to patients with pretreated advanced gastric cancer in the Oncology Departments affiliated with the Hellenic Cooperative Oncology Group (HeCOG)"
NCT00787982,Magnetic Resonance Imaging-Guided Laser Induced Thermal Therapy for Treatment of Metastatic Brain Tumors,PHASE1,Brain Neoplasms,,,
NCT04797182,Avatrombopag for the Primary Prevention of Thrombocytopenia Induced by Cytarabine-based Chemotherapy in Patients With Lymphoma,PHASE2,Thrombocytopenia,,,
NCT05663723,Photobiomodulation for Prevention of Chemotherapy-induced Peripheral Neuropathy in Women With Breast Cancer,NA,Peripheral Nervous System Diseases AND Breast Neoplasms,of the study: To evaluate the effectiveness of photobiomodulation using the LED board in the prevention of peripheral neuropathy in the lower limbs in women with breast cancer undergoing chemotherapy at the Cancer Hospital III of the National Cancer Institute (HCIII/INCA),the effectiveness of photobiomodulation using the LED board in the prevention of peripheral neuropathy in the lower limbs in women with breast cancer undergoing chemotherapy at the Cancer Hospital III of the National Cancer Institute (HCIII/INCA),
NCT00097123,RCT of Misoprostol for Postpartum Hemorrhage in India,NA,Postpartum Hemorrhage,,,
NCT06008223,Clinical Analysis of Vitamin B6 in Sepsis,NA,Sepsis,,,
NCT04102423,CHIP/CCUS Natural History Protocol,,Clonal Hematopoiesis of Indeterminate Potential,"To examine the natural history of people in a study of CHIP and CCUS to (1) verify the association of myeloid somatic mutations with atherosclerosis and blood cancers, and (2) find new potential clinical associations",,
NCT06978023,Novel Chinese Medicine Formula for Diabetes,PHASE2,Type 2 Diabetes,,,
NCT01026623,Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer,PHASE1,Hormone-Resistant Prostate Cancer,,,
NCT03787823,RCT-evaluation of Retzius-sparing Robotic Prostatectomy,NA,Prostate Cancer,,,
NCT04124159,Risk of Recurrent Venous Thromboembolism After Provoked Venous Thromboembolism,,Recurrent Venous Thrombosis,,,
NCT03394859,Electronic Medical Records and Genomics (eMERGE) Phase III,,Cardiac Disease,,,
NCT03401359,The Resistance and Immune Response to Palbociclib in Breast Cancer,NA,Breast Cancer Stage IV,,,
NCT05082259,ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab,PHASE1,Advanced Cancer,"the best strategy to pursue in future later stage tumour specific trials of IAP antagonists in combination with immunotherapy, and to ensure appropriate molecular stratification biomarkers for the greatest benefit to patients",,
NCT03440879,Androgen Deprivation Therapy Muscle Protein Metabolism and Blood Glucose,NA,Prostate Cancer,"to investigate the influence of ADT on the basal muscle protein turnover, as well as the responses to strength training",,
NCT03027479,Skeletal Muscle Energy Metabolism in Women With Weight Loss and Ovarian and/or Endometrial Cancer With Weight Loss,NA,Weight Loss,is to study skeletal muscle metabolism alterations métaboliques associated with weight loss in women with ovarian and/or endometrial cancer according to BMI,,
NCT04075162,Community Benefit of No-charge Calcium Score Screening Program,,Cardiovascular Risk Factor,,,
NCT06097962,Safety and Efficacy of NK510 to Treat NSCLC,EARLY_PHASE1,NSCLC,NK510 in the treatment of relapsed and refractory advanced NSCLC,,
NCT06834646,Comparison of 30-day Morbidity and Mortality in Cancer Patients Based on Emergency Department Location,,Cancer,of the COVER study is to investigate the impact of the location of the emergency department where the patient is seen for their prognosis,,
NCT00276146,Dipyridamole/Magnesium To Improve Sickle Cell Hydration,PHASE2,"Anemia, Sickle Cell",the benefits as well as side effects of giving drugs called dipyridamole and magnesium to patients with sickle cell anemia (SCA),,
NCT00576446,Surgical Resection With Gliadel Wafer Followed by Dendritic Cells Vaccination for Malignant Glioma Patients,PHASE1,Malignant Glioma,"whether after standard therapy of tumor resection surgery, along with placement of Gliadel wafers at time of surgery followed by dendritic cell vaccines will not only generate (start) an immune response, but will provide longer progression free survival",,
NCT03478488,Programmed Death Ligand (PD-L1) Combined With Chemotherapy for Patients With BTC,PHASE3,Biliary Tract Neoplasms,the efficacy and safety of KN035 compared to standard of care (SOC) Gemcitabine-based chemotherapies in the treatment of participants with previously untreated locally advanced or metastatic biliary tract cancer,,
NCT06015503,A Phase Ⅱ Study Assessing the Safety and Efficacy of PLB1004 in EGFR ex20ins Mutation Patients With Advanced and Metastatic Non-small Cell Lung Cancer(NSCLC),PHASE2,Non-Small-Cell Lung Cancer,PLB1004 in EGFR ex20ins mutation patients with Advanced and Metastatic Non-small Cell Lung Cancer(NSCLC),,
NCT01336803,Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI,PHASE2,Bone Cancer,,,
NCT02356627,"The Cancer Home Life Intervention Study. A Randomised, Controlled Multicentre Trial and a Health Economic Evaluation",NA,Activities of Daily Living,,,
NCT06852261,Early vs. Late Referral for Scapular Exercises in Shoulder Function After Neck Dissection,NA,Rehabilitation,to investigate the effects of comparing early versus late referrals for scapular-focused exercise on shoulder function in head and neck cancer patients following neck dissection,,
NCT06384261,A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive Therapy,PHASE2,"Leukemia, Myeloid, Acute",to answer is does cusatuzumab added to venetoclax and azacitidine prolong the length of time participants live compared to venetoclax and azacitidine?,,
NCT07101861,"Breast Cancer Survivors RESET (Reducing Weight and Elevated Stress Levels Using Educational and Behavioral Tools): A Pilot, Feasibility Study",NA,Breast Cancer,,,
NCT03257761,"Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer",PHASE1,"Extrahepatic Bile Duct Adenocarcinoma, Biliary Type",,,
NCT06009627,Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients,PHASE2,Breast Cancer,response rate (ORR) of treatment,the effectiveness and safety of Darxil combined with Exemestane+goserelin neoadjuvant endocrine therapy in HR positive and HER2 negative premenopausal breast cancer patients,
NCT05515627,Atezolizumab for Idiopathic Pulmonary Fibrosis,PHASE1,Idiopathic Pulmonary Fibrosis,"the safety and preliminary efficacy of atezolizumab, an immune checkpoint inhibitor approved for the treatment of various cancers, in patients with idiopathic pulmonary fibrosis (IPF)","atezolizumab, an immune checkpoint inhibitor approved for the treatment of various cancers, in patients with idiopathic pulmonary fibrosis (IPF)",
NCT01768442,MRI for Eval Tumor & Node Response & Normal Tissue Function to Concurrent Chemo & Radiation Therapy in H&N Cancer (GCC1043),,Head and Neck Cancer,"whether advanced MR imaging techniques can be used to determine tumor and node response (i) four weeks following initiation of concurrent chemoRT and (ii) after completion of chemoRT in head and neck cancer, and to assess whether advanced MR imaging techniques can be used to predict early at-risk organ function (salivary gland and mucosal injury) as measured by salivary flow and oral mucositis to chemoradiation therapy (i) four weeks following initiation of concurrent chemoRT and (ii) after completion of chemoRT in head and neck cancer","tumor and node response (i) four weeks following initiation of concurrent chemoRT and (ii) after completion of chemoRT in head and neck cancer, and to assess whether advanced MR imaging techniques can be used to predict early at-risk organ function (salivary gland and mucosal injury) as measured by salivary flow and oral mucositis to chemoradiation therapy (i) four weeks following initiation of concurrent chemoRT and (ii) after completion of chemoRT in head and neck cancer",
NCT02184442,The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves - PII B,NA,Severe,the safety and effectiveness of the SAPIEN XT™ THV with the associated delivery system for inoperable patients with severe symptomatic native aortic stenosis,,
NCT00459342,"Dasatinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer",PHASE2,Non-small Cell Lung Cancer,,,
NCT01236586,"RO4929097 in Children With Relapsed/Refractory Solid or CNS Tumors, Lymphoma, or T-Cell Leukemia",PHASE1,Lymphoma,\- To determine the safety and effectiveness of RO4929097 as a treatment for children and adolescents who have been diagnosed with certain kinds of cancer that have not responded to standard treatment,the state of their disease,the safety and effectiveness of RO4929097 as a treatment for children and adolescents who have been diagnosed with certain kinds of cancer that have not responded to standard treatment
NCT04828486,"Futibatinib and Pembrolizumab for Treatment of Advanced or Metastatic FGF19 Positive BCLC Stage A, B, or C Liver Cancer",PHASE2,Advanced Hepatocellular Carcinoma,,,
NCT06231186,a Feasibility Study of iHD-SRT for BM,NA,"Brain Metastases, Adult",,,
NCT04750473,Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer,PHASE1,Anatomic Stage IV Breast Cancer AJCC v8,,,
NCT05001373,A Phase 1 Study to Evaluate the Safety and Immunogenicity of eOD-GT8 60mer mRNA Vaccine (mRNA-1644) and Core-g28v2 60mer mRNA Vaccine (mRNA-1644v2-Core),PHASE1,Hiv,the Safety and Immunogenicity of eOD-GT8 60mer mRNA Vaccine (mRNA-1644) and Core-g28v2 60mer mRNA Vaccine (mRNA-1644v2-Core) in HIV-1 Uninfected Adults in Good General Health,,
NCT01720173,"Dalantercept in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer",PHASE2,Recurrent Fallopian Tube Carcinoma,,,
NCT02827773,Improving Medication Adherence: A Study With Talking Pill Bottles,NA,Medication Adherence,,,
NCT06415773,Effects of Berberine Ursodeoxycholate (HTD1801) Versus Dapagliflozin in Patients with Type 2 Diabetes Inadequately Controlled with Metformin,PHASE3,T2DM (Type 2 Diabetes Mellitus),the efficacy and safety of berberine ursodeoxycholate (HTD1801) compared to dapagliflozin in patients with type 2 diabetes inadequately controlled with metformin alone,,
NCT00449670,Assess Consistency of Immunogenicity of GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1562902A) in Adults,PHASE3,Influenza,the lot-to-lot consistency of the immunogenicity of a GlaxoSmithKline Biologicals' pandemic influenza candidate vaccine (GSK1562902A) in adults aged between 18 and 60 years,,
NCT06528483,Bladder Preservation With Sacituzumab Govitecan + Zimberelimab for Muscle-Invasive Bladder Cancer,PHASE2,Bladder Cancer,"of this trial is Event Free Survival that is defined as clinical evidence of new or progressing nodal or any distant metastatic disease, radical cystectomy, or death due to any cause from date of inclusion to the first documentation of a EFS event",,
NCT07144683,Anastomotic Leakage After Colorectal Surgery.,,Anastomotic Leak,"to identify and quantify independent risk factors for AL, determine its incidence and impact on outcomes, and develop a predictive model",,
NCT04831983,ABlative Radiotherapy (for) Unfavorable Prostate Tumors,,Prostate Cancer,,,
NCT02182141,An Dose Escalation Study of BIBF 1120 Administered in Patients With Relapsed or Refractory Multiple Myeloma,PHASE1,Multiple Myeloma,"BIBF 1120, pharmacodynamics",,
NCT00057941,Anastrozole and ZD1839 Compared With Fulvestrant and ZD1839 in Postmenopausal Women w/ Metastatic Breast Cancer,PHASE2,Estrogen Receptor-positive Breast Cancer,,,
NCT05764941,Inetetamab Combined With Pyrotinib and Vinorelbine as First-line to Third-line Treatment for HER2-positive Metastatic Breast Cancer,,Breast Neoplasms,the efficacy and safety of inetetamb combined with pyrotinib and vinorelbine as first-line to third-line treatment after trastuzumab progression in HER2-positive metastatic breast cancer,,
NCT02137954,"Efficacy of Lidocaine Versus Placebo in Palliative Care Patients With Opioid-refractory Cancer Pain With Neuropathic Component: a Multicenter, Prospective, Double-blind Randomized Placebo-controlled Study.",PHASE3,Cancer,,,
NCT05524454,Evaluation of a Cone-beam CT Scanner for Image Guided Radiotherapy,NA,Head and Neck Cancer,,,
NCT05298605,Faith in Action! A Church-Based Navigation Model to Increase Breast Cancer Screening in Korean Women,NA,Breast Cancer Female,the intervention,,
NCT03650205,Ivabradine to Prevent Anthracycline-induced Cardiotoxicity,NA,Neoplasms,of this study is to evaluate whether ivabradine might prevent anthracycline-induced cardiotoxicity,whether ivabradine might prevent anthracycline-induced cardiotoxicity,
NCT05654805,"Nutraceutical Improvement of Glucose Metabolism, NAFLD and Insulin Resistance by Oat-fiber Supplementation in Type 2 Diabetes Mellitus Patients",NA,Type 2 Diabetes,"the effectiveness of insoluble, poorly fermentable cereal fiber in a shorter Intervention period in patients with high responsiveness (insulin-naïve overt type 2 diabetes mellitus with insulin resistance and NAFLD), using a fiber drinking supplement",,
NCT00271505,Avastin/Docetaxel/Carboplatin in Non-Small Cell Lung Cancer,PHASE2,Non-Small Cell Lung Cancer,the effectiveness of Avastin® in combination with docetaxel and carboplatin in the treatment of lung cancer,,
NCT04696705,Allogeneic γδ T Cells Immunotherapy in r/r Non-Hodgkin's Lymphoma (NHL) or Peripheral T Cell Lymphomas (PTCL) Patients,EARLY_PHASE1,Non-Hodgkin's Lymphoma (NHL),"to evaluate the safety, tolerability and efficacy of ex-vivo expanded allogeneic γδT cells obtained from a blood-related donor of patients with relapsed or refractory B cell non-Hodgkin's lymphoma (B-NHL) or peripheral T cell lymphoma (PTCL) expect for γδT lymphoma","the safety, tolerability and efficacy of ex-vivo expanded allogeneic γδT cells obtained from a blood-related donor of patients with relapsed or refractory B cell non-Hodgkin's lymphoma (B-NHL) or peripheral T cell lymphoma (PTCL) expect for γδT lymphoma",ex-vivo expanded allogeneic γδT cells obtained from a blood-related donor of patients with relapsed or refractory B cell non-Hodgkin's lymphoma (B-NHL) or peripheral T cell lymphoma (PTCL) expect for γδT lymphoma
NCT04171505,Retrospective Cohort Study of the Effectiveness of the Prophylactic Vaccine Against the Human Papilloma Virus in the Prevention of Recurrence in Women Who Have Received an Excisional Therapy by HSIL / CIN.,,"Cervix, Dysplasia",,,
NCT03355794,A Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG),PHASE1,Diffuse Intrinsic Pontine Glioma,,,
NCT02934256,Icotinib Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors,PHASE2,Vestibular Schwannoma,basis for an enlarged randomized double-blind trial,,
NCT04262466,Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors,PHASE1,Select Advanced Solid Tumors,the safety and efficacy of brenetafusp in adult participants who have the appropriate HLA-A2 tissue marker and whose cancer is positive for PRAME,brenetafusp in adult participants who have the appropriate HLA-A2 tissue marker and whose cancer is positive for PRAME,
NCT02144766,Prevention of Myocardial Dysfunction and Injury Resulting From Salter Innominate Osteotomy by Caudal Block,PHASE4,Cardiac Dysfunction,,,
NCT04893356,Impact of O6-methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation and MGMT Expression on Dacarbazine Treated Sarcoma Patients (MGMT),,Sarcoma,of this study is to investigate whether MGMT expression or MGMT promoter methylation may represent a predictive marker for dacarbazine sensitivity in sarcoma patients,,
NCT06227156,"Disitamab Vedotin in the Treatment With HER2- Expression, Subjects With Locally Advanced or Metastatic Castration-resistant Prostate Cancer",PHASE2,Castration-resistant Prostate Cancer,the effectiveness of Disitamab Vedotin in the treatment of subjects with locally advanced or metastatic castration-resistant prostate cancer,,
NCT01058122,"Collection, Evaluation and Assessment of Adverse Drug Reactions on the Oncology Ward",,Adverse Drug Reactions,"of this study are to determine the frequency of ADE, the comparison of the quality of data sources and collection methods for the detection of ADE in regard to patient characteristics, size, number of medications, the category of ADE, severity, causation, diagnosis, hospitalization, cause of hospitalization and medication cause","the frequency of ADE, the comparison of the quality of data sources and collection methods for the detection of ADE in regard to patient characteristics, size, number of medications, the category of ADE, severity, causation, diagnosis, hospitalization, cause of hospitalization and medication cause",
NCT01991522,A Randomized Control Trial of a Simulation-based Curriculum to Enhance Skills in Colonoscopy,NA,Colorectal Cancer,to test a curriculum in simulation-based colonoscopy with self-directed learning on simulators,,
NCT03668522,Clinical Research of H3F3AK27M in Spinal Glioma and Its Impact on TMZ Chemoradiotherapy,,Spinal Tumor,,,
NCT07076251,"Building Access to Food Through Systems and Solidarity (BASIS): A Subsidized and Culturally-adapted Produce Box Program for Immigrant Communities of Brooklyn, NY",NA,Cardiometabolic Disease,to leverage this program to address cardiometabolic disease disparities in a culturally meaningful way,,
NCT01000051,Eltrombopag for Post Transplant Thrombocytopenia,PHASE2,Thrombocytopenia,,,
NCT02076529,Phamacokinetic and Pharmacodynamic Study of Ramosetron in Chemotherapy Induced Nasea and Vomiting,NA,Colon Cancer,,,
NCT04754529,Yoga Intervention for the Improvement of Cancer-Related Stress in Cancer Survivors,NA,Hematopoietic and Lymphoid Cell Neoplasm,,,
NCT06584929,Rural Smoking Cessation,NA,Smoking Cessation,,,
NCT00141531,Phase II Trial of EOquin in High-risk Superficial Bladder Cancer,PHASE2,Bladder Neoplasms,,,
NCT01210131,Hypoxia-guided Radiotherapy With Cisplatin-etoposide in Stage I-III : Small Cell Lung Cancer(SCLC),NA,Small Cell Lung Cancer (SCLC),,,
NCT04212702,ESR1 Mutations in Asian ER+ Metastatic Breast Cancer on Hormonal Therapy-based Treatments,,Metastatic Breast Cancer,,,
NCT02719574,Open-label Study of FT-2102 With or Without Azacitidine or Cytarabine in Patients With AML or MDS With an IDH1 Mutation,PHASE1,Acute Myeloid Leukemia,,,
NCT02181218,"Phase I Study of Romidepsin, Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed/Refractory Aggressive Lymphomas",PHASE1,"Lymphoma, T-Cell, Cutaneous",,,
NCT05681390,Tislelizumab With Anlotinib and Chemotherapy for Second-line Treatment of Pancreatic Cancer,PHASE2,Pancreatic Neoplasms,,,
NCT00027690,Gefitinib in Treating Patients With Persistent or Recurrent Endometrial Cancer,PHASE2,Recurrent Uterine Corpus Carcinoma,,,
NCT02080897,Evaluating Quality of Life in Patients With Soft Tissue Sarcoma Presenting With Metastatic Lung Disease,,Soft Tissue Sarcoma,the role of palliative surgery in improving Quality of Life (QoL) and symptom control for patients who present with a Soft Tissue Sarcoma (STS) and metastatic lung disease,,
NCT04550910,RCT Comparing 2 Radiotherapy HypoFractionation Schedules In Breast Cancer Patients,NA,Radiotherapy Side Effect,"efficiency of two post mastectomy hypofractionation schedules (40 Gy /15 fx / 3 weeks, 5 days per week VS 28",,
NCT03608410,Intensified Follow-up of Lung Cancer Using Weekly Questionnaires Via the Internet,NA,Lung Cancer,,,
NCT07197060,Hypofractionated Radiotherapy With 3.5 Gy Per Fraction for Early Glottic Cancer,,Early Glottic Cancer,,,
NCT06389760,Nimotuzumab Combined With mFOLFIRINOX/GX as Postoperative Adjuvant Therapy in Pancreatic Cancer,PHASE2,Pancreatic Cancer,the efficacy and safety of Nimotuzumab combined with mFOLFIRINOX/GX for postoperative adjuvant treatment of pancreatic cancer,,
NCT03732482,Temozolomide Combine With Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Non Small Cell Lung Cancer Brain Metastases,PHASE2,Non Small Cell Lung Cancer Metastatic,"response(OR) and prolong the Progress Free Survival(PFS),while with tolerable therapeutic toxicity",,
NCT07199582,Association Between Obesity and Gastroesophageal Reflux Disease,,Gastro Esophageal Reflux,,,
NCT05880082,PPIO-004 Clinical Application of Efficacy Prediction Model Based on Epigenomics Sequencing Technology in Neoadjuvant Immunotherapy for Esophageal Cancer,PHASE2,Esophageal Squamous Cell Carcinoma,"to answer are: Objective response rate, Major pathological response rate",,
NCT04455282,CIRCULATing Biomarkers for Individualized Surgical Therapy in gastroEsophageal Cancer - Phase 1,,Cancer of Esophagus,"), prognostic value, relevance of a set of two additional blood-based biomarkers analyzed from a single blood sampling tube (secondary endpoints)",,
NCT01402024,Study to Evaluate Anti-emetic Effect of Aprepitant Versus Placebo in Children and Adolescent Receiving Chemotherapy,PHASE3,Chemotherapy Induced Nausea and Vomiting,,,
NCT04064424,Cancer Prevention & Online Technologies,NA,Skin Cancer,,,
NCT07213024,Social and Physical Activity as Rehabilitation for Preschool Kids With Cancer,NA,Pediatric Cancer,"), as well as parents' attitudes towards physical activity and the children's general physical function (secondary outcomes)",,
NCT00025324,"Chemotherapy, Surgery, Radiation Therapy and Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Primary CNS Germ Cell Tumors",PHASE2,Brain and Central Nervous System Tumors,,,
NCT01118624,Study of Pralatrexate in Female Patients With Previously-treated Breast Cancer,PHASE2,Breast Cancer,the efficacy (ability to provide a beneficial treatment of the disease) of pralatrexate for the treatment of female patients with advanced or metastatic breast cancer who have failed prior chemotherapy,,
NCT03281824,"Clinical Study of ALT-P7 to Determine Safety, Tolerability and Pharmacokinetics in Breast Cancer Patients",PHASE1,HER2-positive Breast Cancer,,,
NCT07075523,Neuroimaging and Biomarkers of Neurotoxicity After Chimeric Antigen Receptor T-Cell Therapy,,CAR T-Cell Therapy,biomarkers in blood (liquid biomarkers) will be performed to provide a comprehensive characterization of neurotoxicity following chimeric antigen receptor T-cell therapy,,
NCT02784223,Diagnostic Value of 18F-Choline PET/CT in Patients With a Thyroid Nodule With an Indeterminate Cytology: Pilot Study,NA,Thyroid Gland,,,
NCT07076823,Safety and Efficacy of Canagliflozin in Patients With Metastatic High Microsatellite Instability (MSI-H) Colorectal Cancer,PHASE1,Colorectal Cancer,"canagliflozin-tislelizumab combination in metastatic MSI-H CRC, evaluating its impact on PFS, OS, and ORR while dissecting tumor microenvironment modulation mechanisms, thereby pioneering a novel metabolic-immunotherapy paradigm that could redefine treatment paradigms through dual metabolic-immune regulation",,
NCT00233623,"Irinotecan, 5-Fluorouracil and Leucovorin With or Without Iressa in the Treatment of Metastatic Colorectal Cancer",PHASE2,Metastatic Colorectal Cancer,"of the study is to determine if Iressa added to chemotherapy with Irinotecan, 5Fluorouracil and Leucovorin can prolong the period of time without any disease worsening (Time to Progression) in patients with metastatic colorectal cancer","if Iressa added to chemotherapy with Irinotecan, 5Fluorouracil and Leucovorin can prolong the period of time without any disease worsening (Time to Progression) in patients with metastatic colorectal cancer",
NCT00953459,Sunitinib Malate in Treating Patients With Small Cell Lung Cancer,PHASE2,Lung Cancer,,,
NCT02507479,Thiotepa-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies,PHASE2,Non Hodgkin Lymphoma,,,
NCT04614779,Long-term Clinical Study of CN128 in Thalassemia Patients,PHASE2,Thalassemia,• To evaluate the safety and efficacy of long-term orally administration of CN128 in thalassaemia patients with blood transfusion dependent and aged 16 and above,the safety and efficacy of long-term orally administration of CN128 in thalassaemia patients with blood transfusion dependent and aged 16 and above,long-term orally administration of CN128 in thalassaemia patients with blood transfusion dependent and aged 16 and above
NCT03754179,Dabrafenib/Trametinib/Hydroxychloroquine for Advanced Pretreated BRAF V600 Mutant Melanoma,PHASE1,Melanoma,,,
NCT00092196,Study of MK0869 for the Prevention of Chemotherapy-Induced Nausea and Vomiting (0869-071)(COMPLETED),PHASE3,Nausea,the efficacy and tolerability of an investigational drug for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy,,
NCT06026696,Cohort of Neurovascular Diseases Treated in the Acute Phase and Followed at Lariboisière,,Ischemic Stroke,,,
NCT07180862,A Study Evaluating BAT3306 Compared With Keytruda® in NSCLC Cancer Participants,PHASE1,"Carcinoma, Non-Small-Cell Lung",,,
NCT00851162,Using Mesenchymal Stem Cells to Fill Bone Void Defects in Patients With Benign Bone Lesions,PHASE2,Bone Neoplasms,whether using mesenchymal stem cells will heal benign bone lesion defects faster than demineralized bone matrix,,
NCT00458562,Identifying Genes That Predict Risk of Developing Cervical Intraepithelial Neoplasia or Invasive Cervical Cancer,,Cervical Cancer,,,
NCT04779788,I-125 Seeds Loaded Stent Insertion for Inoperable Hilar Cholangiocarcinoma,NA,Hilar Cholangiocarcinoma,I-125 seeds loaded stent insertion for hilar cholangiocarcinoma patients,,
NCT00071188,ZD6474 Alone or in Combination With Paclitaxel and Carboplatin in Subjects With Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC),PHASE2,"Carcinoma, Non-Small-Cell Lung",the appropriate and tolerable dose of ZD6474 (200mg or 300mg) to be administered in combination with paclitaxel and carboplatin in subjects with previously untreated locally advanced or metastatic NSCLC,ZD6474 alone versus that of ZD6474 in combination with paclitaxel and carboplatin versus that of paclitaxel and carboplatin alone in subjects with previously untreated locally advanced or metastatic NSCLC,
NCT02101788,Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer,PHASE2,Borderline Ovarian Serous Tumor,,,
NCT04397003,Personalized Neoantigen Vaccine in Combination With Durvalumab (MEDI4736) in Extensive Stage Small Cell Lung Cancer,PHASE2,Extensive-stage Small Cell Lung Cancer,,,
NCT03565003,A First-in-Human Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors in China,PHASE1,Non-small Cell Lung Cancer,,,
NCT02852161,The Accuracy and Acceptability of Magnet Assisted Capsule Endoscopy in the Diagnosis of Esophageal Pathology: a Pilot Study,NA,Barrett's Oesophagus,the accuracy and acceptability of a magnet assisted capsule endoscopy in detecting esophageal pathology compared to standard endoscopy,,
NCT05273827,Effect of Neoadjuvant Anti-PD-1 Immunotherapy on Perioperative Analgesia and Postoperative Delirium,,Immunotherapy,,,
NCT05777642,Oxygen Nanobubble Drink Impact on Exercise in Elite Athletes,NA,Healthy,the nanobubbles on the exercising ability of the participant,,
NCT00729742,Phase I Imaging Study Evaluating Dalotuzumab (MK0646) in Combination With Erlotinib for Patients With Non-Small Cell Lung Cancer (MK-0646-008),PHASE1,"Carcinoma, Non-small Cell Lung",,,
NCT05921942,The Impact of Metformin Administration on the Clinical Outcome of Stage IV Colon Cancer,PHASE3,Colorectal Cancer,,,
NCT00075686,S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer,PHASE3,Pancreatic Cancer,,,
NCT01048086,90Y DOTA/Retinoic Acid for Neuroblastoma and Neuroendocrine Tumor (NET),PHASE2,Neuroblastoma,the safety and effectiveness of the combination of retinoic acid and Onalta (Y-90-DOTA-tyr3-Octreotide) in treating neuroblastoma and neuroendocrine tumors,,
NCT01172470,Phase II Trial of Pemetrexed-Based Induction Chemotherapy Followed by Concomitant Chemoradiotherapy in Previously Irradiated Head and Neck Cancer Patients,PHASE2,Head and Neck Cancer,"1-year survival of previously irradiated Head and Neck cancer (HNC) patients with loco-regional recurrent disease treated with induction chemotherapy with pemetrexed and gemcitabine followed concomitant pemetrexed, carboplatin and daily radiotherapy",,
NCT00836173,"Rituximab, Ifosfamide, Carboplatin, and Etoposide (RICE) Followed by Gallium Nitrate, Rituximab and Dexamethasone (GARD) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma",PHASE2,Diffuse Large B-cell Lymphoma,,,
NCT00342173,Costa Rican Natural History Study of HPV and Cervical Neoplasia,,Cervical Neoplasia,,,
NCT00001073,Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical Tumors,PHASE3,HIV Infections,,,
NCT00880269,Efficacy and Safety of Panobinostat (LBH589) in Patients With Refractory de Novo or Secondary Acute Myelogenous Leukemia (AML),PHASE2,Refractory Leukemia,the efficacy and safety of single agent oral panobinostat in patients who have refractory de novo or refractory secondary AML,,
NCT06617169,Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors,PHASE1,"Solid Tumor, Adult","ly determine dose increase, no dose change, or dose decrease for each group of two patients",,
NCT00303069,V710 First-In-Man (FIM) Study (V710-001),PHASE1,Staphylococcal Infections,"the vaccine safety at increasing dose levels of the 0657nI protein in Panel A, before expanding the enrollment to the remaining 84 subjects in Panel B",,
NCT04854369,68Ga-PSMA-11 Patients With Newly Diagnosed and Recurrent Prostate Cancer (Firefly),,Prostatic Neoplasms,,,
NCT04557969,"Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis",,Gastric Cancer,To follow people with GISTs and collect tumor tissue so that it can be studied in the lab,,
NCT02015169,Phase II Study of Neoadjuvant XELOX + Lapatinib in HER2(+) Gastric Cancer Patients With Liver Metastasis,PHASE2,HER2-positive Gastric Cancer Patients With Liver Metastasis,,,
NCT03712969,Shenlingcao Oral Liquid for Patients With Stage II or IIIA NSCLC,PHASE4,"Carcinoma, Non-Small-Cell Lung",,,
NCT00191269,Gemcitabine Monotherapy for Metastatic Breast Cancer After Anthracycline and Taxane Regimen,PHASE2,Metastatic Breast Cancer,,,
NCT02734069,Impact of Fat-free Mass in the Carboplatin Calculated Dose and Chemotherapeutic Toxicity in Patients With Advanced NSCLC,,Lung Cancer,,,
NCT03514069,Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma,PHASE1,Glioma,,,
NCT00462969,Cytologic Analysis of Distention Media as a Screening Test for Endometrial Cancer,NA,Endometrial Cancer,,,
NCT05804669,A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome,PHASE1,Cushing Syndrome,"safety, tolerability, pharmacokinetics (PK), and pharmacodynamic biomarker responses associated with CRN04894 (an adrenocorticotropic hormone \[ACTH\] receptor antagonist) in participants with ACTH-dependent Cushing's syndrome (Cushing's disease or Ectopic ACTH Syndrome \[EAS\])",,
NCT06362369,A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy,PHASE1,Advanced Cancer,,,
NCT06171269,Using MRI to Identify Areas to Receive Lower Doses of Radiation Treatment in Men With Prostate Cancerdose Mapping to Preserve Quality of Life,NA,Prostate Cancer,,,
NCT02516969,Surgery With or Without Adjuvant Stereotactic Body Radiotherapy,NA,Head and Neck Cancer,,,
NCT05362669,SMS Messaging for Invitation in the Cervical Cancer Screening Programme,NA,Cervical Cancer,of this study is to assess the impact on cervical cancer screening participation of an invitation method based on text messaging (SMS),the impact on cervical cancer screening participation of an invitation method based on text messaging (SMS),
NCT00026169,Imatinib Mesylate in Treating Patients With Advanced Cancer and Kidney Failure,PHASE1,Malignant Neoplasm,the dose of imatinib mesylate that is most effective with the least amount of toxic side effects in treating patients who have advanced cancer and kidney failure,,
NCT05483283,Empowering Vulnerable and Resilient Latinas to Obtain Breast Cancer Care,NA,Breast Cancer,"1 participants in both study arms will engage in three 30-minute, individual, phone-based sessions with the study team across 3 consecutive weeks",,
NCT04938583,Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer,PHASE1,Ovarian Cancer by FIGO Stage,,,
NCT04306783,In-Home Sensor Monitoring of Older Adults With Cancer,NA,Cancer,,,
NCT01153113,Human Telomerase Reverse Transcriptase Messenger RNA (hTERT mRNA) Transfected Dendritic Cell Vaccines,PHASE1,Metastatic Prostate Cancer,"whether or not this vaccine will stimulate T cells, which can recognize and kill prostate tumor cells",,
NCT00973713,Study of RAD001 in Advanced Cholangiocarcinoma: RADiChol,PHASE2,Cholangiocarcinoma,,,
NCT02890082,"Preservation of Fertility by Ovarian Stimulation Associated With Tamoxifen, Prior Chemotherapy for Breast Cancer",PHASE2,Breast Cancer,of this study is to evaluate the feasibility of ovarian stimulation emergency order not to delay the start of treatment,the feasibility of ovarian stimulation emergency order not to delay the start of treatment,
NCT05855382,"Prevalence of Persistent COVID-19 in Punta Arenas, Magallanes and Chilean Antarctic Region",,COVID-19,"to determine the prevalence of Persistent COVID-19 in 282 individuals in Punta Arenas, Magallanes and Chilean Antarctic Region","the prevalence of Persistent COVID-19 in 282 individuals in Punta Arenas, Magallanes and Chilean Antarctic Region",
NCT05675982,Real-Time Monitoring of Circulating Tumor DNA and Study of Prognostic Factors in Patients Treated With CAR-T Cells,NA,Diffuse Large B Cell Lymphoma,,,
NCT03579082,A Clinical Trial of Decitabine in Relapse and Refractory Diffuse Large B Cell Lymphoma,PHASE4,Diffuse Large B Cell Lymphoma,,,
NCT05053659,Loncastuximab Tesirine and Venetoclax for Relapsed/ Refractory Non-Hodgkin Lymphoma,PHASE1,Relapsed Non Hodgkin Lymphoma,"the correct dose and safety of combining two new cancer drugs, loncastuximab tesirine and venetoclax, as a treatment for relapsed or refractory B cell lymphoma",,
NCT01386580,"An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.",PHASE1,Brain Metastases,"the safety, tolerability, and pharmacokinetics (PK) of 2B3-101 both as single agent and in combination with trastuzumab",,
NCT04567979,Prospective Determination of COVID-19 Infection Rate in a Chemotherapy Unit in Mexico.,,Covid19,this risk,,
NCT03711279,A Study of SHR-1210 Plus Apatinib in Patients With Soft Tissue Sarcoma,PHASE2,Sarcoma,the efficacy of SHR-1210 plus Apatinib versus AMD plus IFO in participants with soft tissue sarcoma,SHR-1210 plus Apatinib versus AMD plus IFO in participants with soft tissue sarcoma,
NCT00596362,Treatment With Intravitreal Avastin for Large Uveal Melanomas,NA,Uveal Melanoma,,,
NCT01471288,Effect of Carum Carvi on Thyroid Hormones and TSH Level,PHASE1,Thyroid Cancer Patients,,,
NCT04894188,Neoadjuvant Hormone and Radiation Therapy Followed by Radical Prostatectomy in Patients With High-Risk Prostate Cancer,NA,Prostate Cancer,,,
NCT07200388,How Emotional Granularity Helps Build Resilience in Young and Middle-Aged Colorectal Cancer Survivors,,Colorectal Cancer (CRC),"to understand how the ability to identify and describe specific emotions (called ""emotional granularity"") influences coping and adaptation (""resilience"") in young and middle-aged colorectal cancer survivors",,
NCT00340288,Fibroid Growth Study,,Uterine Leiomyomas,of the study described herein are to investigate the growth dynamics of uterine leiomyomas in a clinically relevant population of women,,
NCT06274788,Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment,,Parenteral Nutrition Associated Liver Disease (PNALD),,,
NCT06205888,To Compare the Clinical Application of 18F-LNC1007 Injection PET/CT and 18F-FDG PET/CT,,Tumour,"the safety of 18F-LNC1007 injection in the diagnosis of suspected tumor, initial stage, or recurrence monitoring","18F-LNC1007 injection PET/CT versus 18F-FDG PET/CT imaging in patients with tumor with clinical suspicion, initial stage, or recurrence monitoring",
NCT01923103,Natural Disease Progress of Dupuytren Disease,,Dupuytren Contracture,of this study is to enhance our knowledge on the natural disease progression of DD at different stages,,
NCT03465527,Pre-phase Treatment Before R-CHOP Chemotherapy in Elderly Patients With Newly Diagnosed DLBCL,PHASE2,Diffuse Large B Cell Lymphoma,,,
NCT04674527,Pilot Study of Elemene in Treating Patients With Refractory Glioblastoma,PHASE2,Refractory Glioblastoma,the safety and efficacy on elemene injectable emulsion in treating patients with glioblastoma,,
NCT02546427,Hypofractionated Whole Pelvic Radiotherapy of the Prostate,NA,Prostate Cancer,the feasibility of hypofractionated whole pelvis radiotherapy in 35 patients with biopsy-proven intermediate- to high-risk prostate cancer as defined by NCCN risk criteria,,
NCT00357461,Ipilimumab With or Without Vaccine Therapy in Treating Patients With Previously Treated Stage IV Melanoma,PHASE2,Melanoma (Skin),,,
NCT06004661,Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function,PHASE2,Metastatic Castration-Resistant Prostate Cancer (mCRPC),"whether moderate and severe renal impairment have an impact on the biodistribution, dosimetry and safety of lutetium (177Lu) vipivotide tetraxetan (AAA617) administered to participants with progressive PSMA-positive metastatic castration-resistant prostate cancer",,
NCT06446661,Using Text Messages to Improve Oral Chemotherapy for Adolescents and Young Adults With Acute Lymphoblastic Leukemia,NA,Acute Lymphoblastic Leukemia,,,
NCT00400361,A Multiple Ascending Dose Study of R1507 in Patients With Advanced Solid Tumors.,PHASE1,Neoplasms,,,
NCT06051942,PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs,NA,Benign Prostatic Hyperplasia,the performance and safety of the AQUABEAM Robotic System for the resection and removal of prostate tissue in patients experiencing lower urinary tract symptoms (LUTS) and are diagnosed with localized prostate cancer,,
NCT03102242,Atezolizumab Immunotherapy in Patients With Advanced NSCLC,PHASE2,"Carcinoma, Non-Small-Cell Lung",,,
NCT02182986,Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children,,Heart Transplant,,,
NCT05628870,A Trial of HRS-1358 Tablets in Metastatic or Local Advanced Breast Cancer,PHASE1,Breast Cancer,"the safety and tolerability of HRS-1358 monotherapy or combination with Dalpiciclib Isethionate Tablets in patients with metastatic or locally advanced breast cancer in order to estimate the Dose-Limiting Toxicity (DLT), Maximum Tolerated Dose (MTD) and select the Recommended Phase 2 Dose (RP2D)",,
NCT07198373,Exploratory Study on the Efficacy of Zebutinib as Maintenance Therapy Following CAR-T Cell Therapy in Patients With Non-Hodgkin B-Cell Lymphoma,,B Cell Lymphoma,,,
NCT06384183,Kerecis Real-World Fish Skin Graft Registry,,Wounds,,,
NCT02161783,Treatment of Graft Failure After Hematopoietic Stem Cell Transplantation,,Primary Graft Failure,,,
NCT04813783,The Effect of Mucositis Care Training Given to Caregivers in Pediatric Leukemia Cases on Mucosal Barrier Damage,,Leukemia,"to examine the effect of mucositis care training to caregivers of pediatric patients aged 2 to 18 years, on the development of mucositis and the clinic's ""mucosal barrier damage, laboratory-confirmed bloodstream infections""",,
NCT00085254,"Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme",PHASE1,Adult Giant Cell Glioblastoma,,,
NCT02439554,Risk Factors for Medium-term Adverse Outcomes and Predictive Modeling for Breast Cancer Patients,,Breast Cancer,"is to evaluate different aspects of health care received by patients with breast cancer from the diagnostic process, treatment, complications, survival and quality of life, to provide information to improve the effectiveness of interventions, reduce variability, have best predictive rules and increase the quality of life","the external validity in the retrospective cohort in the case of recurrence, complications and mortality","different aspects of health care received by patients with breast cancer from the diagnostic process, treatment, complications, survival and quality of life, to provide information to improve the effectiveness of interventions, reduce variability, have best predictive rules and increase the quality of life"
NCT00337454,Study of BMS-354825 in Subjects With CML Who Are Resistant to or Intolerant of Imatinib or Ph+All in Japan,PHASE1,Chronic Myelogenous Leukemia,is to evaluate the safety of BMS-354825 in subject with chronic phase Chronic Myelogenous Leukemia (CML),the safety of BMS-354825 in subject with chronic phase Chronic Myelogenous Leukemia (CML),BMS-354825
NCT05545254,Health-promoting Lifestyle in a Genetic Counseling Clinic,,Breast Cancer,"ed to describe the health-promoting lifestyle of breast cancer patients and family members in a Chinese genetic counseling clinic, and to explore its various levels with different socio-economic variables",,
NCT06303505,"FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC",PHASE1,Ovarian Cancer,"the safety/tolerability, pharmacokinetics and preliminary efficacy of TUB-040 and to find the best dose of TUB-040 in patients with ovarian cancer and Non Small Cell Lung Cancer",which dose is optimal for patients,TUB-040 and to find the best dose of TUB-040 in patients with ovarian cancer and Non Small Cell Lung Cancer
NCT01245205,Akt Inhibitor MK2206 in Combination With Lapatinib Ditosylate in Patients With Advanced or Metastatic Solid Tumors or Breast Cancer,PHASE1,HER2-positive Breast Cancer,,,
NCT02407405,MEK 1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas,PHASE2,Neurofibromatosis 1 (NF1),To test if selumetinib helps treat PNs,,
NCT04702854,Evaluation of Ultrasound Biomicroscopy in the Local Staging of Cutaneous Melanoma,NA,Cutaneous Melanoma,"of the study is to analyze the interest of ultrasound biomicroscopy in the pre-therapeutic evaluation of the Breslow index of cutaneous melanoma, compared to histological findings",the Breslow Index,
NCT06404905,Clinical Trial of BT02 in Patients With Advanced Solid Tumors,PHASE1,Advanced Solid Tumor,"the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Antitumor Activity of BT02 in Patients with Advanced Solid Tumors",,
NCT01882205,"Comparison Between Chromoendoscopy and Virtual Chromoendoscopy (NBI, I-scan, FICE) for Detection of Neoplasia in Long Standing Ulcerative Colitis",NA,Ulcerative Colitis,,,
NCT02744105,Effect of Spirulina on Liver Fibrosis by Transient Elastography in Beta Thalassemic Children With Hepatitis C,NA,Beta Thalassemia Major,,,
NCT03336905,Implementation of a Program Based on Adapted Physical Activity and Recommendations for Second Cancers Prevention for TYACs,NA,Neoplasms,to implement a clinical program based on adapted physical activity (APA) and cancer prevention recommendations for TYAC during the active treatment period (4-6 months),,
NCT03810105,A Study of Olaparib and Durvalumab in Prostate Cancer,PHASE2,Prostate Cancer,if the combination of olaparib and durvalumab are better than the standard of care for treating prostate cancer,,
NCT03444805,EBMT ADWP Prospective Non-interventional Study: Post-AHSCT Management in SSC Patients (NISSC-2),,Autoimmune Diseases,of the study is to assess the effectiveness of various post-transplant treatment management approaches on clinical and immune biological responses after Autologous Hematopoietic Stem Cell transplantation (AHSCT) for Systemic Sclerosis (SSc) as currently performed by the different treatment protocols used in routine clinical practice across Europe in various EBMT centres,the effectiveness of various post-transplant treatment management approaches on clinical and immune biological responses after Autologous Hematopoietic Stem Cell transplantation (AHSCT) for Systemic Sclerosis (SSc) as currently performed by the different treatment protocols used in routine clinical practice across Europe in various EBMT centres,
NCT05550766,Prognostic Value of RXR-α in Cutaneous Squamous and Basal Cell Carcinoma,,Non-melanoma Skin Cancer,prognosis of SCC \& BCC by using RXR-α biomarker \& attempts to use it in the treatment,,
NCT03264456,Pretreatment Staging of High-Risk Prostate Cancer With 18F-Fluciclovine PET/MRI,PHASE1,Prostate Cancer,,,
NCT00264056,Efficacy of Chemotherapy Combined With Regional Hypothermia in Advanced Malignant Melanoma Patients With Progressive Soft Tissue Metastases,NA,Advanced Metastastic Malignant Melanoma,,,
NCT01768156,Prognostic and Predictive Value of HE4 Biomarker in Metastatic Ovarian Cancer,NA,Metastatic Ovarian Cancer,the role that HE4 could play in the detection of recurrences during the follow-up of metastatic patients,,
NCT03611751,An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis,PHASE3,Psoriasis,,,
NCT03288051,"Effects of Intraoperative, Goal-directed Crystalloid vs. Colloid Fluid Resuscitation on Free Flaps",NA,Optimal Tissue Perfusion,"of this study is to observe the effects of continuous macrohaemodynamic monitoring based, goal-directed fluid therapy on microcirculation of forearm flaps during the perioperative period",,
NCT01588951,Consolidation Therapy for Acute Myeloid Leukemia Guided by Leukemia Stem Cell Behavior,PHASE2,Acute Myeloid Leukemia,"of the trial is to compare the two-year relapse-free survival (RFS) of patients with acute myeloid leukemia (AML), presumed to be at high risk for relapse due to the presence of leukemia stem cells (LSCs) in their bone marrow at first complete remission (CR1), who receive either standard cytarabine-based chemotherapy or allogeneic stem cell transplantation (SCT)",,
NCT06311851,Transarterial Chemoembolization (TACE) Plus Bevacizumab for Liver Metastases,PHASE1,Cancer,,,
NCT07169851,A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer,PHASE2,Nausea,,,
NCT06125951,Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease,PHASE2,Dementia Moderate,Xanamem in in mild or moderate dementia due to AD,,
NCT01081951,"Study to Compare the Efficacy and Safety of Olaparib When Given in Combination With Carboplatin and Paclitaxel, Compared With Carboplatin and Paclitaxel in Patients With Advanced Ovarian Cancer",PHASE2,Ovarian Cancer,olaparib in combination with paclitaxel and carboplatin (AUC4) when compared with carboplatin (AUC6) and paclitaxel alone in patients with advanced ovarian cancer,,
NCT07086651,A Study to Learn About Two Medicines (Apalutamide and Enzalutamide) in People With Metastatic Castration-sensitive Prostate Cancer (mCSPC),,Metastatic Castration Sensitive Prostate Cancer (mCSPC),,,
NCT01921751,High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery,PHASE2,Pancreatic Adenocarcinoma,,,
NCT00399529,"Trastuzumab, Cyclophosphamide, and an Allogeneic GM-CSF-secreting Breast Tumor Vaccine for the Treatment of HER-2/Neu-Overexpressing Metastatic Breast Cancer",PHASE2,Breast Neoplasms,,,
NCT05832450,Predictive Model to Calculate the Risk of RBC Transfusion in Elective Brain Tumours Resections (TScoreBTR),,Brain Tumor Adult,,,
NCT03400150,BioProtect Balloon Implant™ Balloon System Pivotal Study BP-007,NA,Prostate Cancer,,,
NCT04815291,Streamlined Localization Using SCOUT® at Biopsy (STREAMLoc ),NA,Breast Cancer,,,
NCT00930891,Bevacizumab in Extensive Small Cell Lung Cancer,PHASE2,Small Cell Lung Cancer,,,
NCT04068974,Camrelizumab /Apatinib for Recurrent Platinum-resistant Ovarian Cancer,PHASE2,Recurrent Platinum-resistant Ovarian Cancer,,,
NCT01770418,A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer,PHASE1,Lung Neoplasms,,,
NCT07017218,Immunonutrition Effects on Nutrition and Immunity in HNC During Radiotherapy,NA,Head and Neck Cancer,included:Radiotherapy-related adverse events (e,"to investigate the effects of immunonutrition on nutritional status, immune function, and quality of life (QoL) in head and neck cancer (HNC) patients undergoing radiotherapy",
NCT02272790,"Adavosertib Plus Chemotherapy in Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer",PHASE2,"Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation",,,
NCT03074318,Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery,PHASE1,Metastatic Leiomyosarcoma,,,
NCT00927797,"Interventional Study on Pentostatin, Cyclophosphamide and Rituximab in Indolent B-Cell Non-Hodgkin-Lymphoma (B-NHL)",PHASE2,Immunocytoma/Morbus Waldenström,"the efficacy and safety of treatment with Pentostatin/Cyclophosphamide immuno-chemotherapy for patients with newly diagnosed or relapsed Immunocytoma/Morbus Waldenström, B-cell chronic lymphocytic leukemia (B-CLL) and other indolent CD20-positive B-NHL, an open, non-randomized, multi-center prospective phase II-study to evaluate the efficacy and safety of treatment with immuno-chemotherapy is conducted",,
NCT05259813,Phase I Study of JWCAR029 in Subjects With R/R CLL/SLL,PHASE1,"Leukemia, Lymphocytic, Chronic, B-Cell",the safety and efficacy of JWCAR029 in subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma,JWCAR029 in subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma,
NCT00962260,Expanded Access Trial of Plant Expressed Recombinant Glucocerebrosidase (prGCD) in Patients With Gaucher Disease,,Gaucher Disease,,,
NCT03941860,"Testing the Addition of Ixazomib/Placebo to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial",PHASE3,Multiple Myeloma,,,
NCT00003060,Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Metastatic Melanoma,PHASE1,Melanoma (Skin),,,
NCT06491082,Chemotherapy Induced Neuropathy in Cancer Patients,,Chemotherapy-induced Peripheral Neuropathy,"severity of chemotherapy induced Peripheral neuropathy (CIPN) in solid cancer (Head and Neck, Breast, Prostate) patients who planned for at least 4 cycle of chemotherapy in different nutrient status level and gene expression",,
NCT00262782,"Fludarabine or Observation in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia",PHASE3,Chronic Lymphocytic Leukemia,,,
NCT02802124,Carbon Ion Radiotherapy for the Treatment of Chinese Hepatocellular Carcinoma,NA,Hepatocellular Carcinoma,of this research project is to assess the feasibility and safety of carbon-ion radiotherapy for the treatment of localized Chinese hepatocellular carcinoma,the feasibility and safety of carbon-ion radiotherapy for the treatment of localized Chinese hepatocellular carcinoma,
NCT03492424,Ablative Therapy in the Management of Prostate Cancer,,Prostate Cancer,,,
NCT05087459,Treatment of Avatrombopag for Thrombocytopenia in Patients Undergoing Selective Resection of Hepatocellular Carcinoma,,Thrombocytopenia,the efficacy and safety of avatripopa in the treatment of thrombocytopenia in patients with primary hepatocellular carcinoma undergoing elective hepatectomy and its effect on perioperative outcome,,
NCT06052059,A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001),PHASE3,Ulcerative Colitis,the efficacy of tulisokibart in participants with moderately to severely active ulcerative colitis,tulisokibart in participants with moderately to severely active ulcerative colitis,
NCT06812780,"A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD2389",PHASE1,Hepatic Impairment,,,
NCT02422680,Patient Satisfaction With Colonoscopy in a Danish Setting - What Are the Most Important Factors?,,Colorectal Cancer,is to investigate factors associated with patient satisfaction during a colonoscopy,,
NCT04263480,Efficacy and Safety of Carfilzomib in Combination With Ibrutinib vs Ibrutinib in Waldenström's Macroglobulinemia,PHASE2,Waldenstrom Macroglobulinemia,,,
NCT03824080,Evaluating the Efficacy and Safety of Bemcentinib in Patients With Myelodysplastic Syndromes,PHASE2,Acute Myeloid Leukemia,is to assess the efficacy of bemcentinib (BGB324) a highly selective inhibitor of the AXL receptor tyrosine kinase for the treatment of AML and MDS patients failing or being refractory to first line hypomethylating agent (HMA) treatment,the efficacy of bemcentinib (BGB324) a highly selective inhibitor of the AXL receptor tyrosine kinase for the treatment of AML and MDS patients failing or being refractory to first line hypomethylating agent (HMA) treatment,bemcentinib (BGB324) a highly selective inhibitor of the AXL receptor tyrosine kinase for the treatment of AML and MDS patients failing or being refractory to first line hypomethylating agent (HMA) treatment
NCT06959979,Novel Molecular Targets and Innovative Therapeutic Perspective in Medulloblastoma,EARLY_PHASE1,"Medulloblastoma, Childhood","to identify genetic markers of sensitivity to CDK4/6 inhibitors in MB, to improve therapies and overcome resistance",,
NCT06302179,Risk Factors of Venous Thromboembolism After Colorectal Cancer Surgery,,Colorectal Cancer,"was the occurrence of the venous thromboembolism event, including pulmonary embolism",of our study is to find frequency and identify risk factors for venous thromboembolism development in patients who underwent surgery for colorectal cancer,
NCT04974879,Osimertinib Combined With Bevacizumab in the Treatment Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions Metastatic Non-Small Cell Lung Cancer,PHASE2,"Carcinoma, Non-Small-Cell Lung",,,
NCT06559696,Internal Mammary Lymph Nodes Irradiation in High-risk Breast Cancer After Neoadjuvant Chemotherapy,PHASE3,Breast Cancer,of this study is to explore the impact of internal mammary nodal irradiation on disease-free survival in high-risk breast cancer patients (ypN+or supra/subclavicular lymph node positive) after neoadjuvant chemotherapy,,
NCT03199846,Treatment Patterns and Outcomes Study in Patients With Unresectable Stage III and Metastatic (Stage IV) Melanoma in the United States,,Melanoma,,,
NCT06647862,IMM01+Azacitidine VS Placebo +Azacitidine in Patients With Newly Diagnosed Chronic Myelomonocytic Leukemia (CMML1-2),PHASE3,Chronic Myelomonocytic Leukemia,are Complete remission rate and Overall survival,the efficacy of IMM01(timdarpacept) in combination with azacitidine versus placebo in combination with azacitidine in patients with newly diagnosed chronic leukemia monocytic (CMML1-2),IMM01(timdarpacept) in combination with azacitidine versus placebo in combination with azacitidine in patients with newly diagnosed chronic leukemia monocytic (CMML1-2)
NCT01742962,Prevalence of Neglected Side Effects to Radical Prostatectomy,,Prostate Cancer,,,
NCT01165788,Social Adaptation in Long Term Survivors of Blood and Marrow Transplantation,,Social Adaptation,,,
NCT05107388,Continuous Glucose Monitoring Profile Description Under Alpelisib treAtment in Patients With Advanced bREast Cancer,NA,Breast Cancer,,,
NCT04027088,Effect of Preoperative Immunonutrition in Upper Digestive Tract,NA,Immunonutrition,"is to compare the specific effect of the immunonutrients respect to an equivalent formula in caloric-protein value but without immunonutrients, in the surgical evolution of the cancer patient",,
NCT06926088,Impact of BMI on CDK4/6 Inhibitors Efficacy and Safety in Advanced Breast Cancer,,Advanced Breast Cancer,,,
NCT00732888,Effect of Calcium on Tasigna Pharmacokinetics (PK) in Healthy Volunteers,PHASE1,Healthy,,,
NCT01441388,A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors.,PHASE1,"Carcinoma, Renal Cell",,,
NCT06282588,Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers,PHASE2,Prostate Cancer, which is expected to be at 7-8 years from the time of randomization of the first subject,of the THUNDER study is to improve the outcome of high-risk PCa by improved risk stratification,
NCT02664103,Study of Capecitabine and Cyclophosphamide Administered as a Single Pill in Patients With Advanced Breast Cancer,PHASE2,Breast Cancer Metastatic,* To assess the safety for each cohort of patients on a fixed-dose combination pill of capecitabine and cyclophosphamide administered at flat dose and with metronomic schedule (defined as continuous daily treatment without interruption) in patients with metastatic breast cancer,the safety for each cohort of patients on a fixed-dose combination pill of capecitabine and cyclophosphamide administered at flat dose and with metronomic schedule (defined as continuous daily treatment without interruption) in patients with metastatic breast cancer,the compliance under treatment
NCT02253303,"Evaluation of the Extraction-site, - Midline Incision vs Off-midline Incision-",NA,Colon Cancer,the midline extraction incision in patients with colon cancer,,
NCT05303103,Using Mixed-methods Approach to Explore the Long-term Effects of COVID-19,,Covid19,"are to (1) integrate the state of science of Long COVID, (2) describe the changes of various symptoms and HRQOL(Health-related Quality of Life) after 3, 6, 9, and 12 months of COVID-19 diagnosis, (3) explore predicting factors of the existence and severity of Long COVID, and (4) explore how patient experienced COVID-19 symptoms",,
NCT04462861,A New Securement Method for External Tunneled Central Venous Access Devices (CVAD),NA,Central Venous Catheter Exit Site Infection,,,
NCT01124461,BIRN (Biomedical Informatics Research Network) Resources Facilitate the Personalization of Malignant Brain Tumor,,GLIOBLASTOMA MULTIFORME,,,
NCT03078361,"Latinos CARES (Colorectal Cancer Awareness, Research, Education and Screening)",NA,Colorectal Cancer,,,
NCT06781242,Genotype-phenotype Relationship Between Cryptogenic Cholestasis and Familial Intrahepatic Cholestasis,,Cholestatic Liver Disease,,,
NCT05452642,The Supporting Understanding of PCOS Education and Research (SUPER) Study,NA,Polycystic Ovary,,,
NCT03750942,PROphylactic Mesh to Prevent Incisional Hernias at the Former Stoma Site: the PROMISS-trial,NA,Incisional Hernia,To evaluate the incidence of incisional hernias after stoma reversal after preventive mesh placement compared to no mesh placement,the effect of preventive mesh placement on the quality of life and the effect on healthcare cost reduction by avoiding re-intervention,the incidence of incisional hernias after stoma reversal after preventive mesh placement compared to no mesh placement
NCT04813042,Determining the Effectiveness of Working Out Dads to Reduce Mental Health Difficulties in Fathers of Young Children,NA,Mental Health Issue,"to test the effectiveness and cost-effectiveness of WOD, a 6-week week group-based peer support intervention, in reducing fathers' mental health difficulties in early parenthood",,
NCT04070586,Adaptive CT Acquisition for Personalised Thoracic Imaging,,"Cancer, Lung",,,
NCT04560686,Bintrafusp Alfa Before Surgery for the Treatment of Untreated Resectable Non-small Cell Lung Cancer,PHASE2,Resectable Lung Non-Small Cell Carcinoma,,,
NCT01079286,Study of Nelfinavir and Temsirolimus in Patients With Advanced Cancers,PHASE1,Renal Cell Cancer,,,
NCT06242470,A Study of MGC026 in Participants With Advanced Solid Tumors,PHASE1,Advanced Solid Tumor,,,
NCT00631670,Stereotactic Body Radiation Therapy (SBRT) for Tumors Near the Spinal Cord,NA,Spinal Tumors,if Stereotactic Body Radiation Therapy (SBRT) is a good way to treat tumors near the spinal cord,,
NCT05538169,The Management of RT-induced Hyposalivation Using LLLT,NA,Head and Neck Cancer,the changes in the scores of the patient's oral health-related quality of life using validated measurements,the effectiveness of photobiomodulation laser application in the management of patients with radiotherapy-induced hyposalivation,
NCT01721941,TH-302 Plus Doxorubicin Delivered by Trans-Arterial Chemoembolization (TACE) in Patients With Hepatocellular Carcinoma,PHASE1,Hepatocellular Carcinoma,of this phase I dose escalation study is to determine the maximum tolerated dose of TH-302 when administered with doxorubicin via trans-arterial chemo-embolization (TACE) in patients with hepatocellular carcinoma (HCC) who are not transplant candidates and have unresectable disease,the maximum tolerated dose of TH-302 when administered with doxorubicin via trans-arterial chemo-embolization (TACE) in patients with hepatocellular carcinoma (HCC) who are not transplant candidates and have unresectable disease,
NCT02086318,A New Algorithm to Predict Ovarian Age,,Infertility,the reliability of a multimodal diagnostic evaluation of ovarian age in term of both reproductive prognosis and distance to menopause following the guidelines of the Standards for Reporting of Diagnostic Accuracy initiative (STARD),,
NCT03059797,Study of Anlotinib in Patients With Small Cell Lung Cancer (ALTER1202),PHASE2,Small Cell Lung Cancer,,,
NCT00246597,"A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer",PHASE3,Anemia,whether it is possible to measure temporary difficulty with thinking and/or short-term memory in women who are receiving chemotherapy for early stage breast cancer and to determine whether or not treatment with PROCRITÂ® will help decrease any problems with thinking or short-term memory that chemotherapy may cause,,
NCT00837213,Comparative Efficacy and Safety of Benzoyl Peroxide Used in Combination With Clindamycin vs. Benzoyl Peroxide Used in Combination With Clindamycin and Doxycycline in the Treatment of Moderate Acne,PHASE4,Acne,,,
NCT04426760,Fibroids and Infertility - a Study of the Significance of Removal of Fibroids With Regard to Endometrial Receptivity,,"Leiomyoma, Uterine","to explore some of the molecular factors that reduce fertility for women with leiomyomas, taking into account leiomyoma location, size, number and vascularity",,
NCT05902260,The Effects of an Nutritional Intervention on PD-1 ICI in NSCLC,NA,Non-small Cell Lung Cancer,is to investigate the variability of clearance during a 12-weeks nutritional intervention period,,
NCT05672082,Contribution of [18F]DPA-714 PET for Grading and Exploration of the Inflammatory Microenvironment of Glioma.,NA,Glioma,,,
NCT02104882,INTRAGO-Intraoperative Radiotherapy for Glioblastoma - a Phase I/II Study,PHASE1,Glioblastoma Multiforme,"to find out which dose of a single shot of radiation, delivered intraoperatively direct after surgery, is tolerable for patients with GBM",,
NCT05314582,Anticoagulant/Antiaggregant Use and Postoperative Bleeding Risk in Patients With Bladder Tumor and Benign Prostatic Hyperplasia,,Hematuria,,,
NCT05990582,The Alkmaar MLPTI Cohort Study: Outcomes at 9 Years,NA,Preterm Birth,"to determine the relation between growth and body composition in the first two years of life and the waist circumference, growth parameters and blood pressure at the age of 9 years","the relation between growth and body composition in the first two years of life and the waist circumference, growth parameters and blood pressure at the age of 9 years",
NCT00327223,Safety Study of Imexon Treatment of Patients With Metastatic or Disseminated Malignancy,PHASE1,Neoplasm Metastasis,"of the study is to determine the maximally tolerated dose, the pharmacokinetics, and the toxicity of the drug on the designated schedule","the maximally tolerated dose, the pharmacokinetics, and the toxicity of the drug on the designated schedule",
NCT01027923,IV Plerixafor With Mitoxantrone Etoposide and Cytarabine for Acute Myeloid Leukemia (AML),PHASE1,"Leukemia, Myeloid, Acute",,,
NCT06984523,Study of Craniospinal Irradiation With Linac Based Volumetric Modulated Arc Therapy (VMAT) for Patients With Leptomeningeal Metastasis,NA,Leptomeningeal Metastasis,is to determine if linac based VMAT CSI for leptomeningeal metastasis improves central nervous system (CNS) progression free survival (PFS) compared to the historical standard control CNS PFS in patients treated with Involved Field Radiation Therapy (IFRT),if linac based VMAT CSI for leptomeningeal metastasis improves central nervous system (CNS) progression free survival (PFS) compared to the historical standard control CNS PFS in patients treated with Involved Field Radiation Therapy (IFRT),linac based Volumetric Modulated Arc Therapy (VMAT) for craniospinal irradiation (CSI) in solid tumor cancer patients with leptomeningeal metastasis
NCT02271659,Medical and Economic Evaluation for Intermediate-risk Prostate Cancer,NA,Prostate Cancer,of the present phase III study is two-folded: 1) to show a superiority of external beam radiotherapy combined with a brachytherapy boost versus exclusive external beam radiotherapy and 2) to evaluate the economic impact of each treatment,the economic impact of each treatment,
NCT01268059,"A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Untreated, Advanced Non-Small Cell Lung Cancer",PHASE1,Non-small Cell Lung Cancer,"the dose, antitumor activity, safety and pharmacology of MEDI-575 in combination with carboplatin/paclitaxel in subjects with previously untreated, advanced non-small cell lung cancer (NSCLC)",,
NCT00858780,Study Comparing The Effect On Disease Activity When Reducing Or Discontinuing Etanercept In Subjects With RA,PHASE4,Rheumatoid Arthritis,,,
NCT00144079,Multicenter Study Differentiated Thyroid Carcinoma,PHASE3,Thyroid Neoplasms,,,
NCT01142479,Compound Herbal Formula (TPE-1) for Leukopenia and Cancer-related Fatigue in Breast Cancer Patients With Radiotherapy,PHASE2,Breast Cancer,whether TPE-1 have the effects for leukopenia and cancer-related fatigue in breast cancer patients with radiotherapy,,
NCT03511079,Music as a Perioperative Therapy in Breast Cancer Patients,NA,Breast Cancer,,,
NCT03842696,"Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation",PHASE1,Hematologic Diseases,"the recommended phase 2 dose of the drug Vorinostat in children, adolescents and young adults following allogeneic blood or marrow transplant (BMT) and determine whether the addition of Vorinostat to the standard graft versus host disease (GVHD) prophylaxis will reduce the incidence of GVHD",,
NCT00924196,Natural History Study of Patients With Neurofibromatosis Type I,,Neurofibromatosis Type 1,To evaluate people with NF1 over 10 years in order to better understand the natural history of the disease,people with NF1 over 10 years in order to better understand the natural history of the disease,
NCT04967196,Ipilimumab and Nivolumab for the Treatment of Stage III-IV Unresectable Metastatic Melanoma,PHASE1,Clinical Stage III Cutaneous Melanoma AJCC v8,,,
NCT04160962,A Real World Study of Laparoscopic Preservation of the Pylorus Gastrectomy,,Gastric Cancer,"the difference of long-term quality of life, gastric emptying rate, incidence of basic reflux gastritis, bile contraction function, immune index, nutritional index and disease-free survival and overall survival between the two groups",,
NCT06935162,Teclistamab in Previously Treated AL Amyloidosis,PHASE2,AL Amyloidosis,the efficacy and safety of teclistamab,,
NCT02948062,Early Diagnosis Of Childhood Cerebral ALD,,Adrenoleukodystrophy,"boys with adrenoleukodystrophy (ALD) diagnosed early in life, and to prospectively monitor them to determine parameters that will facilitate earlier detection of the childhood cerebral form of the disease",parameters that will facilitate earlier detection of the childhood cerebral form of the disease,
NCT00166088,Effect of a Mediterranean Diet and Omega-3 Fatty Acids on Oxidative Stress and Endothelial Progenitor Cells (EPC's),PHASE2,Obesity,if it is easier to follow a Mediterranean diet or take supplements for patients who are currently ingesting a typical American diet,,
NCT01655888,The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma,PHASE2,Malignant Mesothelioma,to explore the efficacy of a more intensive schedule of treatment with tremelimumab in 29 MM patients,a more intensive schedule of treatment with tremelimumab in 29 MM patients,
NCT00159003,Analysis of Genetic Factors Related to Predisposition and Prognosis of Hematological Malignancies in Israel,,Acute Myeloid Leukemia,,,
NCT00001703,Vaccine Therapy With Tumor Specific Mutated VHL Peptides in Adult Cancer Patients With Renal Cell Carcinoma,PHASE2,Renal Cell Carcinoma,,,
NCT00746161,Evaluation of Double Tract Reconstruction After Total Gastrectomy in Patients With Gastric Cancer,PHASE3,Gastric Cancer,the double tract reconstruction after total gastrectomy in patients with gastric cancer,,
NCT07181161,Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer,PHASE1,Metastatic Prostate Cancer,the safety and tolerability of AZD0516 as monotherapy and/or in combination with other anti-cancer agents for treatment of metastatic prostate cancer,,
NCT04253561,Ipatasertib + Pertuzumab +Trastuzumab in Advanced HER2+ PI3KCA-mutant Breast Cancer Patients,PHASE1,Metastatic Breast Cancer,"the safety and clinical activity of the combination of ipatasertib, trastuzumab and pertuzumab in patients with unresectable locally advanced or metastatic HER2-positive breast cancer with tumors harboring PIK3CA mutations, candidates to receive maintenance HP after first line treatment for metastatic disease with a taxane plus HP",,
NCT03665961,"The Association Between Microbiota, Endotoxaemia and the Host Obesity/ Insulin Resistance (MiPOOP Study)",,Central Obesity,"of this study are to examine the effects of ethnicity, central obesity and dietary components, on the human gut microbiome",,
NCT00461461,a Multifaceted Program for Improving Quality of Care in ICU,NA,Adverse Event,of the study are to determine whether the introduction of a composite intervention program decreases the predefined AEs,whether the introduction of a composite intervention program decreases the predefined AEs,
NCT01694342,Telomere Parameters in Patients With Nonalcoholic Fatty Liver,,FATTY LIVER,"ed to evaluate mechanisms of telomere homeostasis like telomere shortening, telomerase activity, telomere capture and aneuploidy in patients with NAFLD in order to explain previous findings of telomere shortening in these patients","mechanisms of telomere homeostasis like telomere shortening, telomerase activity, telomere capture and aneuploidy in patients with NAFLD in order to explain previous findings of telomere shortening in these patients",
NCT01903642,Study of the Proteome and Cytokines During Inflammatory Syndromes of Different Etiologies.,NA,Inflammatory Disease,,,
NCT05315570,Big Data for Quality of Life in Head and Neck Cancer,NA,Head and Neck Cancer,"of the present study is to reduce and to anticipate, with the use of the non-invasive Big data for quality of life (BD4QoL) platform, the proportion of HNC survivors experiencing a clinically meaningful reduction in QoL",,
NCT05563870,Endoscopy and Radiology-guided Ablation for Inoperable Cholangiocarcinoma,NA,Perihilar Cholangiocarcinoma,"to assess the feasibility, efficacy, and safety of a personalized radiofrequency ablation protocol coupled with complete biliary drainage for patients presenting with inoperable perihilar cholangiocarcinoma","the feasibility, efficacy, and safety of a personalized radiofrequency ablation protocol coupled with complete biliary drainage for patients presenting with inoperable perihilar cholangiocarcinoma",
NCT06609070,CHG0521 Oral Coating in Patients with Solid Tissue Tumor/Recurrent/Metastatic TSCC,NA,Squamous Cell Carcinoma,,,
NCT06158269,DVRd in the Treatment of Patients With Newly Diagnosed Double-hit Multiple Myeloma,PHASE2,Multiple Myeloma,DVRd in patients with newly diagnosed double-hit multiple myeloma (MM) and the feasibility of minimal residual disease (MRD) guided maintenance therapy,,
NCT07102069,Pharmacogenomic and Pharmacoepigenomic Studies of Antipsychotic Drugs in First-Episode Schizophrenia,,Schizophrenia,"to explore the objective markers concerning schizophrenia risk and functional outcome from multiple dimensions such as multi-omics including genomics, proteomics, metabolomics, electrophysiology, imaging, psychosocial, and cognition",,
NCT03850873,A Phase I Study of TQB3616 on Tolerance and Pharmacokinetics,PHASE1,Advanced Breast Cancer,,,
NCT03961373,Standard Versus Super-extended Lymphadenectomy After Neo-adjuvant Chemotherapy for Gastric Cancer,PHASE3,Locally Advanced Gastric Cancer,,,
NCT06221683,Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML,PHASE2,"AML, Childhood",secondarily if there is an improvement over the AML2018 protocol,,
NCT01440283,A Phase II Study of Intensity Modulated Radiation Therapy (IMRT) in High Risk Abdominal Neuroblastoma,PHASE2,Abdominal Neuroblastoma,,,
NCT01789983,Feasibility of an Evidence-based Walking Program in Cancer Pts 60+ During Chemotherapy,,Breast Cancer,,,
NCT01939483,A Pilot Study of Irinotecan in Patients With Breast Cancer and CNS Metastases,NA,Central Nervous System Metastases,,,
NCT05846841,Personalized Tobacco Treatment in Primary Care (MOTIVATE),NA,Physician's Role,,,
NCT01317641,Safety and Pharmacokinetics Study of ODM-201 in Castrate Resistant Prostate Cancer,PHASE1,Prostate Cancer,"safety, tolerability and pharmacokinetics of ODM-201 in patients with castrate resistant prostate cancer",,
NCT04901741,Olaptesed With Pembrolizumab and Nanoliposomal Irinotecan or Gemcitabine/Nab-Paclitaxel in MSS Pancreatic Cancer,PHASE2,Metastatic Pancreatic Cancer,safety and tolerability and time-to-event endpoints,,
NCT05207241,The Effect of Gravity on the Occurrence of Lactational Mastitis,,Lactation Mastitis,to investigate how the scientific guidance on the gravitationally assisted breastfeeding positions will reduce the occurrence of mastitis,,
NCT03512405,Pembrolizumab and Blinatumomab in Treating Participants With Recurrent or Refractory Acute Lymphoblastic Leukemia,PHASE1,CD19 Positive,,,
NCT04704505,Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC),PHASE2,Prostate Adenocarcinoma,,,
NCT03043794,Study of Stereotactic Radiotherapy for Breast Cancer,PHASE2,Breast Cancer,,,
NCT05452694,OpalGenix- Personalized Postoperative Pain Management Following Lumbar Spinal Fusion and Decompression Surgery in Adults,,Lumbar Spine Stenosis,,,
NCT00093366,Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes,PHASE1,Leukemia,,,
NCT03568656,Study to Evaluate CCS1477 in Advanced Tumours,PHASE1,Metastatic Castration-Resistant Prostate Cancer,"the safety, tolerability, PK and biological activity of CCS1477 in patients with metastatic castration resistant prostate cancer, metastatic breast cancer, non-small cell lung cancer or advanced solid tumours",,
NCT01401322,Single Agent Lenalidomide in Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia,PHASE2,Leukemia,,,
NCT00779922,Pharmacokinetics of Lenalidomide (Revlimid®) in Patients With Multiple Myeloma and Impaired Renal Function,PHASE2,Multiple Myeloma,"the pharmacokinetic profile of Revlimid® in patients presenting with Multiple Myeloma and impaired renal function, the safety of Revlimid® in the enrolled patients population",Revlimid®-Dexamethasone combination in patients presenting MM and impaired renal function at completion of 3 cycles of treatment,
NCT04234022,Zn-DDC to Target Hypoxia-NFkappaB-CSCs Pathway in Multiple Myeloma,,Multiple Myeloma,,,
NCT04858529,Neoadjuvant TCHP Versus THP in Patients With HER2-positive Breast Cancer (neoCARHP Study),PHASE3,Neoadjuvant Therapies for HER2+ Breast Cancer,"was the percentage of pCR (ypT0/is, ypN0), which was defined as the absence of any residual invasive cancer in both the breast and axillary lymph nodes",ed to compare the efficacy and safety of TCHP with THP neoadjuvant setting for HER2-positive breast cancer,
NCT00245531,Effects of Endocrine Health on Mental Performance of Men and Women Using Drugs,,Human Immunodeficiency Virus Positive or Negative,,,
NCT04932031,Risk Prediction of Taxane Chemotherapy-Induced Peripheral Neuropathy,,Breast Cancer,,,
NCT00202046,Predictors of Lymphedema Following Breast Cancer Surgery,,Breast Cancer,,,
NCT05498246,Bipolar Coagulation Versus Suture Renorrhaphy in Laparoscopic Partial Nephrectomy,NA,Nephrectomy,,,
NCT04486846,Electronic Post-Treatment Surveillance Program for Prostate Cancer Survivors (eHealth),NA,Prostate Cancer,patient compliance and satisfaction with eVisit follow up care in lieu of in person clinic visits,the feasibility of implementing an eHealth prostate cancer surveillance program through the eVisit electronic medical record patient portal,
NCT01297088,PET/CT (Positron Emission Tomography / Computed Tomography) Investigations With BAY86-9596 (18F) (300 MBq) Following Single Intravenous Administration in Patients With Cancer or Inflammations.,PHASE1,Diagnostic Imaging,,,
NCT00124488,Comparison of Tomotherapy Versus Intensity-modulated Step-and-shoot and Conventional Radiation Treatment Plans for Patients With Locally-advanced Squamous Cell Carcinoma of the Cervix,,Cervix Neoplasm,whether or not IMRT and/or Tomotherapy technology can produce radiation plans that deliver higher doses of radiation to the tumor and lower doses to normal organs when compared to standard radiation plans,,
NCT03417388,Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD,PHASE4,Coronary Artery Disease,"is first occurrence of MACE as death, nonfatal MI, nonfatal stroke/transient ischemic attack (TIA) or hospitalization for heart failure or angina",whether intensive medication treatment to modify risk factors and vascular function in women patients with coronary arteries showing no flow limit obstruction but with cardiac symptoms (i,
NCT05824403,PAncreatic Disease Cohort of TOuLouse,,Pancreatic Diseases,is to develop positive or differential diagnostic tools between benign potentially malignant or malignant pancreatic pathologies,,
NCT02548403,Effect of Simethicone on Bowel Preparation for Colonoscopy,PHASE3,Colorectal Cancer,,,
NCT01855061,Biomarker Development for Response Prediction by DNA Mutational Analysis,,Neoplasm Metastasis,whether it is possible to predict response to chemotherapy in patients with metastatic cancer who are treated with irinotecan by determining the mutational profile of the tumor,,
NCT01416961,Integration of Neutron Therapy in the Treatment Plan for Stage III Non-Small Cell Lung Cancer (NSCLC),PHASE1,Lung Cancer,the feasibility of integrating this therapy with current treatment regimens,,
NCT04118842,A Study in Healthy Subjects to Assess the Pharmacokinetics of Savolitinib When Administered Alone and in Combination With Rifampicin,PHASE1,Solid Tumors,,,
NCT06115642,"A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX43 in Advanced/Metastatic Solid Tumors",PHASE1,Advanced Solid Tumor,the safety and tolerability of HLX43,,
NCT01642186,"Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)",PHASE2,Fibrolamellar Carcinoma,,,
NCT02745886,Metformin Induces a Dietary Restriction-like State in Human,PHASE4,Overweight Subjects,of the study is to investigate whether metformin treatment can induce dietary restriction-like state in human,,
NCT00342186,Genes Involved in Resistance or Susceptibility to Hepatitis B Virus,,"Hepatitis, Viral, Human",,,
NCT00508586,PTC299 and Hormonal Agent for Treatment of Metastatic Breast Cancer,PHASE1,Metastatic Breast Cancer,,,
NCT04182386,Scandinavian Cohort Study for Optimal Use of Portal Vein Embolization,,Hepatic Neoplasm,,,
NCT01727570,Prehabilitation to Overcome the Stress of Surgery: the Role of Nutrition in Enhancing Postoperative Functional Capacity,NA,Colorectal Cancer,the impact of nutritional supplementation with whey protein on postoperative functional capacity in patients undergoing colorectal surgery for cancer,,
NCT06076070,GENomic PROfilation for Therapeutic Purposes in SARComas and Molecular Tumor Board (MTB): Retrospective/Prospective Study in Referral Centers,,Sarcoma,the aptitude to the use of genomic profiling methods for therapeutic purposes and evaluation by the institutional Molecular Tumor Board (MTB) of sarcoma patients with metastatic/locally advanced disease that is inoperable with no viable therapeutic alternatives or with histotypes known to be resistant to available in-label medical treatments and without already therapeutically validated driver mutations,,
NCT00776373,Rapamycin in With High-Dose Etoposide and Cytarabine in Relapsed/Refractory Aggressive Lymphoid Malignancies,PHASE1,ALL,rapamycin in combination with HiVAC in relapsed and refractory patients with aggressive lymphoid malignancies,,
NCT05175573,SuperNO2VA Et Versus Oxygen Face Mask During Deep Sedation,NA,Hypoxemia,"of the study is to prospectively and randomly compare the incidence, duration, and severity of oxygen desaturation between a nasal mask with nasal positive airway pressure (PAP) versus oxygen therapy with a facemask during procedural deep sedation in patients considered high risk for hypoxia (ie: BMI ≥30 kg/m2 or documented Obstructive Sleep Apnea",,
NCT01512173,Study in Infants With Infantile Hemangioma to Compare Propranolol Gel to Placebo,PHASE2,Infantile Hemangioma,of this study is to evaluate topical propranolol efficacy and safety in the management of localized hemangioma,topical propranolol efficacy and safety in the management of localized hemangioma,
NCT06524973,Telehealth Self-Management Coaching Sessions to Improve Quality of Life in Pancreatic Cancer Survivors and Their Family Care Givers,NA,Metastatic Pancreatic Adenocarcinoma,,,
NCT06545669,"C-Raven, a Virtual Tobacco Cessation Intervention in the Community",PHASE4,Tobacco Dependence,,,
NCT06511141,Sacral Neuromodulation for Male Overactive Bladder (MOAB),NA,Overactive Bladder,the post-market clinical outcomes of the Axonics SNM System for treatment of overactive bladder in male patients,,
NCT04479241,LUMINOS-101: Lerapolturev (PVSRIPO) and Pembrolizumab in Patients With Recurrent Glioblastoma,PHASE2,Glioblastoma,"lerapolturev intratumoral infusion followed by intravenous pembrolizumab 14 to 28 days later, and every 3 weeks, thereafter",,
NCT05105841,Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax in Combination With Intravenous (IV) Obinutuzumab or Oral Ibrutinib in Adult Participants With Untreated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL),PHASE2,Chronic Lymphocytic Leukemia (CLL),"how well venetoclax works in combination with obinutuzumab (V+G, Cohort 1) or with ibrutinib (V+I, Cohort 2) in Japanese participants with previously untreated CLL/Small Lymphocytic Lymphoma (SLL)",,
NCT00063154,"Safety and Effect of Pertuzumab in Patients With Advanced Non-Small Cell Lung Cancer, Which Has Progressed After Prior Chemotherapy",PHASE2,Non-small Cell Lung Cancer,if the study drug pertuzumab is effective in treating patients with advanced lung cancer that has recurred following prior chemotherapy,,
NCT04819854,Single and Multiple Ascending Dose Study With EP395,PHASE1,Adult ALL,to determine the safe dose range of EP395 for further clinical development,the safe dose range of EP395 for further clinical development,
NCT05489705,"A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)",,Obstructive Hypertrophic Cardiomyopathy,the safety of mavacamten in patients with symptomatic obstructive HCM in the real-world setting,,
NCT05427305,TAB008 Compared to Avastin® in Patients With EGFR Wild-type Non-squamous Non-small Cell Lung Cancer,PHASE3,Efficacy,compared the objective response rate (ORR) within 6 cycles as read by an independent radiological review committee (IRRC),response rate (ORR) within 6 cycles as read by an independent radiological review committee (IRRC),
NCT04689594,A Study to Evaluate the Esophageal Stenosis Inhibition Effects of CLS2702C/CLS2702D After Endoscopic Submucosal Dissection (ESD) in Patients With Superficial Esophageal Cancer in the Steroid Administration Risk Group,PHASE3,Superficial Esophageal Cancer,"the efficacy and safety of esophageal epithelial regenerative treatment by the transplantation of the product, CLS2702C, to the esophageal wound site after extensive ESD for superficial esophageal cancer in the steroid administration risk group",,
NCT01175694,Dose Optimization for Pulsed-dose-rate (PDR)/High-dose-rate (HDR) Brachytherapy Alone for Early Breast Cancer,PHASE2,Breast Cancer,"the role of a modified dose of pulsed-dose-rate (PDR) and high-dose-rate (HDR) brachytherapy alone as Accelerated Partial Breast Irradiation (APBI) in a defined low-risk group of invasive breast cancer or ductal carcinoma in situ concerning local failure (all ipsilateral local recurrences), in particular regarding the local recurrences, the toxicity and for the cosmetic result",,
NCT00045266,VEGF Trap in Treating Patients With Solid Tumors or Non-Hodgkin's Lymphoma,PHASE1,Lymphoma,,,
NCT03083756,Validation of a Risk Score Opportunistic Infections Development in Kidney Transplant Patients,,Opportunistic Infections,,,
NCT04307056,Evaluation of HIFU in TREATMENT OF LOCALIZED PROSTATE CANCER and OF RECURRENCE AFTER RADIOTHERAPY,NA,Prostate Cancer,,,
NCT03774056,"A Study Evaluating Tolerability, Pharmacokinetics, and Preliminary Efficacy of HC-1119 in Patients.",PHASE1,Metastatic Castration Resistant Prostate Cancer,"is to study the tolerability, safety, and dose-limiting toxicities (DLT) of HC-1119 in patients with mCRPC",HC-1119 in patients with metastatic castration-resistant prostate cancer,
NCT02152722,Breath Test for Biomarkers in Humans Receiving Total Body Irradiation,,Radiation Injury,increased oxidative stress which can be detected by a breath test,,
NCT03276429,Lung Cancer Registry for Lung Cancer Patients,,Lung Cancer,,,
NCT02779751,A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast Cancer,PHASE1,Non Small Cell Lung Cancer,"the safety and efficacy of abemaciclib in combination with pembrolizumab in participants with advanced non-small cell lung cancer (NSCLC) or hormone receptor positive (HR+), human epidermal growth factor receptor negative (HER2-) breast cancer","abemaciclib in combination with pembrolizumab in participants with advanced non-small cell lung cancer (NSCLC) or hormone receptor positive (HR+), human epidermal growth factor receptor negative (HER2-) breast cancer",
NCT01543451,Proof-of-Concept Study in Cancer Patients to Assess Efficacy of Elsiglutide in Preventing Chemotherapy-Induced Diarrhea,PHASE2,Diarrhea,of this study will be to obtain data on the efficacy of elsiglutide in preventing Chemotherapy Induced Diarrhea (CID) in patients with colorectal cancer receiving 5-FU based chemotherapy (FOLFOX4 or FOLFIRI regimen) in comparison to placebo,elsiglutide in preventing Chemotherapy Induced Diarrhea (CID) in patients with colorectal cancer receiving 5-FU based chemotherapy (FOLFOX4 or FOLFIRI regimen) in comparison to placebo,
NCT04761731,To Evaluate the Efficacy and Safety of ADVAGRAF® After Treatment With a Tacrolimus in New Liver Transplant Recipients,PHASE4,Liver Transplantation,is to evaluate the incidence rate of acute rejection reactions after 24 weeks treatment with ADVAGRAF® following 3 months treatment with tacrolimus in new liver transplant recipients,the incidence rate of acute rejection reactions after 24 weeks treatment with ADVAGRAF® following 3 months treatment with tacrolimus in new liver transplant recipients,
NCT00263029,Preoperative Radiotherapy/ Oxaliplatin/ Capecitabine Treatment For Unresectable Locally-advanced Rectal Cancer,PHASE2,Rectal Neoplasms,"the efficacy and safety of the combination of oxaliplatin, capecitabine and radiotherapy as preoperative therapy in locally advanced cancers of the rectum",,
NCT02153931,Internet Support Group for Parents of a Child With Neurofibromatosis Type 1,,Neurofibromatosis 1,\- To see if an ISG for parents with a child with NF1 can give the parents more social support and less anxiety,,
NCT01994031,Dose Escalation and Pharmacokinetic Study of Paclitaxel Liposome Injection in Treating Patients With Advanced Solid Tumor After Failure From Conventional Treatments,PHASE4,Solid Tumors,the maximum tolerated dose (MTD)of paclitaxel liposome injection and to compare the pharmacokinetic characters between paclitaxel liposome injection and paclitaxel injection and to value the effectiveness for cancer treatment,,
NCT00689702,"Cetuximab (Erbitux®), Capecitabine and Radiotherapy in Neoadjuvant Treatment of Patients With Rectal Cancer",PHASE2,Rectal Cancer,,,
NCT03986502,Financial Navigation Intervention in Improving Financial and Clinical Outcomes in Patients With Newly Diagnosed Gastric or Gastroesophageal Junction Adenocarcinoma,NA,Gastric Adenocarcinoma,,,
NCT04139902,Neoadjuvant PD-1 Inhibitor Dostarlimab (TSR-042) vs. Combination of Tim-3 Inhibitor Cobolimab (TSR-022) and PD-1 Inhibitor Dostarlimab (TSR-042) in Melanoma,PHASE2,Melanoma Stage III,,,
NCT07035353,A Real-world Clinical Study of T-DXd for the Treatment of Chinese Patients With HER2 Overexpressing and HER2 Underexpressing Advanced Breast Cancer,,HER2 Overexpression,"tumor evaluation, coadministration/concomitant therapy, adverse events, time to progression/death, and subsequent antitumor therapy were collected at baseline, during treatment, and at subsequent follow-up",,
NCT02910453,VATS Versus Open Pulmonary Lobectomy in the Limelight of OEP,,Lung Cancer,"of this study is to compare VATS- over open lobectomy regarding the differences of chest wall kinematic, analyzed by optoelectronic plethysmography (OEP)",,
NCT01774253,Erivedge (Vismodegib) in the Treatment of Pediatric Patients With Refractory Pontine Glioma,PHASE2,Pontine Glioma,an investigational drug (Vismodegib) for Pontine Glioma that is growing or has come back (reoccurred),,
NCT00003637,Radiation Therapy Alone Compared to Radiation Therapy Plus Chemotherapy in Treating Patients With Previously Untreated Cancer of the Nasopharynx,PHASE3,Head and Neck Cancer,,,
NCT07156045,Study of Allogeneic Anti-PSMA CAR-NK Cell for Metastatic Castration-Resistant Prostate Cancer,EARLY_PHASE1,Prostate Cancer Castration-resistant Prostate Cancer,,,
NCT01390545,"VELVET, a Dose Range Finding Trial of Veltuzumab in Subjects With Moderate to Severe Rheumatoid Arthritis",PHASE2,Rheumatoid Arthritis,,,
NCT00578045,UARK 2006-28 Human Cord Blood Transplantation in Advanced Hematological Malignancies,PHASE1,Multiple Myeloma,,,
NCT05203172,The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials,PHASE4,Solid Tumors,,,
NCT05556772,Optimizing Screening for Cervical Cancer Among Women Living With HIV in the Dominican Republic,NA,Malignant Female Reproductive System Neoplasm,,,
NCT00390195,Randomized Phase I/II of RAD001 in Advanced Hepatocellular Carcinoma (HCC),PHASE1,Hepatocellular Carcinoma,"ed to investigate the safety, efficacy, pharmacokinetics, pharmacogenetics and feasibility of RAD001 in advanced HCC patients",,
NCT02366039,Probe-based Volumetric Laser Endomicroscopy (pVLE) of Endoscopic Mucosal Resection (EMR) Tissue in Patients With Barrett's Dysplasia,,Barrett's Esophagus With High Grade Dsyplasia,"the diagnostic accuracy and precision of the Probe-based Volumetric Laser Endomicroscopy (pVLE) imaging system in detecting dysplasia in BE in both in vivo and ex vivo imaging of Endoscopic Mucosal Resection (EMR) tissue, as compared to standard histopathology",,
NCT03926039,Sharing Decision-making Program for HCC Patients Treatment Decisions,NA,Hepatocellular Cancer,Explore the effectiveness of sharing decision-making program interventions in the early stage of HCC to reduce treatment decisions conflicts and improving decision-making satisfaction,,
NCT00007839,Beta Alethine in Treating Patients With Low-Grade Lymphoma,PHASE1,Lymphoma,,,
NCT02151539,Prospective Outcomes of Second-Line Therapy in Acute Graft-Versus-Host Study Including ECP (POSTAGE),,Graft Versus Host Disease,,,
NCT04273477,Radiomics-based Artificial Intelligence System to Predict Neoadjuvant Treatment Response in Rectal Cancer,,Rectal Cancer,,,
NCT04602377,Addition of Pembrolizumab to the Standard of Care Chemotherapy in Patient With SCCOHT,PHASE2,Small Cell Ovarian Carcinoma,"of this study is to increase the efficacy of the initial chemotherapy by providing immunotherapy and to be able to offer to more patients the possibility of benefiting from an intensification of chemotherapy, which is a major prognostic factor in this population","the initial chemotherapy by providing immunotherapy and to be able to offer to more patients the possibility of benefiting from an intensification of chemotherapy, which is a major prognostic factor in this population",
NCT00003077,Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight Loss,PHASE1,Leukemia,,,
NCT02410577,89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme,NA,Glioblastoma,,,
NCT01722175,Associating Liver Partition With Portal Vein Ligation For Staged Hepatectomy (ALPPS) or Portal Vein Occlusion in Treating Patients With Liver Cancer,PHASE2,"Carcinoma, Hepatocellular",,,
NCT05044975,Improving Sleep in Gynecologic Cancer Survivors,NA,Sleep Disturbance,,,
NCT04262375,"A Phase 2 Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Multi-Cancer Populations With Correlation to Clinical, Molecular and Immunologic Parameters With DNA MethylaTION",PHASE2,Non Small Cell Lung Cancer,,,
NCT03765775,Anlotinib Plus Sintilimab for NSCLC Patients With First-generation EGFR-TKIs Drug Resistance Along With T790M Negative,PHASE2,Carcinoma,,,
NCT06454175,A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 Years,PHASE1,HPV Infection,the safety and tolerability of 15-valent HPV vaccine in 9-45year-old participants,,
NCT03579875,Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders,PHASE2,Fanconi Anemia,,,
NCT06651957,"Anal High-risk HPV, HSIL, and Microbiome Among Hispanic Peoples Living With HIV (PLWH)",,Human Immunodeficiency Virus,,,
NCT05189457,"First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate Cancer",PHASE2,Prostate Cancer,,,
NCT03027557,Treatment of Primary Hyperparathyroidism With Denosumab and Cinacalcet.,PHASE3,Primary Hyperparathyroidism,"to evaluate the effects of Denosumab alone, and in combination with Cinacalcet, as a medical treatment for patients suffering from primary hyperparathyroidism, with mild osteoporosis","the effects of Denosumab alone, and in combination with Cinacalcet, as a medical treatment for patients suffering from primary hyperparathyroidism, with mild osteoporosis",
NCT03015701,S9005 Mifepristone in Meningioma,PHASE3,Meningioma,,,
NCT01367301,"Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer",NA,Stage IA Uterine Sarcoma,,,
NCT03791112,A Phase I Study of BPI-16350 in Patients with Advanced Solid Tumor,PHASE1,Advanced Solid Cancer,"of the study was to assess safety, tolerability, efficacy, and pharmacokinetic characteristics of BPI-16350 in different dose groups","safety, tolerability, efficacy, and pharmacokinetic characteristics of BPI-16350 in different dose groups",
NCT05106712,Vitamin D Supplementation and Improvement of PCOS Therapy and IVF Outcomes in Infertile Saudi Women,NA,Female Infertility,,,
NCT00725712,Study of GSK1363089 in Metastatic Gastric Cancer,PHASE2,"Neoplasms, Gastrointestinal Tract","the best confirmed response rate, safety, and tolerability of GSK1363089 treatment in metastatic gastric carcinoma",,
NCT04868812,Histological Modifications of Postmenopausal Vaginal Mucosa After Repeated Carbon Dioxide (CO2) Laser Treatment,NA,Vaginal Atrophy,the long-term histological and clinical efficacy of MonaLisa Touch procedure for the management of the Genitourinary Syndrome of Menopause (GSM) in postmenopausal female patients,MonaLisa Touch procedure for the management of the Genitourinary Syndrome of Menopause (GSM) in postmenopausal female patients,
NCT06041503,Enfortumab Vedotin With or Without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE),PHASE2,Adenocarcinoma of the Bladder,"To test EV, with or without pembrolizumab, in patients with rarer cancers of the testicles or urinary tract",,
NCT04289961,PDAC Peripheral and Portal Vein Sampling,NA,Pancreatic Adenocarcinoma,,,
NCT04859361,Comparison of Treatment of Cervical Intraepithelial Lesions With Imiquimod or LLETZ,NA,"Intraepithelial Neoplasia, Cervical",to establish the efficacy of treatment with imiquimod (experimental arm) and compare it to the standard treatment with LLETZ (control arm),treatment with imiquimod (experimental arm) and compare it to the standard treatment with LLETZ (control arm),
NCT00187486,"Safety and Efficacy Study of Tarceva, Temodar, and Radiation Therapy in Patients With Newly Diagnosed Brain Tumors",PHASE2,Glioblastoma Multiforme,how effective Tarceva plus Temodar plus radiation is in controlling the growth of glioblastoma and gliosarcoma,,
NCT01392586,Systemic Therapy With or Without Upfront Surgery in Metastatic Breast Cancer,PHASE3,Metastatic Breast Cancer,of this trial is the 2-years survival,,
NCT04626986,Comparison of Microwave Ablation With Breast Conserving Surgery for Breast Tumor,NA,Breast Tumor,,,
NCT04918186,Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer,PHASE2,Ovarian Cancer,participation in the study,,
NCT01665586,Effective Dose of Dexmedetomidine for Sedation in Patients Undergoing TURP/TURB Under Spinal Anesthesia With or Without Fentanyl by Age Groups: Randomized Comparative Study,NA,Benign Prostate Hyperplasia,the dose of dexmedetomidine to provide satisfactory sedation undergoing spinal anesthesia with or without additive small dose intrathecal opioids,,
NCT01270386,A Study of Apatinib in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer,PHASE2,Non-Small-Cell Lung Cancer,whether apatinib can improve progression free survival compared with placebo in patients with advanced non-squamous and non-small cell lung cancer who failed two lines of chemotherapy,,
NCT04924686,Changes of Muramyl Dipeptide in Intestinal and Extra-intestinal Diseases,,Colorectal Cancer,"the change of NOD2 ligands in inflammatory bowel diseases (IBD), CRC, atherosclerotic cardiovascular disease (ACVD), and type 2 diabetes mellitus (DM2 )",,
NCT00300586,IFCT-GFPC 05.02 A Randomized Phase III Trial Assessing in Patients With Advanced Non-small Cell Lung Cancer,PHASE3,Stage IV Non-small Cell Lung Cancer,of this trial is to improve the duration of control disease for PS 0-1 patients who are not progressing on first-line cisplatin-gemcitabine chemotherapy,,
NCT06927986,A Study of SYS6010 and Platinum-based Chemotherapy in Patients With EGFR-mutated NSCLC.,PHASE3,EGFR-mutated Locally Advanced or Metastatic NSCLC,the efficacy and safety of SYS6010 versus platinum-based chemotherapy in participants with EGFR-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC),,
NCT01182883,A Phase I Study of IMC-A12 in Combination With Temsirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors,PHASE1,Brain Stem Neoplasms,* To determine the safety and effectiveness of IMC-A12 and temsirolimus in treating children and adolescents with solid tumors,whether these two drugs may be an effective treatment for recurrent tumors,
NCT05506683,Improving Nighttime Access to Care and Treatment; Part 2- Ghana,NA,Pediatric ALL,"the clinical safety, operational feasibility of implementing,and scalability of the service",,
NCT01978483,Effect of RANKL Inhibition on UV-induced Immunosuppression,PHASE1,Ultraviolet Rays,of this study is to test whether denosumab blocks the immunosuppressive effect of UVB light in healthy subjects,"whether denosumab can reverse UVB-induced immunosuppression, the subjects will have previously been randomized to receive a single 1mL injection of either 60 mg denosumab (group A",
NCT02300883,Observational Prospective Analysis of Biological Characteristics of Mesothelioma Patients,,Malignant Mesothelioma,,,
NCT01185483,Endoscopic Submucosal Dissection in Upper Gastrointestinal Canal With HybridKnife,,"Endoscopy, Digestive System",the feasibility and safety of using HybridKnife for ESD in humans,,
NCT00188383,"Effects of N-Methyl-D-Aspartate (NMDA)-Receptor Antagonism on Hyperalgesia, Opioid Use, and Pain After Radical Prostatectomy",PHASE1,Hyperalgesia,"is to determine whether perioperative NMDA-receptor antagonism has differential effects on postoperative pain, hyperalgesia and morbidity in younger and older patients","whether perioperative NMDA-receptor antagonism has differential effects on postoperative pain, hyperalgesia and morbidity in younger and older patients",
NCT00003883,Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation,PHASE3,Cancer,,,
NCT06791083,Clinical Study of Envafolimab Combined With Fruquintinib and Chemotherapy for Neoadjuvant Treatment of Gastric Cancer,PHASE2,Gastric Cancer,,,
NCT01445483,Neuropsychological Changes in Patients Receiving Radiation Therapy for Brain Metastases,,Brain Metastasis,* To find out if there is a change in patients cognitive (thinking) and daily functioning after standard radiation treatment for brain metastasis that can be measured with tests,quality of life and daily living skills,
NCT05897983,Tens and Rocabado Exercises on TMJ Dysfunction,NA,Head and Neck Cancer,,,
NCT00859469,Eloxatin® Plus Gemcitabine Chemotherapy for Mesothelioma,PHASE2,Mesothelioma,,,
NCT04649983,CD19 and CD22 Targeted CAR-T Cell Therapy for Relapsed/Refractory B Cell Leukemia and Lymphoma,PHASE1,"Leukemia, B-cell",the efficacy and safety of CD19 and CD22 targeted CAR-T cells therapy for patients with relapsed/refractory B Cell Leukemia and Lymphoma,,
NCT04905641,The Feasibility of Bilateral Intermediate Cervical Plexus Block for Thyroidectomy/Parathyroidectomy,,Parathyroid Adenoma,of this study was evaluated the feasibility of bilateral intermediate cervical plexus blockade to be anesthesia for simple thyroid/parathyroid surgery,,
NCT03301454,Study of the Interest of Pursuing or Not the Chemotherapy for Patients With Metastatic Esophageal Cancer,PHASE2,"Esophageal Cancer, Squamous Cell",,,
NCT05278754,Independent Predictors Analysis and Model Construction of Cavitary Central Lung Cancer,,Central Lung Cancer,,,
NCT02725905,Weight Management Counseling in Medical Schools,NA,Obesity, the Objective Structured Clinical Examination (OSCE),"are to refine and compare the efficacy of MME to TE on observed student weight management counseling skills measured through the primary outcome, the Objective Structured Clinical Examination (OSCE)",two approaches to learning weight management counseling: 1)traditional education (TE) and
NCT01692405,"Semi-automatic Download of Prostate Biopsy Cores While Keeping the Orientation, Unfolding and Unity of the Sample",NA,Prostate Cancer,,,
NCT00006366,Radiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum,PHASE2,Colorectal Cancer,,,
NCT04736056,Mindfulness and CBT for Sleep,NA,Hematologic Malignancy,,,
NCT04323956,"Parsaclisib Plus the Standard Drug Therapy in Patients With Newly Diagnosed, High Risk Diffuse Large B-cell Lymphoma",PHASE1,Ann Arbor Stage II Diffuse Large B-Cell Lymphoma,,,
NCT00770822,Clinical Study of the Sonablate® 500 to Treat Localized (T1c/T2a) Prostate Cancer,NA,Prostate Cancer,,,
NCT06925022,Educational Programs Based on Healthy Habits to Improve Quality of Life and Psychosocial Profile in Women With Neurodegenerative Diseases: The ADVICE Protocol Study (Phase 1),NA,Multiple Sclerosis (MS) - Relapsing-remitting,"to analyze the interaction between physical exercise and the phases of the menstrual cycle, evaluating its impact on fatigue, functional capacity, and exercise perception in women with and without Multiple Sclerosis",,
NCT00458822,Melphalan and Autologous Stem Cell Transplant Followed By Bortezomib and Dexamethasone in Treating Patients With Previously Untreated Systemic Amyloidosis,PHASE2,Multiple Myeloma and Plasma Cell Neoplasm,,,
NCT04317651,Crizotinib in ALK Rearranged Non-small-cell Lung Cancer,,Non Small Cell Lung Cancer,ed at assessing the efficacy and safety of crizotinib in ALK positive NSCLC treated in real life setting,,
NCT06833229,Prospective Cohort Study Evaluating 18FDG PET-CT for the Early Prediction of the Efficacy of Immunotherapy Associated or Not With Chemotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Broncho-Pulmonary Carcinoma,,"Carcinoma, Non-Small-Cell Lung (NSCLC)",,,
NCT07105631,Patient-reported Outcomes (PRO) and Treatment Outcomes of Chinese Patients With MSS-type Advanced Colorectal Cancer Who Received the Zidovudine Combination Regimen in the Real World,,Colorectal Cancer,of this study is the safety events of the sidibemab combination regimen,,
NCT03707431,Internet Based Cognitive Behavioral Therapy in Pediatric Chronic Pancreatitis,NA,Chronic Pancreatitis,,,
NCT04324502,Mobile Application to Collect PRO Data in NET Patients,,Neuroendocrine Neoplasms (Tumours),the feasibility of monitoring patient reporting symptoms via mobile devices,,
NCT04968002,"Application of Pablizumab Combined With Apatinib and Chemotherapy in Resectable Non-small Cell Lung Cancer： A Prospective, Single Arm, Single Center Phase II Clinical Study of Neoadjuvant Therapy",PHASE2,Non-small Cell Lung Cancer,the efficacy and safety of pablizumab combined with apatinib and neoadjuvant chemotherapy in patients with stage iia-iiia non-small cell lung cancer,,
NCT02507102,A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM) in Australia,NA,Glioblastoma Multiforme,the effects of the Nativis Voyager therapy in patients with recurrent GBM who have either failed standard of care or are intolerant to therapy,,
NCT05501353,Explore Biomarkers Associated With Prognosis of Recurrent and Metastatic CRC After Surgery by Multi-omics Methods,,Colorectal Cancer Metastatic,1,,
NCT06659653,Safety and Efficacy of PRG-2302 for Refractory or Relapsed B-cell Acute Lymphoblastic Leukemia Disease.,EARLY_PHASE1,Acute Lymphoblastic Leukemia,,,
NCT01265953,"Chemoprevention of Prostate Cancer, HDAC Inhibition and DNA Methylation",NA,Prostate Cancer Prevention,of the study is to identify mechanisms by which compounds found in cruciferous vegetables alter gene expression via epigenetic modifications (changes in gene expression) and may prevent prostate cancer development,,
NCT02574637,"Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease",PHASE2,Crohn's Disease,the efficacy and safety of brazikumab (MEDI2070) in participants with moderate to severe Crohn's disease who have failed or are intolerant to anti-tumor necrosis factor-alpha (anti-TNFα) therapy,,
NCT03706937,The Treatment of Addictions in the Course of Care in Oncology: an Inventory of Fixtures Among Paramedical Professionals,,Paramedical Professional,,,
NCT04067037,Camrelizumab Combined With AVD in the First-line Treatment for Patients With Advanced Classical Hodgkin's Lymphoma,PHASE2,Classical Hodgkin Lymphoma,,,
NCT04238637,Immunotherapy Combined With Y-90 SIRT Therapy in Advanced Stage Intrahepatic Biliary Tract Cancer (BTC),PHASE2,Intrahepatic Cholangiocarcinoma,,,
NCT07079137,A Prospective Observational Study to Determine the Predictive Accuracy of Snakebite Severity Score (SSS) in Identifying Syndrome-Specific Core Outcome Parameters Amongst Envenomated Patients Presenting to the Emergency Department.,,Snake Bite,● To determine the predictive accuracy of Snakebite Severity Score (SSS) done at the time of presentation in identifying syndrome specific core outcomes for snakebites,the predictive accuracy of Snakebite Severity Score (SSS) done at the time of presentation in identifying syndrome specific core outcomes for snakebites,
NCT00012337,ZD 1839 in Treating Patients With Metastatic Kidney Cancer,PHASE2,Kidney Cancer,,,
NCT02731937,Clinical Evaluation of a Dual Energy CT System,NA,General CT Imaging,,,
NCT01278537,Patient Empowerment and Risk-assessed Treatment to Improve Outcome in the Elderly After Onco-surgery,NA,Cancer,,,
NCT04254445,Use of Guidance Videos to Increase Engagement and Decrease Anxiety in Patients Undergoing Pleural Tap,NA,Pleural Effusion,"the effect of the video training on understanding, cooperation and anxiety",,
NCT03324945,Chemotherapy-Induced Cognitive Impairment in Ovarian Cancer Patients,NA,Chemotherapy-induced Cognitive Impairment,,,
NCT05785845,Computed Tomography-Guided Stereotactic Adaptive Radiotherapy (CT-STAR) for the Treatment of Central and Ultra-Central Early-Stage Non-Small Cell Lung Cancer,NA,Early Stage Non-small Cell Lung Cancer,,,
NCT05498545,Universal BCMA-targeted LUCAR-B68 Cells in Patients With Relapsed/Refractory Multiple Myeloma,PHASE1,Relapsed/Refractory Multiple Myeloma,"the Safety, Tolerability, and Efficacy of Universal BCMA-targeted LUCAR-B68 Cells Product in Patients With Relapsed/Refractory Multiple Myeloma",Universal BCMA-targeted LUCAR-B68 Cells Product in Patients With Relapsed/Refractory Multiple Myeloma,
NCT02334345,Skin Protection During Radiotherapy in Patients With Breast Cancer,NA,Radiation Dermatitis,,,
NCT00185445,Efficacy and Safety Study of Oral Fludarabine Phosphate in Combination With Mitoxantrone as First Line Treatment in Follicular NHL,PHASE2,Non Hodgkin Lymphoma,,,
NCT06986772,TGRX-678 Pharmacokinetic Mass Balance,PHASE1,Chronic Myeloid Leukemia,"distribution, metabolism and excretion of TGRX-678, a tyrosine kinase inhibitor indicated for treatment of chronic myeloid leukemia",,
NCT07173972,"Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarcoma.",PHASE2,Soft Tissue Sarcoma (STS),"is local control after 2 years, meaning that the treated tumor has not grown during this period",,
NCT06221072,A Study to Assess the Prevention of Bone-related Events in Patients With Bone Metastases From Malignant Solid Tumors Treated With JMT103 Compared to Zoledronic Acid,PHASE3,Imaging Examination Shows at Least One Site With Bone Metastases From Soild Tumors,the efficacy and safety of JMT103 in patients with bone metastases from malignant solid tumors,if JMT103 is non-inferior to zoledronic acid,
NCT06748495,Real-world First-line Serplulimab-based Immunochemotherapy for Extensive-stage Small Cell Lung Cancer,,Extensive-stage Small Cell Lung Cancer (ES-SCLC),"to compare its findings with the data of the randomized controlled phase III ASTRUM-005 trial (descriptive), providing insights into optimal treatment strategies for this patient population",the efficacy and safety of the first-line treatment serplulimab-based immunochemotherapy for ES-SCLC in real-world clinical practice,
NCT05188495,Trastuzumab(Henlius®) Combined With Pertuzumab(Perjeta®) and Chemotherapy in Chinese Patients With Her2-Positive Metastatic Breast Cancer Previously Treated With Trastuzumab,,HER2-positive Metastatic Breast Cancer,is 6-month Progression-free survival (PFS),Response Rate(ORR),the 6-month progression free survival(PFS) of trastuzumab(Henlius®) combined with Pertuzumab(Perjeta®) and Chemotherapy as first to third line therapy in Chinese patients with HER2 positive metastatic breast cancer who received trastuzumab previously
NCT06706895,"A Single-arm, Single-center Phase II Clinical Study on the Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection Combined With Fruquintinib Capsules in the Second-line Treatment of Patients With Advanced Gastric Cancer",PHASE2,Advanced Gastric Cancer,ed at evaluating the anti-tumor efficacy and safety of paclitaxel polymeric micelles for injection combined with furquintinib as second-line treatment for advanced gastric cancer,,
NCT04089995,Coats Plus Syndrome and LCC Syndrome: Series of 10 Pediatric Cases. Review of Literature and Natural History,,Coats Disease,,,
NCT02168777,"Refametinib (BAY86-9766) in Combination With Regorafenib (Stivarga, BAY73-4506) in Patients With Advanced or Metastatic Cancer",PHASE1,Neoplasms,"the combination treatment in patients with breast cancer, lung cancer, or colorectal cancer, respectively",,
NCT01008475,EMD 525797 in Combination With Cetuximab and Irinotecan in K-ras Wild Type Metastatic Colorectal Cancer,PHASE1,Metastatic Colorectal Cancer,"the safety and clinical activity of the experimental drug EMD 525797 (study drug), a monoclonal antibody targeting alfa integrins, in combination with irinotecan and cetuximab in K-ras wildtype metastatic colorectal cancer patients",,
NCT04460157,Prediction of Liver-related Outcomes After HCV Cure,,"Hepatitis C, Chronic",variable of the study will be the emergence of liver complication (hepatic decompensation or hepatocellular carcinoma) or liver transplant,"To develop and validate a predictive model, applicable to daily practice, of liver complications emergence in hepatitis C virus (HCV)-infected patients and advanced fibrosis, who have achieved sustained viral response (SVR) with direct-acting antivirals (DAA)-based therapy",
NCT03009201,Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery,PHASE1,Advanced Soft Tissue Sarcoma,,,
NCT04669301,Memory and Attention Adaptation Training-Geriatrics (MAAT-G) Phase II,NA,Cancer-related Problem/Condition,,,
NCT03322696,ADAMTS-13 LEVEL AS PREDICTIVE BIOMARKER FOR DEVELOPMENT OF PORTAL VEIN THROMBOSIS IN LIVER CIRRHOSIS (ADAPTHRO),,Liver Cirrhosis,To describe the prospective modification of ADAMTS-13 level and other coagulation variables (e,,
NCT05692596,"The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics",,Pancreatic Ductal Adenocarcinoma,,,
NCT03950362,Bladder PREserVation by RadioTherapy and Immunotherapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer,PHASE2,Non-muscle-invasive Bladder Cancer,,,
NCT03839446,"Phase II Study of the Combination of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin (MEGO) for Patients With Acute Myeloid Leukemia Refractory to Initial Standard Induction Therapy",PHASE2,Acute Myeloid Leukemia,,,
NCT02568046,Sym004 in Combination With FOLFIRI in Metastatic Colorectal Cancer Patients,PHASE1,Metastatic Colorectal Cancer,"Sym004, an investigational medicinal product (IMP), in combination with FOLFIRI (chemotherapy) when administered every second week (Q2W)",,
NCT06653062,Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Hepatocellular Carcinoma Recurrence Surveillance,,Hepatocellular Carcinoma (HCC),the efficacy of circulating tumor mitochondrial DNA (ct-mtDNA) in plasma as a biomarker for minimal residual disease (MRD) assessment and recurrence monitoring in patients with hepatocellular carcinoma,circulating tumor mitochondrial DNA (ct-mtDNA) in plasma as a biomarker for minimal residual disease (MRD) assessment and recurrence monitoring in patients with hepatocellular carcinoma,
NCT00863746,A 3rd/4th Line Placebo-controlled Trial of Sorafenib in Patients With Predominantly Non Squamous Non-Small Cell Lung Cancer (NSCLC).,PHASE3,Carcinoma,,,
NCT01388803,The Depth of Right Bronchial Blocker Placement in Taiwanese in Video-assisted Thoracoscopic Surgery(VATS),,Lung Tumor,,,
NCT01832727,"Phase 1b/2, Multicenter, Open-label Study of Oprozomib and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma",PHASE1,Multiple Myeloma,safety and tolerability,"the maximum tolerated dose (MTD) and recommended Phase 2 dose (RP2D) of oprozomib given orally, once daily, on 2 different schedules",
NCT05025527,Biparametric MRI in Prostate Cancer Screening: a Noninferior Randomized Controlled Study,NA,Prostate Cancer,,,
NCT00243061,AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma,PHASE2,Acral Lentiginous Malignant Melanoma,,,
NCT06979661,Trial of ctDNA of Guidance to Determine PostOperative Radiation Therapy,EARLY_PHASE1,Lung Cancer,Evaluate the role of ctDNA positivity in decision making for postoperative therapy for non-small cell lung cancer,if ctDNA result changed the planned therapy,if radiomic features can be associated with ctDNA positivity/negativity
NCT05107661,Colorectal Screening Strategies in Underserved Populations,,Colorectal Cancer,,,
NCT00116142,Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer,PHASE3,Prostate Cancer,,,
NCT01313442,Acquisition of Blood and Tumor Tissue Samples From Patients With Gastrointestinal Cancer,,Non-GI Cancers,\- To collect blood and tumor samples from individuals who have been diagnosed with gastrointestinal cancers in order to study the immune system s response to the cancer,,
NCT03828942,Monitoring the HeMAtological TOXicity of Drugs (HeMATOX),,Hematological Abnormality,,,
NCT00923442,Biology Studies of Hematologic Cancers,,Acute Lymphoblastic Leukemia,,,
NCT06604442,Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy,PHASE4,Prostate Cancer,,,
NCT01342627,Sorafenib in Elderly Patients With Metastatic Renal Cell Carcinoma,PHASE2,Metastatic Renal Cell Carcinoma,of the trial Primary objective The primary aim of this trial is the evaluation of the efficacy of a patient education program in the reduction of Hand-Foot Skin Reaction (HFSR),a patient education program in the reduction of Hand-Foot Skin Reaction (HFSR),
NCT06521827,The Role of Short Course of Palliative Radiation in Metastatic Cancer Rectum,NA,Metastatic Cancer Rectum,,,
NCT05253261,Decompression of Odontogenic Cysts Using an Appliance Fabricated With a Fully Digital Workflow,NA,Odontogenic Cysts,"of this prospective case series is to present clinical results with cystostomy, decompression and final enucleation of odontogenic cysts using a decompression device fabricated with a full digital workflow and delivered on the day of cystostomy",,
NCT06510361,Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy,PHASE2,Lymphoma,,,
NCT03879161,A Percutaneous Ultrasound Device With Needle Guide for Vascular Access,NA,Vascular Access,the feasibility and safety of using a percutaneous ultrasound device with needle guide for vascular access,,
NCT04007861,Exploring the Link Between Cancer Genetics and PPSP,,Cancer-related Pain,,,
NCT05764161,A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN),PHASE3,Prurigo Nodularis,the safety and tolerability of Ruxolitinib cream in participants with Prurigo Nodularis (PN),,
NCT03613142,Comparison Between Double Tract Anastomosis and Esophagogastrostomy After Radical Proximal Gastrectomy,NA,Gastric Cancer,,,
NCT02873442,Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer,PHASE1,Precision Cell Immunotherapy,the safety and effectiveness of cell therapy using precision cells Combined With TACE in Advanced Liver Cancer,,
NCT00071942,Vaccine Therapy in Treating Patients With Metastatic Breast Cancer,PHASE1,Male Breast Cancer,,,
NCT00123942,Trial of MEDI-507 in CD2-Positive Lymphoproliferative Disease,PHASE1,Lymphoproliferative Disorders,of this study is to determine the maximum tolerated dose (MTD) and safety and tolerability of MEDI-507 in patients with CD2-positive lymphoproliferative disorders,the maximum tolerated dose (MTD) and safety and tolerability of MEDI-507 in patients with CD2-positive lymphoproliferative disorders,
NCT05192486,"A Study of GNC-038, a Tetra-specific Antibody, in Participants With R/R Diffuse Large B-cell Lymphoma (DLBCL)",PHASE1,Diffuse Large B-cell Lymphoma,"the dose-limiting toxicity (DLT), maximum tolerated dose (MTD) or maximum administered dose (MAD) for MTD is not reached of GNC-038","GNC-038 in participants with recurrent or refractory Diffuse Large B-cell lymphoma (DLBCL) will be investigated to assess the dose-limiting toxicity (DLT), maximum tolerated dose (MTD) or maximum administered dose (MAD) for MTD is not reached of GNC-038",
NCT05296070,Open-label of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Marginal Zone Lymphoma,PHASE2,Marginal Zone Lymphoma,,,
NCT03238170,MR-simulation in Radiotherapy for Prostate Cancer,NA,Cancer of the PROSTATE,"the feasibility of acquiring an MR scan in the radiotherapy treatment position as part of the patient's radiotherapy pathway and incorporating the data into our radiotherapy planning systems, so that it can be potentially used to reduce healthy tissue exposure to radiation",,
NCT03164473,Maintenance of Remission with Rituximab Versus Azathioprine for Newly-diagnosed or Relapsing Eosinophilic Granulomatosis with Polyangiitis.,PHASE3,Eosinophilic Granulomatosis with Polyangiitis,"rituximab compared with azathioprine maintenance therapy on duration of remission, in patients with relapsing or newly-diagnosed Eosinophilic granulomatosis with polyangiitis EPGA receiving standard of care therapy including glucocorticoid therapy reduction/withdrawal",,
NCT02955173,Significance of Circulating Tumor Cells in the Treatment of Gastric and Rectal Cancer,NA,Circulating Tumor Cells,,,
NCT00027573,Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney Cancer,PHASE2,Kidney Cancer,,,
NCT05020769,SI-B001 Combined With Osimertinib Mesylate Tablets in the Treatment of Recurrent Metastatic Non-small Cell Lung Cancer.,PHASE2,Non-small Cell Lung Cancer,SI-B001 at monotherapy RP2D or lower combined with Osimertinib in patients with locally advanced or metastatic NSCLC,,
NCT03139669,Cultural Acceptability and Feasibility of HPV Cervical Self Collection Aided by Lay Navigators,NA,Human Papilloma Virus,"to determine whether offering at-home self-collection for HPV testing through a lay navigator network is an acceptable and feasible method to increase access to cervical cancer screening for under-screened women in the Tobacco Footprint in rural far Southwest Virginia (Health Districts 1, 2 and 3)","whether offering at-home self-collection for HPV testing through a lay navigator network is an acceptable and feasible method to increase access to cervical cancer screening for under-screened women in the Tobacco Footprint in rural far Southwest Virginia (Health Districts 1, 2 and 3)",
NCT03433469,Osimertinib in Treating Participants With Stage I-IIIA EGFR-mutant Non-small Cell Lung Cancer Before Surgery,PHASE2,Stage I Non-Small Cell Lung Cancer,,,
NCT00959283,Study of Blood Samples From Newborns With Down Syndrome,,Myeloid Proliferations Associated With Down Syndrome,,,
NCT01715441,Sorafenib in Combination With Irinotecan in Metastatic Colorectal Cancer Patients With KRAS Mutated Tumors,PHASE2,Metastatic Colorectal Cancer Patients With KRAS Mutated Tumors,of this multicenter randomized phase II trial is to determine the efficacy of sorafenib and irinotecan combination versus irinotecan monotherapy or versus sorafenib monotherapy in metastatic colorectal cancer patients with KRAS mutated tumors after failure of all active drugs known to be effective,the efficacy of sorafenib and irinotecan combination versus irinotecan monotherapy or versus sorafenib monotherapy in metastatic colorectal cancer patients with KRAS mutated tumors after failure of all active drugs known to be effective,sorafenib and irinotecan combination versus irinotecan monotherapy or versus sorafenib monotherapy in metastatic colorectal cancer patients with KRAS mutated tumors after failure of all active drugs known to be effective
NCT06459141,The Effect of Acute Normovolemic Hemodilution in Bone Tumor Surgery,NA,Acute Normovolemic Hemodilution,whether ANH will reduce the volume of intraoperative allogeneic red blood cell transfusion when applying goal-directed fluid therapy in patients undergoing bone tumor surgery,"acute normovolemic hemodilution (ANH) has always been controversial, and intraoperative fluid administration strategy is an important confounding factor",
NCT03803241,Cd133+ Cell Infusion in Patients With Colorectal Liver Metastases.,PHASE2,Colorectal Cancer,,,
NCT00132041,Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis,NA,Liver Cancer,,,
NCT02254941,Observational Study to Evaluate the Use of Targeted Therapies in Metastatic Colorectal Cancer,,Metastatic Colon Cancer,"the superiority of the use of monoclonal antibodies the start time of the diagnosis against deferred use, with HR of 0",,
NCT03760354,Corticosteroid Treatment in the Acute Phase of Caustic Ingestion Management,PHASE2,Caustic Esophageal Injury,to develop a therapeutic approach that will prevent the development of refractory and pharyngeal esophageal stenosis,"the effect of early systemic corticosteroid therapy on the risk of refractory esophageal or pharyngeal stenosis within one year of ingestion of a caustic substance in a population of patients at high risk of stenosis, defined according to tomodensitometric criteria (grade IIb: severe lesions, absence of transparietal necrosis), and for whom there is no indication of urgent digestive resection",
NCT00827554,The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma,PHASE2,Hepatocellular Carcinoma,whether addition of LMWH to transarterial chemoembolization (TACE) would improve HCC patient outcome compared with TACE alone,,
NCT04375605,"Neoadjuvant RCT Versus CT for Patients With Locally Advanced, Potentially Resectable Adenocarcinoma of the GEJ",PHASE3,Gastroesophageal Junction Adenocarcinoma,,,
NCT01108705,Comparison of Brivanib and Best Supportive Care (BSC) With Placebo and BSC for Treatment of Liver Cancer in Asian Patients Who Have Failed Sorafenib Treatment,PHASE3,"Carcinoma, Hepatocellular",whether brivanib is an effective treatment for liver cancer in Asian patients who have failed or could not tolerate sorafenib therapy,,
NCT06347094,Precision Nutrition to Improve Cardiometabolic Health With Dietary (Poly)Phenols,NA,Individual Variability in (Poly)Phenol Metabolism,"at assessing whether the effects of a personalized, plant-based diet rich in (poly)phenols on cardiometabolic health depend on the capability to metabolize dietary (poly)phenols, creating predictive models able to explain, at individual level, the cardiometabolic response",,
NCT05893966,Prospective Cohort for Tumor Bed Boost Radiotherapy in HER2 Positive Breast Cancer,,Breast Cancer,,,
NCT05371756,The TIOB - Collection of Patients' Biospecimens for Analysis of Immunological and Molecular Biomarkers.,,Cancer,,,
NCT02867956,Apatinib and Etoposide in Patients With Platinum Resistant or Refractory Ovarian Cancer,PHASE2,Ovarian Cancer,the efficacy and toxicity of apatinib in patients with platinum resistant or refractory ovarian cancer when combined with etoposide,,
NCT05124951,The Efficacy of WVI in Patients With Localized Basal Ganglia Intracranial Germ Cell Tumors,PHASE2,"Intracranial Germ Cell CNS Tumor, Childhood",1,,
NCT04612751,Phase 1b Study of Dato-DXd in Combination With Immunotherapy With or Without Carboplatin in Advanced or Metastatic Non-Small Cell Lung Cancer,PHASE1,Advanced or Metastatic NSCLC,"safety, tolerability, and treatment activity of datopotamab deruxtecan (Dato-DXd) in combination with immunotherapy with or without carboplatin in participants with advanced or metastatic non-small cell lung cancer (NSCLC)",,
NCT05352451,Values and Options in Cancer Care 2 (VOICE 2) A Randomized Pilot Study,NA,"Communication, Multidisciplinary",Aim 1: To evaluate the acceptability and feasibility of recruitment strategies for subjects for VOICE 2 intervention,the acceptability and feasibility of recruitment strategies for subjects for VOICE 2 intervention,"VOICE 2 on oncologist-patient, patient-caregiver, and oncologist-caregiver concordant prognostic understanding, oncologist-patient and oncologist-caregiver therapeutic alliance, patient/caregiver depression/anxiety and death anxiety, and patient/caregiver meaning/purpose"
NCT01703351,Prospective Randomized Trial Comparing the Effectiveness of Continuous Paravertebral Infusion of Local Anesthetics Versus Intravenous Patient-controlled Analgesia on Acute and Chronic Neuropathic Pain After VATS Lobectomy,PHASE2,Lung Neoplasms,,,
NCT00521651,PRelationship Between Physical Activity and Cancer Ris,,Cancer,"the validity and reliability of a new physical activity questionnaire for use in the parent study and to evaluate whether different types of activity and the frequency, intensity, and duration of activity are associated with markers that have been linked to cancer risk, such as C-reactive protein, interleukin 6 and soluble tumor necrosis factor alpha","whether different types of activity and the frequency, intensity, and duration of activity are associated with markers that have been linked to cancer risk, such as C-reactive protein, interleukin 6 and soluble tumor necrosis factor alpha",
NCT02926729,Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy,NA,Breast Cancer,"tissue during lumpectomy surgery for breast cancer in order to reduce the probability that standard pathologic examination of the specimen after the end of the operation will find close or positive margins, thus possibly requiring the patient to have additional breast surgery",,
NCT00017329,PS-341 in Treating Patients With Metastatic Kidney Cancer,PHASE2,Kidney Cancer,,,
NCT03155802,Novel Biomarkers and Echocardiography for Subclinical Cardiac Toxicity in Breast Cancer Patients Receiving Anthracyclines,,Cardiotoxicity,,,
NCT04262453,Obstructive Sleep Apnea Syndrome In Patients Treated For Cancer Of The Upper Aerodigestive Tract,,Upper Aerodigestive Tract Neoplasms,the prevalence and severity of sleep apnea syndrome in patients treated for cancer of the upper aerodigestive tract,,
NCT03899337,"A Trial of CHOP-R Therapy, With or Without Acalabrutinib, in Patients With Newly Diagnosed Richter's Syndrome",PHASE2,Richter Syndrome,the effect of acalabrutinib taken in combination with CHOP-R compared to taking CHOP-R alone in patients with newly diagnosed Richter's Syndrome (RS),,
NCT06793137,Intestinal Microbiome Modulation With Antibiotics in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer,PHASE2,"Rectal Cancer, Adenocarcinoma","to modulate the intestinal microbiota through a phase 2 clinical trial, with the use of metronidazole as the intervention",,
NCT04822337,"Study of Carfilzomib, Lenalidomide, Dexamethasone and Belantamab Mafodotin in Multiple Myeloma",PHASE1,Multiple Myeloma,the overall response to this study treatment combination,,
NCT00649337,"Earlier Breast Cancer Detection Using Automated Whole Breast Ultrasound With Mammography, Including Cost Comparisons",NA,Breast Neoplasms,whether addition of automated whole breast ultrasound to the usual screening mammography in a population of asymptomatic women with mammographically dense breasts will result in a significantly greater number of breast cancers discovered than would be found by mammography alone,,
NCT03111537,Methods Project 4: Clinical Trial - Amended,NA,Tobacco Smoking,,,
NCT05771337,Circular RNA and Chemerin in Breast Cancer Patient,,Breast Cancer,ed to evaluate the role of serum chemerin as a biomarker of breast cancer,the role of serum chemerin as a biomarker of breast cancer,
NCT03483337,New MRI Biomarkers in Head and Neck Cancers,,Head and Neck Cancer,,,
NCT05282745,A Multicenter Cohort Study of HPV Viral Load in Predicting the Postoperative Recurrence of HSIL,,HPV Infection,,,
NCT06459245,Resistance Training to Prevent Lymphedema After Breast Cancer Surgery Randomized Controlled Study,NA,Breast Cancer Female,,,
NCT06126172,Radiomics of Treatment-naive Prostate Cancer Patients on Multiparametric MRI for Risk Stratification and Treatment Outcomes Predictions,NA,Prostate Cancer,,,
NCT00644072,SNX-5422 to Treat Solid Tumor Cancers and Lymphomas,PHASE1,Lymphoma,"To determine the highest safe dose, or maximum tolerated dose (MTD), of SNX-5422 that can safely be given to patients with solid tumor cancers and lymphomas when taken twice a week",the tumor response to treatment,"the highest safe dose, or maximum tolerated dose (MTD), of SNX-5422 that can safely be given to patients with solid tumor cancers and lymphomas when taken twice a week"
NCT05298072,Identification of Novel Inflammation-related Biomarkers for Early Detection of Anthracycline-induced Cardiotoxicity in Breast Cancer Patients,,Cardiotoxicity,"to identify possible set of inflammatory biomarkers before, during and after anthracycline-based chemotherapy in breast cancer patients to identify (sub)clinical chemotherapy-related cardiac dysfunctionCRCD to identify patients who would benefit from additional cardioprotective therapy",,
NCT04762277,A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa,PHASE2,Hidradenitis Suppurativa,,,
NCT06598475,"Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents",NA,Human Papillomavirus Infection,implementation and future sustainability of the facilitator-driven implementation strategies across nine clinical practice sites,"the provider- and practice-level characteristics that influence the impact of implementation strategies guided by practice facilitation in each clinical practice, to test whether the facilitator-driven provider- and practice-level implementation strategies increase provider recommendations and Human Papilloma Virus (HPV) vaccination rates and to evaluate implementation and future sustainability of the facilitator-driven implementation strategies across nine clinical practice sites",
NCT04193657,Toward a Comprehensive Supportive Care Intervention for Older or Frail Men With mCRPC,,Metastatic Prostate Cancer,to study a prevalent population of elderly or frail patients with mCRPC whom are often excluded from clinical trial participation,,
NCT04217057,Imaging CCR2 Receptors With 64Cu-DOTA-ECL1i in Head and Neck Cancer,PHASE1,Head and Neck Cancer,,,
NCT03758742,Effect of Whole Fruit on Glycemic Control in Adults With Type 2 Diabetes,NA,"Diabetes Mellitus, Type 2",is glycemic control," this study will also test whether consuming a large amount of fructose in whole food form affects liver fat, pancreatic fat, and cardiovascular disease risk factors",the effects of increasing whole fruit as a food group in type 2 diabetes patients
NCT02354586,A Study of Niraparib in Patients With Ovarian Cancer Who Have Received Three or Four Previous Chemotherapy Regimens,PHASE2,Ovarian Neoplasms,the safety and efficacy of niraparib in ovarian cancer patients who have received three or four previous chemotherapy regimens,niraparib in ovarian cancer patients who have received three or four previous chemotherapy regimens,
NCT01148173,High-dose Chemotherapy and Stem Cell Transplantation for Central Nervous System (CNS) Relapse of Aggressive Lymphomas,PHASE2,"Lymphoma, Non-Hodgkin",,,
NCT04958473,A Study of Sintilimab in Combination With Axitinib in Advanced Renal Cell Cancer,PHASE2,Renal Cell Carcinoma,sintilimab combined with axitinib in patients with advanced renal cell carcinoma was conducted,,
NCT03381573,Long-term Observational Study of the Safety of Roflumilast,,COPD,of all-cause mortality and evaluation of potential safety issues identified during the clinical trials of roflumilast,of this study is to evaluate the long-term safety of roflumilast in the treatment of COPD with main focus on the primary outcome of all-cause mortality and evaluation of potential safety issues identified during the clinical trials of roflumilast,the long-term safety of roflumilast in the treatment of COPD with main focus on the primary outcome of all-cause mortality and evaluation of potential safety issues identified during the clinical trials of roflumilast
NCT06563869,Sintilimab With Chemotherapy Plus PEG-rhG-GSF for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma,PHASE3,Esophageal Squamous Cell Carcinoma,ing to evaluate the efficacy and safety of sintilimab combined with platinum-based chemotherapy + pegylated recombinant human granulocyte stimulating factor as neoadjuvant treatment for resectable esophageal squamous cell carcinoma patients,the efficacy and safety of sintilimab combined with platinum-based chemotherapy + pegylated recombinant human granulocyte stimulating factor as neoadjuvant treatment for resectable esophageal squamous cell carcinoma patients,
NCT00489983,Trial of Pemetrexed or Pemetrexed With Gemcitabine for Patients With Advanced Lung Cancer Who Are Not Eligible for Platinum-Based Chemotherapy and Have Not Previously Been Treated With Chemotherapy,PHASE2,Non-Small Cell Lung Cancer,,,
NCT04158583,A Study to Evaluate the Safety and Tolerability of RO7296682 in Participants With Advanced Solid Tumors,PHASE1,Solid Tumors,the safety and tolerability of RO7296682 in participants with advanced solid tumors,,
NCT04385641,Study on the Safety and Effectiveness of UCB-NK Cell Infusion in the Treatment of Advanced Gastric Cancer and Gastroesophageal Cancer,NA,Advanced Gastric Cancer,,,
NCT00295841,Cytarabine and Clofarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia,PHASE1,Leukemia,,,
NCT01547741,Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer,PHASE3,Breast Cancer,,,
NCT05266105,A Phase 1 Study of Oral OP-1250 in Combination With Palbociclib in HR+/HER2- Breast Cancer Patients,PHASE1,Breast Cancer,"the safety and pharmacokinetic (PK) profile, and estimate the preliminary anti-tumor activity of the combination in adult subjects with hormone receptor-positive (ER+ / HER2-) advanced or metastatic breast cancer (MBC)","the maximum tolerated dose (MTD) of OP-1250 in combination with palbociclib (Ibrance®️, Pfizer Inc",
NCT05761054,Sarcoma Preoperative Radiation With Simultaneous INTegrated Boost (SPRINT),NA,Soft Tissue Sarcoma,,,
NCT01302405,Safety and Efficacy Study of PRI-724 in Subjects With Advanced Solid Tumors,PHASE1,Advanced Solid Tumors,"a previously unexamined intermediate dose, if indicated, to more fully characterize tolerability",,
NCT04161794,Multimodal Intervention for Patients With Non-small Cell Lung Cancer,NA,Cachexia; Cancer,,,
NCT05195294,Study of HBV-TCR T Cells (LioCyx-M) as Monotherapy or as Combination With Lenvatinib for HBV-related HCC,PHASE2,Hepatocellular Carcinoma,the safety and efficacy of autologous T-cells transfected with mRNA encoding Hepatitis-B virus (HBV)-antigen-specific T cell receptor (TCR) (LioCyx-M) as monotherapy or as combination with lenvatinib for the treatment of advanced HBV-related hepatocellular carcinoma (HCC),autologous T-cells transfected with mRNA encoding Hepatitis-B virus (HBV)-antigen-specific T cell receptor (TCR) (LioCyx-M) as monotherapy or as combination with lenvatinib for the treatment of advanced HBV-related hepatocellular carcinoma (HCC),
NCT04296994,A Study of QL1706 in Subjects With Advanced Malignant Tumor,PHASE1,Advanced Malignant Tumor,"Pharmacokinetics (PK) and immunogenicity, and to preliminarily assess the anti-tumor activity of QL1706 in subjects with advanced malignant tumor",the maximum tolerated dose (MTD) and to establish a recommended Phase 2 dose (RP2D) of QL1706,
NCT00577694,Clofarabine and Gemtuzumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia,PHASE1,Leukemia,,,
NCT06963866,Comparing ASCT Followed by Anti-BCMA CAR-T vs. ASCT Alone in NDMM Patients Eligible for ASCT,PHASE2,"Multiple Myeloma, Newly Diagnosed",,,
NCT01367366,Dx Mediastinal Malignant LAP:Compare PET and EBUS-TBNA,,Mediastinal Lymphadenopathy,of this study is to compare the accuracy of PET and EBUS-TBNA for correct staging of the mediastinum for lung cancer patients,,
NCT01246856,"MIBG Scintigraphy and Strain Echocardiography in the Detection of Subclinical Cardiovascular Effects One Year After (Neo)Adjuvant Breast Cancer Treatment With Docetaxel, Doxorubicin and Cyclophosphamide (TAC): a Pilot Study",,Breast Cancer,,,
NCT05101356,A Cancer Vaccine (Labvax 3(22)-23) and GM-CSF Alone or in Combination With Pembrolizumab for the Treatment of Advanced Stage Adenocarcinoma,PHASE1,Advanced Adenocarcinoma,,,
NCT02679222,Comparing the Ketogenic Effect of Coconut Oil and Different MCTs,NA,Healthy Adults,"of this study is to compare the ketogenic effect of coconut oil and three MCT oils (60-40 , tricaprylin and triheptanoate) on the production of ketones in healthy adults",,
NCT03589222,"SELIBORDARA: Selinexor, Bortezomib and Daratumumab in Multiple Myeloma",PHASE2,Refractory Multiple Myeloma,,,
NCT01064622,Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer,PHASE2,Pancreatic Adenocarcinoma,,,
NCT00003951,DX-8951f in Treating Patients With Metastatic Cancer of the Pancreas,PHASE2,Pancreatic Cancer,,,
NCT06495151,Endometriosis and Complement System,,Endometriosis,to identify novel biomarkers to aid in the development of effective noninvasive diagnostic methods,whether the levels of alternative complement molecules change in the blood serum and peritoneal fluid of endometriosis patients compared to healthy subjects,
NCT06197451,Validity and Reliability of a Turkish Version of MD Anderson Inventory Dysphagia Inventory,,Dysphagia,,,
NCT01938651,Ultra High Field MRI and MRS Techniques in Diagnosing Breast Cancer,NA,Breast Cancer,,,
NCT00387751,Bevacizumab and Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma,PHASE2,Recurrent Melanoma,,,
NCT07082751,Prognostic Model for MASLD Related Cirrhosis,,Metabolic Dysfunction Associated Steatotic Liver Disease,"was cumulative incidence of liver-related events (including decompensation events, hepatocellular carcinoma, liver transplantation, and liver-related mortality) and all-cause mortality",,
NCT00461851,"Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-naive Patients With Advanced/Metastatic Bladder Carcinoma",PHASE2,Bladder Cancer,"time to progression and response proportion of patients with advanced or metastatic transitional cell carcinoma of bladder receiving 6 cycles of gemcitabine, carboplatin and sorafenib and then maintenance sorafenib",,
NCT04708951,Comparison of Adenoma Detection Rate With ENDOCUFF VISION® vs. G-EYE®,NA,Adenoma,,,
NCT05559151,Effect and Mechanism of Remimazolam Benzenesulfonate on Enhanced Recovery After Surgery in Patients Undergoing Radical Gastrectomy for Gastric Cancer,NA,Remimazolam Benzenesulfonate on Nenhanced Recovery After Surgery,,,
NCT05934851,A Study Evaluating the Effect of Frozen-Section Directed Excision Surgery on Vulvar Dysplasia,NA,Vulvar Neoplasm,,,
NCT02991651,Study of IRX4204 With Erlotinib in Previously Treated Advanced NSCLC,PHASE1,"Lung Cancer, Nonsmall Cell",,,
NCT03245151,"Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors",PHASE1,Recurrent and Refractory Solid Tumors,response rate (ORR) at Week 16 as the outcome measure,"a maximum tolerated dose (MTD) and recommended Phase 2 dose (RP2D), and to describe the toxicities of lenvatinib administered in combination with everolimus once daily to pediatric participants with recurrent/refractory solid tumors",
NCT00844129,Spinal Abnormalities in Neurofibromatosis Type 1 (NF1),,Neurofibromatosis Type 1,the incidence and clinical history of neurofibromatosis type 1-related spinal abnormalities,,
NCT06007729,ARTEMIS-006: HS-20093 in Patients With Head and Neck Squamous Cell Carcinoma and Other Solid Tumors,PHASE2,Head and Neck Squamous Cell Carcinoma,"the efficacy, safety, pharmacokinetics (PK) and immunogenicity of HS-20093 as a monotherapy in patients with head and neck squamous cell carcinoma and other solid tumors",,
NCT04689529,Unnecessary Mastectomy Due to False Size Prediction by Preoperative Imaging Studies in Breast Cancer,NA,Breast Cancer,,,
NCT03879629,Treating Breast Cancer Patients Undergoing Trastuzumab Treatment With Carvedilol to Reduce Incidence of Heart Failure,PHASE2,Breast Cancer,,,
NCT02989129,Trial of Quercetin in the Treatment and Prevention of Chemotherapy-induced Neuropathic Pain in Cancer Patients,EARLY_PHASE1,Polyneuropathies and Other Disorders of the Peripheral Nervous System,,,
NCT03125629,Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals,PHASE2,Cancer Diagnosis,,,
NCT00062231,Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer,NA,Chronic Myeloproliferative Disorders,,,
NCT05570331,Clinical Evaluation of HPV Integration Triage for Detection of Cervical Precancer in HPV-positive Women,,HPV Infection,,,
NCT01390402,Alloreactive Haploidentical Natural Killer (NK) Cells With Busulfan and Fludarabine/ATG,PHASE2,Leukemia,,,
NCT01905202,The Safety and Tolerability of Secretrol in Patients With Barrett's Esophagus,PHASE1,Barrett's Esophagus,,,
NCT06259253,Understanding Patient Experience Among Asians at MD Anderson,,Cancer,,,
NCT05727553,Implementation of Online Adaptive Radiotherapy for Breast Cancer Patients on Ethos (BREAST-ART),,Breast Cancer,"of this study is to translate the offline adaptive workflow to an online adaptive workflow, and investigate the experiences of patients who have been treated with online adaptive radiotherapy for breast cancer (BREAST-ART)",,
NCT04848337,Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate Cancer,PHASE2,Prostate Cancer Metastatic,,,
NCT00536653,Changes in Bone Mineral Density and Fracture Risk in Patients Receiving Androgen Deprivation Therapy for Prostate Cancer,NA,Osteoporosis,of this study is to determine the long term effects of two types of hormonal treatment for advanced prostate cancer (LHRH agonists and the antiandrogen bicalutamide)on the bone mineral density of patients,the long term effects of two types of hormonal treatment for advanced prostate cancer (LHRH agonists and the antiandrogen bicalutamide)on the bone mineral density of patients,
NCT04689802,To Identify Potential New Urine Marker Panel for Cancer Screening,,Cancer,,,
NCT06685653,Personalized Neoantigen MRNA Vaccine Combined with Adebrelimab in Non-Small Cell Lung Cancer Patients,EARLY_PHASE1,NSCLC,the safety and tolerability of personalized mRNA tumor vaccine RGL-270 targeting tumor-specific neoantigens and Adebrelimab (a humanized PD-L1 monoclonal antibody) in patients with resectable NSCLC and those with NSCLC who have relapsed or metastasized after first-line standard therapy,,
NCT04170153,Tuvusertib (M1774) in Participants With Metastatic or Locally Advanced Unresectable Solid Tumors (DDRiver Solid Tumors 301),PHASE1,Metastatic or Locally Advanced Unresectable Solid Tumors,Tuvuseritib (M1774) as monotherapy and in combination with the poly (ADP-ribose) polymerase (PARP) inhibitor niraparib,,
NCT07166445,Deep Learning for Automated Discrimination Between Stage T1-T2 and T3 Renal Cell Carcinoma on Contrast-Enhanced CT,,"Carcinoma, Renal Cell",to develop and validate a contrast-enhanced CT-based deep-learning model for automatic and accurate preoperative discrimination between T1-T2 and T3 renal cell carcinoma,,
NCT06777745,Model Supported Breast Examination Training for Midwifery Students,NA,Breast Self-Examination,,,
NCT01831245,"Right-sided Colon Tumor, Laparoscopic Versus Open Surgery, in an ERAS Protocol",,Colon Tumor,,,
NCT00002845,Interleukin-2 in Treating Patients With Metastatic Melanoma,PHASE2,Melanoma (Skin),,,
NCT04362072,Study of Lorlatinib In People With ALK-positive Non-small Cell Lung Cancer,PHASE4,Carcinoma,,,
NCT05617872,Vinegar-induced Collection of Duodenal Pancreatic Juice Via Endoscopic Ultrasound,NA,Pancreatic Cancer,the best operating condition for vinegar-induced collection of duodenal pancreatic juice via endoscopic ultrasound,,
NCT05587972,"Real World Treatment Experience of Patients With Breast, Lung, or GI Cancer or Multiple Myeloma Using Remote Symptom Monitoring",NA,Breast Cancer,,,
NCT03598595,"Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or Refractory Osteosarcoma",PHASE1,Recurrent Osteosarcoma,,,
NCT03270995,Cognitive-Existential Group Therapy to Reduce Fear of Cancer Recurrence: A RCT Study,NA,Breast Neoplasms,,,
NCT00566995,Phase II Study of Vandetanib in Individuals With Kidney Cancer,PHASE2,Renal Cancer,the size of participants tumors,,
NCT05468177,Cetuximab in Combination With Anti-PD-1 and mFOLFOX Treat For RAS/BRAF wt Right-Sided Colon Cancer,PHASE2,Colonic Neoplasms,the efficacy and safety of cetuximab combined with anti-PD-1 and mFOLFOX6 in the treatment of RAS/BRAF WT locally advanced or metastatic right colon cancer,,
NCT00288275,"Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer",,Ovarian Cancer,,,
NCT07057375,The Effect of Pulsed Electromagnetic Field Therapy on Muscle Mass and Muscle Strength in Prostate Cancer Patients Treated With Androgen Deprivation Therapy,NA,Prostate Cancer,the effect of Pulsed electromagnetic fields (PEMF) on improving muscle mass and strength in prostate cancer patients with ADT,,
NCT00099775,Caspofungin to Prevent Candidiasis in Adults in Hospital Intensive Care Units,PHASE3,Candidiasis,,,
NCT01104675,Study of Oral ENMD-2076 Administered to Patients With Ovarian Cancer,PHASE2,Ovarian Cancer,"whether oral ENMD-2076 is effective in treatment of patients with platinum resistant ovarian, fallopian, or peritoneal cancer",,
NCT00427375,Local Excision in Downstaged Rectal Cancer,PHASE3,Rectal Neoplasms,,,
NCT02668575,Integrating Supportive Care in Cystic Fibrosis,NA,Cystic Fibrosis,"the feasibility, acceptability, and perceived effectiveness of an embedded supportive care intervention, whereby a supportive care specialist will be integrated within the usual care experience of patients with advanced CF",,
NCT02909075,A Study to Assess Thymic Function Using PET/CT and MRI,,CD34 Selected Peripheral Blood Stem Cell Graft,,,
NCT00385775,Study of XIAP Antisense for Advanced Cancers,PHASE1,Advanced Cancer,,,
NCT04892875,A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck Cancers,PHASE1,Head and Neck Cancer,,,
NCT02112357,Feasibility of a Molecular Characterisation Approach to Treatment,,Advanced Gastrointestinal Cancers,the feasibility of sequencing locally advanced/metastatic gastrointestinal cancers in real-time to enable future treatment stratification by molecular characteristics,,
NCT03921957,Study of the Decrease of Length of Stereotactic Body Radiation Therapy in Lung Cancer,NA,Stage IA - IB Non Small Cell Lung Cancer,,,
NCT04938401,Construction and Application of a Risk Prediction Model Forepistaxis After Pituitary Tumor Resection,,Pituitary Tumor,to establish an evaluation system for predicting the risk of epistaxis after endoscopic transsphenoidal pituitary surgery（ 2) Objective to determine the risk factors of epistaxis after endoscopic transsphenoidal pituitary adenoma surgery,the validity of the model,the risk factors of epistaxis after endoscopic transsphenoidal pituitary adenoma surgery
NCT03687957,rhIL-7-hyFc on Increasing Lymphocyte Counts in Patients With Newly Diagnosed Non-severe Lymphopenic Gliomas Following Radiation and Temzolomide,PHASE1,Glioma,the effect of rhIL-7-hyFc on lymphocyte counts in patients with high grade glioma (HGG),,
NCT01176357,Adiponectin and Inflammatory Mediators in Mediastinal Adipose Tissues,,Coronary Artery Disease,"to analyze the expression of adiponectin and inflammatory mediators in mediastinal adipose tissue between patients with CAD and with valve diseases, and to correlate these parameters with clinical atherosclerotic risks, medications (statins or antiplatelet), and blood sugar",,
NCT04565457,A Pilot Study Evaluating the Effect of 2D Antiscatter Grids on CBCT Image Quality,NA,Prostate Cancer,"is to assess the improvement in tissue visualization in an observer study, which will be conducted in a blinded fashion","the improvement in tissue visualization in an observer study, which will be conducted in a blinded fashion",
NCT01949701,Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*02 Disease Controlled Advanced Non-small Cell Lung Cancer,PHASE1,Non-small Cell Lung Cancer,,,
NCT06545201,RE001 T Cell Injection for the Treatment of KRAS G12V Mutated Solid Tumors,PHASE1,KRAS G12V,,,
NCT06798701,Virtual Reality for Symptom Management in Patients Undergoing Hematopoietic Stem Cell Transplantation,NA,Hematopoietic and Lymphatic System Neoplasm,,,
NCT03063112,Radiofrequency and Chemical Neurolysis of Thoracic Splanchnic Nerve for Abdominal Cancer Pain,NA,Abdominal Cancer,,,
NCT00047112,Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer,PHASE3,Esophageal Cancer,,,
NCT02626312,"Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function",PHASE1,Cholangiocarcinoma,,,
NCT06311981,Carbon Ion Radiotherapy for Locally Advanced Lung Cancer in Elderly Patients,PHASE2,Non-small Cell Lung Cancer,,,
NCT06727981,First-Line and Neoadjuvant Immunotherapy for Gastric Cancer,,Advanced Gastric Cancer,"to evaluate the efficacy and safety of immune checkpoint inhibitors as first-line and neoadjuvant therapy for advanced gastric cancer, while also investigating relevant biomarkers to better understand their role in immunotherapy outcomes","the efficacy and safety of immune checkpoint inhibitors as first-line and neoadjuvant therapy for advanced gastric cancer, while also investigating relevant biomarkers to better understand their role in immunotherapy outcomes",
NCT03260881,Liraglutide Effects on Epicardial Fat Inflammatory Genes,PHASE4,Type2 Diabetes,,,
NCT06380803,Surgical Skill Labs for Robotic Mastectomy and Educational Program Using a Surgical Guide by Artificial Intelligence,,Breast Neoplasms,,,
NCT00452803,Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in N2 Positive IIIA Non Small Cell Lung Cancer (NSCLC),PHASE2,Lung Cancer,,,
NCT06926127,Genomic Profiling of Genetic and Rare Diseases,NA,Rare Diseases,to enhance the Rare Diseases network by integrating genomic knowledge with clinical practice,,
NCT01747642,Safety and Efficacy of Oncoxin Plus Surafineb in Hepatocellular Carcinoma,PHASE2,Quality of Life,,,
NCT05340686,Braining- Aerobic Physical Activity As Add on Treatment in Bipolar Depression,NA,Bipolar Disorder,,,
NCT04594161,Effectiveness of Drainage by PCN vs. JJ in Patients With Symptoms of Obstructive Kidney Disease Caused by Urolithiasis,NA,Urolithiasis,,,
NCT02215161,Selinexor in Treating Patients With Abiraterone Acetate and/or Enzalutamide Refractory Metastatic Castration-Resistant Prostate Cancer,PHASE2,Castration Levels of Testosterone,,,
NCT01866670,"Effect of the Nursing Intervention ""Spiritual Support""",PHASE2,Breast Neoplasms,,,
NCT00241670,Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid,PHASE3,Brain Cancer,"of the study ""Fluorescence-guided resection of malignant gliomas with 5-Aminolevulinic acid (5-ALA) vs",the clinical usefulness of this method,how accurately contrast agent-accumulating tumour can be removed by primary surgery and to assess the clinical usefulness of this method
NCT00864383,Controlled Comparison of Two Moxifloxacin Containing Treatment Shortening Regimens in Pulmonary Tuberculosis,PHASE3,Pulmonary Tuberculosis,to find and evaluate new drugs and regimens that shorten the duration of tuberculosis therapy,"the efficacy, safety and acceptability of two moxifloxacin-containing treatment combinations to determine whether substituting ethambutol with moxifloxacin in one combination, and/or substituting isoniazid with moxifloxacin in another combination, makes it possible to reduce the duration of treatment for TB","whether substituting ethambutol with moxifloxacin in one combination, and/or substituting isoniazid with moxifloxacin in another combination, makes it possible to reduce the duration of treatment for TB"
NCT07143669,Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations,,Clonal Mast Cell Disease,,,
NCT02444754,Attitudes and Knowledge Regarding Clinical Trials in Underserved Populations Receiving Care at the Comprehensive Cancer Center of Wake Forest University,,Malignant Neoplasm,,,
NCT02094105,Endoscopic Screening on Esophageal Cancer,NA,Esophageal Squamous Cell Carcinoma,To evaluate whether endoscopic screening and early intervention program could reduce the incidence or mortality of ESCC,whether endoscopic screening and early intervention program could reduce the incidence or mortality of ESCC,
NCT04022005,Chidamide + R-GemOx Regimen as Salvage Treatment for Transplant-ineligible Patients With Relapsed/Refractory DLBCL,PHASE2,"Lymphoma, Large B-Cell, Diffuse",the safety and efficacy of Chidamide with R-GemOx(rituximab、gemcitabine plus oxaliplatin) regimen in the treatment of transplant-ineligible patients with relapsed/refractory diffuse large B-cell lymphoma,Chidamide with R-GemOx(rituximab、gemcitabine plus oxaliplatin) regimen in the treatment of transplant-ineligible patients with relapsed/refractory diffuse large B-cell lymphoma,
NCT04897854,Timing of Start of systemIc Treatment for Asymptomatic Metastasized Pancreatic Cancer,PHASE3,Metastatic Pancreas Cancer,the timing of when to start chemotherapy in order to optimize the benefits of chemotherapy relative to the side effects,,
NCT03841305,Simultaneous Portal and Hepatic Vein Versus Portal Vein Embolizations for Hypertrophy of the Future Liver Remnant,PHASE2,Liver Metastasis Colon Cancer,,,
NCT00387205,Study To Assess Long Term Safety Of Pazopanib,PHASE1,"Carcinoma, Renal Cell",the long term safety of pazopanib and to continue to provide pazopanib to patients who participated in a GSK sponsored pazopanib study until pazopanib is available commercially,,
NCT03589105,"A Study to Provide Complementary Efficacy, Safety and Patient Reported Outcomes Data in Participants With Active Relapsing Forms of Multiple Sclerosis (MS) in a Pragmatic Setting",PHASE4,Multiple Sclerosis,,,
NCT06258694,Venous Thrombo-Embolism Imaging Database (VTE-ID),,Venous Thromboembolism,,,
NCT00804466,Human Papillomavirus Epidemiology in Nigeria,NA,Human Papillomavirus 18,* To examine the age distribution of HPV infection and relationship to cancer of the cervix among Nigerian women,,
NCT04576156,A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment,PHASE3,Myelofibrosis,the overall survival of participants treated with imetelstat compared to best available therapy with intermediate-2 or high-risk Myelofibrosis (MF) who are relapsed/refractory (R/R) to Janus Kinase (JAK)-Inhibitor treatment,,
NCT01016756,Genetic Analysis of PHACE Syndrome (Hemangioma With Other Congenital Anomalies),,PHACE Syndrome,,,
NCT04045756,Focal Laser Ablation for the Treatment of Focal Low-Intermediate Risk Prostate Cancer,NA,Prostate Cancer,"of the study is to evaluate the short-term (2 years) efficacy of FLA treatment of low-intermediate risk prostate cancer Secondary objective is to investigate multiparametric prostate MRI as a follow-up diagnostic investigation, evaluating possible glandular morphostructural changes and their correlation with clinical data","the short-term (2 years) efficacy of FLA treatment of low-intermediate risk prostate cancer Secondary objective is to investigate multiparametric prostate MRI as a follow-up diagnostic investigation, evaluating possible glandular morphostructural changes and their correlation with clinical data",Transperineal Laser Ablation (TPLA) with Image Fusion and Multi-parametric (mpMRI) Follow-up in Focal Low-intermediate Risk Prostate Cancer
NCT00695422,Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials,,Aids-related Malignancies,,,
NCT00769951,Study of Physical and Mental Health of Older Patients With Newly Diagnosed Cancer,,Cognitive/Functional Effects,,,
NCT04316351,Efficacy and Safety of Toripalimab (JS001) Combined With Pemetrexed and Anlotinib for Patients With T790M Positive Non-Small Cell Lung Cancer After Osimertinib Resistance,PHASE2,IIIb/IV NSCLC With T790M Positive Mutations Failed to Osimertinib Therapy,,,
NCT00071851,Safety of and Immune Response to an HIV-1 DNA Vaccine (VRC HIVDNA009-00-VP) in HIV Uninfected Adults,PHASE1,HIV Infections,,,
NCT05356351,"An Open-label, Single-arm, Multicenter Phase II Clinical Study： Evaluating RC48-ADC Combined With Triplizumab in the Neoadjuvant Treatment of Her2-positive Muscle-invasive Bladder Cancer",PHASE2,Neoadjuvant Treatment of Her2-positive Muscle-invasive Bladder Cance,"response rate (ORR),Duration of response (DoR) , progression-free survival (PFS), overall survival (OS), and safety","the neoadjuvant treatment of Her2-positive Muscle-invasive Bladder Cancer in patients with objective response rate (ORR),Duration of response (DoR) , progression-free survival (PFS), overall survival (OS), and safety",
NCT06397651,A Randomised Controlled Trial to Evaluate the Impact of Complement Theory's Live 1:1 Exercise Coaching and Personalised Digital Application on Cancer Survivors' Cost of Care,NA,Breast Cancer,the impact of Complement Theory's Live 1:1 Exercise Coaching and Personalized Digital Application on Cancer Survivors' Cost of Care,,
NCT04579029,PRELUDE Study of Lymphatic Surgery to Treat Breast Cancer Related Lymphoedema,NA,Breast Cancer,,,
NCT02129829,PROLIFICA - West African Treatment Cohort for Hepatitis B,,"Hepatitis B, Chronic",to evaluate a number of steps required to successfully treat patients with chronic hepatitis B virus infection to prevent cirrhosis and liver cancer,a number of steps required to successfully treat patients with chronic hepatitis B virus infection to prevent cirrhosis and liver cancer,whether screening for hepatitis B using a point of care test is feasible and effective
NCT01444729,Post Approval Commitment Study,,Dupuytren's Contracture,,,
NCT05390229,Screening Contrast-enhanced Mammography,,Breast Cancer,"of this study is to compare the diagnostic performance of two diagnostic methods, namely CESM and MRI, in the evaluation of a lesion suspicious of breast cancer in 300 Quebec women referred for the investigation of breast cancer",,
NCT05078229,Evaluating Stress Management Among Allogeneic HCT Caregivers,NA,Burden,,,
NCT05635929,Oral Mucositis and Quality of Life With a Mucosa Topical Composition in Head & Neck Cancer Patients.,NA,Oral Mucositis,,,
NCT03730129,Humoral Immunodeficiency in CLL and Therapy With Subcutaneous Ig,PHASE2,Secondary Immune Deficiency Disorder,,,
NCT04969731,Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer,PHASE3,Pancreatic Ductal Adenocarcinoma,,,
NCT01217931,Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START Trial,PHASE2,Kidney Cancer,,,
NCT02918253,HDR Focal: Feasibility Study,NA,Prostate Cancer,to evaluate the role of focal HDR brachytherapy for well-defined disease based on multiparametric MRI (mpMRI),the role of focal HDR brachytherapy for well-defined disease based on multiparametric MRI (mpMRI),
NCT03368053,Long-term Immunogenicity of the HIV gp120-NefTat/AS01B Vaccine (GSK SB732461),PHASE1,"Infection, Human Immunodeficiency Virus",the long-term persistence of binding antibody responses against V1V2 and gp120 in subjects who were vaccinated with the envelope glycoprotein 120 (gp120)-negative factor (Nef)Tat/ Adjuvant System 01B (AS01B) (GSKSB732461) vaccine candidate,,
NCT00671437,Determine Tumor Response Using Fluorodeoxyglucose (FDG)- Positron Emission Tomography (PET)/Computed Tomography (CT) Before and After Cetuximab in Patients With Head and Neck Cancer,PHASE2,"Carcinoma, Squamous Cell",,,
NCT02525237,Apatinib in Combination With S-1 as First-Line Treatment in Patients With Advanced Gastric Cancer,PHASE2,Gastric Cancer,the efficacy and safety of Apatinib combined with S-1 as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma,,
NCT05645237,HRQOL in Prostate Cancer Patients Treated With Radiotherapy,,Prostate Cancer,"at evaluating health-related quality of life after radiotherapy for prostate cancer, using modern hypofractionated radiotherapy schedules",,
NCT03517137,Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II Study,PHASE2,Advanced Hodgkin Lymphoma,of this trial is to assess whether treatment adaptation based on a very early FDG-PET/CT results in improved efficacy while minimizing treatment toxicity in advanced stage Hodgkin Lymphoma (HL) patients treated with brentuximab vedotin (BV)-containing regimens,whether treatment adaptation based on a very early FDG-PET/CT results in improved efficacy while minimizing treatment toxicity in advanced stage Hodgkin Lymphoma (HL) patients treated with brentuximab vedotin (BV)-containing regimens,
NCT00901537,Azacitidine and Cisplatin in Patients With Advanced Lung or Head and Neck Cancer,PHASE1,Non-small Cell Lung Cancer,,,
NCT02489045,Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension,PHASE4,Liver Diseases,,,
NCT06427239,Exploratory Clinical Study of HRS-4642 Combined With Adebelimab in the Treatment of Advanced Pancreatic Cancer,PHASE1,Pancreatic Cancer,"the safety, tolerability and efficacy of HRS-4642 combined with adebelimab in subjects with locally advanced or metastatic pancreatic ductal adenocarcinoma",HRS-4642 combined with adebelimab in subjects with locally advanced or metastatic pancreatic ductal adenocarcinoma,
NCT04265339,The Interplay Between Addiction to Tobacco Smoking and Sleep Quality Among Healthy Adults,NA,Tobacco Dependence,"1) To examine physiological and psychological factors predicting reduced quality of sleep among smokers, including: poor pulmonary function, the degree of nicotine dependence, altered regulation of stress systems (HPA axis and the sympathetic nervous system), and emotional distress (anxiety and depression)",,
NCT05553639,HB-302/HB-301 Therapy in Participants With Metastatic Castration-Resistant Prostate Cancer,PHASE1,Prostate Cancer Metastatic,,,
NCT02521077,Intravenous Ascorbic Acid in Women Receiving Adjuvant or Neo-Adjuvant Chemotherapy for Early Stage Breast Cancer,PHASE2,Fatigue,,,
NCT03967977,Study of Tislelizumab in Combination With Chemotherapy Compared to Chemotherapy Alone for Participants With Urothelial Carcinoma,PHASE3,Urothelial Carcinoma,,,
NCT03146377,Study of Xeloxiri Regimen for Patients With Refractory Metastatic Colorectal Cancer,PHASE2,Colorectal Cancer,"to assess the efficacy and tolerability of triplet combination of capecitabine, oxaliplatin and irinotecan (Xeloxiri regimen) in treating patients with refractory metastatic colorectal cancer","the efficacy and tolerability of triplet combination of capecitabine, oxaliplatin and irinotecan (Xeloxiri regimen) in treating patients with refractory metastatic colorectal cancer",
NCT01195077,Could Dietary Algae Affect Immunity and Viral Counts in People With HIV?,PHASE1,HIV Infections,,,
NCT03389477,"Los Tres Paso: Neoadjuvant Palbociclib Monotherapy, Concurrent Chemoradiation Therapy, Adjuvant Palbociclib Monotherapy in Patients With p16INK4a Negative, HPV-Unrelated Head and Neck Squamous Cell Carcinoma",PHASE2,Head and Neck Squamous Cell Carcinoma,"the results of treating patients with HPV-unrelated head and neck squamous cell carcinoma with neoadjuvant single-agent palbociclib, followed by chemoradiation (either cisplatin + IMRT or cetuximab + IMRT depending on patient characteristics), followed by adjuvant single-agent palbociclib",,
NCT03403777,Avelumab in Refractory Testicular Germ Cell Cancer.,PHASE2,Testicular Neoplasms,AVELUMAB in patients with multiple relapsed/refractory germ cell tumors (GCTs),,
NCT03009877,Preoxygenation With Optiflow™ in Morbidly Obese Patients is Superior to Face Mask,NA,"Obesity, Morbid",,,
NCT05722275,Prediction of Peritoneal Metastasis for Gastric Cancer Based on Radiomics,,Gastric Cancer,,,
NCT01121575,A Study Of Combined C- MET Inhibitor And PAN-HER Inhibitor (PF-02341066 And PF-00299804) In Patients With Non- Small Cell Lung Cancer,PHASE1,Non Small Cell Lung Cancer,,,
NCT05442957,Building a Renewed ImaGe After Head & Neck Cancer Treatment (BRIGHT) Multi-Site RCT,NA,Head and Neck Cancer,"), measures of psychological and social well-being and quality of life (QOL), and measures of theory-derived mechanisms of change underlying BRIGHT (mediators)",,
NCT02820857,Assessment of the Efficacy of Bevacizumab in Combination With Folfiri as Second-line Treatment in Patients Suffering From an Advanced Inoperable Poorly Differentiated Neuroendocrine Carcinoma of an Unknown or Gastroentero-pancreatic Primary Cancer,PHASE2,Neuroendocrine Carcinomas,"of this study is to show that, after the failure of a first-line chemotherapy using platinum-etoposide, the combination Folfiri-bevacizumab allows significant prolongation of overall survival in adult patients with GEP-NEC","bevacizumab has also been suggested in patients with NEC, but never in the context of a phase II study",
NCT00557557,Safety Study of Oxaliplatin and 5-fluorouracil Followed by FUDR for Unresectable Colorectal Liver Metastases,PHASE1,Colorectal Liver Metastases,the maximum tolerated dose and dose limiting toxicity of 5-FU in combination with Oxaliplatin delivered via isolated hepatic perfusion,,
NCT01520701,Impact of Applying a Bandage Skin Hydrogel on the Pains of the Head and Neck in Patients With Cancer of Head and Neck Treated With Radiotherapy,PHASE3,Head and Neck Cancer,,,
NCT00627419,"A Study Evaluating the Safety and Antitumor Activity of IPI-504, in Patients With Metastatic Melanoma",PHASE2,Metastatic Melanoma,the antitumor activity of IPI-504 in patients with metastatic melanoma,,
NCT03376503,Nanogen Pegfilgrastim (Pegcyte) PK/PD Clinical Study in Breast Cancer Patients,PHASE1,Breast Cancer,the serum concentration of investigational drugs at specific time points in the first cycle,,
NCT00003327,Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer,PHASE2,Head and Neck Cancer,,,
NCT04764227,Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shanghai 17),PHASE2,Esophagus Cancer,safety and 2-year local control rate for postoperative concurrent chemoradiotherapy for esophageal squamous cell carcinoma,,
NCT02034227,"Safety, Tolerability Study of SG2000 in the Treatment of Advanced Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia",PHASE1,Acute Myeloid Leukemia,"if the experimental drug, SG2000 is safe and tolerable in the treatment of participants with advanced chronic lymphocytic leukemia and acute myeloid leukemia whose standard treatment did not work, whose cancer came back or who are not candidates for other types of standard therapy",,
NCT06198842,Low Dose Treosulfan Based Conditioning Regimen and PTCy in HSCT for Nijmegen Breakage Syndrome,PHASE2,Nijmegen Breakage Syndrome,of the current study is to evaluate the safety and efficacy of low dose treosulfan based conditioning regimen in HSCT with post-transplant cyclophosphamide in Nijmegen breakage syndrome,the safety and efficacy of low dose treosulfan based conditioning regimen in HSCT with post-transplant cyclophosphamide in Nijmegen breakage syndrome,low dose treosulfan based conditioning regimen in HSCT with post-transplant cyclophosphamide in Nijmegen breakage syndrome
NCT06444542,Understanding Patient Preference on Colorectal Cancer Screening Options-PSU,,Colo-rectal Cancer,"of this study is to examine whether the availability of a blood-based screening option, which can be done at the point of service and is familiar to patients, will improve patient compliance to recommended CRC screening",,
NCT04123886,A Phase I Study Evaluating SCB-313(Recombinant Human TRAIL-Trimer Fusion Protein) for the Treatment of Malignant Pleural Effusion,PHASE1,Malignant Pleural Effusion,the safety and tolerability of single dose of SCB-313 by intrapleural injection,the maximum tolerated dose (MTD) of SCB-313,
NCT01977586,Functional Imaging in the Assessment of mRCC Response to Sunitinib,NA,Metastatic Renal Cell Carcinoma,of this study is to assess whether functional magnetic resonance imaging (MRI) techniques are able to detect which patients with metastatic renal cell carcinoma will derive benefit from treatment with anti-angiogenic drugs early in their treatment,whether functional magnetic resonance imaging (MRI) techniques are able to detect which patients with metastatic renal cell carcinoma will derive benefit from treatment with anti-angiogenic drugs early in their treatment,
NCT00866086,Comfort Level of Two Abdominal Compression Methods Used to Hold Patients Still While Undergoing Stereotactic Body Radiation Therapy for Lung Tumors,PHASE1,Lung Cancer,,,
NCT02275286,Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients,PHASE1,"Liposarcoma, Myxoid",,,
NCT03871686,Promotion of Well-being of Young Adult Brain Cancer Survivors,NA,"Brain Tumor, Pediatric","the effectiveness of an Internet-based, behavioral activation intervention to promote well-being in a young adult survivors of childhood brain tumor",,
NCT05631886,Combination of CAR-DC Vaccine and ICIs in Malignant Tumors,PHASE1,"Solid Tumor, Adult",to: assess the safety and antitumor effects of TP53-EphA-2-CAR-DC vaccine,"the safety, efficacy and immune response of autologous EphA2-targeting CAR-DC vaccine loaded with TP53 mutant peptide (TP53-EphA-2-CAR-DC) in combination with ICIs",
NCT05287386,A Single-Arm Phase II Clinical Study of Pemigatinib in the Treatment of Advanced Non-Small Cell Lung Cancer Patients With FGFR Alterations Who Have Failed Standard Therapy,PHASE2,Advanced Non-Small Cell Lung Cancer,,,
NCT00001586,Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): DNA Microarray Gene Expression Analysis,PHASE2,Chronic Lymphocytic Leukemia,-To gain further knowledge about CLL/SLL and the role of rituximab and fludarabine in treating the disease,,
NCT04303286,The Effect of Gut Microbiota on Postoperative Liver Function Recovery in Patients With Hepatocellular Carcinoma,,Gut Microbiota,,,
NCT06376786,Italian iTTP Registry,,TTP - Thrombotic Thrombocytopenic Purpura,"ed at better defining and understanding the natural history, disease severity, and clinical outcomes of patients with immune-mediated thrombotic thrombocytopenic purpura (iTTP) in Italy",,
NCT01720186,Evaluation of a Pneumotachograph (SPI) for the Production of PET and CT Acquisitions Synchronized With Breath for the Assessment of Extension of Lung Cancer,NA,Non Small Cell Lung Cancer,the acceptability and performance of the experimental medical device (SPI) used during an imaging examination (PET / CT 4D imaging in synchronized mode centered on the thorax),,
NCT06371586,Neo-Sequence 2：NCT Plus Anti-angiogenesis Therapy and Immunotherapy for LADGC,PHASE2,Gastric Cancer,,,
NCT03992170,Study of Daratumumab in Multiple Myeloma (MM) Patients in >VGPR/MRD-positive,PHASE2,Myeloma Multiple,"of this study is to evaluate Daratumumab effect on MRD-positive patients with Multiple Myeloma (MM) who achieved \>VGPR after any therapy (ASCT, VMP, Rev-Dex)","Daratumumab effect on MRD-positive patients with Multiple Myeloma (MM) who achieved \>VGPR after any therapy (ASCT, VMP, Rev-Dex)",
NCT04405570,"Safety, Tolerability and Efficacy of Molnupiravir (EIDD-2801) to Eliminate Infectious Virus Detection in Persons With COVID-19",PHASE2,"SARS-CoV-2 Infection, COVID-19",,,
NCT00017173,"S0011, Gene Therapy & Surgery Followed by Chemo & RT in Newly Diagnosed Cancer of the Mouth or Throat",PHASE2,Head and Neck Cancer,,,
NCT03560973,"A Double Blind, Placebo Controlled, Randomized Phase II Study Evaluating Gemcitabine With or Without Ramucirumab , for II Line Treatment MPM",PHASE2,Mesothelioma,,,
NCT05884073,Exercise for Oncology Care Professionals,NA,"Burnout, Caregiver","the feasibility and acceptability, and impact of a 12-week exercise intervention on oncology care provider burnout",,
NCT04566783,Identification of Etiopathological and Clinical Factors in Persistent Genital Arousal Disorder,,Restless Genital Syndrome,,,
NCT04874883,Effect of the Use of Symbiotics in Patients With Colon Cancer,PHASE4,Symbiotic,"ing at the adequate infusion of enteral diets and, consequently, nutritional needs",the impact of perioperative supplementation with symbiotic on clinical outcomes and intestinal function of patients with colon cancer and digestive airways undergoing colorectal resection,
NCT05673083,Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma,,Multiple Myeloma in Relapse,patient activation,the impact of All4Cure enrollment on patients with multiple myeloma,
NCT00512083,Phase II Study of AS1411 Combined With Cytarabine to Treat Acute Myeloid Leukemia,PHASE2,"Leukemia, Myeloid","of this study is to assess the efficacy and safety of AS1411, over a range of doses, when combined with cytarabine, in the treatment of patients with primary refractory or relapsed acute myeloid leukemia (AML)","the efficacy and safety of AS1411, over a range of doses, when combined with cytarabine, in the treatment of patients with primary refractory or relapsed acute myeloid leukemia (AML)",
NCT02320383,CLLR3: Bendamustine + GA101 (BG) in Relapsed or Refractory CLL Followed by GA101 Maintenance for Responding Patients,PHASE2,Chronic Lymphocytic Leucemia,,,
NCT04011969,The Role of Gut Microbiome and Chronic Inflammation in Young-onset Colorectal Cancer,,Colorectal Cancer,to investigate the role of gut microbiome pattern and inflammation marker NF-ҡB in young-onset colorectal cancer,,
NCT00396383,Treatment With AMD3100 (Plerixafor) in MM Patients to Mobilize PBCs For Collection and for Transplantation,PHASE2,Multiple Myeloma,,,
NCT07214883,UCF MammoChat: Image Repository,,Breast Cancer,"to develop AI models to better read diagnostic mammograms for various populations and types of breast cancer, using the images that participants donate and their responses from study questionnaire to improve patient outcomes",,
NCT06325683,Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma,PHASE2,Progressive Glioblastoma,,,
NCT03518554,"A First in Human, Dose Escalation Study of JAB-3068 （SHP2 Inhibitor） in Adult Patients With Advanced Solid Tumors",PHASE1,Non-small Cell Lung Cancer,"the safety, tolerability, pharmacokinetics, and preliminary evidence of antitumor activity of JAB-3068 in adult patients with advanced solid",,
NCT04588454,18F-PSMA PET/CT for Visualization of Glioblastoma Multiforme,NA,Glioblastoma Multiforme,uptake of PET tracer 18F-PSMA-1007 in primary glioblastoma,,
NCT02139605,"""Phase III Randomized Trial Comparing D2 vs D3 Lymphadenectomy With Gastric Cancer Following Neoadjuvant Chemotherapy",NA,Gastric Cancer,,,
NCT04465305,A Randomized Controlled Study on the Treatment of Sacral Canal Cysts With Sacral Canal Reinforcement,NA,Tarlov Cysts,"the safety of nerve root sleeve reconstruction and sacroplasty in reducing the safety of postoperative cyst recurrence Sex and effectiveness, so as to further improve the surgical treatment of sacral canal cysts, improve the curative effect, and formulate the operation specifications for the treatment of sacral canal cyst",,
NCT02131805,Electronic Skin Surface Brachytherapy for Cutaneous Basal Cell and Squamous Cell Carcinoma,NA,Cutaneous Basal Cell,the effectiveness of electronic skin surface brachytherapy (ESSB) for early stage basal or squamous cell carcinoma of the skin using a new device,,
NCT03887494,"Study of the Impact of the Femoral Implant ""Y-strut"" on Lytic Bone Metastases of the Femoral Neck (WAZA-ARY)",NA,"Neoplasms, Bone Tissue",,,
NCT01481194,ACVDL Treatment for Patients With Newly Diagnosed Multiple Myeloma,PHASE2,Multiple Myeloma,"the efficacy and safety of the combination treatment of doxorubicin, cyclophosphamide, bortezomib, dexamethasone, and lenalidomide in newly diagnosed multiple myeloma patients",,
NCT01804166,A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL),PHASE4,Hepatosplenic T-Cell Lymphoma,,,
NCT02343666,HIV-Resistant Gene Modified Stem Cells and Chemotherapy in Treating Patients With Lymphoma With HIV Infection,PHASE1,Human Immunodeficiency Virus 1 Positive,,,
NCT00430066,Effects of Imatinib Mesylate in Polycythemia Vera,PHASE2,Polycythemia Vera,how the disease is responding to the drug,"the activity of Glivec 400 mg po daily, as single agent, in inducing a haematological response in Polycythemia Vera",
NCT01830166,Focal Therapy for Prostate Cancer - A Pilot Study of Focal Low Dose Rate Brachytherapy,NA,Prostate Cancer,"the long term use of multi-modal, multi-parametric prostate cancer imaging, combining data from MRI, ultrasound and 11C-choline PET/CT",the extent of cancer and suitable treatments,
NCT00001466,Study of Clinical and Molecular Manifestations of Genetic Disorders,,Hereditary Diseases,,,
NCT02958566,Multimodal Narcotic Limited Perioperative Pain Control With Colorectal Surgery,PHASE4,Colon Cancer,of this study is to investigate the cost and efficacy of treating patients undergoing colorectal surgical resections with an opioid limited pain control regimen as part of an Enhanced Recovery After Surgery (ERAS) Protocol,treating patients undergoing colorectal surgical resections with an opioid limited pain control regimen as part of an Enhanced Recovery After Surgery (ERAS) Protocol,
NCT06379256,Evaluation of Immune Responses and Outcomes in Patients With Hepatocellular Carcinoma Undergoing Radiotherapy,,Hepatocellular Carcinoma,"to prospectively assess immunological responses and dose-volumetric parameters, while identifying predictors of clinical outcomes in patients undergoing definitive radiotherapy for hepatocellular carcinoma",,
NCT01077856,GARDASIL™ Vaccine Impact in Population Study (V501-033),,Human Papillomavirus Infections,the impact of GARDASIL™ human papillomavirus (HPV) vaccine in the general female population by utilizing nationwide registry databases in the participating Nordic countries,,
NCT03494322,EACH: Evaluating Avelumab in Combination With Cetuximab in Head and Neck Cancer,PHASE2,Head and Neck Cancer,to see if giving cetuximab along with an immune checkpoint inhibitor drug called avelumab is better at treating advanced H\&N cancer than giving avelumab on its own,,
NCT02956122,A Phase 2/3 Study of GLASSIA for the Treatment of Acute GvHD,PHASE2,Graft Versus Host Disease,the safety and efficacy of GLASSIA as an add-on biopharmacotherapy to standard-of-care steroid treatment as the first-line treatment in participants with acute GvHD with lower GI involvement,GLASSIA as an add-on biopharmacotherapy to standard-of-care steroid treatment as the first-line treatment in participants with acute GvHD with lower GI involvement,
NCT04137822,Expanded Access Program Using IMM-101 for Patients With Advanced Pancreatic Cancer,,Pancreas Cancer,,,
NCT06781151,A Study to Explore Personalized Treatment for Patients With Recurrent Gynecological Malignancies Based on MTB,,Ovarian Cancer Recurrent,to observe and evaluate the clinical efficacy of personalized treatment plans developed through molecular tumor profiling and multidisciplinary consultation,molecular tumor profiles,personalized targeted therapies guided by molecular tumor profiling and multidisciplinary consultation
NCT06333951,AMG 193 Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104).,PHASE1,Thoracic Tumors,to determine maximum tolerated dose (MTD) or recommended combination dose of the MTA-cooperative PRMT5 inhibitor AMG 193 administered in combination with other therapies in adult participants with metastatic or locally advanced methylthioadenosine phosphorylase (MTAP)-deleted thoracic tumors,maximum tolerated dose (MTD) or recommended combination dose of the MTA-cooperative PRMT5 inhibitor AMG 193 administered in combination with other therapies in adult participants with metastatic or locally advanced methylthioadenosine phosphorylase (MTAP)-deleted thoracic tumors,
NCT00467129,Genes That Affect Disease Outcome in Patients With Metastatic Colorectal Cancer,,Colorectal Cancer,,,
NCT01865929,Minimally Invasive Benign Hysterectomy,NA,Menorrhagia,,,
NCT01895829,Ferumoxytol - Iron Oxide Nanoparticle Magnetic Resonance Dynamic Contrast Enhanced MRI,EARLY_PHASE1,Head and Neck Cancer,,,
NCT00084929,The National CT Colonography Trial,NA,Colorectal Cancer,,,
NCT03775031,Chemical Peels and Fractional Laser on IGF-1 Levels in Skin,NA,Skin Cancer,the impact of fractional laser versus chemical peels on IGF-1 levels in skin,,
NCT06425302,A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma,PHASE2,"Lymphoma, Follicular",the efficacy and safety of golcadomide in combination with rituximab in participants with newly diagnosed advanced stage Follicular Lymphoma (FL),,
NCT06832202,"A Phase II Study of HLX22 in Combination With Trastuzumab Deruxtecan in HER2-low, Hormone Receptor Positive Locally Advanced or Metastatic Breast Cancer Patients",PHASE2,HER2-low Hormone Receptor Positive Breast Cancer,,,
NCT01386502,CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors,PHASE1,Breast Cancer,\- To test the safety and effectiveness of CT-011 and the p53 genetic vaccine to treat adults with solid tumors that have not responded to standard treatments,,
NCT00004002,PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma,PHASE1,Lymphoma,,,
NCT03977753,"Randomized, Placebo-controlled, Double Blind Study to Evaluate the Efficacy of 2LVERU®JUNIOR and 2LVERU® on the Treatment of Warts",PHASE4,Common Wart,the treatment on the disappearance of warts at the end of treatment (6-month visit) between the 2LVERU® JUNIOR and 2LVERU® versus the placebo group,,
NCT05996653,CEST in Low-grade Glioma Study,NA,Low-grade Glioma,to predict early changes in LGG,LGG tumour progression and aims to predict early changes in LGG,
NCT04683653,Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer,PHASE1,Endometrial Cancer,,,
NCT03986437,A Prospective Study to Collect Images in Patients Treated With Iodine-131 as Part of a European Research Project in Radiation Protection.,,Differentiated Thyroid Cancer,ing to collect standard of care imaging of patients treated with Iodine-131 for the determination of dosimetric studies,,
NCT04418245,CT Biomarkers Identification by Artificial Intelligence for COVID-19 Prognosis,,Covid-19,,,
NCT00436072,"ZD6474, Cetuximab, and Irinotecan in Patients With Metastatic Colorectal Cancer",PHASE1,Colorectal Cancer,,,
NCT05152472,"A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined with Atezolizumab Versus Imatinib Resumption Alone in Patients with Unresectable Advanced Gastrointestinal Stromal Tumors (GIST) After Failure of Standard Treatments",PHASE2,Unresectable Gastrointestinal Stromal Tumor (GIST),,,
NCT04622072,XZP-5809-TT1 Tablets in Patients With T790M Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer,PHASE1,Non Small Cell Lung Cancer,response rate (ORR) in patients With T790M Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer,"safety and tolerability of XZP-5809-TT1 tablets after treatment with epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) in patients With T790M Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer, and to determine the maximum tolerated dose (MTD) and dose-limiting toxicity (DLT)",the maximum tolerated dose (MTD) and dose-limiting toxicity (DLT)
NCT04994795,Predictive Multimodal Signatures Associated With Response to Treatment and Prognosis of Patients With Stage IV Non-small Cell Lung Cancer,,Non-small Cell Lung Cancer Metastatic,,,
NCT00569595,Improving Health Habits in Impoverished Populations,PHASE3,Diabetes,,,
NCT03307395,Middle Meningeal Artery Embolization for Treatment of Chronic Subdural Hematoma,NA,Chronic Subdural Hematoma,"the safety and efficacy of MMA embolization compared to traditional surgical management for symptomatic, chronic, and medically refractory SDH","MMA embolization compared to traditional surgical management for symptomatic, chronic, and medically refractory SDH",
NCT00858039,Cardiotoxicity of Adjuvant Trastuzumab,,Breast Neoplasms,of this study is to evaluate the utility of NT pro-BNP as a predictive biomarker for the development of trastuzumab related cardiotoxicity (TRC),the utility of NT pro-BNP as a predictive biomarker for the development of trastuzumab related cardiotoxicity (TRC),
NCT01888939,Effects of Interrupting Sedentary Behavior on Metabolic and Cognitive Outcomes in Children,PHASE1,Healthy Volunteer,\- To understand if breaking up sitting with walking helps children s bodies better use sugars and improves children s concentration,,
NCT02867839,Adjuvant Chemotherapy With S-1 Plus Oxaliplatin Versus S-1 Alone in Locally Advanced Gastric Cancer,PHASE3,Gastric Cancer,the efficacy and safety of S-1 plus Oxaliplatin versus S-1 only as adjuvant chemotherapy after curative distal gastrectomy in patients with locally advanced gastric cancer,,
NCT00431639,Effects of Pet Therapy on Pain in Cancer Patients,PHASE2,Cancer,,,
NCT00195039,Treatment With Radiolabeled Monoclonal Antibody HuJ591-GS (177Lu-J591) in Patients With Metastatic Prostate Cancer,PHASE2,Prostate Cancer,,,
NCT03433313,Efficacy and Safety Study of EG12014 Compared With Herceptin in Subjects With HER2 Positive Early Breast Cancer,PHASE3,Breast Cancer,,,
NCT06429813,Remotely Monitored Exercise Interventions in Patients with MCSPC Undergoing ADT (Prostate 006),NA,Castrate Sensitive Prostate Cancer,,,
NCT02713113,Efficacy of Low Dose Sugammadex in Reversal of NMB in Laparoscopic Barbaric Surgery,PHASE3,Bariatric Patients,ed to compare the efficacy and safety of sugammadex at doses of 1,,
NCT02935920,A Study on Optimizing Follow-up for Postmenopausal Women With Breast Cancer Treated With Adjuvant Endocrine Therapy,NA,Breast Cancer,Evaluation of the experience and feasibility of PRO data in connection with individualized follow-up of postmenopausal women with breast cancer,the patient's need for consultations,
NCT06486220,"PFLL Combined With PD-1 Antibody With or Without FMT for Oligometastatic NPC,a Phase III ,Open, Randomized Clinical Trial.",PHASE3,Nasopharyngeal Carcinoma,"low-dose long term 5-FU pumping (""old fire soup"") therapy combined with immunotherapy and reduce the occurrence of toxic side effects in patients with metastatic nasopharyngeal carcinoma",,
NCT05010720,Prevelance of Frailty and Its Associated Factors in Patients With Axial Spondyloarthritis,,Frailty,"of our study was to investigate the prevalence of frailty and the relationship between frailty and disease activity, physical functional level, quality of life and other associated factors in individuals with Axial Spondyloarthritis",,
NCT03435120,Quality of Life Study Breakthrough Cancer Pain Treated in Medical Oncology Services (CAVIDIOM),,Breakthrough Pain,the quality of life of cancer patients with breakthrough cancer pain treated in medical oncology services in Spanish hospitals,,
NCT03525782,Anti-MUC1 CAR T Cells and PD-1 Knockout Engineered T Cells for NSCLC,PHASE1,Lung Neoplasm Malignant,the safety and efficacy of the anti-MUC1 CAR T cells and /or PD-1 knockout engineered T cells for patients with advanced non-small cell lung cancer,the anti-MUC1 CAR T cells and /or PD-1 knockout engineered T cells for patients with advanced non-small cell lung cancer,
NCT00022282,AE-941 in Treating Patients With Relapsed or Refractory Multiple Myeloma,PHASE2,Multiple Myeloma and Plasma Cell Neoplasm,,,
NCT01312324,Neoadjuvant Chemotherapy for Locally Advanced Thymic Cancer,PHASE2,Locally Advanced Stage III or IV Thymic Cancer,whether neoadjuvant docetaxel plus cisplatin can increase the complete resection rate in advanced thymic carcinoma,,
NCT01071824,Comparison of Limb Size of Transverse Coloplasty Pouch,NA,Colon Cancer,of the study is the comparison of pouch function with two different sizes of limb of transverse coloplasty pouch after rectal resection and total mesorectal excision,,
NCT06160323,Upfront EUS CGN/CPN vs Conventional Step up Approach for Inoperable Painful Pancreatic Cancer,NA,Pancreatic Cancer Non-resectable,,,
NCT00918723,"Vorinostat, Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma",PHASE1,Chronic Lymphocytic Leukemia,,,
NCT01723423,Mastectomy Reconstruction Outcomes Consortium (MROC) Study,,Breast Cancer,and compare from the patient's point of view the leading options for breast reconstruction after mastectomy,,
NCT07105059,A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma,PHASE1,Multiple Myeloma,,,
NCT05554380,"Study of Chemotherapy Plus Ipatasertib for People With Solid Tumors With PTEN/AKT Mutations, A ComboMATCH Treatment Trial",PHASE2,Locally Advanced Malignant Solid Neoplasm,,,
NCT03244059,Belimumab Treatment of Emphysema Patients With Anti-GRP78 Autoantibodies,PHASE2,Chronic Obstructive Pulmonary Disease,effects of belimumab on levels of autoantibodies against glucose regulated protein 78 (GRP78) among patients with pulmonary emphysema attributable to cigarette smoking,,
NCT00827580,Eniluracil Hand Foot Syndrome,PHASE1,Breast Cancer,,,
NCT06191679,Decision Aid for Education and Support About Cancer Treatment,NA,Cancer,"DECIDES, a web-based decision support application that provides education about cancer and cancer treatment and provides support to encourage adolescent and young adult (AYA) patients, their caregivers, and oncology health care providers to make informed decisions about cancer treatment together",,
NCT06575296,Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant,PHASE1,Acute Leukemia,,,
NCT06533696,"A Comparison of Microscopy and Enzyme Linked Immunosorbent Assay for Diagnosis of Giardia Lamblia in Children, Sohag",,Giardia Lamblia Infection,the efficacy of Human anti Giardia lamblia antibody (ELISA) kitst in comparison to direct microscopy in the diagnosis of G,Human anti Giardia lamblia antibody (ELISA) kitst in comparison to direct microscopy in the diagnosis of G,
NCT02434562,Development and Validation of in Vitro Cell-based Bioassays for Nuclear Receptor Activation,,Hypogonadism,,,
NCT04873362,A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy,PHASE3,Breast Cancer,,,
NCT04329962,Metabolism and Absorption of Anthocyanins From Extract and Whole Blueberry Powder Confections in Healthy Adults,NA,Healthy Diet,,,
NCT04176562,Prospective SPINE Registry,,Sacroiliac; Fusion,,,
NCT00364962,Treatment Result of KTP Laser Nasopharyngectomy in Recurrent NPC Patients,,Recurrent,,,
NCT02701088,"Study of SIB-IMRT in Combination With 5-FU and Mitomycin-C Among Patients With Locally Advanced Anal Canal Cancer: Efficacy, Safety and Quality of Life",PHASE2,Locally Advanced Anal Canal Cancer,,,
NCT01931488,124I-MIBG Tracer Evaluation of Myocardial Sympathetic Denervation and Assessment of Neuroendocrine Tumors.,PHASE2,Parkinson Disease,,,
NCT01612988,"Treatment With Bendamustine, Ofatumumab and MethylPrednisolone in Relapsed B-CLL",PHASE2,B-cell Chronic Lymphocytic Leukemia (B-CLL),,,
NCT05156788,"Tislelizumab（Anti PD-1), Lenvatinib and GEMOX Transformation in the Treatment of Potentially Resectable, Locally Advanced Biliary Tract Cancer",PHASE2,Biliary Tract Cancer,of this study is to assess the R0 resection rate of tislelizumab combined with Lenvatinib and Gemox chemotherapy in the conversion therapy of potentially resectable locally advanced BTC,the R0 resection rate of tislelizumab combined with Lenvatinib and Gemox chemotherapy in the conversion therapy of potentially resectable locally advanced BTC,
NCT06951646,ctDNA-MRD Guided Escalation of Ivonescimab and Docetaxel in Advanced NSCLC With Long-Term Responses to First-line Immunotherapy (CR1STAL-Adaptive),PHASE2,Non Small Cell Lung Cancer,"the safety and efficacy of Ivonescimab (PD-1/VEGF bispecific antibody) combined with docetaxel versus standard treatment in patients with advanced NSCLC who have achieved long-term benefit from first-line immune checkpoint inhibitors (ICIs), but are ctDNA-MRD positive","Ivonescimab (PD-1/VEGF bispecific antibody) combined with docetaxel versus standard treatment in patients with advanced NSCLC who have achieved long-term benefit from first-line immune checkpoint inhibitors (ICIs), but are ctDNA-MRD positive",
NCT01738646,Ph II SAHA and Bevacizumab for Recurrent Malignant Glioma Patients,PHASE2,Recurrent Glioblastoma Multiforme,,,
NCT06196788,Transcatheter Arterial Infusion to Patients With Advanced Pancreatic Cancer,PHASE2,Pancreatic Cancer,the efficacy of gemcitabine and nab-paclitaxel venous injection plus transcatheter arterial infusion to Patients with Advanced Pancreatic Cancer,gemcitabine and nab-paclitaxel venous injection plus transcatheter arterial infusion to Patients with Advanced Pancreatic Cancer,
NCT06683703,Utidelone Injection Combined with Bevacizumab Injection for Non-small Cell Lung Cancer Patients with Brain Metastases,PHASE2,Non-small Cell Lung Cancer Patients with Brain Metastases,"of the first stage was to determine the combined dose of the first stage and the second stage, and to compare the intracranial efficacy of the two treatment groups","the intracranial efficacy of Utidelone combined with Bevacizumab in patients, and the secondary purpose was to evaluate the other intracranial efficacy, systemic efficacy, safety and tolerability of Utidelone combined with Bevacizumab in patients, and to explore the improvement of patients' quality of life","the combined dose of the first stage and the second stage, and to compare the intracranial efficacy of the two treatment groups"
NCT03227003,DNA Methylation and 1-C Metabolism Nutrient Intake,,DNA Methylation,,,
NCT04493203,Nivolumab Plus Axitinib in Patients With Anti-PD1 Refractory Advanced Melanoma,PHASE2,Advanced Melanoma,,,
NCT03931642,BLINAtumomab After R-CHOP Debulking Therapy for Patients With Richter Transformation,PHASE2,Richter Syndrome,"the efficacy, safety and tolerability of blinatumomab administered after R-CHOP debulking therapy in patients with Richter Syndrome (RS) of diffuse large B-cell lymphoma (DLBCL) histology",,
NCT00984542,Bendamustine as Second-Line Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer,PHASE2,Lung Cancer,,,
NCT06479070,"Prognostic Value of Measuring CtDNA in a Cohort of Patients With Stage III and IV Upper Aero-digestive Tract (UADT) Cancer , Treated With Curative RADiOtherapy With or Without Concomitant Treatment.",NA,SCC - Squamous Cell Carcinoma,of this study is to evaluate the value of measuring the quantity of circulating tumor DNA (ctDNA) at 1 month post-treatment as a predictive factor for PFS at 24 months,the value of measuring the quantity of circulating tumor DNA (ctDNA) at 1 month post-treatment as a predictive factor for PFS at 24 months,
NCT03184870,A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Participants With Advanced Solid Tumors,PHASE1,Colorectal Cancer,"the safety profile, tolerability, drug levels, drug effects, and preliminary efficacy of BMS-813160 alone or in combination with either chemotherapy or nivolumab or chemotherapy plus nivolumab in participants with metastatic colorectal and pancreatic cancers",BMS-813160 alone or in combination with either chemotherapy or nivolumab or chemotherapy plus nivolumab in participants with metastatic colorectal and pancreatic cancers,
NCT00002069,A Study of DTC in Patients With AIDS and AIDS Related Complex,NA,HIV Infections,if ditiocarb sodium (sodium diethyldithiocarbamate,,
NCT02834169,French National Registry of Rare Peritoneal Surface Malignancies,,Rare Peritoneal Surface Malignancies,at the collection of data from patients presenting with a rare peritoneal surface malignancy in France,"treatment strategies, the RENAPE registry aims at the collection of data from patients presenting with a rare peritoneal surface malignancy in France",
NCT00538473,Evaluate Safety and Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults,PHASE2,Influenza,,,
NCT00899054,Safety and Efficacy Study of P276-00 in Combination With Radiation in Subjects With Advanced Head and Neck Cancer,PHASE1,Squamous Cell Carcinoma of Head and Neck,the combination in treatment of advanced head and neck cancer,,
NCT07000305,A Study of Cetuximabβ Combined With Envolimab and mFOLFOX6 in Subjects With Advanced Colorectal Cancer,PHASE2,Advanced Colorectal Cancer,,,
NCT04132505,Binimetinib and Hydroxychloroquine in Treating Patients With KRAS Mutant Metastatic Pancreatic Cancer,PHASE1,Metastatic Pancreatic Adenocarcinoma,,,
NCT03656705,CCCR-NK92 Cells Immunotherapy for Non-small Cell Lung Carcinoma,PHASE1,Non-small Cell Lung Cancer,the safety and effects of CCCR-modified NK92(CCCR-NK92)infusions in previously treated advanced non-small cell lung carcinoma(NSCLC),,
NCT00188305,A Randomized Trial of Cancer Risk and Health Education in Relatives of Colorectal Cancer Patients,PHASE3,Colon Cancer,of this study is to test the efficacy of two modes (in-person vs,two modes (in-person vs,
NCT02258594,"Promoting Respect and Ongoing Safety Through Patient-centeredness, Engagement, Communication and Technology",NA,Medical Intensive Care Unit (MICU) Patients,,,
NCT03579966,Long Term Safety Study of Amifampridine Phosphate in MuSK-MG (Muscle Specific Tyrosine Kinase Myasthenia Gravis),PHASE3,"Myasthenia Gravis, MuSK",,,
NCT06892756,"Effect of Cyclosporine Drug Interaction on the Absorption, Metabolism and Elimination of CHF6001 in Healthy Volunteers. Drug-Drug Interaction 2 (DDI2) Study",PHASE1,Chronic Obstructive Pulmonary Disease (COPD),"the potential effect of cyclosporine (probe inhibitor of P glycoprotein \[P-gp\] and breast cancer resistance protein \[BCRP\] transporters) on CHF6001 (Tanimilast) systemic exposure following single dose administration, by comparing the area under the curve (AUC) from time 0 to the last quantifiable concentration (AUC0 t) and the maximum plasma concentration (Cmax) of CHF6001 with and without cyclosporine",,
NCT01528956,Studying Genes in Samples From Younger Patients With Adrenocortical Tumor,,Adrenocortical Carcinoma,,,
NCT04960956,Glycosylation of Exosomes in Prostate and Urothelial Carcinoma,,Prostate Cancer,,,
NCT06437522,A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors,PHASE2,Head and Neck Squamous Cell Carcinoma,,,
NCT02830451,Metastatic Tumor Research and Outcomes Network,,Metastatic Spine Tumor,"to collect patient information such as patient demographics, co-morbidities, clinical, diagnostic, and therapeutic data, as well as information on adverse events and HRQOL outcomes specific for patients with metastatic spine tumor(s)",,
NCT05232851,A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer,PHASE1,Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,,,
NCT00283829,Immunotherapy After Chemotherapy for Patients With Hormone Refractory Metastatic Prostate Cancer,PHASE1,Prostate Cancer,,,
NCT01282151,TaxoteRe Plus Cisplatin Versus AlImta Plus Cisplatin in 1st Line Non-squamous Cell Type Lung Cancer,PHASE3,"Carcinoma, Non Small Cell Lung",,,
NCT04296929,The Effect of Complex Decongestive Physiotherapy on Sensory Parameters in Breast Cancer Related Lymphedema.,NA,Lymphedema,of this study was to determine the effect of complex decongestive physiotherapy in women with unilateral breast cancer-related lymphedema on sensory parameters,the effect of complex decongestive physiotherapy in women with unilateral breast cancer-related lymphedema on sensory parameters,
NCT03628131,Combination Chemotherapy With Pazopanib in Children and Adolescents With Relapsed/Refractory Solid Tumors,PHASE1,Relapsed Pediatric Solid Tumor,the safety and efficacy of combination chemotherapy with Pazopanib in pediatric patients with relapsed/refractory solid tumor,combination chemotherapy with Pazopanib in pediatric patients with relapsed/refractory solid tumor,
NCT00003931,Diagnostic Study of Gene Alterations in Patients With Acute Myeloid Leukemia,,Leukemia,,,
NCT02124902,Neoadjuvant Treatment of Triple Negative Breast Cancer Patients With Docetaxel and Carboplatin to Assess Anti-tumor Activity,PHASE2,Triple Negative Breast Neoplasms,the anti-tumor activity (in terms of pathologic complete response rate) of neoadjuvant docetaxel in combination with carboplatin,,
NCT06589102,Prevalence and Consequences of Hyperlactemia Following Pancreatic Surgery,,Pancreatic Cancer,,,
NCT00782002,"Safety Study of IMC-18F1,to Treat Advanced Solid Tumors in Subjects That no Longer Respond to Standard Therapy",PHASE1,Advanced Solid Tumors,"if IMC-18F1 is safe for patients, and also to determine the best dose of IMC-18F1 to give to patients",,
NCT05921253,Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy,NA,Breast Cancer,"if low level vagus nerve stimulation will lead to improvement in heart function, heart rate variation, and in the levels of certain chemical markers of inflammation in study participants' blood",,
NCT06360653,a SIngle Center Study of Post-operative STEReotactic RAdiotherapY for Endometrial Cancer,NA,Endometrial Cancer,of the present prospective study is to assess the outcomes in terms of acute toxicity of post-operative stereotactic radiotherapy for endometrial cancer,the outcomes in terms of acute toxicity of post-operative stereotactic radiotherapy for endometrial cancer,
NCT04739202,Personalized Targeted IMMUNOtherapy-based Regimens in Recurrent GASTric Adenocarcinoma (IMMUNOGAST),PHASE2,Gastric Adenocarcinoma,,,
NCT01625702,Clinical Significance of Circulating Tumor Cells (CTCs) in Blood of Patients With Advanced/Metastatic Gastric Cancer,NA,Gastric Cancer,,,
NCT04741802,TOPS for African American Breast Cancer Survivors,NA,Feasibility and Acceptability of the TOPS Program,of these aims are to a) determine if the TOPS materials and format are possible and accepted by overweight and obese African American breast cancer survivors,,
NCT00061945,Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia,PHASE1,Acute Undifferentiated Leukemia,,,
NCT06568172,"Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer",PHASE3,Recurrent Head and Neck Cutaneous Squamous Cell Carcinoma,,,
NCT00460395,Surgery Versus Stereotactic Radiosurgery in the Treatment of Single Brain Metastasis: A Randomized Trial,PHASE3,Brain Cancer,"* To compare the survival (overall, systemic, and neurological) of patients with single cerebral metastases treated with either conventional surgical resection or stereotactic radiosurgery",,
NCT07111195,Feasibility of ONCOhabitats for Surgical and Treatment Planning in IDH-Wildtype Glioblastoma (SINUE),,Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype,to evaluate whether imaging biomarkers derived from pre-surgical MRI using ONCOhabitats can predict overall survival and support clinical decision-making,whether imaging biomarkers derived from pre-surgical MRI using ONCOhabitats can predict overall survival and support clinical decision-making,
NCT05000996,Gut Microbiota in Metabolic Surgery,,Bariatric Surgery Candidate,"to fill these research gaps by establishing a longitudinal, observational study of metabolic surgery patients and applying multi-omics to identify stool, blood, and/or tissue microbial features related to post-surgery cardiometabolic outcomes",,
NCT03451162,"Safety, Tolerability, and Pharmacokinetic (PK) Study of DHES0815A in Participants With Human Epidermal Growth Factor Receptor (HER)2-Positive Breast Cancer",PHASE1,Breast Cancer,,,
NCT05968846,Repeat PET/CT Imaging of Patients With Amyloid 124I-AT-01 to Measure Changes in Organ-specific Amyloid Load,PHASE2,Systemic Amyloidosis,"whether changes in organ-specific uptake of 124I- AT-01 can be measured by PET/CT imaging and further, whether these values correlate with changes in a subject's disease status and thereby enable monitoring of disease response over time in terms of organ-specific amyloid load",,
NCT05185388,Socioeconomic Inequalities in the Diagnosis and Treatment of Colon and Ovarian Cancer in England Between 2016-2017,,Treatment Related Cancer,,,
NCT04874688,"Child Health, Agriculture and Integrated Nutrition",NA,Stunting,will be the proportion of infants in each trial arm reaching daily energy requirements at 9 months of age (visit window 9-11 months of age),,
NCT05208788,Urinary Biomarkers in Paediatric Kidney Transplantation (pKTx),,Renal Transplantation,"to test and validate the panel of study urinary biomarker to assess whether (1) reference values differ between paediatric renal transplant patients, patients with chronic kidney disease stage IV and V (CKD IV-V) and children without any disease, (2) characteristic changes in concentration profile may be observed after event-specific injury, (3) differences between paediatric renal transplant patients with AR and other causes of AKI can be detected, and (4) stratification of renal transplant patients to different histological types of AR is possible","whether (1) reference values differ between paediatric renal transplant patients, patients with chronic kidney disease stage IV and V (CKD IV-V) and children without any disease, (2) characteristic changes in concentration profile may be observed after event-specific injury, (3) differences between paediatric renal transplant patients with AR and other causes of AKI can be detected, and (4) stratification of renal transplant patients to different histological types of AR is possible",
NCT01810003,Impact of EPA and DHA Supplementation on Plasma Biomarkers of Inflammation (n3),NA,"Cardiovascular Disease, Inflammation",of the proposed research is to compare the anti-inflammatory effects of EPA and DHA in men and women with MetS,EPA and DHA is influenced by sex/gender is also unknown,
NCT00412503,Temozolomide in Association With Topotecan in Refractory or Relapsed Malignant Tumors in Children and Adolescents,PHASE1,Refractory Tumors,to determine Maximum Tolerated Dose and dose limiting toxicities of each drug when associated and to assess efficacy of the combination,efficacy of the combination,Maximum Tolerated Dose and dose limiting toxicities of each drug when associated and to assess efficacy of the combination
NCT00893503,Scope Pilot Research Study,,Colorectal Cancer,,,
NCT05357027,HPV16 E6 TCR T Cells for Cervical Carcinoma,PHASE1,Cervical Carcinoma,To evaluate the safety and efficacy of TCR-T cells in the treatment of cervical carcinoma,the safety and efficacy of TCR-T cells in the treatment of cervical carcinoma,TCR-T cells in the treatment of cervical carcinoma
NCT03149861,Detection of Clinically Significant Prostate Cancer With 18F-DCFPyL PET/MR,NA,"Neoplasm, Prostate",measure in this study is the proportion of clinically significant prostate cancers that are detected with PET/MRI compared to MRI alone,,
NCT06034561,Bortezomib-based Regimen for Refractory or Relapsed Acute Lymphoblastic Leukemia,PHASE2,"Acute Lymphoblastic Leukemia, in Relapse","ing to examine the complete response rate of a bortezomib-based salvage regimen in adults with refractory or relapsed acute lymphoblastic leukemia (ALL), seeking to compare outcomes with the available literature and with our historical data on relapsed/refractory ALL",,
NCT07166042,Guided Meditation During Radiation Therapy for Breast and Gynecological Malignancies,PHASE3,Breast Cancer,the effect of brief mindfulness-guided meditations during radiation therapy (RT) for patients with anxiety related to RT for breast and gynecological cancers,,
NCT06720142,Mg OSTEOCRETE Post-Treatment Outcomes,,Cancer of Bone,"of this study is to determine the amount of time it takes for bone to heal after treatment with Mg OSTEOCRETE, and to better understand the efficacy of this treatment through clinical and patient-reported outcomes","the amount of time it takes for bone to heal after treatment with Mg OSTEOCRETE, and to better understand the efficacy of this treatment through clinical and patient-reported outcomes",this treatment through clinical and patient-reported outcomes
NCT03091842,Exercise Intervention in Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Cancer,NA,Cancer Survivor,,,
NCT05079386,Clinical Feasibility of a New Voice Prosthesis,NA,Laryngectomy,"of this clinical investigation is to evaluate the short-term clinical feasibility of a new voice prosthesis and explore its acceptability, limitations and advantages","the short-term clinical feasibility of a new voice prosthesis and explore its acceptability, limitations and advantages",
NCT04987086,68Ga-PSMA PET in the Renal Cell Carcinoma,NA,Renal Cancer,"the diagnostic efficacy of 68Ga-PSMA PET in metastatic lesions of locally advanced and advanced renal cell carcinoma, and to compare with that of enhanced CT","68Ga-PSMA PET in metastatic lesions of locally advanced and advanced renal cell carcinoma, and to compare with that of enhanced CT",
NCT06147570,A Study of HS-10365 in Patients With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer,PHASE2,Nonsmall Cell Lung Cancer,,,
NCT01484470,Umbilical Cord Transplantation for the Elderly Population,PHASE2,Hematologic Malignancies,,,
NCT02713373,Cetuximab and Pembrolizumab in Treating Patients With Colorectal Cancer That is Metastatic or Cannot Be Removed by Surgery,PHASE1,Recurrent Colorectal Carcinoma,,,
NCT05484583,Durvalumab Combined With Consolidation Radiotherapy After First-line Treatment in Extensive Stage Small Cell Lung Cancer With Oligometastases,PHASE2,Lung Cancer,,,
NCT04005183,Renal Cell Carcinoma Microenvironment Discovery Project,,Renal Cell Carcinoma,is to leverage this data resource to identify novel therapeutic targets and biomarkers to improve the clinical management of this disease,,
NCT00493883,Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors,PHASE1,"Carcinoma, Hepatocellular",* Provide supervised access to treatment with TheraSphere to eligible patients with primary and metastatic cancer to the liver,,
NCT00343083,"Evaluation of Cetuximab (ERBITUX) and Concurrent Carboplatin, Paclitaxel & Radiotherapy in the Management of Patients With Advanced Locoregional Squamous Cell Carcinomas of the Head and Neck (GCC 0442)",PHASE2,Cancer of Head and Neck,the response of the tumor to the treatment regimen that will be used in this study,,
NCT00005973,BMS-214662 in Treating Patients With Solid Tumors,PHASE1,"Unspecified Adult Solid Tumor, Protocol Specific",,,
NCT06511869,AZD4205 in Peripheral T Cell Lymphoma Following First-Line Therapy (JACKPOT26),PHASE2,Peripheral T-cell Lymphoma,the safety and anti-tumor activity of AZD4205 at 150 mg once daily in participants with PTCL who have achieved tumor response after first-line systemic therapy (with or without combination radiotherapy) and are ineligible for HSCT assessed by the investigator as ineligible for HSCT or have no plan for HSCT,,
NCT05706883,Clinical and Molecular Findings in Patients With Cervical/Supraclavicular Metastasis From Non-small-cell Lung Cancer (NSCLC),,Lung Cancer Metastatic,,,
NCT01626183,Studying RNA in Samples From Younger Patients With T-Cell Acute Lymphoblastic Leukemia,,Leukemia,,,
NCT03570541,TQL-block for Laparoscopic Hemicolectomy,PHASE4,Postoperative Pain,of this study is to investigate the efficacy of the ultrasound-guided bilateral transmuscular quadratus lumborum block on reducing postoperative opioid consumption,the ultrasound-guided bilateral transmuscular quadratus lumborum block on reducing postoperative opioid consumption,
NCT05104541,Impact of Weight Loss in Cirrhosis With Obesity and MAFLD,NA,Liver Cirrhosis,,,
NCT00026741,Research in Skin Inflammation,,Psoriasis,,,
NCT05785754,DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors,PHASE1,Advanced or Metastatic Solid Tumors,the effects of DCSZ11 as a monotherapy and in combination in patients with advanced or metastatic solid tumors,,
NCT00980954,Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy,PHASE3,Cervical Cancer,,,
NCT00028405,Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors,PHASE1,Liver Metastasis,,,
NCT04646005,Cemiplimab and ISA101b Vaccine in Adult Participants With Recurrent/Metastatic Human Papillomavirus (HPV)16 Cervical Cancer Who Have Experienced Disease Progression After First Line Chemotherapy,PHASE2,Cervical Cancer,"of the study is to estimate the clinical benefit of cemiplimab + ISA101b after progression on first line chemotherapy, as assessed by objective response rate (ORR)","preliminary efficacy of cemiplimab + ISA101b as measured by duration of response (DOR), progression-free survival (PFS), and overall survival (OS)","cemiplimab + ISA101b as measured by duration of response (DOR), progression-free survival (PFS), and overall survival (OS)"
NCT07052994,"A Phase Ia/Ib Trial of Revumenib Combined With Cytarabine, Daunorubicin, and Gemtuzumab Ozogamicin (GO) in Frontline and Relapsed /Refractory Pediatric Acute Leukemia Patients",PHASE1,Pediatric Acute Leukemia,,,
NCT02441894,Combination of Cabazitaxel With Prednisolone With Primary Prophylaxis With PEG-G-CSF in Treatment of Patients With Prostate Cancer,PHASE4,Prostate Cancer,To assess the tolerability of cabazitaxel 25 mg per body surface area (m\^2) with primary prophylactic polyethylene glycol-granulocyte-colony stimulating factor (PEG-G-CSF) in terms of the incidence rate of febrile neutropenia (FN) (defined: absolute neutrophil count \[ANC\] \<1000 per volume \[mm\^3\] and a single temperature of \>38,the tolerability of cabazitaxel 25 mg per body surface area (m\^2) with primary prophylactic polyethylene glycol-granulocyte-colony stimulating factor (PEG-G-CSF) in terms of the incidence rate of febrile neutropenia (FN) (defined: absolute neutrophil count \[ANC\] \<1000 per volume \[mm\^3\] and a single temperature of \>38,
NCT05603156,A Study of Olverembatinib Combined With Inotuzumab Ozogamicin in the Treatment ph+ ALL With MRD Persistent Positive,NA,Ph+ ALL,,,
NCT06574256,Investigation of the Effects of Online Education Application on Gynecological Cancer Patients Receiving Chemotherapy,NA,Gynecological Cancer,of the study was to examine the effect of online nursing education given to women diagnosed with gynecological cancer and receiving chemotherapy,,
NCT04280822,Neo-adjuvant Immunochemotheray Versus Neo-adjuvant Chemotherapy for Resectable Esophageal Carcinoma,PHASE3,Esophageal Cancer,is to evaluate whether the neo-adjuvant immunochemotherapy Toripalimab (JS001) with cisplatin and paclitaxel followed by right thoracic approach esophagectomy with total 2-field lymph node dissection improves the overall survival of thoracic esophageal cancer patients versus neo-adjuvant chemotherapy,whether the neo-adjuvant immunochemotherapy Toripalimab (JS001) with cisplatin and paclitaxel followed by right thoracic approach esophagectomy with total 2-field lymph node dissection improves the overall survival of thoracic esophageal cancer patients versus neo-adjuvant chemotherapy,
NCT06663722,Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host Disease,PHASE2,Chronic Graft Versus Host Disease,,,
NCT01107522,Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas,PHASE1,"Solid Tumors, Glioblastoma, Recurrent Malignant Gliomas","the safety, tolerability, and the maximum tolerated dose/recommended phase II dose of carboxyamidotriazole orotate (CTO) as a single agent in patients with advanced or metastatic solid tumors",,
NCT04939051,Obeticholic Acid for Prevention in Barrett's Esophagus,PHASE2,Barrett Esophagus,,,
NCT02049151,Tecemotide Following Concurrent Chemo-radiotherapy for Non-small Cell Lung Cancer,PHASE3,"Carcinoma, Non-Small-Cell Lung","response following primary concurrent chemo-radiotherapy (CRT), comparing overall survival (OS) time in subjects treated with tecemotide versus subjects treated with tecemotide-matching placebo",,
NCT05319431,A Phase II Study of AK104 Plus Lenvatinib and TACE in HCC,PHASE2,"Unresectable, Non-metastatic Hepatocellular Carcinoma","the efficacy and safety of AK104 plus lenvatinib combined with on-demand TACE in participants with unresectable, non-metastatic hepatocellular carcinoma",,
NCT02478931,Study of Personalized Cancer Therapy to Determine Response and Toxicity,,Cancer,,,
NCT01538602,Mean Platelet Volume and TXA2 Levels in Patients With Polycystic Ovary Syndrome (PCOS),,Polycystic Ovary Syndrome,"ing to correlate the mean platelet volume, the thromboxane A2 level and the PCOS, an observational study was planned",,
NCT04113902,"The Effects of Health Education About Human Papilloma Virus and Cervical Cancer Prevention on Knowledge, Attitudes, Beliefs and Behaviors",NA,Health Education,"To determine the effects of health education about Human Papilloma Virus infection and cervical cancer prevention on knowledge, attitudes, beliefs and behaviors of adolescent girls and their mothers","the effects of health education about Human Papilloma Virus infection and cervical cancer prevention on knowledge, attitudes, beliefs and behaviors of adolescent girls and their mothers",
NCT05857202,Oxidative Stress and Inflammation Biomarkers in Surgically Treated Patients With Laryngeal Cancer,,Oxidative Stress Induction,"of the study will be to assess concentrations of inflammatory biomarkers (IL-1, IL-6) and oxidative stress factors (MDA, SOD, GPKS1) in postoperative course in surgically treated patients with laryngeal carcinoma and in possible complication occurrence",the quality of life in patients with surgically treated laryngeal carcinoma,
NCT07205029,"""Predictive Models of the Morphological Evolution of the Human Body to Improve Adherence and Motivation in Dietetic-nutritional Treatments of Overweight and Obesity"" [Modelos Predictivos de Evolución Corporal Para Mejorar la Adherencia en Tratamientos de Sobrepeso y Obesidad]",NA,Body Image,"of this clinical trial is to evaluate the effect of a personalized intervention based on the benefits of 4D body modeling and virtual reality techniques, combined with a dietary-nutritional treatment focused on the Mediterranean Diet, as a tool to improve motivation for change, adherence to treatment and health parameters in patients with overweight and obesity","the effect of a personalized intervention based on the benefits of 4D body modeling and virtual reality techniques, combined with a dietary-nutritional treatment focused on the Mediterranean Diet, as a tool to improve motivation for change, adherence to treatment and health parameters in patients with overweight and obesity","whether a personalized intervention based on the benefits of 4D modeling and virtual reality, combined with a Mediterranean Diet-focused treatment, is effective in addressing overweight and obesity"
NCT00188929,Assessment of Treatment Response Using PET/CT Scanner - Non Hodgkin's Lymphoma,PHASE2,"Lymphoma, Non-Hodgkin",,,
NCT05977829,Endometrial Malignancy in Breast Cancer Patients With or Without AUB,,Endometrial Neoplasms,"the hysteroscopic, histopathologic, and ultrasonographic aspects of uterine monitoring in postmenopausal breast cancer patients with or without abnormal uterine bleeding (AUB), as well as to calculate the risk of endometrial cancer in women with or without AUB",,
NCT05495529,Biliary or Digestive Protection by Room Air Interposition for Thermal Ablation of Central Hepatic Tumors,,"Radiology, Interventional","to analyse retrospectively the feasibility, the safety, and the efficiency, of biliary or digestive protection with room air interposition for thermal ablation of central liver tumors with high iatrogenic risk",,
NCT00329329,Study of Satraplatin With Capecitabine to Treat Advanced Solid Malignancies,PHASE1,Malignancies,the maximally tolerated dose (MTD) and Phase 2 recommended dose of satraplatin when administered in combination with capecitabine in patients with advanced solid malignancies,,
NCT04350229,Endocrinological Changes Due to Pre-medications of Chemotherapy in Patients With Breast Cancer,NA,Breast Cancer,of this study is to evaluate the omission of corticosteroid doses as a pre-medication in cancer treatment after the second week of treatment with taxane in a curative setting,the omission of corticosteroid doses as a pre-medication in cancer treatment after the second week of treatment with taxane in a curative setting,
NCT06751329,A Study of DM002 in Patients With Advanced Solid Tumors,PHASE1,Ovarian Neoplasms,"the safety of the study drug at different dose levels, to understand what your body does to the study drug, and to find the best dose of study drug in people who have advanced solid tumor cancers",,
NCT00217529,"Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer",PHASE1,Fallopian Tube Cancer,,,
NCT04329429,A Study of RC48-ADC in Subjects With HER2 Overexpressed Metastatic Biliary Tract Cancer,PHASE2,Biliary Tract Cancer,,,
NCT03043729,mFOLFOX6 vs. mFOLFOX6 + Aflibercept as Neoadjuvant Treatment in MRI-defined T3-rectal Cancer,PHASE2,Rectal Cancer,,,
NCT05997329,Nutrition Throughout the Treatment Course - Expanding Care From Hospital to Home,NA,Head and Neck Cancer,of the project is to reduce the prevalence of malnutrition and increase the quality of life among patients with HNC,,
NCT05283629,nCCR for Chemotherapy Related Cognitive Impairment Randomized Study,NA,Chemo-brain,,,
NCT07167329,Real-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL Trial,PHASE2,Von Hippel Lindau,"the therapeutic effects, benefits, and adverse effects of belzutifan, as well as the timing of treatment response and disease progression in patients with von Hippel-Lindau (VHL) syndrome",,
NCT05459129,A Study Evaluating Efficacy and Safety of Multiple Treatment Combinations in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck (Morpheus-Head and Neck Cancer),PHASE1,Squamous Cell Carcinoma of the Head and Neck,,,
NCT01963702,A Phase II Trial of Exploring the Predictive Factors of TX and XELOX Regimen in the First Line Treatment of MGC,PHASE2,Gastric Cancer,,,
NCT03506802,TCR Genetically Engineered PBMC and PBSC After Melphalan Conditioning Regimen in Treating Participants With Relapsed and Refractory Multiple Myeloma,PHASE1,HLA-A*0201 Positive Cells Present,,,
NCT06119802,Prediction of UA/SOD Ratio as a Biomarker of Oxidative Stress in Atrial Fibrillation,,Atrial Fibrillation,,,
NCT01238653,Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic Procedures,,Liver Cancer,,,
NCT05607953,Pressure Enabled Intrapancreatic Delivery of SD-101 With Checkpoint Blockade for Locally Advanced Pancreatic Adenocarcinoma,PHASE1,Locally Advanced Pancreatic Adenocarcinoma,,,
NCT03408353,"Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT Study",,Breast Carcinoma,,,
NCT06122753,Preemptive TIPS for Variceal Bleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis,NA,Portal Hypertension,is survival free of variceal rebleeding at 6 weeks from inclusion,,
NCT02744053,DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer,EARLY_PHASE1,Estrogen Receptor Negative,,,
NCT03131037,Intratumoral Gene Mediated Cytotoxic Immunotherapy in Patients With Resectable Non-Small Cell Lung Cancer,PHASE1,Lung Cancer,of the study is to evaluate the safety of CAN-2409 plus prodrug when combined with standard surgery for NSCLC,the safety of CAN-2409 plus prodrug when combined with standard surgery for NSCLC,the immunologic changes induced by CAN-2409 plus prodrug
NCT01355445,Vincristine and Irinotecan With or Without Temozolomide in Children and Adults With Refractory/Relapsed Rhabdomyosarcoma,PHASE2,RHABDOMYOSARCOMA,these combinations in patients with recurrent or refractory rhabdomyosarcoma,,
NCT03163745,Asymptomatic Spontaneous Bacterial Peritonitis in Patients With Decompensated Liver Cirrhosis,,Spontaneous Bacterial Peritonitis,,,
NCT00377845,Cervix Cytological Screening - Comparison of Tampon Self-Test and the Routine Smear.,EARLY_PHASE1,Uterine Cervical Dysplasia,,,
NCT01853345,iCAT for Recurrent/Refractory/HR Solid Tumors,,Pediatric Solid Tumor,,,
NCT06125145,Geriatric Assessment and Promotores (GAP) Pilot Feasibility Study,NA,Breast Cancer,their health and provide coaching to help them feel better,,
NCT06063070,First-line Maintenance Treatment With Fluzoparib Plus Bevacizumab in Advanced BRCA Wild Type Ovarian Cancer,PHASE2,Ovarian Cancer,is to evaluate median progression free survival of fluzoparib plus bevacizumab,median progression free survival of fluzoparib plus bevacizumab,
NCT06423170,A Single-arm Phase II Clinical Study of the Efficacy and Safety of Camrelizumab Combined With GEMOX for Unresectable GBCs,PHASE2,Unresectable Gallbladder Cancer,of this study was to evaluate the efficacy and safety of Camrelizumab combined with gemcitabine and oxaliplatin (GEMOX) for unresectable gallbladder cancer,the efficacy and safety of Camrelizumab combined with gemcitabine and oxaliplatin (GEMOX) for unresectable gallbladder cancer,
NCT06923670,Prevalence Of Germline Gene Mutations In Patients With Myeloproliferative Neoplasms With Family History,NA,Polycythemia Vera,of the study would be to investigate the presence of germline mutations in MPN patients selected on the basis of a family history of myeloid neoplasms through the analysis of both already recognized genes and other potentially implicated ones,,
NCT06471270,Validation of Salivary Proteomic Biomarkers for Early Detection of Oral Cancer in Egyptian Population,NA,Oral Cancer,,,
NCT06232070,Real World Evaluation of Lunit INSIGHT MMG Technology,,Breast Cancer,"to address this issue in the first instance, maintaining standard of care for all patients seen within the 2 week wait pathway, by introducing the use of Lunit INSIGHT MMG into one of two arms within this prospective, observational parallel cohort study","and compare the sensitivity and specificity of a Lunit INSIGHT MMG assisted human reading to the standard care double human reading process within mammography review at a ""one-stop"" breast clinic (non-inferiority study)",
NCT04613570,SUrveillance of PREMalignant Stomach - Individualized Endoscopic Follow-up,NA,Atrophic Gastritis,"To describe for the first-time patients with premalignant conditions both clinically (familial history), histologically (OLGA/OLGIM",,
NCT03397173,TET2 Mutations in Myelodysplastic Syndromes and Acute Myeloid Leukemia With Azacitidine + Ascorbic Acid,PHASE2,Myelodysplastic Syndromes,the efficacy of treatment with azacitidine (an FDA approved drug for the treatment of MDS) and high dose ascorbic acid in patients with TET2 mutations,treatment with azacitidine (an FDA approved drug for the treatment of MDS) and high dose ascorbic acid in patients with TET2 mutations,
NCT06831669,Metabolomics to Predict Treatment Response and Toxicities in Rectal Cancer,,Rectal Neoplasm Malignant,This study aims to evaluate the metabolomic profiles of individuals with locally advanced rectal cancer undergoing TNT and to identify a panel of metabolites that can predict treatment response and toxicities,the predictive performance of the identified metabolites,the metabolomic profiles of individuals with locally advanced rectal cancer undergoing TNT and to identify a panel of metabolites that can predict treatment response and toxicities
NCT00093769,Bortezomib and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma,PHASE2,Lymphoma,,,
NCT05462873,A Study to Investigate the Safety and Tolerability of Intravenous QEQ278 in Patients With Advanced Solid Tumors,PHASE1,"Carcinoma, Non-Small-Cell Lung",,,
NCT04380441,Quality of Life Model for Older Patients With AML,,"AML, Adult",,,
NCT05985954,Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination With Cetuximab and Encorafenib in Patients With Unresectable or Metastatic Colorectal Cancer Who Have Previously Received EGFR or BRAF-directed Therapy,PHASE1,Metastatic Colorectal Cancer,,,
NCT01484041,Dovitinib Plus an Aromatase Inhibitor for Metastatic Breast Cancer,PHASE1,Breast Cancer,how well these medications work together and/or if they have any side effects in patients with hormone-receptor positive metastatic breast cancer who have demonstrated progression of disease after first line hormonal therapy,,
NCT00866905,Ixabepilone and Cyclophosphamide as Neoadjuvant Therapy in HER-2 Negative Breast Cancer,PHASE2,Breast Cancer,ixabepilone in combination with cyclophosphamide for the neoadjuvant treatment of locally advanced breast cancer,non-anthracycline neoadjuvant therapy,
NCT00677105,A Safety and Dose-finding Study of JNJ-26481585 for Patients With Advanced Solid Malignancies and Lymphoma.,PHASE1,Lymphoma,the safety of the drug (JNJ-24681585 a drug in development for cancer) in patients with advanced or refractory solid malignancies or lymphoma on the maximum dose that can be tolerated by these patients,,
NCT05593094,A Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Solid Tumors,PHASE1,Advanced Solid Tumors,"the safety, tolerability, PK and efficacy of ZN-A-1041 as a monotherapy or in combination in participants with HER2-positive advanced solid tumors with or without brain metastases",ZN-A-1041 as a monotherapy or in combination in participants with HER2-positive advanced solid tumors with or without brain metastases,
NCT05895994,Research Development13(RD13)-02 Cell Injection in Patients With Relapsed or Refractory Cluster Of Differentiation 7(CD7)-Positive Hematological Malignancies,EARLY_PHASE1,Neoplasms,"is to evaluate the safety of CD7 Chimeric Antigen Receptor-T(CAR-T) therapy for patients with CD7-positive relapsed or refractory T-Acute Lymphoblastic Leukemia(ALL)/Lymphoblastic Lymphoma(LBL)/Acute Myelogenous Leukemia(AML), and to evaluate the pharmacokinetics of CD7 CAR-T in patients。","the safety of CD7 Chimeric Antigen Receptor-T(CAR-T) therapy for patients with CD7-positive relapsed or refractory T-Acute Lymphoblastic Leukemia(ALL)/Lymphoblastic Lymphoma(LBL)/Acute Myelogenous Leukemia(AML), and to evaluate the pharmacokinetics of CD7 CAR-T in patients。",
NCT05887466,Study to Evaluate the Safety and Efficacy of ESC-derived Dopamine Progenitor Cell Therapy in PD Patients,PHASE1,Parkinson's Disease,"allogenic embryonic stem cell-derived A9 dopamine progenitor cell (A9-DPC) therapy in patients who were diagnosed with Parkinson's disease ≥ 5 years ago, as a treatment for delaying or stopping the progression of Parkinson's disease or inducing recovery of damaged brain",,
NCT01018966,Study of Ixabepilone (BMS-247550) in Patients With Solid Tumors,PHASE1,Solid Tumors,"the DLT, MTD and recommended Phase II dose of ixabepilone in Japanese patients with solid tumors",,
NCT02567656,Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in T-cell Lymphoma,PHASE1,"Lymphoma, T-Cell, Peripheral","the safety, PK and efficacy of RP6530, a dual PI3K delta/gamma inhibitor in patients with relapsed and refractory T-cell Lymphoma","RP6530, a dual PI3K delta/gamma inhibitor in patients with relapsed and refractory T-cell Lymphoma",
NCT04400656,PROState Pathway Embedded Comparative Trial,,Prostate Cancer,,,
NCT01146756,MEK Inhibitor and Thoracic Radiotherapy Trial,PHASE1,Non Small Cell Lung Cancer,"of improving symptoms, achieving tumour control and optimising quality of life",the recommended dose for Phase 2 trials (RP2D),
NCT04880356,Longitudinal Study of Ultra-rare Inherited Metabolic and Degenerative Neurological Diseases.,,Inherited Disease,"of the study is the improvement of the clinical knowledge of ultra-rare inherited metabolic and degenerative neurological diseases (prevalence less than 5:100,000) in adulthood through the systematic longitudinal collection of clinical, laboratory and instrumental data",,
NCT05965856,A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma and Other Solid Tumors,PHASE2,Urothelial Carcinoma,,,
NCT03595722,Exploring HIFU as a Treatment for Rectal and Other Pelvic Cancers,NA,Rectal Cancer,to recruit thirty patients with early rectal cancer who are due to undergo an operation to remove their cancer,the treatment of a cohort of patients with inoperable rectal cancer,HIFU in this instance
NCT04370522,Characterization of Innate Immune System in Patients With Luminal Advanced Breast Cancer,,Metastatic Breast Cancer,,,
NCT03624751,Follow up for Patients With Thyroid Cancer Planed for Radioiodine Scan or Treatment,,Thyroid Cancer,ing to observe the difference of metabolic profiles between patients choose Thyrogen® injection and Eltroxin® withdrawal,,
NCT02658851,Cold Plasma for the Reduction of Lymphoceles Following PLND,NA,Lymphoceles Following Pelvic Lymph Node Dissection,Bovie Medical's J-Plasma® helium based plasma technology in the reduction of lymphoceles following pelvic lymph node dissection (PLND) during robotic assisted radical prostatectomy (RARP),,
NCT05668351,Stereotactic Ablative Radiation Therapy for Prostate Cancer,NA,Prostate Cancer,,,
NCT02990351,Efficacy of Loco-regional Treatment for Hepatocellular Carcinoma Prior to Living Donor Liver Transplantation in Egypt,,Hepatocellular Carcinoma (HCC),ed to analyze the outcomes of loco-regional treatment prior Living Donor Liver Transplantation in patients with HCC,,
NCT02301351,Effects of Implicit Messaging by Cigarette Pack Color on Smoking Behaviors,NA,Cigarette Smoking Behavior,,,
NCT02261051,"Symptom Management, Quality of Life and Satisfaction With Care for Advanced Stage Cancers - Control Arm",,Cancer,"of the study is to compare the proportion of advanced cancer patients who have a hospitalization or emergency department visit in the last 6 months of life before and after implementation of a new care model that provides more comprehensive symptom management and supportive care, including earlier referral to palliative care",measures of quality of life and satisfaction in both groups,
NCT06850402,Evaluation of a Novel Optical Microscope With a Deep Depth of Field (DeepDOF) to Provide Histologic-quality Images on Cervical Biopsies and Loop Electrosurgical Excision Procedure (LEEP) Specimens at the Point-of-care,NA,Cervical Cancer,,,
NCT03909802,Effect of Self- and Family Management of Diabetic Foot Ulcers Programs on Health Outcomes,NA,Diabete Mellitus,,,
NCT07074353,Irinotecan Liposomes in Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer,PHASE3,Locally Advanced Rectal Cancer,was to compare the efficacy and safety of irinotecan liposomes combined with or without standard TNT,,
NCT01490437,Pemetrexed and Cisplatin in Advanced Urothelial Carcinoma,PHASE2,Urothelial Carcinoma,the efficacy and safety of pemetrexed plus cisplatin in advanced urothelial carcinoma,,
NCT02852837,Dose Escalation Study of JNJ-54767414 (Daratumumab) in Chinese Participants With Relapsed or Refractory Multiple Myeloma Who Failed at Least 2 Prior Lines of Systemic Therapy,PHASE1,Multiple Myeloma,"the tolerability, safety and the pharmacokinetic (PK) profile of daratumumab in Chinese participants with relapsed or refractory multiple myeloma (RRMM) who failed at least 2 prior lines of systemic therapy (Part 1 and Part 2)",,
NCT03296137,Adoptive Cell Therapy Across Cancer Diagnoses,PHASE1,Cancer,,,
NCT06455553,Interpretability of the Quantra® Viscoelastic Test in Patients With Haematological Malignancies With Profound Thrombocytopenia Below 50x10 G/L.,NA,Hematologic Malignancies,"the interpretability of viscoelastic tests (Quantra® and ROTEM® type) in relation to platelet levels measured in standard biology in patients with haematological malignancies, hospitalized in day hospitals or full hematology wards, presenting thrombocytopenia strictly below 50 G/L",,
NCT02284945,Randomized Controlled Trial of Open Stabilisation Versus TPS,NA,Metastatic Spinal Disease,of treatment is to help with pain and to reduce the risk of these neurological problems,,
NCT00003495,Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer,PHASE2,Stage IV Lung Cancer,the effects (good and bad) that Antineoplaston therapy has on patients with Stage IV or Recurrent Lung Cancer,,
NCT03745495,HIV Self-Testing AND Uptake and Retention of PrEP Among Older Adolescent MSM and TGW,,Men or Transgender Women Who Have Sex With Men,,,
NCT01089595,Trial of Tasigna (Nilotinib) 400 mg Twice Daily Alone or With Gleevec (Imatinib Mesylate) 400 mg Daily for Patients With Advanced Gastrointestinal Stromal Tumor (GIST),PHASE2,GIST,,,
NCT05447195,Phase 2 Study of CAN008 in Subjects With GBM,PHASE2,Newly-diagnosed Glioblastoma,are to evaluate the clinical efficacy and safety of CAN008 plus TMZ during and after radiation therapy in newly-diagnosed subjects with glioblastoma who have undergone surgical excision,the clinical efficacy and safety of CAN008 plus TMZ during and after radiation therapy in newly-diagnosed subjects with glioblastoma who have undergone surgical excision,
NCT05171595,Real Time ST-segment Deviation Detection in High-risk Patients Detected by Wireless Single-lead ECG,,Myocardial Injury,"to describe the frequency of significant ST-deviations, defined as ECG-ST-deviations \<-0",,
NCT02471495,RITE-EUROPE (Radiofrequency-Induced Thermochemotherapy Effect-EUROPE),PHASE3,Bladder Cancer,"the proportion of disease-free patients, starting from administration of the first study treatment to at least 12-months after the first treatment, and up to 2 years (the latter only in patients choosing to participate in longer-term disease-free-survival data collection)",,
NCT01131039,"Safety and Efficacy Study of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer",PHASE2,Fallopian Tube Neoplasms,"whether the administration of bevacizumab and gemcitabine given by IV infusion can prolong survival, delay tumor growth, and/or shrink tumors in patients with ovarian cancer, primary peritoneal, or fallopian tube cancer",,
NCT05483439,A Study of Immunotherapy Combined With Neoadjuvant Therapy Versus Neoadjuvant Therapy for Breast Cancer,PHASE2,Stage II-III Breast Cancer,,,
NCT01071239,Hematopoietic Stem Cell Transplant for Fanconi Anemia,PHASE2,Fanconi Anemia,,,
NCT01155739,Procalcitonin as a Marker for the Length of Antibiotic Treatment in Peritonitis and Intra-abdominal Infections,,Secondary or Tertiary Peritonitis,,,
NCT03990077,Study of HL-085 Plus Docetaxel in Patients With KRAS Mutant NSCLC,PHASE1,Nsclc,"tolerability, safety , pharmacokinetics and efficacy in patients with KRAS mutant NSCLC by using HL-085 and Docetaxel",,
NCT02462577,Effect of Locally Administered Morphine and Bupivicaine on Acute and Chronic Postmastectomy Pain,PHASE2,Acute Pain,,,
NCT02573077,An Observational Study Measuring Outcomes in Cancer Patients Treated for Moderate to Severe Hyponatremia in Italy,,Hyponatremia,,,
NCT04206475,Feasibility Randomized Trial for an Intensive Memory-Focused Training Program for School Aged Children With Acquired br.Inj.,NA,Acquired Brain Injury,"of this feasibility trial are the description, implementation, and test of an intensive program specific to the training and re-adaptation of memory function in children (IM-FTP)",,
NCT06863857,Dual-energy SPEctral CT to Evaluate Response to First-line Therapies in Patients With Metastatic Clear Cell REnal Cancer,,Renal Cancer,the utility of dual-energy spectral computed tomography (CT) scan in monitoring treatment in patients with metastatic clear cell carcinoma of the kidney,,
NCT00874757,Effect of Rosuvastatin Response in Healthy Subjects: Potential Mechanisms of Anti-inflammatory Effects,,Healthy,,,
NCT04363957,Gynecologic Brachytherapy-Specific Educational Video,NA,Cervical Cancer,patient-reported satisfaction and patient anxiety for gynecologic high-dose rate brachytherapy (a radiation procedure),,
NCT00112957,"Vaccine Therapy in Patients With Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer",PHASE2,Fallopian Tube Cancer,"were to evaluate maintenance of remission at 12 months, time to failure of vaccine therapy, cellular and humoral immunity and any correlation with time to failure, and safety","maintenance of remission at 12 months, time to failure of vaccine therapy, cellular and humoral immunity and any correlation with time to failure, and safety",
NCT07102212,Telemedicine-mHealth Symptom Cluster Intervention for Advanced Cancer Patients: Finding Our Center Under Stress (FOCUS),NA,Lung Cancer,of this proposed randomized effectiveness trial is to evaluate the impact of this telemedicine-mHealth symptom cluster intervention with patients from rural and Appalachian communities (where the PI was raised),the impact of this telemedicine-mHealth symptom cluster intervention with patients from rural and Appalachian communities (where the PI was raised),
NCT05293912,SG2501 Safety Study in Subjects with Relapsed or Refractory Hematological Malignancies and Lymphoma.,PHASE1,Hematological Malignancy,"the safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity, and preliminary efficacy of SG2501 in subjects with relapsed or refractory hematological malignancies and lymphoma",SG2501 in subjects with relapsed or refractory hematological malignancies and lymphoma,
NCT01033981,Cost Effectiveness Of Sunitinib In Central America And Caribbean,,Metastatic Renal Cell Carcinoma,,,
NCT03349281,Pevonedistat With VXLD Chemotherapy for Adolescent/Young Adults With Relapsed/Refractory ALL or Lymphoblastic NHL,PHASE1,Refractory Acute Lymphoblastic Leukemia,,,
NCT03064581,A Pap Test Intervention to Enhance Decision Making Among Pacific Islander Women,NA,Cervical Cancer,,,
NCT05248581,Living Donor Liver Transplant for Unresectable Colorectal Liver Metastases,,Colorectal Cancer Metastatic,,,
NCT00494728,Smoking Cessation for Depressed Smokers,PHASE1,Smoking,1,"within-subject changes in neurophysiological responses to emotional and smoking-related stimuli across treatment sessions, and the relation of these changes to abstinence and depressive symptoms at end of treatment, and 3- and 6-months",
NCT06994806,A Study to Investigate the Safety and Efficacy of KQB168 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies,PHASE1,Solid Tumor Malignancies,,,
NCT04526106,"REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other Advanced Solid Tumors",PHASE1,FGFR2 Amplification,"the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PDy), and antineoplastic activity of RLY-4008, a potent and highly selective FGFR2 inhibitor, in patients with unresectable or metastatic cholangiocarcinoma (CCA) and other solid tumors",,
NCT02715804,A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma,PHASE3,Pancreatic Ductal Carcinoma,,,
NCT06946004,Normobaric Oxygen Therapy in Colorectal Cancer Patients,NA,Colorectal Cancer (CRC),"include biomarkers of erythropoiesis, oxidative stress, and immune response","to evaluate the effects of NBO exposures on (1) supporting erythropoiesis by measuring erythropoietin (EPO) levels and hypoxia-inducible factors (HIF-1α), (2) reducing oxidative stress and improving stress and emotional well-being, and (3) modulating immune function by assessing cytokine profiles","the effects of NBO exposures on (1) supporting erythropoiesis by measuring erythropoietin (EPO) levels and hypoxia-inducible factors (HIF-1α), (2) reducing oxidative stress and improving stress and emotional well-being, and (3) modulating immune function by assessing cytokine profiles"
NCT00017108,Chlorambucil in Treating Patients With Advanced Chronic Lymphocytic Leukemia,PHASE3,Leukemia,the effectiveness of different regimens of chlorambucil in treating patients who have advanced chronic lymphocytic leukemia,,
NCT02249208,Sentinel Lymph Node Biopsy With Superparamagnetic Iron Oxide for Breast Cancer Patients After Neoadjuvant Treatment.,PHASE3,Breast Cancer,the detection rate and the false negative rate of sentinel lymph node (SLN) by superparamagnetic iron oxide (SPIO) alone or in addition to radioisotope and compared to the standard method (blue and radioisotope) after neoadjuvant chemotherapy in patients with node-positive breast cancer converted to node negative after treatment by ultrasound,,
NCT06415708,Obinutuzumab Combined With Bendamustine in the Treatment of Mature B-cell Lymphoma,PHASE2,B Cell Lymphoma,"the efficacy and safety of maintenance therapy with obinutuzumab for 2 years in patients ≥ 18 years of age with newly diagnosed mature B-cell lymphoma (including follicular lymphoma\[FL\], marginal zone cell lymphoma\[MZL\] , waldenström macroglobulinemia\[WM\], hairy-cell leukemia variant\[HCL-v\]) who achieved ≥ PR after 6 cycles of obinutuzumab in combination with bendamustine",,
NCT03701308,Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy,PHASE2,Acute Myeloid Leukemia,,,
NCT03455608,PRO-ACTIVE: Prophylactic Swallow Intervention for Patients Receiving Radiotherapy for Head and Neck Cancer,NA,Dysphagia,"to reverse an already impaired swallowing ability, whereas PRO-ACTIVE therapy aims to prevent or reduce severity of dysphagia",,
NCT07028125,Digital Monitoring of Self-reported Symptoms by Patients Treated With Cabozantinib Plus Nivolumab for Advanced Clear-cell Renal Carcinoma,PHASE4,Renal Cell Carcinoma (Kidney Cancer),of the study is to evaluate the impact of digital monitoring of self-reported symptoms (PROs) on the adjustment of treatment management in patients treated with cabozantinib plus nivolumab for advanced clear cell renal cell carcinoma (RCC) in real life during the first 3 months of combined treatment,the impact of digital monitoring of self-reported symptoms (PROs) on the adjustment of treatment management in patients treated with cabozantinib plus nivolumab for advanced clear cell renal cell carcinoma (RCC) in real life during the first 3 months of combined treatment,
NCT03107325,Biokinetics Study for F-18 FDG in Pediatric Molecular Imaging,PHASE4,Childhood Neoplasm,of this investigation is to optimize pediatric patient absorbed dose by keeping it as low as possible while maintaining excellent diagnostic quality of nuclear medicine images,how the PK in pediatric patients differs from adults,
NCT01553825,Assessment of Patient Experience During Treatment for Cancer,,Carcinoma,,,
NCT05060276,Study to Assess an Anti-Trop2 Antibody Drug Conjugate in Relapsed or Refractory Solid Tumors,PHASE1,Relapsed Solid Neoplasm,,,
NCT00340340,Genetic Epidemiology of Lung Cancer and Smoking,,Lung Cancer,,,
NCT03509168,The Efficacy and Safety of Preoperative Misoprostol in Blood-loss Reduction During Myomectomy.,PHASE2,Uterine Fibroid,"ed at exploring the benefit of preoperative use of a readily available uterotonic, Misoprostol in reduction of intraoperative blood loss during open myomectomy with the Null hypothesis stating: there is no difference in mean blood loss during open myomectomy whether one preoperatively inserts a single dose of 400mcg vaginal misoprostol or not",,
NCT00161668,Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care,,Acute Myeloid Leukemia,the safety of Mylotarg therapy in routine practice,,
NCT04668768,HM-178: Assessing Methods for Improvement in Methotrexate Toxicity Management and Detection of Central Nervous System Involvement of Aggressive Lymphoma,PHASE2,Lymphoma,,,
NCT01793168,Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford,,Rare Disorders,,,
NCT04680468,Study of Belantamab Mafodotin as Pre- and Post-autologous Stem Cell Transplant and Maintenance for Multiple Myeloma,PHASE2,Myeloma,,,
NCT00003291,Molecular Genetic Lesions and Clinical Outcomes in Children With Acute Lymphoblastic Leukemia,,Leukemia,,,
NCT00711191,A Study On An Immunostimulant Antibody In Combination With Chemotherapy For Advanced Cancer Of The Pancreas,PHASE1,Pancreatic Neoplasm,to seek evidence that activation of certain cells of the immune system will be safe and well tolerated in combination with cytotoxic chemotherapy,,
NCT01995591,Indocyanine Green (ICG) in the ex Vivo Detection of Sentinel Lymph Node (SLN)in Colon Cancer,,Colon Cancer,,,
NCT05483374,The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers,,Head and Neck Cancer,"whether data value are present, valid and believable",,
NCT06164574,Immunotherapy in Uncommon and 20ins EGFR-mut Lung Cancers,,Lung Cancer,,,
NCT04066218,Sexual Function Screening in Childhood Cancer Survivors,,Childhood Cancer,,,
NCT05494918,First-In-Human Study in Subjects With Advanced or Metastatic Solid Malignant Tumors,PHASE1,Advanced Solid Tumors,"the safety, tolerability, PK, and preliminary anti-tumor activity of JSKN003 in subjects with advanced inoperable or metastatic solid malignant tumors that are expected to be HER2 expression",,
NCT04989218,Durvalumab and Tremelimumab With Platinum-based Chemotherapy in Intrahepatic Cholangiocarcinoma (ICC),PHASE1,Cholangiocarcinoma,of 52% and improve complete resection rates in intrahepatic cholangiocarcinoma,"the activity, safety and feasibility of doublet immunotherapy and platinum-based chemotherapy in resectable intrahepatic cholangiocarcinoma with high risk features",
NCT05480618,Slow Yogic-Derived Breathing and Respiration and Cardiovascular Variability in Spinal Cord Injury Patients,NA,Spinal Cord Injuries,,,
NCT00889590,Adjuvant Zoledronic Acid in High Risk Giant Cell Tumour of Bone (GCT),PHASE2,Giant Cell Tumor of Bone,,,
NCT06926790,Neoadjuvant Nivolumab Plus Ipilimumab in Resectable NSCLC (GALAXY 3),PHASE2,Lung Cancer - Non Small Cell,to evaluate the safety and feasibility of neoadjuvant nivolumab plus ipilimumab followed by surgery in treating locally advanced and resectable NSCLC,the safety and feasibility of neoadjuvant nivolumab plus ipilimumab followed by surgery in treating locally advanced and resectable NSCLC,preoperative immunochemotherapy for patients with PD-L1 expression \<1% remains to be improved
NCT05252390,NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors,PHASE1,Advanced Solid Tumor,the safety and the dose(s) of NUV-868 to be used as monotherapy and in combination with olaparib or enzalutamide for the Phase 2 portion,these study treatments,
NCT00297297,Improved Preoperative Selection of Cold Thyroid Nodules,,Thyroid Nodules,,,
NCT06708897,"A Phase 1 Study of ZE50-0134 in Relapsed and Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Select Low-grad Lymphomas",PHASE1,CLL / SLL,"ing to evaluate the safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy of ZE50-0134 in relapsed and refractory chronic lymphocytic leukemia, small lymphocytic lymphoma, and select low-grad lymphomas","the safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy of ZE50-0134 in relapsed and refractory chronic lymphocytic leukemia, small lymphocytic lymphoma, and select low-grad lymphomas","ZE50-0134 in relapsed and refractory chronic lymphocytic leukemia, small lymphocytic lymphoma, and select low-grad lymphomas"
NCT02955290,"CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck Cancer",PHASE1,Advanced Head and Neck Squamous Cell Carcinoma,,,
NCT02486497,Adjuvant Gemcitabine Versus 5-FU/Leucovorin Based on hENT1 Immunostaining,NA,Pancreatic Cancer,,,
NCT00451997,Gleevec/Low-Dose Ara-C Study for Elderly Patients With AML and Myelodysplastic Syndromes,PHASE2,"Leukemia, Myeloid",,,
NCT02097810,"Study of Oral RXDX-101 in Adult Patients With Locally Advanced or Metastatic Cancer Targeting NTRK1, NTRK2, NTRK3, ROS1, or ALK Molecular Alterations.",PHASE1,Locally Advanced Solid Tumors,safety and tolerability of entrectinib via standard dose escalation scheme and determine the recommended Phase 2 dose,,
NCT02032810,Phase I of Histone Deacetylase (HDAC) Inhibitor Panobinostat With Ipilimumab With Unresectable III/IV Melanoma,PHASE1,Melanoma,,,
NCT02719613,Continuing Treatment for Participants Who Have Participated in a Prior Protocol Investigating Elotuzumab,PHASE2,Multiple Myeloma,,,
NCT02151760,"Study of 18F-DCFPyL, a Second Generation Low-molecular Weight PSMA-based PET Radiotracer, in Patients With Prostate Cancer",PHASE1,Metastatic Prostate Cancer,"the safety, biodistribution, and radiation dosimetry of 18F-DCFPyL, and to detect prostate cancer by visual analysis",,
NCT02922920,Effects of Tart Cherry Juice on the Body,NA,Cardiovascular Risk Factors,,,
NCT01778582,"Perspective-taking, and Examining the Clinical Trial Informed Consent Process",,Emotions,"\- To study perspective taking, and to study how people understand the information and enrollment process for a clinical trial",,
NCT04154982,N-Acetylcysteine Protection Against Radiation Induced Cellular Damage,PHASE2,Cardiac Arrhythmia,,,
NCT02793024,Shopping Smart - Adolescent Intervention to Improve Shopping Practices Where You Live and Learn,NA,Food Choices,"of this project is to develop and test the effectiveness of a Cooperative Extension enhanced intervention titled ""Smart Shopping,"" aimed at improving the shopping practices of adolescents with the ultimate goal of increasing fruit and vegetable intake",,
NCT00006124,Celecoxib in Treating Patients With Bladder Cancer,PHASE2,Recurrent Bladder Cancer,,,
NCT02442323,A Pilot Study of a Home-Based Walking Intervention for Pancreatic Cancer Patients,NA,Cancer of Pancreas,"of the proposed pilot project are to: (1) Assess the feasibility of implementing a 12-week, home-based walking program among pancreatic cancer patients",,
NCT00416559,Observation of Young Patients With Localized Neuroblastoma Who Have Undergone Surgery Only,PHASE2,Long-term Effects Secondary to Cancer Therapy in Children,,,
NCT00307723,"Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer",PHASE1,Pancreatic Cancer,,,
NCT00173680,Methylation Status of CD44 Promoter Region in Primary Lung Cancer,,Non-Small Cell Lung Cancer,,,
NCT03875079,"A Study to Evaluate Safety and Therapeutic Activity of RO6874281 in Combination with Pembrolizumab, in Participants with Advanced or Metastatic Melanoma",PHASE1,Metastatic Melanoma,the safety and therapeutic activity of RO6874281 in combination with pembrolizumab,,
NCT03291379,Vandetanib-eluting Radiopaque Embolic Beads in Patients With Resectable Liver Malignancies,EARLY_PHASE1,"Carcinoma, Hepatocellular",,,
NCT00509496,Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Anti-gp100:154-162 TCR Gene Engineered Lymphocytes,PHASE2,Skin Cancer,"* To determine whether an anti-melanoma protein receptor can be put in cells removed from patients' tumors or blood and then reinfused, with the purpose of shrinking tumors",safety and effectiveness of the treatment,"whether an anti-melanoma protein receptor can be put in cells removed from patients' tumors or blood and then reinfused, with the purpose of shrinking tumors"
NCT00410696,Pegfilgrastim Versus Filgrastim After High-dose Chemotherapy,PHASE2,Hematological Neoplasms,"of the study is to evaluate the efficacy and the safety of pegfilgrastim versus filgrastim, administered after high-dose chemotherapy and peripheral stem cell reinfusion","the efficacy and the safety of pegfilgrastim versus filgrastim, administered after high-dose chemotherapy and peripheral stem cell reinfusion",
NCT01008462,"Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia",PHASE2,B-Cell Prolymphocytic Leukemia,,,
NCT03495479,Aneustat Treatment of Localized Prostate Cancer Under Active Surveillance,,Prostate Cancer,"how OMN54 affects PSA, overall tumor burden in addition to any changes in urinary flow",,
NCT01137162,Clinical and Pathologic Studies of Patients Undergoing Treatment With EGFR Inhibitors,,"Anal, Colon, and Rectal Cancers",the homing phenotype of leukocytes from peripheral blood and skin biopsies of patients receiving EGFR inhibitors,,
NCT00522262,Alberta Physical Activity and Breast Cancer Prevention (ALPHA) Trial,NA,Breast Neoplasms,,,
NCT02172846,"Hypofractionated Proton Beam Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Stage II-III Non-Small Cell Lung Cancer",PHASE1,"Carcinoma, Non-Small-Cell Lung",,,
NCT04606446,Study of PF-07248144 in Advanced or Metastatic Solid Tumors,PHASE1,Locally Advanced or Metastatic ER+ HER2- Breast Cancer,"safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of PF-07248144 and early signs of clinical efficacy of PF-07248144 as a single agent and in combination with other agents",PF-07248144 as a single agent and in combination with other agents,
NCT05902988,A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer,PHASE1,Advanced Solid Tumor,VLS-1488 in subjects with advanced cancers,,
NCT02729103,Treatment Patterns in Metastatic Prostate Cancer,,Prostatic Neoplasm,),,
NCT03280303,Palbociclib in Real World Practice,,Advanced Breast Cancer,,,
NCT00864227,Evaluating the Safety and Effectiveness of an Umbilical Cord Blood Stem Cell Transplant (BMT CTN 0604),PHASE2,Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,,,
NCT03542227,Standard Operating Procedures for Anti-HPV (Human Papillomavirus) Antibody Detection in First-void Urine,,Human Papilloma Virus Infection,of the study is to develop and implement robust analytical protocols for first-void urine sample preparation and antibody assays to monitor vaccine induced immunity against HPV (Human Papillomavirus),,
NCT05009927,Efficiency of Imatinib Treatment After 10 Years of Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (Gist-Ten),PHASE2,Metastatic Gastrointestinal Stromal Tumor (GIST),if the re-introduction of Imatinib at relapse is still an efficient treatment for the control of disease,,
NCT02918461,Emerging From the Haze for Gynecologic Cancer Survivors,NA,Gynecologic Neoplasms,of this study is to quantify the impact of a trainee-taught Emerging from the Haze course on gynecologic cancer survivors' self-report of cognitive changes based on the change of FACT-Cog score,,
NCT00107861,Interferon-Beta Gene Transfer (Ad.hIFN-β) as Treatment for Refractory Colorectal Carcinoma With Liver Metastases,PHASE1,Colorectal Carcinoma,the safety and any harmful effects of an intravenous injection of Ad,,
NCT00001561,Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation,PHASE3,Graft vs Host Disease,,,
NCT03720561,A Study to Evaluate Ibrutinib Retention in Chronic Lymphocytic Leukemia Participants Treated in a Real World Setting,,"Leukemia, Lymphocytic, Chronic, B-Cell",,,
NCT06297161,A Study to Learn About the Study Medicine Bosulif in Adult Patients With Chronic Myeloid Leukemia(CML).,,Chronic Leukemia Myelogenous,,,
NCT03993561,Treatment Summary and Survivorship Care Plans (TSSP),NA,Survivorship,of the study is to establish the highest level of evidence to evaluate treatment summary and survivorship care plans (TSSPs) by piloting the TSSPs on patients with HNC,treatment summary and survivorship care plans (TSSPs) by piloting the TSSPs on patients with HNC,whether TSSPs result in improved implementation of recommendations for HNC survivors and improved quality of life and satisfaction
NCT02278861,Oral Isotretinoin Versus Topical Tretinoin for Actinic Keratosis,PHASE2,Actinic Keratosis,,,
NCT06202261,A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast Cancer,PHASE1,Metastatic Breast Cancer,"TQB2930 combined with albumin-paclitaxel (cohort 3), or chemotherapy selected by investigators (cohort 4)",,
NCT03169842,Cyst Fluid Glucose for On-site Diagnosis of Mucinous Pancreatic Cysts,NA,Pancreatic Cyst,,,
NCT06405542,Exercise-based Rehabilitation to Treat Persistent Chemotherapy Induced Peripheral Neuropathy (CIPN),PHASE1,Chemotherapy-induced Peripheral Neuropathy,,,
NCT02821442,"""Electro Acupuncture in the Treatment and Management of Chemotherapy Induced Peripheral Neuropathy""",NA,Breast Cancer,the effectiveness of Electro acupuncture (EA) for treatment of persistent painful CIPN symptoms in patients with stages 1-3 breast cancer treated with docetaxel chemotherapy 6 months prior,,
NCT06779942,"The Association Between IL17, Acute Respiratory Distress Syndrome and Acute Respiratory Failure",,Acute Respiratory Distress Syndrome (ARDS),,,
NCT01813942,Platform for Medical Information Extraction From Incomplete Data,,Liver Cancer,,,
NCT01798108,Dose Escalation Study of Radium-223 Dichloride in Patients With Advanced Skeletal Metastases,PHASE1,Neoplasm Metastasis,,,
NCT00828308,"Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer",PHASE2,Prostate Cancer,,,
NCT01402908,A Phase III PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related HCC After Surgical Resection,PHASE3,Cancer,if PI-88 is effective and safe in patients who have had surgery to remove primary liver cancer,,
NCT06266325,Development and Validation of a Dementia Life Expectancy Tool,,Dementia,,,
NCT03531125,Gene Expression in Pancreatic Cancer,,Pancreatic Cancer,whether the investigators can track gene expression (using a technique called RNA sequencing) in pancreatic cancer cells between two separate time points,,
NCT06309225,Dose Adjusted Chemoradiotherapy in HPV-Associated Oropharynx Cancer of the Elderly,NA,Oropharynx Cancer,,,
NCT00186225,Stem Cell Transplant From Matched Unrelated or Partially Matched Related Donors,NA,Blood Cancer,the use of unrelated donors for hematopoietic cell transplantation in the treatment of hematologic and lymphoid malignancies,,
NCT05239676,Autologous Hematopoietic Stem Cell Transplantation Combined With CAR-T Cells in the Treatment of Refractory and Relapsed Malignant Lymphoma,EARLY_PHASE1,Lymphoma,,,
NCT06054776,"Acalabrutinib, Obinutuzumab, and Glofitamab for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma",PHASE2,Mantle Cell Lymphoma,,,
NCT03134976,Wound Complications in Head and Neck Surgery,,Hypothyroidism; Surgery,of this study is to identify risk factors for poor wound healing as well as biologic markers associated with wound related complications in head and neck surgery,,
NCT05143840,Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase,PHASE2,"Chronic Myeloid Leukemia, Chronic Phase",of this study is to evaluate the efficacy and safety of asciminib in newly diagnosed CML-CP,the efficacy and safety of asciminib in newly diagnosed CML-CP,
NCT01674140,S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer,PHASE3,Breast Cancer,,,
NCT06569368,Trial Utilizing Metronidazole to Optimize the Microbiome of Rectal Adenocarcinoma Undergoing Neoadjuvant Therapy,PHASE2,Rectal Adenocarcinoma,,,
NCT01719068,Early Detection of Lung Cancer and Mesothelioma in Workers Exposed to Asbestos,,Mesothelioma,"to develop a lung cancer screening program for workers in British Columbia, Canada exposed to asbestos who are at risk of developing lung cancer/pleural mesothelioma",,
NCT06107868,Phase 1 Study of RP-6306 With Carboplatin and Paclitaxel in TP53 Ovarian and Uterine Cancer,PHASE1,Recurrent Ovarian Cancer,investigational drug RP-6306 in combination with carboplatin and paclitaxel in patients with TP53 mutated ovarian or uterine cancer,RP-6306 in combination with carboplatin and paclitaxel,
NCT02111850,T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 Positive,PHASE1,Cervical Cancer,The purpose of this study is to determine a safe number of these cells to infuse and to see if these particular tumor-fighting cells (anti-MAGE-A3-DP0401/0402 cells) cause tumors to shrink and to be certain the treatment is safe,a safe number of these cells to infuse and to see if these particular tumor-fighting cells (anti-MAGE-A3-DP0401/0402 cells) cause tumors to shrink and to be certain the treatment is safe,
NCT02200250,Long Term Barrett's Endoscopic Mucosal Resection Study,,Barretts Esophagus,,,
NCT02554591,Genomic Landscape of Ceritinib,,"Carcinoma, Non-Small-Cell Lung",,,
NCT00118274,"Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma",PHASE1,Melanoma (Skin),,,
NCT04800991,NuGa (Nutrition for Gastric Cancer Patients),NA,Gastric Cancer,"of this pilot study is to evaluate the feasibility and efficacy of Rhexium Onco Nutrition, HDT-202 for post-operative care in patients who have undergone gastrectomy","the feasibility and efficacy of Rhexium Onco Nutrition, HDT-202 for post-operative care in patients who have undergone gastrectomy","Rhexium Onco Nutrition, HDT-202 for post-operative care in patients who have undergone gastrectomy"
NCT02970474,A Study Utilizing 3D Printing in Patients Undergoing External Beam Radiation Therapy,PHASE1,Radiotherapy,whether the shortcomings of conventional bolus preparation can be overcome by using a 3D printer,,
NCT04568174,First in Human Study to Test the Safety and Preliminary Efficacy of PPSGG in Patients With Anti-MAG Neuropathy,PHASE1,Anti-MAG Neuropathy,,,
NCT01047774,The Effect of Soy Protein on Post- Breast Cancer Surgery Pain,PHASE2,Pain,the effects of adding soy protein to the diet before surgery on the development of chronic pain,,
NCT03680274,Lessening Organ Dysfunction With VITamin C,PHASE3,Sepsis,,,
NCT01065818,Early Prediction of Pathology Response of Chemoradiotherapy With FLT PET,NA,Esophageal Cancer,,,
NCT00415818,Immunotherapy With TG4010 in Patients With Advanced Non-Small Cell Lung Cancer,PHASE2,"Carcinoma, Non-Small-Cell Lung",is to assess the efficacy of TG4010 combined to chemotherapy in comparison with chemotherapy alone in patients with advanced non small cell lung cancer,the efficacy of TG4010 combined to chemotherapy in comparison with chemotherapy alone in patients with advanced non small cell lung cancer,TG4010 combined to chemotherapy in comparison with chemotherapy alone in patients with advanced non small cell lung cancer
NCT00080574,The Effect of Thyroid Hormone on Drug Elimination in Cancer Patients,PHASE2,Thyroid Cancer,what happens to the test drugs in the body,,
NCT04988074,"Trial of Cemiplimab, or Cemip-Chemo Followed by Biomarker-guided Treatment for Pts w/HPV H&N Ca",PHASE2,HPV-Related Squamous Cell Carcinoma,if it is feasible to use neoadjuvant immunotherapy (or immunotherapy plus chemotherapy) to reduce treatment intensity and improve long-term quality of life while maintaining very high cure rates,,
NCT01184274,A Phase I Study of SB939 in Pediatric Patients With Refractory Solid Tumours and Leukemia,PHASE1,Leukemia,,,
NCT05151718,Multiomic Approach to Radioresistance of Ependymomas in Children and Adolescents,,Ependymoma of Brain,"is to collate in a single database called NETSPARE (Network to Structure and Share Pediatric data to Accelerate Research on Ependymoma) the clinical, histological, biological, imaging and radiotherapy data from two consecutive studies that included 370 children and adolescents with ependymoma since 2000 in France",,
NCT02888418,Safety and Immunogenicity Study of Human Papilloma Virus Vaccine in Women Aged 9 to 30 and Men Aged 9 to 17,PHASE1,Cervical Cancer,,,
NCT05910190,Buprenorphine for Cancer Pain,PHASE4,Cancer-Related Pain,for withdrawal symptoms,,
NCT02322190,Biomarkers in Acute Graft-Versus-Host Disease and Extracorporeal Photopheresis Added to Investigator Chosen Therapies of Steroid Refractory Acute GVHD,PHASE2,Chronic Graft vs. Host Disease,\- To learn more about treatments for acute GVHD after allogeneic stem cell transplantation,,
NCT01070290,A Study of ARQ 197 Versus Investigator's Choice of Second-Line Chemotherapy in Patients With Locally Advanced or Metastatic Gastric Cancer Who Have Progressive Neoplastic Disease Following Treatment With One Prior Chemotherapy Regimen,PHASE2,Gastric Cancer,the progression free survival (PFS) of patients with advanced gastric cancer following treatment with either ARQ 197 or one of three standard regimens (investigator's choice),,
NCT00352690,"A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in Stage III Non-Small Cell Lung Cancer",PHASE2,"Carcinoma, Non-Small-Cell Lung",the role of paclitaxel poliglumex and carboplatin in the treatment of unresectable Stage III non-small cell lung cancer along with radiation therapy in a multi-institutional trial,,
NCT03776890,DeStress for Health: Partnering With Granville and Vance Counties to Reduce Stress and Cancer Risk,NA,Stress Reduction,whether a positive psychology intervention paired with a health behavior intervention is successful in decreasing perceived stress and increasing positive affect in residents of Vance and Granville County,,
NCT04238390,Ceftolozane-tazobactam Versus Meropenem for ESBL and AmpC-producing Enterobacterales Bloodstream Infection,PHASE3,Bacteremia Caused by Gram-Negative Bacteria,whether ceftolozane-tazobactam is as effective as meropenem with respect to 30 day mortality in the treatment of bloodstream infection due to third-generation cephalosporin non-susceptible Enterobacterales or a known chromosomal AmpC-producing Enterobacterales (Enterobacter spp,,
NCT03276013,"Pembrolizumab in Combination With Doxorubicin in Advanced, Recurrent or Metastatic Endometrial Cancer",PHASE2,Endometrial Neoplasms,,,
NCT04764513,Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCT,PHASE1,Acute Myeloid Leukemia,,,
NCT01591213,St. Jude Cancer Education for Children Program: The Feasibility of Teacher Delivery (Pilot Study),,Healthy,,,
NCT00105313,Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia,PHASE1,Lymphoma," we will determine the MTD and examine clinical responses and immune cell populations to determine an OBD, and describe the safety and tolerability of MEDI-507","an OBD, and describe the safety and tolerability of MEDI-507",
NCT06400160,Clinical Trial of TB511 in Advanced Solid Tumors,PHASE1,NSCLC,Response Rate (ORR) of TB511 monotherapy and TB511 in combination with Pembrolizumab in patients with advanced solid tumors (based on Response Evaluation Criteria In Solid Tumors Version 1,the Objective Response Rate (ORR) and anti-tumor activity of TB511 monotherapy (based on RECIST v1,the safety and tolerability of TB511 monotherapy in patients with advanced solid tumors and to determine the Maximum Tolerated Dose (MTD) and the Recommended Phase II Dose (RP2D)
NCT04668820,"Reliability and Acceptability of Real-time Virtual Video Pediatric Gait, Arms, Legs and Spine (V-pGALS)",NA,Musculoskeletal Abnormality,"of this study is to investigate acceptability and reliability of real-time virtual video Pediatric Gait, Arms, Legs and Spine (V-pGALS) assessment for musculoskeletal assessment of children for telemedicine visits",,
NCT01105182,Radiofrequency Ablation Combined With Chemotherapy for Pulmonary Tumors,,NSCLC,short and long term outcomes after radiofrequency ablation (RFA) combined with chemotherapy for pulmonary malignancies in patients who are not candidates for surgical resection,"RFA combined with chemotherapy for the treatment of lung tumors by assessing its impact on local tumor control, progression free survival, overall survival, dyspnea score and quality of life (QOL)",
NCT00527982,Celecoxib as Adjuvant Biologic Therapy in Patients With Head and Neck and Lung Cancer,PHASE2,Head and Neck Cancer,1,,
NCT04030624,Remote Electronic Patient Monitoring in Gastrointestinal Cancer,NA,Gastrointestinal Cancer,"a program that involves remote electronic monitoring of vital signs and symptoms of patients with gastrointestinal cancer who were recently hospitalized at Massachusetts General Hospital or presented to the oncology clinic for an unplanned, urgent visit",,
NCT02942524,Checklist Tool in Engaging Patients in the Discharge Planning Process,NA,Hospitalization,,,
NCT01418859,Clinical Study in Post-operation Treatment of Cervical Cancer,,Cervical Cancer,"the effect of additional chemotherapy in postoperation therapy of cervical cancer patients with risk factors (big tumor, deep invasion or tumor thrombi in the vascular system)",,
NCT00082459,"Trial to Compare the Routes of Administration of an Investigational, Personalized, Therapeutic Cancer Vaccine Oncophage (HSPPC-96) in Patients With Metastatic Renal Cell Carcinoma",PHASE2,Renal Cell Carcinoma,the safety of HSPPC-96 and which route of administration achieves a better response with the vaccine,,
NCT03817359,Use of a Remifentanil-propofol Mixture in Patients Undergoing Breast Cancer Surgery,NA,Anesthetics,,,
NCT04224480,Longitudinal Immune-phenotyping of HCC Following MK-3475,PHASE1,Hepatocellular Carcinoma,,,
NCT00225979,Safety and Efficacy of Long-acting Repeatable Octreotide Acetate for Injectable Suspension vs. Surgery in Treatment-naïve Patients With Acromegaly,PHASE3,Acromegaly,of this study is to assess the safety and efficacy of long-acting repeatable formulation of octreotide and to compare it to the safety and efficacy of surgery in patients with acromegaly who have not had any previous treatment for acromegaly,the safety and efficacy of long-acting repeatable formulation of octreotide and to compare it to the safety and efficacy of surgery in patients with acromegaly who have not had any previous treatment for acromegaly,long-acting repeatable formulation of octreotide and to compare it to the safety and efficacy of surgery in patients with acromegaly who have not had any previous treatment for acromegaly
NCT06620679,Mapping the Effect of (neuro)inflammation on Stress Sensitivity in the Brain of Healthy Men,NA,Inflammation,the effects of inflammation on stress responses in the brain of healthy men,,
NCT03977662,Pancreatic Islets and Parathyroid Gland Co-transplantation for Treatment of Type 1 Diabetes,PHASE1,Type 1 Diabetes,"is to test the hypothesis that co-transplantation of allogeneic PTG with adult pancreatic islets (derived from same deceased donor) in the IM site in people with Type 1 diabetes with functioning kidney and/or liver transplants is safe, allows islet engraftment, and leads to insulin independence",,
NCT06760962,"Reflective Mindfulness and Emotional Regulation Training to Enhance Nursing Students' Self-Awareness, Understanding, and Regulation",NA,Undergraduate Health Professional Students,,,
NCT06494046,Defining Musical Toxicity and Its Effect on Patient Well-being,,Breast Carcinoma,,,
NCT07073846,"Effect of Lidocaine-Dexmedetomidine on Pain, Inflammation, and Oxidative Stress After Bariatric Surgery.",PHASE4,Morbid Obesity Requiring Bariatric Surgery,,,
NCT04181346,Pregabalin for the Prevention of Chemotherapy Induced Nausea and Vomiting,PHASE2,Nausea,,,
NCT01936688,A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-012),PHASE3,Plaque-type Psoriasis,the efficacy and safety/tolerability of SCH 900222/MK-3222 in a population of participants with moderate-to-severe plaque psoriasis,,
NCT05784688,Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors,PHASE1,Solid Tumor,"safety, Pharmacokinetics, and efficacy of TU2218 in combination with Pembrolizumab in patients with advanced solid tumors",TU2218 in combination with Pembrolizumab in patients with advanced solid tumors,
NCT07190703,Research on Early Diagnosis and Risk Stratification Biomarkers of Anti-Tumor Drug-Associated Interstitial Pneumonia Driven by Multi-Omics Integration,,Anti-Tumor Drug-Associated Interstitial Pneumonia,"to construct an early diagnostic biomarker panel and risk stratification model for anti-tumor drug-related ILD through integrative analysis of multi-omics data including genomics, transcriptomics, proteomics, and metabolomics",,
NCT03741127,Long-Term Follow-Up Study for Subjects Treated With P-BCMA-101,PHASE1,Multiple Myeloma,"the risk of delayed adverse events (AEs) and assess long-term efficacy, and PK and quantification of P-BCMA-101 T cells",,
NCT02980861,Laparoscopic Versus Open Gastrectomy With Splenic Hilum Lymph Nodes Dissection,PHASE3,Gastric Cancer,to compare the safety and feasibility of LTG and OTG for advanced proximal gastric cancer,,
NCT01595750,"Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Roflumilast on Endothelial Function in Patients With Chronic Obstructive Pulmonary Disease",PHASE4,Chronic Obstructive Pulmonary Disease,,,
NCT06200168,Electroacupuncture for the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients With Breast Cancer,PHASE3,Electroacupuncture,to evaluate the use of electroacupuncture in combination with olanzapine-containing standard quadruple antiemetic drugs for the treatment of nausea and vomiting induced by highly emetogenic chemotherapy (HEC) in patients with breast cancer,the use of electroacupuncture in combination with olanzapine-containing standard quadruple antiemetic drugs for the treatment of nausea and vomiting induced by highly emetogenic chemotherapy (HEC) in patients with breast cancer,
NCT02435550,iCare for Cancer Patients,NA,Myelodysplastic Syndromes,,,
NCT00053950,Pyrazoloacridine and Stem Cell or Bone Marrow Transplantation in Treating Young Patients With High-Risk Neuroblastoma,PHASE1,Disseminated Neuroblastoma,,,
NCT01211691,"Study of KB004 in Subjects With Hematologic Malignancies (Myelodysplastic Syndrome, MDS, Myelofibrosis, MF)",PHASE1,Myelodysplastic Syndrome (MDS),,,
NCT01483274,Decitabine and Vaccine Therapy for Patients With Relapsed AML Following Allogeneic Stem Cell Transplantation,PHASE1,Acute Myelogenous Leukemia,,,
NCT05244174,Impact of Pancreatic Endoscopic Drainage on Exocrine Pancreatic Function in Unresectable Pancreatic Cancer,NA,Pancreatic Neoplasm Malignant Head Primary,"The aim of this study is to assess the impact of transpapilar drainage of the main pancreatic duct on exocrine pancreatic function, nutritional status, and life survival in patients with unresectable pancreatic adenocarcinoma","the impact of transpapilar drainage of the main pancreatic duct on exocrine pancreatic function, nutritional status, and life survival in patients with unresectable pancreatic adenocarcinoma",
NCT06017518,An Observational Study of Local Relapse After High Grade Osteosarcoma,,Osteosarcoma,,,
NCT03223818,The Impact of Fast-track Perioperative Program After Liver Resection in Hong Kong Chinese Patients,NA,Liver Cancer,"of this study is to compare the clinical and immunological outcomes of Hong Kong Chinese patients undergoing liver resection for liver cancer with a ""conventional"" vs a ""fast-track"" perioperative program",,
NCT02406118,Phase II Clinical Trial for the Evaluation of the Efficacy of Transanal TME,NA,Rectal Cancer,transanal total mesorectal excision,,
NCT06584318,Exploratory Study of Intermittent Hypoxia Intervention on Colorectal Cancer,NA,Colorectal Cancer,to explore the safety and efficacy of intermittent hypoxia intervention on patients with colorectal cancer,intermittent hypoxia intervention on patients with colorectal cancer,
NCT05880290,Performance of the Gynaecological Examination in the Lateral Decubitus Position,NA,Medical Care,,,
NCT00694590,Study of AMD3100 (Plerixafor) and Rituximab in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma,PHASE1,Chronic Lymphocytic Leukemia (CLL),is to determine the maximum tolerated dose (MTD) of plerixafor when combined with rituximab as treatment for previously treated patients with CLL or SLL,"if plerixafor can make CLL/SLL (Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma) cells more sensitive to being killed by rituximab, an anti-cancer drug that is commonly used in treating CLL and SLL",
NCT04414397,A Study Evaluating JUVÉDERM® VOLUMA® XC Injectable Gel for Correction of Temple Hollowing in Adult Participants ≥ 22 Years Old,PHASE3,Temple Hollowing,of this study are to evaluate the safety and effectiveness of Juvederm® Voluma® XC injectable gel in adult participants seeking correction of temple hollowing,the safety and effectiveness of Juvederm® Voluma® XC injectable gel in adult participants seeking correction of temple hollowing,
NCT05268510,"Chemotherapy and Pembrolizumab, Followed by Pembrolizumab and Olaparib As Firstline Therapy in Her-2 Negative Gastric/GEJ Adenocarcinoma",PHASE2,Esophagogastric Adenocarcinoma,,,
NCT06671210,Clinical Performance of Urine HPV Testing in Males,,HPV,to further refine this detection system to develop a stable and reliable methodology for detecting HPV using self-collected urine samples from males,,
NCT03583710,Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence,PHASE3,ENSAT Stage I Adrenal Cortex Carcinoma,,,
NCT03750110,Yorkshire Enhanced Stop Smoking Study,NA,"Cancer, Lung",,,
NCT05193110,Two Years Follow up of Polyetheretherketone (PEEK) Sub-periosteal Implant Retaining Maxillary Fixed Prosthesis,NA,Mastication Disorder,,,
NCT02907710,Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma,PHASE3,Nasopharyngeal Carcinoma,,,
NCT05491213,TELESCOPE- TELEhealth Shared Decision-making COaching,NA,Lung Neoplasms,"), greater knowledge of lung cancer screening benefits and harms, and lower decisional conflict",,
NCT05561413,Gynaecology Exercise and Mindfulness Study,NA,Gynecologic Cancer,"of this study is to explore the feasibility and effectiveness of conducting a mindfulness and home-based walking and strength training program on fatigue, psychological outcomes and quality of life for gynecological cancer survivors",,
NCT05704413,Digestive Biobank for Exploring Microbiota-host Interactions,,Inflammatory Bowel Diseases,,,
NCT06736613,A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma,PHASE2,Diffuse Large B Cell Lymphoma,,,
NCT00980213,Evaluation of the Cost and Effectiveness Sunitinib Compared to Interferon-Alfa in Finland,,Neoplasms,,,
NCT00152113,Haploidentical Stem Cell Transplant for Patients With Sickle Cell Disease and Prior Stroke or Abnormal Transcranial Ultrasound,PHASE1,Sickle Cell Disease,of this study is to assess the safety of haploidentical stem cell transplantation for children and adolescents with severe sickle cell disease and stroke or abnormal transcranial Doppler ultrasound requiring chronic transfusion therapy,the safety of haploidentical stem cell transplantation for children and adolescents with severe sickle cell disease and stroke or abnormal transcranial Doppler ultrasound requiring chronic transfusion therapy,
NCT06515860,Neurofibromatosis Type 1 Tumor Early Detection Study,,Neurofibromatosis Type 1,if a liquid biopsy (i,,
NCT04336982,A Safety and Efficacy Study of CC-90009 Combinations in Subjects With Acute Myeloid Leukemia,PHASE1,"Leukemia, Myeloid, Acute",the safety and efficacy of CC-90009 in combination with anti-leukemia agents in participants with acute myeloid leukemia (AML),CC-90009 in combination with anti-leukemia agents in participants with acute myeloid leukemia (AML),
NCT01619124,Osteonecroses in Pediatric Patients With ALL,,Osteonecrosis,is the reduction of ON-associated morbidity,,
NCT04820023,Phase 1/2 Study of BBT-176 in Advanced NSCLC With Progression After EGFR TKI Treatment,PHASE1,NSCLC,the anti-tumor activity of BBT-176 (Part 2),,
NCT04824859,A Geriatric Assessment Electronic Platform for Older Patients With Cancer (eGAP - Electronic Geriatric Assessment Platform),NA,Cancer,,,
NCT01324180,"Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL)",PHASE1,Acute Lymphoblastic Leukemia,,,
NCT04496180,Prevena to Prevent Surgical Site Infection After Emergency Abdominal Laparotomy,NA,Surgical Site Infection,to study the economic impact of CINPt used after abdominal emergency laparotomies,,
NCT07105579,Effectiveness and Safety of Blinatumomab and Donor Lymphocyte Infusion in Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation for High-risk Ph Negative B Cell Acute Lymphoblastic Leukemia,PHASE2,Leukemia,the effectiveness and safety of Blinatumomab and Donor Lymphocyte Infusion in maintenance therapy after allogeneic hematopoietic stem cell transplantation for high-risk Ph negative B cell acute lymphoblastic leukemia,,
NCT06151379,Muscle Parameters and Pathological Response in Breast Cancer Patients,,Neoadjuvant Chemotherapy,ed to accurately measure muscle mass and predict pCR to NAC and its effect on clinical outcomes,,
NCT06305962,177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors,EARLY_PHASE1,PDL1 Gene Mutation,"safety, tolerability, biodistribution, radiation dosimetry and preliminary anti-tumour activities of 177Lu-RAD204 in participants with selected solid tumours, to identify the MTDs/ recommended doses of 177Lu-RAD204 for future exploration",,
NCT02093962,Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer,PHASE2,Non-small Cell Lung Cancer,whether TH-302 in combination with pemetrexed is safe and effective in the treatment of non-squamous non-small cell lung cancer,,
NCT06660862,Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer.,PHASE4,Prostate Cancer,"to investigate the impact of darolutamide in combination with standard-of-care androgen deprivation on physical activity, specifically step count, and its correlation with important markers of safety in vulnerable adults who screen positive by a brief geriatric assessment (GA) and metastatic hormone-sensitive prostate cancer",,
NCT01877096,Motivational Interviewing for Colonoscopy,NA,Colorectal Cancer,a motivational interviewing intervention to increase African Americans' screening colonoscopy rates,,
NCT06147362,"68Ga-NOTA-PEG2-RM26 PET/CT, First in Man Study",PHASE1,Cancer,PET/CT images,68Ga-NOTA-PEG2-RM26 in prostate cancer patients,
NCT05213962,Local and Regional Radiotherapy for Nipple Sparing Mastectomy With Implant,,Breast Cancer,,,
NCT00961896,"A Trial to Evaluate the Safety, Local Tolerability, Pharmacokinetics and Pharmacodynamics of LDE225 on Skin Basal Cell Carcinomas in Gorlin Syndrome Patients",PHASE2,Treatment for Basal Cell Carcinomas (BCCs) in Gorlin Syndrome Patients,"the safety, local tolerability, pharmacokinetics and pharmacodynamics of multiple topical administrations of LDE225 (a specific Smoothened inhibitor) on skin basal cell carcinomas in Gorlin's syndrome patients",,
NCT04979988,Study to Evaluate Clinical Real World Outcomes of Lorlatinib After Alectinib in ALK-Positive NSCLC Japanese Patients,,ALK-positive Non-small-cell Lung Cancer,the clinical real world outcomes of lorlatinib in second/later line setting anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor (TKI) to TKI sequence sequence treatment after failure of alectinib as a first-line treatment in Japanese ALK positive non-small cell lung cancer (NSCLC),,
NCT00420303,Study Evaluating Etanercept for the Treatment of Refractory Heel Enthesitis in Spondylarthropathy,PHASE4,"Spondylarthropathies, Enthesitis",the efficacy and safety of Etanercept in patients with spondylarthropathy and refractory heel enthesitis,,
NCT03511703,The Study of The Treatment of Postoperative Adjuvant Apatinib vs. TACE in Hepatocellular Carcinoma Patients,PHASE2,Hepatocellular Carcinoma,,,
NCT04517461,Coagulation and Vitamin K in Head and Neck Microvascular Free Flap Surgery,,Head and Neck Cancer,if these parameters can help predict patients at risk for bleeding or flap thrombosis,,
NCT04903561,Increase in Response by Offering Self-sampling Devices in Belgian GP Practices to Non-screened Women,NA,Cervical Cancer,,,
NCT01652261,Very Early FDG-PET/CT-response Adapted Therapy for Advanced Hodgkin Lymphoma (H11),PHASE3,Hodgkin Lymphoma,"of the trial is to show that doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD)-based response-adapted therapy for advanced-stage Hodgkin lymphoma, with treatment intensification (bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone (BEACOPPesc) in case of a positive fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) after one cycle of ABVD, has non-inferior efficacy compared with the intensive BEACOPPesc regimen",the prognostic value of FDG-PET/CT after one cycle of BEACOPPesc,
NCT06101927,Molecular Imaging of Prostate-Specific Membrane Antigen Using Labeled Technetium-99m BQ0413,PHASE1,Prostate Cancer,the distribution of \[99mTc\]Tc- BQ0413 in normal tissues and tumors at different time intervals,dosimetry of \[99mTc\]Tc- BQ0413,
NCT02902627,Pain in Oncolgy: Evaluation of a Non Invasive Monitoring Device (ANI). A Monocentric Prospective Study,NA,Pain,of the research is to estimate the Analgesia Nociception Index (ANI) as a parameter giving the possibility of measuring the pain in painful metastatic cancer,,
NCT06957327,A Study of ERAS-601 in People With Chordoma,PHASE1,Chordoma,,,
NCT00389727,Simultaneous Integrated Boost (SIB)- IMRT,PHASE2,"Carcinoma, Squamous Cell","of the study will be acute toxicity assessed during treatment and during the first 3 months following the completion of radiotherapy The secondary endpoint will include loco-regional control, disease-free survival, survival and late toxicity at 2 years after completion of radiotherapy",of the study is to assess the feasibility of increasing dose of irradiation with IMRT using a SIB approach over 6 weeks,the feasibility of increasing dose of irradiation with IMRT using a SIB approach over 6 weeks
NCT00524186,"Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal Cancer",PHASE1,Esophageal Cancer,,,
NCT01951586,Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer,PHASE2,Non-Small Cell Lung Cancer,,,
NCT04683770,Prognostic Value of Biomarkers in HR + / HER2 - Advanced Breast Cancer,,Breast Cancer,ed to explore a prospective observational clinical study on the efficacy prediction and survival prediction of HR + / HER2 - biomarkers detection in patients with advanced breast cancer,,
NCT04428086,A Pharmacokinetic Interaction Study Between Apatinib and Rosuvastatin or Metformin in Solid Tumor Subjects.,PHASE1,"Solid Tumor, Adult",of the study was to assess investigate the pharmacokinetic effects of Apatinib on Rosuvastatin or Metformin,investigate the pharmacokinetic effects of Apatinib on Rosuvastatin or Metformin,
NCT01693770,Primary Pain Palliation in Bone Metastases Treated With Magnetic Resonance-guided Focused Ultrasound,PHASE1,Secondary Malignant Neoplasm of Bone,the clinical performance of MRgFUS primary treatment of painful bone metastases and determine the potential of this technique for local tumor control,,
NCT04719273,Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer,PHASE2,Refractory Endometrial Adenocarcinoma,,,
NCT00192673,Poly(Ethylene Glycol)(PEG)-Asparaginase During Two Treatment Courses,PHASE4,Acute Lymphoblastic Leukemia,,,
NCT03094273,Prospective Study of 2 mm Margins for the Biopsy of Dysplastic Nevi,,Dysplastic Nevi,the utility of removing Dysplastic Nevi with a defined 2 mm margin,,
NCT01937273,The Nutritional Status of Chemo-radiotherapy Patients,,Malnutrition,"to baseline the nutritional status of chemo-radiotherapy patients undergoing treatment at the Alan Walker Cancer Care Centre (Darwin), identify contributors to nutritional deterioration and determine if there is a difference between Indigenous and non-Indigenous patients",,
NCT06619769,eSense-Cancer: Adapting an Online Intervention for Sexual Health Concerns to Gynecologic Cancer,NA,Gynecologic Cancers,to assess how well an adapted online health intervention meets the sexual health needs of gynecologic cancer survivors and to test the efficacy of the new platform,how well an adapted online health intervention meets the sexual health needs of gynecologic cancer survivors and to test the efficacy of the new platform,the new platform
NCT00773383,A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Having Received Tarceva Monotherapy.,PHASE2,Non-Small Cell Lung Cancer,"response rate, time to response, time to progressive disease and duration of response will also be evaluated",,
NCT00603694,Hippocampal Radiation Exposure and Memory,,Arteriovenous Malformation,changes in memory function that may be associated with such exposures,,
NCT00104754,Liposomal SN-38 in Treating Patients With Small Cell Lung Cancer,PHASE2,Lung Cancer,,,
NCT05289505,Evaluation of Music on the Level of Anxiety Felt During External Radiotherapy Sessions,,Radiotherapy Side Effect,,,
NCT04790305,Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer,PHASE4,Carcinoma Breast,the efficacy of Huaier Granule on postoperative adjuvant therapy of high-risk early-stage triple-negative invasive ductal carcinoma,Huaier Granule on postoperative adjuvant therapy of high-risk early-stage triple-negative invasive ductal carcinoma,
NCT05050305,Marizomib Central Nervous System (CNS),PHASE2,Multiple Myeloma,,,
NCT05775705,L-DEP Regimen Combined With PD-1 Antibody as Induction Therapy for Epstein-Barr Virus-positive LA-HLH,PHASE3,PD-1 Antibody,,,
NCT07014605,Smoking Cessation Program for Lao People With HIV,NA,Smoking Cessation,"(Reach, Effectiveness, Adoption, Implementation, and Maintenance) framework to include more contextual factors relevant to program implementation",the resource use and costs of implementing AA-MAP and AA-SH,the reach and effectiveness of AA-MAP versus AA-SH
NCT06952894,Feasibility of RUS Lung in MITS,NA,Lung Cancer,to demonstrate the feasibility and efficacy of RUS Lung Surgical Navigation System in patients undergoing minimally invasive thoracic surgery(MITS),RUS Lung Surgical Navigation System in patients undergoing minimally invasive thoracic surgery(MITS),
NCT03687294,Diagnostic Accuracy of Human Transcriptional Activator(MYB) Expression by ELISA Technique Versus Immmunohistochemistry in Detecting Salivary Gland Carcinomas,,Malignant Neoplasm of Salivary Gland,,,
NCT04477694,The Effect of Diabetes Mellitus in Colonoscopy Under Sedoanalgesia,,"Diabetes Mellitus, Type 2",Diabetes Mellitus (DM) is a common endocrine disease in the world,,
NCT06850766,The Feasibility and Efficacy of Dose Timing (Morning vs Evening) of Temozolomide in the Treatment of Glioblastoma,NA,IDH-Wildtype Glioblastoma,"participant recruitment, safety, health-related quality of life, and changes in condition over time",,
NCT00165880,"An Open-label, Randomized, Phase II Study of the Efficacy and Safety of Indisulam (E7070) in Combination With Capecitabine",PHASE2,Metastatic Breast Cancer,,,
NCT00224679,APACC Study:Prospective Study on Aspirin Efficacy in Reducing Colorectal Adenoma Recurrence,PHASE3,Colon Adenomas,,,
NCT01117779,Tracking Renal Tumors After Cryoablation Evaluation,,Kidney Neoplasms,,,
NCT01411579,Use of DwI-MR to Predict Chemotherapy Response of Liver Metastases and Hepatocarcinoma,,Liver Metastases,if each single patient will respond (R) or not (NR) to the CHT through liver DW-MRI performed from 3 days to 3 weeks after the beginning of CHT,,
NCT04285996,IMaging Pilot Study of the αvβ6 Integrin Radiotracer [18F]-A20FMDV2 in PAtients With Solid Cancer Types,NA,Cancer,the safety of the radiotracer and how it is taken up in the body,,
NCT03546088,Awake Nasal Intubation in Laryngopharyngeal Tumors,NA,Airway Management,,,
NCT05369988,VALIDATION OF THE VIBe INTRAOPERATIVE BLEEDING SCALE IN LIVER SURGERY,,Surgical Hemorrhage,intraoperative bleeding has led to their inappropriate selection on many occasions,,
NCT02519088,A New Approach to a Personalized Patient Blood Management Program (pPBM) in Total Hip Arthroplasty (THA),,Postoperative Anemia,is to increase the patient safety by using the pPBM App and to reach a more efficient management of resources,,
NCT01345903,Robotic-Assisted Surgery in Treating Patients With Spine Tumors,NA,Adult Spinal Cord Neoplasm,,,
NCT00403403,A Study of Bevacizumab in Previously Untreated Extensive-Stage Small Cell Lung Cancer (SALUTE),PHASE2,Small Cell Lung Cancer,,,
NCT01260103,Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma,PHASE3,Optic Nerve Glioma,"To compare progression free survival (PFS), the time from randomization to progressive disease,in children with optic pathway glioma (OPG) age ≥ 6 months to \< 18 years, who receive combination antineoplaston therapy (ANP therapy) vs",,
NCT04033627,TCDαβ/CD45RA Haploidentical Transplantation in Children With Leukemia,NA,Relapsed Pediatric ALL,,,
NCT06728527,PARTial BREast RECONstruction With Chest Wall Perforator Flap,,Breast Cancer Early Stage Breast Cancer (Stage 1-3),,,
NCT00512642,Fluorescence Bronchoscopy and Molecular Characterization of Abnormal Bronchial Lesions: Novel Approaches for Early Detection of Lung Cancer in High Risk Patients,,Cancer,,,
NCT05840042,Epidemiology and Risk Factors of Uterine Fibroids in China,,Uterine Fibroid,,,
NCT04159142,Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-negative Breast Cancer,PHASE2,Triple Negative Breast Cancer,the efficacy and safety of the following two combinations: i) nab-paclitaxel+carboplatin,,
NCT02595242,Safety and Efficacy Study of CNOP Chemotherapy in Diffuse Large B Cell Lymphoma,PHASE1,Diffuse Large B Cell Lymphoma,"whether Mitoxantrone Hydrochloride Liposome Injection plus Cyclophosphamide,Vincristine and Prednison(CNOP)is safe and effective in the treatment of Diffuse Large B Cell Lymphoma",,
NCT02757586,Treatment of Chronic Lymphocytic Leukemia,,"Leukemia, Lymphocytic, Chronic, B-Cell",,,
NCT06109870,Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening,NA,HPV,,,
NCT05661370,App Teaches Doctors to Diagnose Skin Cancer,NA,Melanoma (Skin),ed to examine if self-paced learning with a novel digital patient-case-based educational platform can increase primary care physicians' diagnostic accuracy of malignant and benign skin lesions on both the level of benign/malignant and the diagnosis level,,
NCT06958770,Combining Electrical Impedance Tomography and Thoracic Ultrasound Toinvestigate Dynamic Changes,,ARDS (Moderate or Severe),the dynamic changes of lung ultrasound during electrical impedance tomography (EIT) PEEP titration and across the first week of ARDS,,
NCT06267170,"A Multicenter, Real-world Study of Adebrelimab in the Treatment of Extensive Stage Small Cell Lung Cancer",,"SCLC,Extensive Stage",,,
NCT05110573,Single-centre Propensity Score-matched Comparison of Laparoscopic Versus Open Pancreatoduodenectomy,,Pancreatic Neoplasms,,,
NCT00681473,Late Effects of Proton Radiation Therapy in Patients With Low-Grade Glioma,NA,Low Grade Gliomas,,,
NCT02903069,Study of Marizomib With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Brain Cancer,PHASE1,Glioblastoma,"whether an investigational drug known as marizomib (MRZ) will improve the treatment of newly diagnosed glioblastoma patients by delaying the growth of the cancer, reducing the size of the tumor, and/or improving survival",,
NCT02619669,Neoadjuvant Run-In Study With TAK-228 Followed by Letrozole/TAK-228 in Women With High-Risk ER+/HER2- Breast Cancer,PHASE1,Breast Cancer,,,
NCT06315205,"Evaluation of the Pharmacokinetics, Safety, and Tolerability of IM Letrozole LEBE in Healthy Post-menopausal Women",PHASE1,Healthy,"the pharmacokinetic (PK), safety, and tolerability of Letrozole LEBE in healthy post-menopausal women",,
NCT04575883,HIIT in Youth With Congenital Heart Disease (MedBIKE),NA,Congenital Heart Disease,this program in a broader CHD population,,
NCT04597541,A Study of AK112 for Advanced Solid Tumors,PHASE1,"Solid Tumor, Adult","response rate,progression-free survival and overall survival per RECIST1",,
NCT04325841,Phase II Study of Anti-CD19 CAR-T Cells Treating Leukemia Children,PHASE2,"Acute Lymphoblastic Leukemia, Pediatric",,,
NCT04560205,Tocilizumab in COVID-19 Lahore General Hospital,PHASE1,SARS-CoV Infection,,,
NCT00407654,VEGF Trap in Treating Patients With Previously Treated Metastatic Colorectal Cancer,PHASE2,Recurrent Colon Cancer,,,
NCT06861894,Active Surveillance After Neoadjuvant Adebrelimab Combined With Chemoradiotherapy for Resectable ESCC,PHASE2,Esophageal Squamous Cell Carcinoma,is 2-year overall survival rate in this watch-and-wait cohort,,
NCT06682494,Enhancing Oral Cancer Awareness Among Minorities,NA,Oral Cancer,the impact of AI-powered chatbot interactions versus traditional educational handouts on increasing participants' knowledge of oral cancer and its prevention,,
NCT03306394,A Study of Trifluridine/Tipiracil (Also Known as S 95005 or TAS-102) in Patients With a Pretreated Colorectal Cancer That Has Spread (Metastatic).,PHASE3,Metastatic Colorectal Cancer,,,
NCT02191566,S-1/Oxaliplatin for High Risk Patients Who Underwent Gastrectomy,PHASE2,Stomach Cancer,,,
NCT01658956,Effectiveness of Reduced GCSF Dosing in Patients With a Low to Moderate Risk of Febrile Neutropenia,PHASE2,Breast Cancer,"to confirm that a reduced dosage of GCSF is effective in preventing febrile neutropenia among patients with breast cancer, treated with chemotherapy and presenting with a low to moderate risk of developing febrile neutropenia",,
NCT04481256,TGF-β And PDL-1 Inhibition in Esophageal Squamous Cell Carcinoma Combined With Chemoradiation TheRapY,NA,"Carcinoma, Squamous Cell","of this study is to assess the feasibility of treatment with bintrafusp alfa combined with definitive chemoradiation (carboplatin, paclitaxel and radiation) in patients with squamous cell carcinoma of the esophagus or gastroesophageal junction","the feasibility of treatment with bintrafusp alfa combined with definitive chemoradiation (carboplatin, paclitaxel and radiation) in patients with squamous cell carcinoma of the esophagus or gastroesophageal junction",
NCT07186556,Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention,PHASE2,Cancer,,,
NCT05942456,Soluble B7-H3 as a Biomarker for Osteosarcoma,,Biomarker,,,
NCT05826756,Project PEER: Understanding the Lung Cancer Patient ExperiEnce in the Real-World Setting,,Lung Cancer Patients,,,
NCT01808222,FACBC for Recurrent Prostate Cancer,PHASE2,Recurrent Prostate Cancer,,,
NCT06157151,PRGN-2009 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer,PHASE2,Cervical Cancer,,,
NCT06764251,Tislelizumab Combined with SOX Regimen in the Treatment of Locally Advanced Gastric Cancer/gastroesophageal Junction Adenocarcinoma,PHASE2,Gastric/Gastroesophageal Junction Adenocarcinoma,the efficacy of neoadjuvant long-term treatment with tislelizumab in combination with SOX in the treatment of locally advanced gastric/gastroesophageal junction adenocarcinoma,neoadjuvant long-term treatment with tislelizumab in combination with SOX in the treatment of locally advanced gastric/gastroesophageal junction adenocarcinoma,
NCT00337129,S0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer,PHASE2,Head and Neck Cancer,,,
NCT06012929,A Study of ONC201 for Refractory Meningioma,PHASE2,Meningioma,,,
NCT06572631,Multi-antigen Specific CD8+ T Cells With Decitabine and Lymphodepleting Chemotherapy for the Treatment of Patients With Relapsed or Refractory AML or MDS Following an Allogeneic Hematopoietic Cell Transplantation From a Matched Donor,PHASE1,Recurrent Acute Myeloid Leukemia,,,
NCT04481802,The Effect of RadiaAce Gel in the Prevention and Treatment of Radiation Dermatitis in Breast Cancer Patients,NA,Breast Cancer,of the study is to evaluate the safety and performance of RadiaAce as compare to Biafine in reducing the proportion of breast cancer patients that experience grade 2 or higher RD as measured by the RTOG scoring system,the safety and performance of RadiaAce as compare to Biafine in reducing the proportion of breast cancer patients that experience grade 2 or higher RD as measured by the RTOG scoring system,
NCT07176702,A Phase II Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy,PHASE2,Metastatic PDAC,,,
NCT02843802,Combination of Cryosurgery and NK Immunotherapy for Advanced Liver Cancer,PHASE1,Secondary Malignant Neoplasm of Liver,of this study is the safety and efficacy of cryosurgery plus NK immunotherapy to advanced liver cancer,cryosurgery plus NK immunotherapy to advanced liver cancer,
NCT00003202,Gemcitabine Plus Radiation Therapy or Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer,PHASE1,Lung Cancer,,,
NCT05428553,CSP vs EMR for >6mm Superficial Non-ampullary Duodenal Tumors,NA,Duodenal Tumor,,,
NCT00379353,The Effects of Thalidomide on Symptom Clusters,PHASE2,Advanced Cancers,,,
NCT04659837,Training Response Inhibition to Obesogenic Foods,NA,Inhibitory Control Training,"to evaluate the feasibility, acceptability, mechanism of action, effectiveness and persistence of a home computer-based inhibitory control training","the feasibility, acceptability, mechanism of action, effectiveness and persistence of a home computer-based inhibitory control training",
NCT01967537,Evaluation of 68Gallium-DOTATATE PET/CT for Detecting Neuroendocrine Tumors,PHASE2,Neuroendocrine Tumors,"\- To see how well a new experimental imaging agent, 68Gallium-DOTATATE, detects unknown primary and metastatic NETs in the gastrointestinal system and pancreas",,
NCT00235937,Study on Pre-menopausal Patients With Advanced ER and PR + BC Treated With Arimidex Plus Zoladex,PHASE2,Breast Cancer,"the efficacy and tolerance of the association of two drugs already marketed and used to treat your disease: Arimidex® 1 Mg per day per os and Zoladex® 3,6 Mg in injections under cutaneous once per month in subjects with breast cancer",,
NCT00033137,Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer,,Kidney Neoplasms,,,
NCT02950337,Stereotactic Body Radiation Therapy for Un-biopsied Early- Stage Non Small Cell Lung Cancer,NA,Non Small Cell Lung Cancer,,,
NCT00921037,First Clinical Study of Erbium - Yttrium Aluminium Garnet (YAG) Laser Vaporization of Cutaneous Neurofibromas,PHASE2,Cutaneous Neurofibromas,whether multiple cutaneous neurofibromas in patients with neurofibromatosis type 1 can be removed with an erbium-YAG-laser,,
NCT06066437,NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial,PHASE1,Prostate Cancer,,,
NCT01714037,A Clinical Study on the Safety and Efficacy of Debio 0932 in Combination With Standard of Care in Patients With Non-small Cell Lung Cancer [NSCLC],PHASE1,Non-small Cell Lung Cancer,,,
NCT04204837,Nivolumab for Treatment of Squamous Cell Carcinoma of the Skin,PHASE2,Squamous Cell Carcinoma of the Skin,Response Rate (ORR) of immunotherapy with Nivolumab (Group 1) and Nivolumab plus Relatlimab (Group 2) in patients with locally advanced/metastatic squamous cell carcinoma of the skin using Response Criteria in Solid Tumors Version 1,the Objective Response Rate (ORR) of immunotherapy with Nivolumab (Group 1) and Nivolumab plus Relatlimab (Group 2) in patients with locally advanced/metastatic squamous cell carcinoma of the skin using Response Criteria in Solid Tumors Version 1,
NCT01517945,Attention and Interpretation Modification (AIM) for Fear of Cancer Recurrence: An Intervention Development Study,,Breast Cancer,,,
NCT04359745,Improving Treatment of Glioblastoma: Distinguishing Progression From Pseudoprogression,,Glioblastoma,"of this study is to provide doctors with a computer program that will use MRI images of the brain that are routinely obtained throughout treatment, in order to help them more accurately identify when the cancer regrows",,
NCT01226472,Extension Study in Subjects Who Relapsed After Complete Response on Study KW-0761-001,PHASE2,Peripheral T-cell Lymphoma,,,
NCT02428972,Assessment of Cognitive Functions and Quality of Life in Patients Undergoing Surgery for Supratentorial Brain Tumor,NA,Brain Tumor,was to compare early postoperative recovery and cognitive functions within the two groups,of their study was to compare the effects of 3 anesthetic regimens on hemodynamics and recovery characteristics of the patients,
NCT00004039,Combination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma,PHASE2,Lymphoma,,,
NCT05931939,Laparoscopic Ileal Interposition and Weight Regain,NA,Obesity,,,
NCT02196480,23-valent Polysaccharide Pneumococcal Vaccine in Juvenile Idiopathic Arthritis Patients Under Anti-TNF Therapy,PHASE4,Juvenile Idiopathic Arthritis,To assess immunogenicity and safety of the 23-valent polysaccharide pneumococcal vaccine (PPV23) in JIA patients with and without anti-TNF therapy,immunogenicity and safety of the 23-valent polysaccharide pneumococcal vaccine (PPV23) in JIA patients with and without anti-TNF therapy,
NCT06828380,A Study Comparing Immunotherapy Alone Versus Immunotherapy Combined With Radiotherapy in Patients With Hepatocellular Carcinoma (HCC) With Vascular Invasion,PHASE2,Advanced Hepatocellular Carcinoma (HCC),to investigate the efficacy and safety of concurrent therapy of Immunotherapy based combination therapy and Radiotherapy in patients with advanced HCC showing macrovascular invasion,,
NCT00900679,Effects of a Teaching Intervention With an Advanced Practice Nurse on Quality of Life and Psychosocial and Symptom Distress in Patients With Ovarian Cancer,NA,Ovarian Cancer,,,
NCT00911079,Pilot Study of a Catheter-based Ultrasound Hyperthermia System,NA,Cervical Cancer,,,
NCT03836196,Optimizing Prostate Cancer Treatment in Men With Advanced Local Disease,NA,Prostate Cancer,,,
NCT05974696,A Research Registry on Aggressive PitNETs,,Endocrine Tumor,,,
NCT00349362,Testosterone for Men With Insulin Treated Type 2 Diabetes,PHASE4,Hypogonadism,,,
NCT04443296,Study of Tumor Infiltrating Lymphocytes Following CCRT in the Treatment of Patients With Cervical Carcinoma,PHASE1,Cervical Carcinoma,"the feasibility, toxicity and effectiveness of cisplatin concurrent chemoradiotherapy plus TIL in treating patients with FIGO stage IIIA to IVA cervical carcinoma",,
NCT02679196,"The Safety, Pharmacokinetic and Pharmacodynamic Effect of KA2237 (PI3 Kinase p110β/δ Inhibitor) In B Cell Lymphoma",PHASE1,"Lymphoma, B Cell","safety/tolerability, pharmacokinetic and pharmacodynamics effects of KA2237 (PI3 Kinase p110β/δ Inhibitor) in patients with B Cell Lymphoma and determine the maximum tolerated dose (MTD) in Part I of the study",,
NCT03034096,General Anesthetics in CAncer REsection Surgery (GA-CARES) Trial,PHASE4,"Anesthesia, General",is all-cause mortality,,
NCT06769061,The Use of Acupuncture to Reduce Chemotherapy Induced Peripheral Neuropathy in Gynaecological Cancer Patients,NA,"Gynaecological, Urological or Rectal Cancer",To explore the feasibility and effectiveness of acupuncture on reducing Chemotherapy Induced Peripheral Neuropathy (CIPN) in gynaecological cancer patients who have received carboplatin and paclitaxel chemotherapy combination,the feasibility and effectiveness of acupuncture in reducing CIPN in gynaecological cancer patients,CIPN
NCT00445861,"Cetuximab, Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery",PHASE1,Esophageal Cancer,,,
NCT01655927,Efficacy of Tranexamic Acid in Brain Tumor Resections,PHASE3,Brain Tumors,whether Tranexamic Acid is effective or not in the reduction of intraoperative bleeding loss in brain tumors resections,,
NCT04425642,Effects of Parenteral Nutrition in HSCT,NA,Hematologic Malignancy,to identify the role of parenteral nutrition in the context of rapidly changing supportive care approaches in HSCT,,
NCT02861742,Impact of Emotional Skills of Young Women and Their Partner on Adjustment to Cancer,NA,Aging,,,
NCT05650242,"A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BA1106 in Advanced Solid Tumors",PHASE1,Solid Tumors,"the safety, tolerability pharmacokinetics, preliminary efficacy of BA1106 in participants with advanced solid tumors",BA1106 in participants with advanced solid tumors,
NCT05325242,Elbow Artery Embolization for Tennis Elbow,NA,"Lateral Epicondylitis, Unspecified Elbow",the safety and efficacy of elbow artery embolization (EAE) for the treatment of symptomatic lateral epicondylitis (tennis elbow),elbow artery embolization (EAE) for the treatment of symptomatic lateral epicondylitis (tennis elbow),
NCT02199886,Dose-escalation Study of BIBH 1 in Patients With Non-small Cell Lung Cancer Scheduled for Surgical Resection,PHASE1,Lung Neoplasms,"the toxicity, pharmacokinetics, biodistribution and imaging characteristics associated with increasing doses of 131I-BIBH 1, to compare the uptake of 131I-BIBH 1 in tumour to that of normal tissue in patients with non-small cell lung cancer and to measure human anti-human antibody (HAHA) concentrations",,
NCT02812186,Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery,PHASE4,Cholecystitis,,,
NCT05669586,Organoids Predict Therapeutic Response in Patients With Multi-line Drug-resistant Lung Cancer,PHASE2,Lung Cancer,"the consistency and accuracy of the organogenic (PDO) model for patients with lung cancer, to predict the clinical efficacy of anticancer drugs, and to speculate and select personalized treatment regiments for patients with lung cancer who are resistant to multi-line standard therapies","anticancer drugs, and to speculate and select personalized treatment regiments for patients with lung cancer who are resistant to multi-line standard therapies",
NCT04422470,Registry of Patients With Hematologic Disease and COVID-19 in Russia,,Coronavirus Infection and Hematologic Diseases,the clinical course and outcomes of COVID-19 and the underlying disease in patients with hematologic disease (malignant or non-malignant),,
NCT03689673,Study of the Effectiveness of ETIASA® (Sustained Release 5-Aminosalicylate) in Maintenance Treatment of Ulcerative Colitis (UC),,Ulcerative Colitis,the effectiveness of Etiasa® for preventing relapse in Chinese patients with quiescent UC,,
NCT03904173,Establishment of Molecular Profiling for Individual Clinical Routine Treatment Decision in Early Breast Cancer,,Breast Cancer,,,
NCT05018273,Study of VB10.NEO in Combination With Atezolizumab in Solid Tumors,PHASE1,"Solid Tumors, Adult","the safety, tolerability, antigen-specific immune response and preliminary antitumor activity associated with VB10",,
NCT01798173,"Environmental, Metabolic and Nutritional Factors of Hepatocellular Carcinoma in Cirrhotic Patients",NA,Cirrhosis With Hepatocellular Carcinoma,,,
NCT02501473,Study of Intratumoral G100 With Or Without Pembrolizumab or Rituximab In Participants With Follicular Non-Hodgkin's Lymphoma (MK-3475-174/IMDZ-G142),PHASE1,Follicular Low Grade Non-Hodgkin's Lymphoma,G100 will be examined alone or with pembrolizumab,,
NCT02064673,Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy,PHASE3,Prostate Cancer,if the adjuvant use of Curcumin improves recurrence-free survival,,
NCT06472973,ADDICTOlogical Intervention in LIVEr Transplantation Recipients,NA,Alcohol Associated Liver Disease,,,
NCT04537273,Clinical and Pathological Characteristics as Prognostic Factors in Locally Advanced Cervical Cancer,,Cervical Cancer,"of this study is to evaluate clinical and pathological prognostic factor in terms of treatment outcomes, disease-free survival (DFS) and overall survival (OS) in a retrospective cohort of patients with LACC treated with standard chemoradiotherapy in a reference center in México",prognostic clinical and pathological factors,
NCT05899673,An Extension Study to Learn About the Long-Term Safety of Fazirsiran and if Fazirsiran Can Help People With Alpha-1 Antitrypsin Liver Disease,PHASE3,Alpha1-Antitrypsin Deficiency,of this study is to learn if fazirsiran is safe during long-term use in people with liver disease caused by the abnormal Z-alpha-1 antitrypsin (Z-AAT) protein,,
NCT00773669,Male Breast Cancer Summa Health System/Akron City Hospital Experience 1995-2007,,Breast Cancer,the male breast cancer patient population at Summa Health System/Akron City Hospital over a period of 18 years and compare the findings to historical data,,
NCT05698069,Turkish Version of Pain Modulation Index,,Chronic Pain,"the validity and reliability of the Turkish version of Pain Modulation Index, 125 volunteers with chronic pain were enrolled in the study",,
NCT05811169,Quest for Tumour Evolution of Non-small Cell Lung Cancer,,Non-small Cell Lung Cancer,,,
NCT02568683,Safety and Efficacy of Entospletinib (ENTO [GS-9973]) Combined With Vincristine (VCR) in Adult Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NHL),PHASE1,Non-Hodgkin Lymphoma,of this study is to evaluate the safety of ENTO with VCR in participants with relapsed or refractory B-cell NHL,the safety of ENTO with VCR in participants with relapsed or refractory B-cell NHL,
NCT03680183,Clinical Pharmacokinetics of TKIs in Chinese Patients of Hepatitis B (HBV),,Non Small Cell Lung Cancer,,,
NCT03136783,New Tumor Models in Three Dimensions and in a Human Skin Environment for Personalized Melanoma Therapy,NA,Melanoma (Skin),,,
NCT02030483,Palbociclib in Combination With Lenalidomide and Dexamethasone for Multiple Myeloma,PHASE1,Multiple Myeloma,,,
NCT04141241,Phase 2a Study to Evaluate the Safety and Efficacy of PH100 Tablet in T2DM Patients With Recent Cardiovascular,PHASE2,Type 2 Diabetes Mellitus With Circulatory Complciation,,,
NCT02873741,New Strategies to Assess Anal Cancer Risk In Women,,Human Immunodeficiency Virus (HIV),,,
NCT00450541,Fatigue Experience in Cancer Patients,,Advanced Cancer,,,
NCT04363541,Local Thermotherapy for Patients With Mild-to-moderate COVID-19,NA,COVID-19,,,
NCT00062894,Study of Untreated or Transformed Follicular Non-Hodgkin's Lymphoma With Fission-Derived Iodine I 131 Tositumomab,PHASE1,Non-Hodgkin's Lymphoma,the blood pharmacokinetics in patients with previously untreated or relapsed follicular or transformed follicular non-Hodgkin's lymphoma who have received a dosimetric dose of fission-derived iodine I 131 tositumomab,,
NCT02761694,"Vevorisertib (ARQ 751) as a Single Agent or in Combination With Other Anti-Cancer Agents, in Solid Tumors With PIK3CA / AKT / PTEN Mutations (MK-4440-001)",PHASE1,Cancer,"of this study are: Part 1 - Vevorisertib as single agent: To assess the safety and tolerability of vevorisertib in participants with advanced solid tumors with v-Akt murine thymoma viral oncogene homolog (AKT) 1, 2, 3 genetic alterations, activating phosphatidylinositol-3-kinase (PI3K) mutations, phosphatase and tensin homolog deleted on chromosome ten (PTEN)-null, or other known actionable PTEN mutations","the safety and tolerability of vevorisertib in participants with advanced solid tumors with v-Akt murine thymoma viral oncogene homolog (AKT) 1, 2, 3 genetic alterations, activating phosphatidylinositol-3-kinase (PI3K) mutations, phosphatase and tensin homolog deleted on chromosome ten (PTEN)-null, or other known actionable PTEN mutations",
NCT03600766,Mirabegron for Treatment of Erectile Dysfunction in Patients With LUTS Secondry to BPH: A Randomized Study,PHASE2,BPH,,,
NCT04417166,Pembrolizumab and Radiotherapy for Patients With NK/T Cell Lymphoma,PHASE2,"Lymphoma, Extranodal NK-T-Cell",of the trial is to evaluate the activity and tolerability of the anti PD1 agent Pembrolizumab in combination with RadioTherapy for the initial treatment of previously untreated patients with limited stage NK/T cell lymphoma who are not eligible to chemotherapy,the activity and tolerability of the anti PD1 agent Pembrolizumab in combination with RadioTherapy for the initial treatment of previously untreated patients with limited stage NK/T cell lymphoma who are not eligible to chemotherapy,
NCT04037566,CRISPR (HPK1) Edited CD19-specific CAR-T Cells (XYF19 CAR-T Cells) for CD19+ Leukemia or Lymphoma.,PHASE1,Leukemia Lymphocytic Acute (ALL) in Relapse,,,
NCT06130566,A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis,PHASE3,Dermatitis Atopic,,,
NCT06982222,"Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones",PHASE1,Anatomic Stage IV Breast Cancer AJCC v8,,,
NCT00661622,Halt Growth of Liver Tumors From Uveal Melanoma With Closure of Liver Artery Following Injection of GM-CSF,PHASE2,Uveal Melanoma,,,
NCT03802851,HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer,NA,Prostate Cancer,if holmium laser enucleation of the prostate (HoLEP) for the treatment of lower urinary tract symptoms (LUTS) and/or urinary retention alters the treatment course for patients concurrently diagnosed with prostate cancer,,
NCT03822351,Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC,PHASE2,Stage III Non-small Cell Lung Cancer,,,
NCT02215551,Predictors of Decompressive Laminectomy Outcomes,,Lumbar Spinal Stenosis,of this study is to identify conditions other than LSS that place Veterans at risk of poor DL outcomes so that future comparative effectiveness studies can be designed that examine the impact of a more comprehensive approach to treatment,,
NCT01227551,A Study of Intratumoral CAVATAK™ in Patients With Stage IIIc and Stage IV Malignant Melanoma (VLA-007 CALM ),PHASE2,Malignant Melanoma,the clinical efficacy of Intratumoral (IT) CVA21 in terms of immune-related Progression-Free Survival (irPFS) at 6 months as monitored via immune-related Response Criteria \[irRECIST 1,Intratumoral (IT) CVA21 in terms of immune-related Progression-Free Survival (irPFS) at 6 months as monitored via immune-related Response Criteria \[irRECIST 1,
NCT06959251,Glycine and Magnesium+Thiamine for the Treatment of Primary Ciliary Dyskinesia,NA,Primary Ciliary Dyskinesia,,,
NCT04101851,Omission of SLNB in Triple-negative and HER2-positive Breast Cancer Patients with RCR and PCR in the Breast After NAST,NA,Breast Cancer Female,,,
NCT07147751,Characterization of Primary Central Nervous System Diffuse Large B Cell Lymphoma (PCNS-DLBCL) by Multiomic Approach,,Primary Central Nervous System Diffuse Large B Cell Lymphoma (PCNS-DLBCL),,,
NCT03210129,Motivational Interviewing to Increase Physical Activity Behaviour in Cancer Patients,NA,"Cancer, Breast",ed at increasing the patients' motivation for a behavioural change through open-ended discussions,the cost-effectiveness of the intervention,
NCT03518229,Pilot Study of Intervention to Reduce Sunburns in Melanoma Survivors,NA,Melanoma (Skin),,,
NCT03151629,International Registry for Men With Advanced Prostate Cancer (IRONMAN),,Prostate Cancer,,,
NCT00764829,Blood Samples to Evaluate Biomarkers of Donor Chimerism,,Leukemia,,,
NCT04337931,A Study to Evaluate Sotigalimab (APX005M) in Subjects With Unresectable or Metastatic Melanoma,PHASE2,Unresectable Melanoma,of the study is to evaluate the efficacy of sotigalimab (APX005M) administered at 2 different schedules to adult participants with unresectable or metastatic melanoma,the efficacy of sotigalimab (APX005M) administered at 2 different schedules to adult participants with unresectable or metastatic melanoma,sotigalimab (APX005M) administered at 2 different schedules to adult participants with unresectable or metastatic melanoma
NCT06601231,To Quantify the Impact of Addition of the GAAD Score to Imaging in Patients with Chronic Liver Disease Eligible for HCC Surveillance.,,"Cancer, Hepatocellular",,,
NCT05610202,Tolerability and Pharmacokinetics Study of TQB3702 Tablets in Hematologic Tumor Subjects,PHASE1,Hematologic Malignancy,the tolerability and preliminary efficacy of TQB3702 tablets in hematological tumor subjects,TQB3702 tablets in hematological tumor subjects,
NCT04601402,GEN-001 (Live Biotherapeutic Product) and Avelumab Combination Study for Patients With Solid Tumors Who Have Progressed on Anti-PD-(L)1 Therapy,PHASE1,Solid Tumor,"the safety and tolerability, biological and clinical activities of GEN-001 in patients with locally advanced or metastatic solid tumors who have progressed on at least two lines of approved therapy for their histological subtypes which includes an anti-PD-1 or anti-PD-L1 based therapy (as mono or combination), when administered as combined with avelumab",,
NCT06374602,Efficacy of Pembrolizumab and Lenvatinib in Patients With Anaplastic Thyroid Cancer,PHASE2,Anaplastic Thyroid Cancer,,,
NCT05259553,Biomarkers in Multiple Myeloma,NA,Hematological Patients,,,
NCT00531453,"A Study to Evaluate Two Different Regimens of VELCADE in Combination With Dexamethasone, Thalidomide and Cyclophosphamide (VDT vs VDTC) in Newly Diagnosed Multiple Myeloma",PHASE2,Multiple Myeloma,"the efficacy and safety of treatment with a regimen of VELCADE, dexamethasone, and thalidomide (VDT) or VELCADE, dexamethasone, thalidomide, and cyclophosphamide (VDTC) in subjects with newly diagnosed symptomatic multiple myeloma who have received no prior treatment and are candidates to receive high-dose therapy and autologous bone marrow/stem cell transplantation",,
NCT04176237,School-based Randomized Trial of SunSmart Interventions,NA,Skin Neoplasm,of this study is to test a novel classroom-based intervention to motivate youth to limit their sun exposure,,
NCT04392037,Iberdomide Combined With Low-dose Cyclophosphamide and Dexamethasone,PHASE2,Multiple Myeloma,,,
NCT03961737,"Study of the Response to Irradiation on Prostatic Explants ex Vivo, as a Predictive Factor of the Clinical Response to Irradiation of Prostate Cancers",NA,Prostate Cancer,an early tumor tissue response profile to irradiation,,
NCT03203837,Biomarker Analyses in Hepatocellular Carcinoma (HCC) Patients Treated With TheraSphere®,,Hepatocellular Carcinoma,,,
NCT00753545,Assessment of Efficacy of AZD2281 in Platinum Sensitive Relapsed Serous Ovarian Cancer,PHASE2,Ovarian Cancer,if AZD2281 is effective and well tolerated in maintaining the improvement in your cancer after previous platinum-based chemotherapy,,
NCT02982720,Evaluating Combination Immunotherapy for Advanced Cholangiocarcinoma With Pembrolizumab and PEG-Intron,PHASE2,Advanced Cholangiocarcinoma,,,
NCT00027820,Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer,PHASE1,Adult Acute Myeloid Leukemia in Remission,,,
NCT00918320,Studies of Temozolomide in Combination With Topotecan in Refractory and Relapsed Paediatric Solid Tumours,PHASE2,Neuroblastoma,whether the combination of Hycamtin (Topotecan) and Temozolomide is effective in the treatment of relapsed and refractory neuroblastoma and other paediatric solid tumors,,
NCT03422120,Human Blood Specimen Collection to Evaluate Immune Cell Function,,Colorectal Cancer,,,
NCT01651182,Tranexamic Acid Versus Placebo for Blood to Reduce Perioperative Bleeding Post-liver Resection,PHASE3,Cancer,the pharmacokinetic and pharmacodynamic properties of two well studied dosing regimens of TXA will provide guidance in determining the optimal TXA dosing regimen for patients undergoing major liver resection,,
NCT05783024,Advanced Data-Aided Medicine Part Lung Cancer,,Lung Cancer,,,
NCT00237224,Open Label Study of Postmenopausal Women With ER and /or PgR Positive Breast Cancer Treated With Letrozole,PHASE4,Breast Cancer,"safety and efficacy (measured by clinical tumor response) of letrozole daily dose, 2",,
NCT02872623,EnteroCT With Enteroclysis Versus Enterography-MRI for the Diagnosis of Tumors of the Small Intestine: a Pilot Study,NA,Suspicion of Tumor of the Small Intestine,,,
NCT05615623,Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric DIPG,PHASE1,Brain Tumor,the safety and efficacy of targeted blood brain barrier disruption with Exablate Model 4000 Type 2,targeted blood brain barrier disruption with Exablate Model 4000 Type 2,
NCT03631823,Gut Microbiota and Glioblastoma Multiforme Prognosis,,"Gut Microbiota, Glioblastoma Multiforme, Microglia, Tumor Related Macrophagocyte, Prognosis",,,
NCT05823480,Magrolimab in Combination with Azacitidine After Allogeneic HCTin Treating Patients with High-Risk AML or MDS,PHASE1,Acute Myeloid Leukemia,,,
NCT00000979,Comparison of ddI Versus Zidovudine in HIV-Infected Patients,PHASE2,HIV Infections,,,
NCT04495179,A Study of AZD4635 With Durvalumab and With Cabazitaxel and Durvalumab in Patients With mCRPC.,PHASE2,Progressive Metastatic Castrate-Resistant Prostate Cancer,,,
NCT03981679,Circulating-free DNA Assessment as a Tool to Predict Colorectal Cancer in Subjects With a Positive Fecal Immunoassay.,NA,Colorectal Cancer,of the work is to measure the cfDNA concentration in subjects undergoing colonoscopy because of a positive immunological fecal test,"the DNA present in the circulating blood (circulating DNA or cfDNA): allowed a significant advance in the personalized management of cancers, as a non-invasive test capable of producing diagnostic, prognostic, theranostic, and of therapeutic follow-up type",
NCT01265979,WB-DWI for Early Prediction of Therapy Response in Patients With Advanced Metastatic GIST Treated With Regorafenib,,Gastrointestinal Stromal Tumors,WB DWI as early predictor of response to treatment with regorafenib or placebo in patients with advanced metastatic GIST,,
NCT06141096,MB07133 for the Treatment of Patients With Unresectable Hepatocellular Carcinoma,PHASE2,Safety Issues,"the efficacy, tolerance, and safety of different doses of MB07133 in the treatment of unresectable advanced primary liver cancer",,
NCT04669496,"Phase II-III Clinical Trial of PD1 Antibody (Toripalimab), Lenvatinib and GEMOX Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors",PHASE2,Intrahepatic Cholangiocarcinoma,to compare the prognosis in intrahepatic cholangiocarcinoma between Toripalimab combined with leventinib and GEMOX neoadjuvant treatment and the current clinical surgical treatment (traditional group),,
NCT05969496,Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus,PHASE2,Renal Cancer,of this study is to evaluate whether the combination of Pembrolizumab and Axitinib given in the neoadjuvant setting can change the Inferior Vena Cava Tumor Thrombus burden,whether the combination of Pembrolizumab and Axitinib given in the neoadjuvant setting can change the Inferior Vena Cava Tumor Thrombus burden,
NCT04379362,MRI-guided Focal Laser Ablation,PHASE2,Prostate Cancer,,,
NCT06084962,A Study of DeepTag-GPRC5D Targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple Myeloma,PHASE1,Relapse/Refractory Multiple Myeloma,DeepTag-GPRC5D targeted CAR-T cells therapy for refractory/relapsed multiple myeloma,,
NCT00951262,"Intervention Study on Life Review Among Advanced Cancer Patients in Fuzhou, China",PHASE4,Advanced Cancer,to develop a life review program and test its effectiveness on a sample of patients with advanced cancer patients receiving palliative care at home in Fuzhou,,
NCT03560362,Postoperative Pain Control With Lipossomic Extended Release Bupivacaine,PHASE1,"Pain, Postoperative",,,
NCT06477562,Surveillance Endoscopy After Proximal Gastriectomy With Double Tract Reconstruction.,,Gastric Cancer,to analyze the rate of proper remnant stomach observation following proximal gastrectomy(PG) with double tract reconstruction (DTR),,
NCT00899262,"Biomarkers for Early Detection of Lung Cancer in Patients With Lung Cancer, Participants at High-Risk for Developing Lung Cancer, or Healthy Volunteers",,Lung Cancer,,,
NCT06664762,Left Lateral Position Versus Supine Position in Colonoscopy,NA,Colorectal Cancer Screening,of this protocol,,
NCT00077246,ABI-007 in Treating Patients With Chemotherapy-Naïve Stage IV Non-Small Cell Lung Cancer,PHASE1,Lung Cancer,,,
NCT05080088,Retrospective Evaluation of 3 Colonic Adenoma Detection Strategies,,Adenoma Colon,,,
NCT00082303,Music Imagery for Patients Receiving Chemotherapy for Leukemia or Non-Hodgkin's Lymphoma,PHASE1,Leukemia,,,
NCT02896803,Fluorouracil and Oxaliplatin as First-line for Advanced Pancreatic Cancer,PHASE2,Pancreatic Neoplasms,is to assess the objective response rate according to RECIST criteria (version 1,response rate according to RECIST criteria (version 1,the objective response rate according to RECIST criteria (version 1
NCT00002627,Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer,PHASE1,Breast Cancer,,,
NCT05891561,"Short-course Trastuzumab, Pertuzumab with Taxanes in the Adjuvant Treatment of Early HER2-positive Breast Cancer",PHASE2,Breast Cancer,,,
NCT00077961,"Rituximab Plus CAMPATH in Patients With Relapsed/Refractory Low-Grade or Follicular, CD20-positive, B-cell NHL",PHASE1,Non-Hodgkin's Lymphoma,"of phase I, while the primary objective of phase II will be to determine overall response","the optimal dose of subcutaneous CAMPATH when used in combination with rituximab for patients with relapsing or refractory, low-grade or follicular, CD-20-positive, B-Cell non-Hodgkin's Lymphoma",
NCT00434161,A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Multiple Myeloma,PHASE3,Multiple Myeloma,the efficacy and effect of palifermin on the incidence of oral mucositis in subjects with multiple myeloma receiving Melphalan followed by autologous peripheral blood stem cell transplantation,,
NCT04697186,Helicobacter Pylori Eradication With Berberine Plus Amoxicillin Triple Therapy Versus Bismuth-containing Quadruple Therapy,PHASE4,Dyspepsia,"at evaluating efficacy and safety of berberine hydrochloride, amoxicillin and rabeprazole triple therapy versus bismuth-containing quadruple therapy(amoxicillin, clarithromycin, rabeprazole and bismuth) in the first eradication treatment of H",,
NCT00619242,The Effects of Sorafenib on Molecular Barrett's Esophagus Cancer,NA,Esophageal Cancer,whether sorafenib is able to change pre-cancerous cells in a way that we believe is important in the progression of cancer,,
NCT03317886,Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer,PHASE3,Pancreatic Ductal Adenocarcinoma,of this study is to evaluate the advantage of mesenteric approach during pancreaticoduodenectomy (PD) for pancreatic ductal adenocarcinoma (PDAC),the advantage of mesenteric approach during pancreaticoduodenectomy (PD) for pancreatic ductal adenocarcinoma (PDAC),
NCT00429286,Preserving Function in Breast Cancer Patients,,Breast Cancer,"measures will be acceptance rates for enrollment in the study, retention rates across both intervention arms, and satisfaction levels with the PST intervention",of this R03 small grant application are to:1) Test the feasibility of enrolling and retaining newly diagnosed breast cancer patients in a clinical trial to assess telephone-based PST,telephone-based PST
NCT06800586,Tumors and Respiratory System Diseases Due to Air Pollution: New Biomarkers of Exposure and Effects,,COPD,"to examine the exposure to atmospheric pollutants in a group of non-smoking patients suffering from lung cancer, chronic obstructive pulmonary disease (COPD), and leukemia",,
NCT02416570,Is Clarithromycin a Potential Treatment for Cachexia in People With Lung Cancer?,PHASE2,Cachexia,to identify if clarithromycin (CLM) has potential as a widely available and inexpensive treatment for cachexia (the loss of muscle mass) in people with non-small cell lung cancer (NSCLC),,
NCT00807170,Investigate the Maximum Tolerated Dose of Vandetanib and Concurrent Whole Brain Radiotherapy (WBRT) in Patients With Non-small Cell Lung Cancer (NSCLC) and Brain Metastases,PHASE1,Non-small Cell Lung Cancer (NSCLC),,,
NCT03021486,"Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent Cancer",PHASE2,Advanced Malignant Neoplasm,,,
NCT02917369,Integrative Analysis of Large-cell Lung Cancer,,Lung Cancer,,,
NCT06519669,Autologous Tumor-Infiltrating Lymphocyte Injection(GT201) for Treatment of Patients with Advanced Lung Cancer,NA,Adult,"ed at evaluating the safety and tolerability of Autologous Tumor-Infiltrating Lymphocyte (GT201 injection ) for treatment of patients with Advanced lung cancer,while evaluating pharmacokinetic characteristics and efficacy assessment",,
NCT06709469,"Phase I Clinical Trial of CART Cell Therapy for Refractory/Relapsed Acute Lymphoblastic Leukemia in Children, Adolescents and Young Adults",PHASE1,Precursor Cell Lymphoblastic Leukemia-Lymphoma,,,
NCT01284569,Study to Assess Safety and Efficacy of Anti-Interleukin 6-receptor (IL6R) Nanobody in Rheumatoid Arthritis (RA) Patients,PHASE1,Rheumatoid Arthritis,"whether the ALX-0061, a Nanobody targeting the receptor for interleukin 6 (IL6R), is safe and effective after single or multiple administrations to patients with rheumatoid arthritis (RA)",,
NCT02284269,Meta-analysis in Post-marketing Surveillances for SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus,,"Diabetes Mellitus, Type 2",the safety and efficacy of long-term use of each under actual clinical practice conditions,long-term use of each under actual clinical practice conditions,
NCT00911183,Diffuse Large B Cell Non-Hodgkin's Lymphoma in the Vulnerable/Frail Elderly. A Multicentric Randomized Phase II Trial,PHASE2,Lymphoma,,,
NCT03421483,Assessing Colonic Folate Absorption & Metabolism,NA,Folate,of this study is to assess how folic acid supplementation influences colonic folate absorption and metabolism in humans,how folic acid supplementation influences colonic folate absorption and metabolism in humans,
NCT04456283,Survival of Patients With a Reduction in the Number of Lymph Nodes in Rectal Cancer After Neoadjuvant Chemoradiotherapy,,Cancer of Rectum,To analyze the survival of patients with a reduction in the number of resected LN in patients submitted to neoadjuvant and total excision of the mesorectum with rectal cancer,the difference in survival between patients with less than 12 LN in complete versus incomplete response,
NCT02976441,Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas,EARLY_PHASE1,Astrocytoma,,,
NCT06670105,A Phase 2 Trial of Glofitamab for Minimal Residual Disease in Patients With Large B-cell Lymphoma,PHASE2,B-cell Lymphoma,,,
NCT00556205,Bevacizumab With or Without Sunitinib in Sunitinib-Refractory Renal Cell Carcinoma,PHASE2,Renal Cell Carcinoma,,,
NCT00193505,Ifosfamide/Carboplatin/Etoposide/Rituxan Followed by Zevalin in Relapsed/Refractory Intermediate Grade B-Cell Lymphoma,PHASE2,Non-Hodgkins Lymphoma,treatment with 90Y Zevalin following a short course of salvage chemotherapy in patients with relapsed/refractory intermediate grade B-cell non-Hodgkin's lymphoma,,
NCT01427205,Phase II Study of Cetuximab With or Without OSI-906 in Head and Neck Squamous Cell Carcinoma (HNSCC),PHASE2,Head and Neck Cancer,Primary Objective(s): To assess progression-free survival (PFS) among patients with head and neck squamous cell carcinoma (HNSCC) treated with a combination of cetuximab plus OSI-906 and compare it with PFS among patients treated with cetuximab plus placebo,progression-free survival (PFS) among patients with head and neck squamous cell carcinoma (HNSCC) treated with a combination of cetuximab plus OSI-906 and compare it with PFS among patients treated with cetuximab plus placebo,
NCT05333705,Donor Immune Cell Therapy for Acute Myeloid Leukemia,PHASE1,Acute Myeloid Leukemia,to introduce a new technology of donor NK cell infusion,,
NCT03905941,Relative Desirability of Metformin vs. Birth Control Pill in Treating PCOS in Women of Later Reproductive Age,EARLY_PHASE1,Polycystic Ovary Syndrome,the relative desirability of metformin vs,,
NCT03245541,Radiation Therapy in Combination With Durvalumab for People With Pancreatic Cancer,PHASE1,Pancreatic Adenocarcinoma,,,
NCT06547541,Pilot - Resistance Exercise for Inpatient Treatment in T2D,PHASE1,"Diabetes Mellitus, Type 2",,,
NCT03109054,Endogenous Melatonin Level and Pre- Postoperative Anxiety in Bariatric Surgery Patients.,,Anxiety Disorders,of this study was to determine the relationship between endogenous melatonin levels and anxiety levels in patients with bariatric surgery,the relationship between endogenous melatonin levels and anxiety levels in patients with bariatric surgery,
NCT01525966,Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer,PHASE2,Inflammatory Breast Cancer,,,
NCT04614766,A Clinical Trial Evaluating the Safety of Combining Lutathera(R) and Azedra(R) to Treat Mid-gut Neuroendocrine Tumors,PHASE1,Gastro-enteropancreatic Neuroendocrine Tumor,,,
NCT00126256,Trial Comparing Two Strategies of Chemotherapy for Metastatic Colorectal Cancer,PHASE3,Colorectal Cancer,"of this randomized trial is to evaluate the potential benefit of a bitherapy with 5-fluorouracil (5-FU) and oxaliplatin as first line chemotherapy compared with a sequential chemotherapy with 5-FU alone as first line chemotherapy followed by the combination of 5-FU with oxaliplatin in case of progressive disease, in terms of progression-free survival and overall survival in patients with advanced colorectal cancer","the potential benefit of a bitherapy with 5-fluorouracil (5-FU) and oxaliplatin as first line chemotherapy compared with a sequential chemotherapy with 5-FU alone as first line chemotherapy followed by the combination of 5-FU with oxaliplatin in case of progressive disease, in terms of progression-free survival and overall survival in patients with advanced colorectal cancer",
NCT05506956,Post-transplant Flotetuzumab for AML,PHASE1,"Leukemia, Myeloid, Acute","if the study drug, flotetuzumab, is safe and tolerable when given to participants with acute myeloid leukemia (AML) that has relapsed after transplant",,
NCT04937322,Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry.,,Bile Duct Cancer,,,
NCT04216251,PRevention Using EPA Against coloREctal Cancer,PHASE1,Colorectal Adenoma,,,
NCT05002751,Quantifying Radiation Induced Vaginal Stenosis,,Vaginal Stricture,,,
NCT06664229,Development of Pressure Sensor Based Dementia and Fall Prevention Program for Older Adults,NA,"Dementia, Mild",the program to improve cognitive and physical functions of older adults via a pilot study and a main study with randomized control trial design,,
NCT05910229,Telephone Paramedical Support Prior to the Radiotherapy Simulation Scanner for Patients with Prostate Cancer,NA,Radiotherapy,the impact of a phone call before the simulation CT scan in management of care of patients with prostate cancer,,
NCT02465229,Comparison of Diagnostic Accuracy Before or After Stricture Dilation in Biliary Stricture,NA,Biliary Strictures,,,
NCT01588431,Bevacizumab/Ph 2 for Locally Advanced Head and Neck Cancer,PHASE2,"Carcinoma, Squamous Cell of Head and Neck",") and progression-free survival, overall survival and objective response rates of docetaxel, cisplatin, cetuximab, and bevacizumab (TPE-A) followed by radiation therapy, cisplatin, cetuximab, and bevacizumab (XPE-A)","to evaluate the rate of complete responses with induction therapy (primary endpoint) and progression-free survival, overall survival and objective response rates of docetaxel, cisplatin, cetuximab, and bevacizumab (TPE-A) followed by radiation therapy, cisplatin, cetuximab, and bevacizumab (XPE-A)","the rate of complete responses with induction therapy (primary endpoint) and progression-free survival, overall survival and objective response rates of docetaxel, cisplatin, cetuximab, and bevacizumab (TPE-A) followed by radiation therapy, cisplatin, cetuximab, and bevacizumab (XPE-A)"
NCT03612531,Manual Therapy in Treating Fibrosis-Related Late Effect Dysphagia in Head and Neck Cancer Survivors,NA,Cancer Survivor,,,
NCT03326102,Oral Paclitaxel Efficacy Safety and PK in Recurrent and Metastatic Breast Cancer,PHASE2,Recurrent or Metastatic Breast Cancer,"of this study is to evaluate the efficacy, safety and pharmacokinetics of DHP107 (Oral Paclitaxel, Korea brand name: Liporaxel®) compared to IV Paclitaxel in patients with Recurrent or Metastatic Breast Cancer","the efficacy, safety and pharmacokinetics of DHP107 (Oral Paclitaxel, Korea brand name: Liporaxel®) compared to IV Paclitaxel in patients with Recurrent or Metastatic Breast Cancer",
NCT02503202,Evaluation of the Safety and Immunogenicity of Three Consistency Lots and a High-Dose Lot of rVSV-ZEBOV-GP (V920 Ebola Vaccine) in Healthy Adults (V920-012),PHASE3,Prevention of Ebola Infection,,,
NCT02997202,A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML),PHASE3,Acute Myeloid Leukemia,,,
NCT02448537,A Phase II Multi-Strata Study of PM01183 as a Single Agent or in Combination With Conventional Chemotherapy in Metastatic and/or Unresectable Sarcomas,PHASE2,Metastatic Sarcoma,,,
NCT06910124,Linvoseltamab in Addition to Lenalidomide (L2) During Maintenance Therapy of NDMM to Deepen Responses or Redrive MRD Negativity After Relapse,PHASE2,Multiple Myeloma,how long you remain MRD-,,
NCT00742924,Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma,PHASE1,Sarcoma,,,
NCT05944224,A Study to Efficacy and Safety of SPH4336 Monotherapy or in Combination With Cadonilimab in Patients With Advanced Solid Tumors.,PHASE1,Advanced Solid Tumors,the efficacy and safety of SPH4336 monotherapy or in combination with Cadonilimab in the patients with selected advanced solid tumors,,
NCT06863324,Impact of Individual Radiosensitivity on Late Toxicities of Radiosurgery in Essential Trigeminal Neuralgia,NA,Trigeminal Neuralgia Treated by Radiosurgery,,,
NCT05759923,"First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients with Selected Advanced And/or Metastatic Solid Tumours",PHASE1,Advanced Ovarian Carcinoma,,,
NCT00293423,GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma,PHASE1,Brain and Central Nervous System Tumors,,,
NCT03306459,"Psychological Traits, Sexuality and Quality of Life in Patients With Polycystic Ovary Syndrome",,Polycystic Ovary Syndrome,,,
NCT00004259,Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas,PHASE3,Brain and Central Nervous System Tumors,,,
NCT06930859,Non-interventional Study to Assess the Effectiveness and Safety of Ribociclib in the Adjuvant Therapy of Hormone Receptor Positive (HR+) HER2-negative Stage II and III Breast Cancer in Real Clinical Practice in Russia,,Breast Cancer,at evaluating the efficacy of adjuvant ribociclib in combination with hormone therapy (aromatase inhibitor ± GnRH aginost) in various subgroups of patients with HR+HER2- stage II-III breast cancer in real clinical practice in Russia,adjuvant ribociclib in combination with hormone therapy (aromatase inhibitor ± GnRH aginost) in various subgroups of patients with HR+HER2- stage II-III breast cancer in real clinical practice in Russia,
NCT01313780,A Study to Evaluate Efficacy and Safety of Oxycodone/Naloxone Compared to OxyContin in Korean Cancer Patients,PHASE4,Cancer,"Bowel Habit (worsening/no change/improving), Total dose and frequency of rescue medication, Quality of Life (QOL",,
NCT07144280,A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC),PHASE3,Non-small Cell Carcinoma,,,
NCT02095379,Oligosecretary Myeloma: Prevalence and Its Clinical Significance,,Multiple Myeloma,to investigate the prevalence and clinical course of oligosecretary myeloma,,
NCT04235179,Adjuvant Stereotactic Pelvic Irradiation in Endometrial Cancer,PHASE2,Endometrial Cancer,,,
NCT05383079,Combination of Radium-223 and Lutetium-177 PSMA-I&T in Men with Metastatic Castration-Resistant Prostate Cancer,PHASE1,Metastatic Castration-resistant Prostate Cancer,,,
NCT04397679,"Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma",PHASE1,Glioblastoma,"the safety of partial brain radiation therapy, temozolomide, chloroquine, and tumor treating fields therapy in patients with gliobastoma",both radiation and tumor treating fields therapy,
NCT06118996,Breast 3DUS ABUS System Comparison,NA,Breast Diseases,,,
NCT00046696,A Study of NM-3 Administered Orally in Patients With Advanced Solid Tumors.,PHASE1,Neoplasms,,,
NCT06677827,Effect of Adding Magnesium Sulphate As Adjuvant to Bupivacaine in Ultrasound Guided External Oblique Intercostal Plane Block in Upper Abdominal Cancer Surgery.to Assess the Total Postoperative Opioid Consumption in the First 24 H and Evaluate Post Operative VAS Score,PHASE4,Upper Abdominal Cancer Surgery,,,
NCT01162642,Green Tea Anticancer Mechanisms in Smokers,NA,Cancer,whether green tea may lower the risk of certain cancers,,
NCT06586242,Efficacy and Safety of Penpulimab Combined With Anlotinib and Chemotherapy,PHASE2,Esophageal Cancer,,,
NCT05173142,HMPL-453 (FGFR Inhibitor) in Combination With Chemotherapy or Anti-PD-1 Antibody in Advanced Solid Tumors,PHASE1,Solid Tumor,"the safety, tolerability, and preliminary efficacy of HMPL-453 combined with chemotherapy or anti-PD-1 antibody in patients with advanced solid tumors",HMPL-453 combined with chemotherapy or anti-PD-1 antibody in patients with advanced solid tumors,
NCT02133742,"A Dose Finding Study To Evaluate Safety, Drug Interaction, Tumor Markers Of Axitinib In Combination With MK-3475 In Adult Patients With Previously Untreated Advanced Renal Cell Cancer",PHASE1,Renal Cell Carcinoma,,,
NCT02066870,Icotinib and Arsenic Trioxide in Treating Non-small-cell Lung Cancer Patients With Resistance to EGFR-TKI,PHASE1,Non-small Cell Lung Cancer,,,
NCT00899873,Biomarkers in Samples From Patients With Chronic Lymphocytic Leukemia Treated on Clinical Trial ECOG-2997,,Leukemia,,,
NCT01029873,QUILT-2.008: Study of ALT-801 With Cisplatin in Patients With Metastatic Melanoma,PHASE1,Metastatic Melanoma,"the safety, determine the Maximum-Tolerated Dose (MTD), and characterize the pharmacokinetic profile of ALT-801 given with cisplatin in patients who are chemotherapy naïve and have metastatic melanoma that is considered surgically incurable",,
NCT06978673,Neurolytic Block Techniques In Abdominal Visceral Cancer Pain,NA,"Cancer, Malignant Tumors",to compare celiac plexus neurolysis and splanchnic nerve neurolysis for the treatment of abdominal visceral pain and its influence on the quality of life of patients with cancer,,
NCT06008873,Association Between Preoperative Insomnia and Postoperative Quality of Recovery : A Prospective Observational Study,,Sleep Disorder,"of the study is to investigate the association between preoperative insomnia and postoperative QoR, the association between preoperative insomnia and postoperative ARI,and to describe preoperative sleep traits",the insomnia severity during hospitalization while awaiting surgery,the overall recovery after surgery
NCT05947669,Efficacy and Safety of Infliximab for Immune Checkpoint Inhibitor Induced Colitis,PHASE3,Colitis,whether the early introduction of biological treatment with a TNF-alpha inhibitor (infliximab) in addition to corticosteroids for severe ir-colitis/diarrhoea will reduce the time to grade ≤ 1 ir-colitis/diarrhoea compared to corticosteroids alone in patients scheduled for ICI treatment for solid tumors and untreated mCTCAE grade 2-4 diarrhoea or colitis,,
NCT01492569,Acupuncture Point Stimulation for Treatment of Chemotherapy Nausea and Vomiting,NA,Childhood Acute Lymphoblastic Leukemia,,,
NCT00217373,"Vaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA)",PHASE1,Adult Solid Neoplasm,,,
NCT06576973,Adbelimumab Combined With Chemotherapy and Apatinib in Patients With Resectable Esophageal Squamous Cell Carcinoma,PHASE2,Esophageal Squamous Cell Carcinoma,to assess the efficacy and safety of using adbelizumab with chemotherapy and apatinib as neoadjuvant therapy for resectable ESCC,the efficacy and safety of using adbelizumab with chemotherapy and apatinib as neoadjuvant therapy for resectable ESCC,
NCT02592473,Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia,NA,Prostatic Hyperplasia,"the safety, efficacy, and feasibility of performing prostatic artery embolization (PAE) using endovascular techniques and particle embolics in men suffering from lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH)",,
NCT04633369,The Role of the Microbiome in the Response to Dietary Fibers Intake During Intermediate Fasting,NA,Dietary Fibers,,,
NCT00672269,Study Investigating MEN1 and SDHD in Familial Carcinoid Tumors,,Carcinoid Neuroendocrine Cancer,,,
NCT02133183,Sapanisertib Before and After Surgery in Treating Patients With Recurrent Glioblastoma,PHASE1,Glioblastoma,,,
NCT02917083,"CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)",PHASE1,Hodgkin's Lymphoma,,,
NCT04603183,"ABemaciclib, ET ± paclItaxel in aGgressive HR+/HER2- MBC trIaL",PHASE2,Breast Cancer Metastatic,,,
NCT04550494,Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations,PHASE2,Anatomic Stage III Breast Cancer AJCC v8,,,
NCT03990194,Real-life Study of Patients After 3-months of Leuprorelin 5mg Implant in Prostate Cancer,,Prostate Cancer,,,
NCT02866994,Project Connect Online: An Internet-based Intervention for Women With Breast Cancer,NA,Breast Neoplasms,,,
NCT04304794,Iodinated Contrast Media Induced Hyperthyroidism,,Hyperthyroidism/Thyrotoxicosis,the influence of ICM on thyroid status and advantages of prophylactic therapy during ICM exposure in patients with euthyroid goiter and cardiovascular comorbidities,,
NCT03775694,Diffusion MRI-1 Imaging Database,,Epilepsy,,,
NCT05047094,A Safety and Efficacy Study for Combinational Treatment of DaRT and Check Point Inhibitor for Recurrent Unresectable or mHNSCC,NA,Head and Neck Squamous Cell Carcinoma,,,
NCT04503694,Neoadjuvant Regorafenib in Combination with Nivolumab and Short-course Radiotherapy in Stage II-III Rectal Cancer,PHASE2,Rectal Cancer Stage II,,,
NCT04694066,Qigong for Pre-frail and Frail Older Cancer Survivors,NA,Cancer,is to conduct a pilot study for testing out the feasibility and acceptability of a qigong intervention to the elderly cancer survivors,,
NCT02350166,Short-term Effects of LASI Surgery Versus Conventional Laparotomy for Colorectal Liver Metastasis,PHASE3,Colorectal Cancer,of this trial is to observing short-term operative effects after surgeries,,
NCT03027466,Integrating Use of Self-Affirmation Content Into a Mobile App to Promote Quit Attempts With Text-Based Smoking Cessation Intervention Messaging,NA,Number of Quit Attempts,"To explore people s values, smoking attitudes, and smoking behavior",,
NCT03830866,Study of Durvalumab With Chemoradiotherapy for Women With Locally Advanced Cervical Cancer (CALLA),PHASE3,Locally Advanced Cervical Cancer,the efficacy and safety of durvalumab + Chemoradiotherapy versus Chemoradiotherapy alone as treatment in Women With Locally Advanced Cervical Cancer,,
NCT05413356,Ruxolitinib for Newly Diagnosed Bronchiolitis Obliterans Syndrome,PHASE2,Bronchiolitis Obliterans Syndrome,,,
NCT00980122,Aggressiveness of Care at the End of Life in Cancer Patients,,Advanced Cancer,,,
NCT02909751,Tocotrienol in Combination With Neoadjuvant Chemotherapy for Women With Breast Cancer,PHASE2,Breast Cancer,,,
NCT04225429,Tazemetostat Expanded Access Program for Adults With Epithelioid Sarcoma,,Epithelioid Sarcoma,,,
NCT03801837,Effect of Macadamia Nut on Cardiometabolic Risk Factors,NA,Cardiovascular Risk Factor,,,
NCT02335437,Chronic Fatigue Following Acute Epstein-Barr Virus Infection in Adolescents,,"Fatigue Syndrome, Chronic",,,
NCT00641537,CLARITY Extension Study,PHASE3,Relapsing-Remitting Multiple Sclerosis,,,
NCT04623437,Responsible Side Effects Management in Oncology,,Pharmacovigilance,,,
NCT00024037,Laser Therapy in Preventing Oral Mucositis in Patients Undergoing Bone Marrow Transplantation,PHASE2,Oral Complications,the effectiveness of laser therapy in preventing oral mucositis in patients who are undergoing bone marrow transplantation,,
NCT01994837,A Phase 2 Study of ABT-199 in Subjects With Acute Myelogenous Leukemia (AML),PHASE2,Acute Myelogenous Leukemia,,,
NCT00004937,Acridine Carboxamide in Treating Patients With Recurrent Glioblastoma Multiforme,PHASE2,Brain and Central Nervous System Tumors,,,
NCT01538537,Safety of ON 01910.Na as a 3-day Infusion in Patients With Advanced Cancer,PHASE1,Advanced Cancer,of this study is to determine the largest dose of ON 01910,the largest dose of ON 01910,
NCT06299462,PTCy and ATG for MSD and MUD Transplants,PHASE1,Acute Myeloid Leukemia,,,
NCT00446888,Effects of Nutritional Supplementation (Product 4808) on Acute Skeletal Muscle Protein Synthesis in Cancer Patients,NA,Cancer,the factors that control the rate at which muscle tissue can be produced in subjects with cancer,,
NCT01278888,"Minimally Invasive or Open Surgery for Lung Cancer: Pain, Quality of Life and Economics.",NA,Nonsmall Cell Lung Cancer Cellular Diagnosis,,,
NCT05368688,Microbiome in Colorectal Cancer Onset and Progression,,Colorectal Cancer,,,
NCT06270888,Hypofractionation (Radiation) Trial for Multiple Myeloma,PHASE1,Multiple Myeloma,,,
NCT06495827,Predicting Response to Chemotherapy in Colorectal Cancer Via Multi-dimensional Analyses of the Tumor Associated Neutrophils,,Tumor Associated Neutrophils,ed to investigate the prognostic significance of TIICs and its biological predictive value in CRC,,
NCT06870461,Hepatic Excision and Ablation Log,,Malignant Liver Tumor,"to establish a registry for liver surgery and ablation procedures to improve patient care, advance research, and enhance surgical quality",,
NCT03935061,Effects of Mulberry Juice on Inflammatory Status and Clinical Symptoms in Patients With General Anxiety Disorder,NA,General Anxiety Disorders,"the auxiliary effect of mulberry juice in general anxiety disorder, including differences in psychiatric symptoms and levels of IL-related markers between the experimental and control groups, and contribution of IL-related genes in the auxiliary effect",,
NCT06733961,SCUBE-1 and VAP-1 Levels on Diagnosis Pulmonary Embolism,,Pulmonary Embolism Acute,of this study is to investigate the relationship between the diagnosis and prognosis of alternative biomarkers such as SCUBE-1 and VAP-1 in the diagnosis of clinically suspected acute PTE,,
NCT03506386,Multiple Myeloma (MM) Profile in Brazil: A Retrospective Observational Analysis,,Multiple Myeloma,,,
NCT00271986,Peritoneal Microdialysis in Patients Undergoing Low Anterior Resection (LAR) for Recto-sigmoid Cancer,,Cancer of Rectum,of the present study is to investigate the clinical use of peritoneal microdialysis and whether is able to detect anastomotic leakage prior to clinical symptoms develops,,
NCT00267670,Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASH,PHASE2,Nonalcoholic Steatohepatitis,,,
NCT05916170,A Study of Hookah Café Customers in the Atlanta Area,NA,Waterpipe Tobacco Smoking,the effectiveness of health warnings on waterpipe smoking behavior in a real-world setting,,
NCT00154986,IGFBP-3 in Ovarian Cancer Invasion,NA,Ovarian Carcinoma,,,
NCT04406870,Sirolimus in the Treatment for Infantile Hepatic Hemangioendothelioma(IEEH),PHASE4,Hemangioendothelioma of Liver,"sequential treatment of sirolimus to refractory IHHE patients resistant with propranolol, to improve the therapeutic effect, reduce the side effects of traditional treatment methods (hormones, interferon), and reduce the number of operations and interventions and to provide a clinical basis for the application of the new therapeutics model of IHHE of ""propranolol + sequential sirolimus treatment""",,
NCT03003273,"Early Stoppage Versus Continuation of Antimicrobial Therapy in Low Risk Pediatric Cancer Patients With Febrile Neutropenia, Before Recovery of Counts: -DALFEN Study",PHASE3,"Neutropenia, Febrile",,,
NCT06482073,Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (Interception for Suspected Lung Cancer),,Lung Carcinoma,,,
NCT00629473,Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Malignancies,PHASE1,Advanced Cancer,,,
NCT02371369,Phase 3 Study of Pexidartinib for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS),PHASE3,Pigmented Villonodular Synovitis,to evaluate the effectiveness of an investigational drug called pexidartinib for the treatment of certain tumors for which surgical removal could cause more harm than good,the effectiveness of an investigational drug called pexidartinib for the treatment of certain tumors for which surgical removal could cause more harm than good,
NCT02482441,"A Phase 1a/b Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of OMP-131R10",PHASE1,Advanced Relapsed Tumors,"the safety, tolerability, and PK of OMP-131R10 as a single agent for advanced solid tumors and in subjects with metastatic colorectal cancer",,
NCT04116541,A Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations/Characteristics in Advanced / Metastatic Tumors.,PHASE2,Malignant Solid Tumor,ing to assess the efficacy and safety of different Matched Targeted Therapy (MTT) in independent and parallel cohorts of treatment,the efficacy and safety of different Matched Targeted Therapy (MTT) in independent and parallel cohorts of treatment,
NCT03768141,International Liver Surgery Outcomes Study,,Liver Diseases,which level of complexity should be routinely offered for high tumour burden and anatomically difficult scenarios,,
NCT05476341,A Phase I Clinical Trial of Bevacizumab Injection,PHASE1,Rectal Cancer,"to compare bevacizumab injection with Avastin The similarity of pharmacokinetics, tolerance, safety and immunogenicity",,
NCT05034354,Virtual Remote Physiological Monitoring Program of Children With Heart Disease,NA,Pediatric ALL,,,
NCT04332705,Cryptosporidium Infection and Human Colorectal Cancer,,Colonic Neoplasms,of this study is to determine prevalence and to identify species of Cryptosporidium among a French digestive cancer population,prevalence and to identify species of Cryptosporidium among a French digestive cancer population,
NCT03069105,An Exploratory Study of Caregiver Burden Among Family Caregivers of Patients With Cancer,,Caregivers,,,
NCT01351805,"Vitamin D and Fish Oil for Autoimmune Disease, Inflammation and Knee Pain",NA,Autoimmune Diseases,the effects of the supplements on chronic knee pain,,
NCT06031194,Pharmacogenomics Effects on High-Dose Methotrexate Clearance in Patients With Diffuse Large B-Cell Lymphoma,,Central Nervous System Lymphoma,,,
NCT05654194,Azacitidine Combined With Venetoclax and ATRA in Newly Diagnosed AML,PHASE3,Acute Myeloid Leukemia,the safety and efficiency of azacitidine (AZA) combination with venetoclax and ATRA in Patients With Newly diagnosed acute myeloid leukemia,,
NCT06504394,A Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) Coformulated With Berahyaluronidase Alfa (MK-3475A) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL)(MK-3475A-F65),PHASE2,Classical Hodgkin Lymphoma Recurrent,response rate (ORR) of pembrolizumab (+) berahyaluronidase alfa SC in adult participants with Relapsed or Refractory Classical Hodgkin Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL),"the pharmacokinetics (PK) profile of pembrolizumab following subcutaneous (SC) injection of pembrolizumab coformulated with hyaluronidase, and to evaluate the objective response rate (ORR) of pembrolizumab (+) berahyaluronidase alfa SC in adult participants with Relapsed or Refractory Classical Hodgkin Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL)",the objective response rate (ORR) of pembrolizumab (+) berahyaluronidase alfa SC in adult participants with Relapsed or Refractory Classical Hodgkin Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL)
NCT00324194,A Phase I Study of MGCD0103 Given Twice Weekly in Patients With Leukemia or Myelodysplastic Syndromes,PHASE1,Leukemia,,,
NCT06457594,Prospective PROM and PREM Analysis Demonstrating Specification Advantage and Language Barriers,,Head and Neck Cancer,The investigators describe the EORTC INFO 25 translation process followed by investigation of subpopulation where action is most needed,,
NCT07059156,Multicenter Study of Combined Chemotherapy and Transplantation for Adult ALL,PHASE2,"Acute Lymphoblastic Leukemia, Adult","include disease-free survival (DFS) and complete remission (CR) rates, while secondary endpoints encompass relapse rate, overall survival (OS), and safety","to evaluate an integrated treatment protocol for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia (Ph- ALL), combining induction chemotherapy, consolidation therapy, and allogeneic hematopoietic stem cell transplantation (allo-HSCT) to improve treatment efficacy and survival rates","an integrated treatment protocol for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia (Ph- ALL), combining induction chemotherapy, consolidation therapy, and allogeneic hematopoietic stem cell transplantation (allo-HSCT) to improve treatment efficacy and survival rates"
NCT06709456,Drainage Of Pleural Effusions in the Intensive Care Unit (DOPE-ICU) - Feasibility Trial,NA,Pleural Effusions,,,
NCT00354822,"Fludarabine,Cyclophosphamide and Rituximab Followed by Zevalin for Non-Follicular Indolent Lymphomas.",PHASE2,"Lymphoma, Non-Hodgkin",to evaluate antitumor activity in term of the sum of complete and partial response (O,antitumor activity in term of the sum of complete and partial response (O,
NCT05298722,"Prediction of Surgical Resectability After FOLFIRINOX Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: the Role of Diffusion Weighted Magnetic Resonance Imaging, Radiomics and Liquid Biopsy (PeRFormanCe Trial)",NA,Pancreatic Cancer,"to validate, in a prospective patient cohort, the predictive value of recently published single nucleotide polymorphisms (SNPs) in genes that regulate cancer progression, invasion, and metastasis",,
NCT04006951,Development of a Clinical and Biological Database in Rectum Cancer,NA,Rectal Neoplasms,,,
NCT06183151,Capillary-Venous Paired Collection,,Cancer,,,
NCT00710151,Neurotoxicity in Primary Central Nervous System Lymphoma (PCNSL): An International Observational Study of Cognition in Long Term Survivors,,Primary Central Nervous System Lymphoma (PCNSL),,,
NCT03000751,CT DOSE Collaboratory,NA,Ionizing Radiation Exposure,,,
NCT01252329,Comparison of Elective Lymph Node Treatment Versus Clinical Observation in the Absence of Palpable Lymph Nodes for High Risk Skin Squamous Cell Carcinoma (SCC),NA,High Risk Cutaneous Squamous Cell Carcinoma,is to compare outcomes between the two arms,,
NCT00207129,Effect of Capecitabine on the Pharmacokinetics of BMS-247550 and BMS-247550 on the Pharmacokinetics of Capecitabine and Its Metabolites in Patients With Advanced Malignancies,PHASE1,Advanced Solid Tumors,,,
NCT01960829,Everolimus in Selected Patients With Metastatic Melanoma: Efficacy and Safety Study,PHASE2,Melanoma,is to evaluate efficacy profile of everolimus,efficacy profile of everolimus,
NCT01770431,Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma After Radical Hepatectomy,PHASE4,Hepatic Carcinoma,the efficacy and safety of Huaier Granule for prevention of recurrence and metastasis of hepatocarcinoma after radical hepatectomy,,
NCT03331731,A Phase II Study to Determine Pembrolizumab as Frontline Treatment of Patients With Hodgkin Lymphoma,PHASE2,Hodgkin Lymphoma,,,
NCT06206902,F01 in the Treatment of Relapsed/Refractory Non-hodgkin's Lymphoma,PHASE1,Non-Hodgkin's Lymphoma,"the safety and tolerability of F01 in subjects with relapsed/refractory non-Hodgkin lymphoma, and to determine MTD and/or RD",MTD and/or RD,
NCT03470402,Decision Support for BRCA Testing in Ethnically Diverse Women,NA,Breast Cancer,of this study is to expand genetic testing for hereditary breast and ovarian cancer syndrome to a broader population of high-risk women by prompting appropriate referrals from the primary care setting with the use of an electronic health record-embedded breast cancer risk navigation (BNAV) tool,,
NCT05664737,A Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants and to Evaluate the Safety and Pharmacokinetics in and Adolescent Participants With Alpha (α)-Thalassemia,PHASE2,Anemia,the efficacy and safety of luspatercept plus best supportive care (BSC) vs placebo plus BSC on anemia in adult participants with α-thalassemia hemoglobin H (HbH) disease and determine the safety and drug levels in adolescent participants,,
NCT01192945,Non-interventional Study With Azacitidin (Vidaza®),,MDS,,,
NCT05073172,StrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer Patients,NA,Breast Carcinoma,to see whether StrataXRT may help to prevent dermatitis after radiation therapy,,
NCT03292172,"A Study to Evaluate the Safety, Pharmacokinetics and Clinical Activity of RO6870810 and Atezolizumab (PD-L1 Antibody) in Participants With Advanced Ovarian Cancer or Triple Negative Breast Cancer",PHASE1,Advanced Ovarian Cancer,,,
NCT05053295,Investigator-initiated Pilot Study to Investigate the Efficacy and Safety of Immuncell-LC in Combination With Nivolumab (Opdivo) in Subjects With Advanced or Recurrent Gastric Cancer,NA,Relapsed or Advanced Gastric Adenocarcinoma,the efficacy and safety of combination therapy of Immuncell-LC and nivolumab in patients with relapsed or advanced gastric adenocarcinoma or gastro-esophageal junction cancer,,
NCT05538195,Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors,PHASE1,Gastric Cancer,"ing to evaluate the safety and efficacy of CEA-targeted CAR-T cell preparations, and to preliminarily observe the study drug in CEA-positive advanced malignant tumors","the safety and efficacy of CEA-targeted CAR-T cell preparations, and to preliminarily observe the study drug in CEA-positive advanced malignant tumors","CEA-targeted CAR-T cell preparations, and to preliminarily observe the study drug in CEA-positive advanced malignant tumors"
NCT00333788,Follow-up to Welcome Study C87042 [NCT00308581] Examining Certolizumab Pegol (CDP870) in Subjects With Crohn's Disease,PHASE3,Crohn's Disease,the safety of certolizumab pegol (CDP870) as well as examine the evolution of long term efficacy in Crohn's disease patients who completed study C87042 \[NCT00308581\],,
NCT00741988,Ixabepilone and Carboplatin +/- Bevacizumab in Advanced Non-Small-Cell Lung Cancer,PHASE2,Non-Small Cell Lung Cancer,,,
NCT04586088,Apatinib and Camrelizumab in Recurrent or Metastatic Nasopharyngeal Carcinoma With First-line Treatment Failure,PHASE2,Nasopharyngeal Carcinoma,the efficacy and safety of apatinib and camrelizumab in recurrent or metastatic nasopharyngeal carcinoma who failed at least the first-line treatment,,
NCT06074588,Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004),PHASE3,Non-small Cell Lung Cancer (NSCLC),"sacituzumab tirumotecan versus chemotherapy (docetaxel or pemetrexed) for the treatment of previously-treated non-small cell lung cancer (NSCLC) with exon 19del or exon 21 L858R EGFR mutations (hereafter referred to as EGFR mutations or EGFR-mutated) or any of the follow genomic alterations: ALK gene rearrangements, ROS1 rearrangements, BRAF V600E mutations, NTRK gene fusions, MET exon 14 skipping mutations, RET rearrangements, or less common EGFR point mutations of exon 20 S768I, exon 21 L861Q, or exon 18 G719X mutations",,
NCT06495203,A Study to Understand the Usage of an Artificial Intelligence Technology Called DARWEN for Eye Disorders and to Find Out the Factors Influencing Treatment Frequencies in People With nAMD and RVO,,Neovascular Age-related Macular Degeneration,,,
NCT06167603,Exploring Brain Molecular Imaging and Blood Biomarkers in Subjects With Glucocerebrosidase Mutations: Toward a Precision Medicine Approach to Characterize Parkinson's Disease Clinical Trajectories,,Parkinson Disease,,,
NCT01142427,Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia,,Acute Lymphoblastic Leukemia,,,
NCT06684327,"Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced Tumors",PHASE2,"Paget Disease, Extramammary",,,
NCT04157127,Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma,PHASE1,Pancreatic Adenocarcinoma,,,
NCT02499861,Phase I/II a Study of Decitabine in Combination With Genistein in Pediatric Relapsed or Refractory Malignancies,PHASE1,Cancer,,,
NCT03074461,Transverse Coloplasty vs. Side-to-end Anastomosis Following Low Anterior Resection (LAR): CSAR Trial,NA,Rectal Cancer,is to determine whether the transverse coloplasty pouch or the side-to-end anastomosis as rectal reservoir reconstruction offers the best functional results,whether the transverse coloplasty pouch or the side-to-end anastomosis as rectal reservoir reconstruction offers the best functional results,
NCT02684461,Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxel,PHASE2,Non Small Cell Lung Cancer,,,
NCT01326286,Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR) for Localized Prostate Cancer,,Prostate Cancer,,,
NCT06602986,Measuring the Density of Iodine in Lipiodol Depositions: Detecting an Invisible Residual Tumor After Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma,NA,HCC - Hepatocellular Carcinoma,To detect presence of a residual tumor in patients of hepatocellular carcinoma (HCC) treated with Lipiodol based conventional trans arterial chemoembolization (cTACE) using density measurements on follow-up computed tomography (CT) scans Study Design: Prospective observational interventional study Place and Duration of Study: Interventional Radiology department of Armed Forces Institute of Radiology and Imaging (AFIRI) from April 2023-March 2024 Methodology: 96 patients undergoing conventional TACE were included in the study and followed up for residual tumor or tumor free status assessment using density measurement for iodine depositions using CT scan analysis and compared with gold standard digital subtraction angiography (DSA),,
NCT02168270,Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma,PHASE1,Anaplastic Astrocytoma,,,
NCT07020273,CONNECT Cancer Survivors With Tobacco Treatment,NA,Tobacco Use,the comparative effectiveness of two different informatics-enabled implementation strategies on increasing tobacco treatment and improving smoking cessation rates for cancer control and prevention,,
NCT03391973,Pembrolizumab in Patients With Poor-Prognosis Carcinoma of Unknown Primary Site (CUP),PHASE2,Carcinoma of Unknown Primary,,,
NCT00440973,Safety Study of Specific Tumor Target Drug Plus Immune System Therapy in Patients With Kidney Cancer,PHASE2,"Carcinoma, Renal Cell","if the combination of therapy to strengthen the immune system (Interleukin - 2) plus a specific tumor target therapy (Bevacizumab) can prolong the time between the start of treatment and disease progression, decrease tumor size, as well as determine if the combination therapy is safer and less toxic than the standard treatment for renal cell carcinoma",,
NCT00925873,GOELAMS SA4 Study: the Role of Fludarabine in the Treatment of Acute Myeloid Leukemia in the Elderly,PHASE3,Acute Myeloid Leukemia,,,
NCT01755169,Ketamine in Chronic Kid's (KiCK) Pain,PHASE2,Chronic Pain,,,
NCT04349969,"A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK117 as Monotherapy or in Combination With AK104",PHASE1,Neoplasms Malignant,"the safety, tolerability, PK, immunogenicity, pharmacodynamics, and preliminary antitumor activity of AK117 as monotherapy or in combination with AK104 in subjects with advanced or metastatic solid tumors",,
NCT04202341,Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs),,Generalized Myasthenia Gravis,,,
NCT02024841,Intraperitoneal Docetaxel With Cisplatin and TS-ONE for Gastric Cancer With Peritoneal Carcinomatosis,PHASE1,Gastric Cancer,,,
NCT02496741,Metformin And Chloroquine in IDH1/2-mutated Solid Tumors,PHASE1,Glioma,"metformin and chloroquine in isocitrate dehydrogenase 1/2-mutated (IDH1/2MT) patients with a glioma, intrahepatic cholangiocarcinoma or chondrosarcoma",,
NCT03291054,Epacadostat and Pembrolizumab in Patients With GIST,PHASE2,Gastrointestinal Stromal Tumors,of overall response rate,"is to assess the efficacy of combined Indoleamine 2,3-dioxygenase (IDO) and PD-1 inhibition in a single arm phase II trial of epacadostat and pembrolizumab in patients with advanced imatinib-refractory GIST, using a primary endpoint of overall response rate","the efficacy of combined Indoleamine 2,3-dioxygenase (IDO) and PD-1 inhibition in a single arm phase II trial of epacadostat and pembrolizumab in patients with advanced imatinib-refractory GIST, using a primary endpoint of overall response rate"
NCT06086054,Effect of a Childcare Resource on Cervical Cancer Prevention,NA,Cervical Dysplasia,1: Determine the prevalence of unmet childcare needs among women with abnormal cervical cancer screening and establish the relevance of childcare as a social determinant of health in the context of cervical dysplasia,"the effectiveness of an intervention linking eligible patients to our childcare facility compared to standard of care on retention in care, defined as show-rate for the initial visit in the gynecology dysplasia clinic",
NCT01820754,Evaluation of Circulating T Cells and Tumor Infiltrating Lymphocytes (TILs) During / After Pre-Surgery Chemotherapy in Non-Small Cell Lung Cancer (NSCLC),PHASE2,Non Small Cell Lung Cancer,whether the combination of neoadjuvant chemotherapy (chemotherapy before surgery) plus ipilimumab for lung cancer increases the number of patients with detectable circulating T cells with specificities against tumor associated antigens (TAA) from zero percent (0%) of patients prior to therapy to 20% of patients after neoadjuvant chemotherapy plus ipilimumab,,
NCT05852041,rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance,EARLY_PHASE1,Prostate Adenocarcinoma,,,
NCT05942105,Different Localization Techniques for Non-palpable Breast Lesions Comparison: a Retrospective and Multicentric Clinical Study,,Breast Cancer,"the effectiveness of the new ""wire-free"" methodics ensuring a safe surgical resection with tumor-free margins and, in some cases, a better aesthetic result",their efficacy in the localization of non-palpable breast lesions,
NCT06766305,QL1706 Combined With SOX Used in Theperioperative Treatment,PHASE1,Gastric Cancers,the efficacy and safety of QL1706 combined with SOX for the treatment of resectable locally advanced gastric or gastroesophageal junction adenocarcinoma,,
NCT00626405,Bevacizumab and Temozolomide or Bevacizumab and Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed by Surgery,PHASE2,Melanoma (Skin),,,
NCT03520894,Radiotherapy in Preoperative Setting With CyberKnife for Breast Cancer,NA,Early Breast Cancer,"of this study is to prospectively evaluate, in patients affected by early breast cancer, safety and feasibility of single fraction radiotherapy with Cyberknife R in preoperative setting, and to identify factors predictive for outcome based on biologic and clinical parameters",,
NCT04375566,Progressive Web App About Individualized Patient Decision Aid for NSCLC Stage I-II,,Lung Cancer Stage I,,,
NCT00005666,Utility of Anatometabolic Imaging for Radiation Treatment Planning for Lung Cancer,NA,"Carcinoma, Non-Small-Cell Lung",,,
NCT05002556,AFU Registry of the Therapeutic Management and Follow-up of Non-Muscle-Invasive Bladder Cancer,,Non-Muscle-Invasive Bladder Cancer,,,
NCT01292356,Study of Skin Toxicity of Cetuximab: Find a Link Between Skin Inflammation and Tumor Response,PHASE2,Metastatic Colon Cancer,"of this study is to investigate a link between cutaneous inflammatory response in patients treated with anti-EGFR, serum level of anti-EGFR and treatment efficacy",,
NCT03365622,Efficacy of IV Acetaminophen Versus Oral Acetaminophen,PHASE4,Nephrectomy,"of this study is to determine whether intravenous acetaminophen compared to enteric acetaminophen offers increased efficacy in patients who are scheduled for laparoscopic donor nephrectomy and for patients scheduled for robot-assisted, laparoscopic nephrectomy for cancer at the University of Rochester Medical Center","whether intravenous acetaminophen compared to enteric acetaminophen offers increased efficacy in patients who are scheduled for laparoscopic donor nephrectomy and for patients scheduled for robot-assisted, laparoscopic nephrectomy for cancer at the University of Rochester Medical Center",
NCT06108622,Prevelance Of Cutaneous Disorders Among Patients With Heamatologic Malignancies,,Dermatologic Disorders With Heamatologic Malignancies Patients,,,
NCT06377722,Cabozantinib Treatment Prior to Cytoreductive Nephrectomy in Patients With Advanced or Metastatic Renal Cells Cancer,PHASE2,Renal Cell Carcinoma Metastatic,,,
NCT02579551,Effectiveness of Narrow Margins in Patients With Low-Risk Basal Cell Carcinoma Undergoing Surgery,NA,Skin Basal Cell Carcinoma,the least amount of tissue that must be removed to give an acceptable cure rate,,
NCT06508229,Adebrelimab Combined With Albumin Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable ESCC,PHASE2,Esophageal Squamous Cell Carcinoma,,,
NCT02576431,A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors,PHASE2,Solid Tumors Harboring NTRK Fusion,,,
NCT05821231,Study Evaluating the Safety and Efficacy of MEDI5752 in Combination With Stereotactic Radiotherapy in Patients With Metastatic Sarcoma,PHASE1,Soft Tissue Sarcoma,of this dose exploration phase I trial is to determine the Maximum Tolerated Dose and the toxicity profile of MEDI5752 when administrated with stereotactic radiotherapy in patients with metastatic sarcoma with lung metastases,"the safety profile and the preliminary activity of the bispecific antibody anti PD-1/CTLA-4 MEDI5752 in combination with SBRT delivered on one lung metastatic lesion, in patients with metastatic soft tissue sarcoma",the Maximum Tolerated Dose and the toxicity profile of MEDI5752 when administrated with stereotactic radiotherapy in patients with metastatic sarcoma with lung metastases
NCT01004731,"Study of Anti-Epidermal Growth Factor Receptor (EGFr) Antibody, Cetuximab, in Combination With Gemcitabine/Carboplatin in Patients With Stage IV Lung Cancer",PHASE1,Stage IV Non-Small Cell Lung Cancer,"is to evaluate the toxicity profile, response rate, and time to progression of Cetuximab administered in combination with either Carboplatin + Gemcitabine in patients with advanced non-small cell lung cancer with positive EGFr expression","the toxicity profile, response rate, and time to progression of Cetuximab administered in combination with either Carboplatin + Gemcitabine in patients with advanced non-small cell lung cancer with positive EGFr expression",
NCT07205731,"Phase II Study Evaluating Safety and Efficacy of Tislelizumab for Elderly Patients Unfit for Chemotherapy, With Advanced Esophageal Squamous-cell Carcinoma",PHASE2,Esophageal Squamous Cell Carcinoma (ESCC),"the percentage of patients alive at 6 months in elderly patients, not eligible to an platinum-based chemotherapy, but who can received the Tislelizumab treatment alone as first-line treatment for an advanced esophageal squamous-cell carcinoma (ESCC)",,
NCT03672253,CAR-T Re-treatment for Refractory/Relapsed Multiple Myeloma,PHASE1,Multiple Myeloma,the safety and efficacy of autologous reinfusion of CAR-T cells targeting BCMA in the treatment of refractory/relapsed multiple myeloma (r/r MM) who get recurrence and progression after previous CAR-T cell therapy,autologous reinfusion of CAR-T cells targeting BCMA in the treatment of refractory/relapsed multiple myeloma (r/r MM) who get recurrence and progression after previous CAR-T cell therapy,
NCT00871702,Infusion of Genetically Modified T Cell for Post Transplant Patients With Relapsed Disease,PHASE1,Leukemia,The primary purpose is to perform PET imaging of CD34-TK transduced allogeneic donor T cells in patients who have relapsed hematologic malignancies after allogeneic hematopoietic stem cell transplantation (SCT),if ganciclovir administration to patients who develop Graft versus Host Disease (GVHD)results in clinical improvement after infusions of CD34-TK75 transduced lymphocytes,
NCT02701153,Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort,NA,Recurrent Adult Soft Tissue Sarcoma,,,
NCT00002153,"Topical Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenylhydrazone (A-007) in the Treatment of Advanced Malignancies Including Kaposi's Sarcoma and Lymphoproliferative Disorders",PHASE1,"Sarcoma, Kaposi",topical A-007 in patients with advanced malignancies including Kaposi's sarcoma and lymphoproliferative disorders,,
NCT03050853,The Appeal and Impact of E-cigarettes in Smokers With SMI,NA,Tobacco Dependence,,,
NCT07071337,"A Study of SKB264 Versus Investigator's Choice of Chemotherapy in Subjects With Unresectable Locally Advanced, Relapsed, or Metastatic HR+/HER2- Breast Cancer Who Have Previously Failed Endocrine Therapy",PHASE3,Metastatic Breast Cancer,"the efficacy and safety of SKB264 in patients with unresectable locally advanced, recurrent, or metastatic HR+/HER2- breast cancer who have previously failed endocrine therapy",,
NCT02776137,Postoperative Concurrent Chemoradiotherapy With Docetaxel for High-Risk Squamous Cell Carcinoma of Head and Neck,PHASE2,Head-and-neck Cancer,the efficacy and safety of concurrent chemoradiotherapy with docetaxel in HNSCC patients,,
NCT00958737,Combination Chemotherapy for 3 Months or 6 Months in Treating Patients With Stage III Colon Cancer,PHASE3,Colorectal Cancer,,,
NCT00225745,Ghrelin Levels in Pancreatic Cancer Patients,,Pancreatic Cancer,measure for this study is plasma ghrelin level,,
NCT03323645,Prosthetics Registry and Outcomes in Urology at Duke,,Penile Implantation,,,
NCT03684772,Topical Ionic Contra-Viral Therapy in Actinic Keratosis,PHASE2,Actinic Keratosis,"ICVT comprised of digoxin and furosemide (dual agent), digoxin (single agent), furosemide (single agent) in patients with AK",,
NCT00342472,"Environmental and Biological Monitoring Pilot Study for Polycyclic Aromatic Hydrocarbons in Linxian, China",,Esophageal Cancer,"the association of PAHs with the high rate of esophageal cancer in Linxian, China, we plan to analyze samples of food for the presence of PAHs, samples of blood for Hb adducts (a marker of long-term PAH exposure), samples of urine for 1-OH-Pyrene glucuronide (a maker of short-term PAH exposure), and samples of coal for characteristics that may be associated with increased carcinogenesis","whether polycyclic aromatic hydrocarbons (PAHs) are contributing to the high rate of esophageal cancer in Linxian, China",
NCT03321045,Positron Emission Tomography (PET) Imaging with Zirconium-89 (89Zr)-Trastuzumab for Prediction of HER2 Targeted Therapy Effectiveness,EARLY_PHASE1,Breast Cancer,which patients are likely to respond to targeted HER2 agents as single agent therapy,,
NCT00163761,Efficacy Study of Outpatient Therapy for Lymphoma,PHASE2,Non-Hodgkin's Lymphoma,,,
NCT06418061,"Study of IBI3005 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors",PHASE1,Unresectable,the safety and tolerability of IBI3005 and to determine the maximum tolerated dose (MTD) and the recommended Phase 2 Dose (RP2D) of IBI3005,the maximum tolerated dose (MTD) and the recommended Phase 2 Dose (RP2D) of IBI3005,
NCT06730542,Zanubrutinib in Combination With Pola-R-CHP and High-dose Methotrexate in Patients With Secondary CNS Lymphoma,PHASE1,CNS Lymphoma,the effects (good and bad) of Zanubrutinib in Combination with Pola-R-CHP and High-dose Methotrexate in patients with Secondary Central Nervous System (CNS) Lymphoma,,
NCT04738786,Clinical Study Evaluating the Proper Surgical Safety Margin for Early Stage Oral Tongue Cancers,NA,Tongue Cancer,the efficacy and safety of 1,,
NCT04547686,Efficacy of a Smoke-Free Homes Intervention,NA,"Cessation, Smoking",,,
NCT04487886,Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection (COVID-19),PHASE2,COVID-19,,,
NCT04179370,Vitamin D and Health Status of British African-Caribbean Women,,Vitamin D Deficiency,"to determine the vitamin D status of British Afro-Caribbean women, as well as determine the effects of sun exposure, dietary vitamin D intake, muscular strength, lifestyle and anthropometrical (height, weight etc","the vitamin D status of British Afro-Caribbean women, as well as determine the effects of sun exposure, dietary vitamin D intake, muscular strength, lifestyle and anthropometrical (height, weight etc",
NCT02775370,A Study of Apatinib in Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and Neck,PHASE2,Adenoid Cystic Carcinoma,the efficacy and safety of Apatinib Mesylate in patients with ACC,,
NCT04337970,Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer,PHASE1,Kidney Cancer,,,
NCT02173873,Ziv-aflibercept in Eyes With Retinal Diseases and Poor Vision-phase I,PHASE1,Age Related Macular Degeneration,,,
NCT05175469,Flow Cytometric Analysis of Peripheral Blood Neutrophil Myeloperoxidase Expression for Ruling Out Myelodysplastic Syndromes: Protocol for a Diagnostic Accuracy Study,,Myelodysplastic Syndromes,of the multicenter MPO-MDS-Valid study project is to prospectively validate the diagnostic accuracy of intra-individual RCV for peripheral blood neutrophil myeloperoxidase expression quantified by flow cytometric analysis among consecutive patients referred for suspected MDS,,
NCT02412683,Neurotoxic Symptoms in Adjuvant Chemotherapy in Patients With Colorectal Cancer,,Colorectal Neoplasms,is to investigate how colorectal cancer patients with oxaliplatin adjuvant chemotherapy experience neurotoxic effects and if the experience of the symptoms change over time during treatment and how symptoms affect patients' daily lives and quality of life,,
NCT06930183,Awake Thoracic Epidural Anesthesia Versus General Anesthesia in Thoracotomy,NA,Awake,to compare awake thoracic epidural anesthesia and general anesthesia in thoracotomy,,
NCT00720083,Chemotherapy and Radiation Therapy (RT) With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck Cancer,PHASE2,Head and Neck Cancer,,,
NCT04281641,Markers to Evaluate the Efficacy of PH-based Regimen as a Neoadjuvant Therapy for Operable HER2 Positive Breast Cancer,NA,HER2-positive Breast Cancer,pre-operative pertuzumab plus trastuzumab (PH) combined with chemotherapy for early stage or locally advanced human epidermal growth factor receptor-2 (HER-2) positive primary breast cancer,,
NCT05482841,Lung Ultrasound Score After ENT Cancer Surgery,,Cancer of Head and Neck,of this study is to characterize the pulmonary status of patients after ENT cancer surgery,,
NCT06113705,Imaging and Biological Markers for Prediction and Identification of Glioblastoma Pseudoprogression: a Prospective Study.,NA,Glioblastoma,,,
NCT00593294,Oral Contraceptive and Cardiovascular Risk in PCOS,PHASE4,Polycystic Ovary Syndrome,,,
NCT00719966,Effect of Aromatase Inhibitor Therapy on Blood Vessel Function in Postmenopausal Women With Breast Cancer,,Breast Cancer,,,
NCT00002556,Combination Chemotherapy With or Without High Dose Cyclophosphamide and Recombinant Interferon Alfa-2b in Treating Patients With Previously Untreated Stage I-III Multiple Myeloma,PHASE3,Stage I Multiple Myeloma,,,
NCT03560856,"A Biomarker Study of Palbociclib + Fulvestrant for Second, and Third Line of Postmenopausal Women With hr+/her2- Advanced Breast Cancer",PHASE2,Breast Cancer,fulvestrant and/or palbociclib in the population of patients with metastatic lesions harboring ESR1 mutations was reported,,
NCT06627556,A Study of Single and Multiple Ascending Doses of H021 in Healthy Participants,PHASE1,Ulcerative Colitis,the safety and tolerability of H021 tablets following oral administration of single and multiple ascending doses in healthy participants,,
NCT00101166,Universal Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)-Producing and CD40L Expressing Bystander Cell Line for Tumor Vaccine in Melanoma,PHASE2,Melanoma (Skin),,,
NCT00740922,"Evaluation of the Safety Follow-up of Becaplermin or Placebo Gel Following Treatment of Chronic, Full Thickness Diabetic Ulcers",,Platelet-Derived Growth Factor,,,
NCT01816022,Myeloproliferative Neoplasms and Bone Structure,,Polycythemia Vera,the effect of CMPN (Chronic myeloproliferative neoplasm) to the bone,,
NCT06152822,Pyrotinib Combined With Capecitabine and Bevacizumab for Patients With HER2 Positive Breast Cancer and Brain Metastases,PHASE2,Breast Cancer With Brain Metastases,is to provide a new drug regimen for HER2 positive breast cancer patients with brain metastases by balancing survival benefits and patient quality of life,,
NCT04604522,Evaluating Clonogenic Epithelial Cell Populations in Patients With Bronchiolitis Obliterans Syndrome,,Bronchiolitis Obliterans,,,
NCT03216551,Mediastinal Staging Accuracy of a Selective Lymphadenectomy Strategy in Early Stage NSCLC (ECTOP-1003),,Lymph Node Metastases,,,
NCT06133751,Effect of 8-week Supplementation With Black Chokeberry on Recovery in Highly Trained Rowers,PHASE4,Inflammation;Muscle(S),,,
NCT01578551,Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma.,PHASE2,"Carcinoma, Non-Small-Cell Lung",the 1 year progression-free survival (PFS) of the combination of metformin and standard chemotherapy in patients with previously untreated advanced or metastatic pulmonary adenocarcinoma,,
NCT02410551,Pacritinib Before Transplant for Myeloproliferative Neoplasms (MPN),PHASE2,Myeloproliferative Diseases,,,
NCT06708351,"Enhancing Cervical Cancer Screening and Treatment in Women Living With HIV in Kenya, the ENHANCE LINKAge Trial",NA,HIV Infection,"This study seeks to explore and innovate strategies to overcome patient-, provider-, and system-level barriers to implementing CC screening and referral guidelines, link WLWH who require further diagnostic testing and/or treatment with effective and accessible care, and document services for accountability and quality improvement",,
NCT03089151,Denver Garden Environment and Microbiome Study Disease,NA,Diet Modification,,,
NCT03869151,Pretreatment Lymphocyte Monocyte Ratio on Outcome HCC Patients,,Hepatocellular Carcinoma,the prognostic role of pretreatment LMR in hepatocellular carcinoma(HCC),,
NCT04086251,Remote Electronic Patient Monitoring in Oncology Patients,NA,Cancer,,,
NCT04365751,To Compare the Efficacy of Microwave Ablation and Laparoscopic Hepatectomy for Hepatocellular Carcinoma,NA,Hepatocellular Carcinoma,percutaneous microwave ablation and laparoscopic hepatocellular carcinoma resection (tumor diameter 3,,
NCT04628351,Bladder Training in Radical Prostatectomy,NA,Urinary Incontinence,of this study is to evaluate the effect of the structured bladder training program on lower urinary tract symptoms and quality of life in patients undergoing radical prostatectomy,the effect of the structured bladder training program on lower urinary tract symptoms and quality of life in patients undergoing radical prostatectomy,
NCT02628951,Ramucirumab/Paclitaxel as Second-line Treatment in Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma With Integrative Genomic Analysis,PHASE2,Gastric Adenocarcinoma,,,
NCT06215651,Cadonilimab and Lenvatinib for Conversion Therapy in Unresectable Hepatocellular Carcinoma,PHASE2,Cadonilimab and Lenvatinib,the effectiveness and safety of the combination therapy of Cadonilimab and Lenvatinib for conversion treatment in unresectable hepatocellular carcinoma,,
NCT00070551,GTI-2040 and High-Dose Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia,PHASE1,Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities,,,
NCT04191551,The GAstric Precancerous Conditions Study,,Gastric Cancer,,,
NCT00513851,Phase 1 Study of OSI-930 in Cancer Patients,PHASE1,Advanced Solid Tumors,,,
NCT01238029,"Dose Finding Study for Combination of Capecitabine, Lapatinib and Vinorelbine in Metastatic Breast Cancer",PHASE1,Metastatic Breast Cancer,,,
NCT06074029,Exploratory Study on the Therapeutic Effect Prediction Model of Advanced BTC Immunotherapy,PHASE1,Biliary Tract Cancer,"the efficacy of ICI treatment in the early stages or even before treatment, serving as a reliable tool for selecting patients who are likely to benefit from ICI treatment",immune checkpoint inhibitors (ICI) in Chinese patients with biliary tract cancers,
NCT02501031,Flaxseed Intervention Study to Assess Sex Hormone Levels Among Post-Menopausal Women,NA,Healthy,,,
NCT00518102,The Risk of Cancer in Users of Regranex (Becaplermin) and Matched Comparators (Nonusers of Regranex [Becaplermin]),,Diabetes Mellitus,,,
NCT05875402,"XKDCT080 in GCC-positive Recurrent or Refractory Solid Tumors With Single Center, Single Arm, and Dose Escalation",NA,Colon Cancer,,,
NCT00001702,Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Blastomycosis Dermatitidis Infection in Patients Not Infected With HIV and Complications Associated With Blastomycosis Dermatitidis Infection,,Blastomycosis,,,
NCT01441453,Transient Elastography in Hepatectomy for Hepatocellular Carcinoma,NA,Surgery,whether liver transient elastography performed before the surgical procedure is able to predict liver failure in patients undergoing hepatectomy for hepatocellular carcinoma,,
NCT03004053,Feasibility Testing of a Novel Endoscope for Reflectance Confocal Microscopy of Normal Oral Tissue In Vivo,,Oral Tissue,a new technology that uses a laser and takes pictures of the microscopic structure of tissue,,
NCT06813053,A Novel Patient Decision Aid for Surgical Treatment Options in Early-Stage Breast Cancer,NA,Breast Cancer,"the feasibility and acceptability of a novel decision aid (DA) in a newly diagnosed, early-stage breast cancer population",,
NCT02806037,Utility of Intra-operative Image Guidance System for Missing Metastases,,Colorectal Cancer,,,
NCT05586737,Immunomodulatory Therapy in Women With Autoimmune Premature Ovarian Insufficiency,PHASE2,Autoimmune Diseases,Number of antral follicles and the size of the largest follicle in response to ovarian stimulation,and purpose: To study if rituximab therapy can improve ovarian response to gonadotropin stimulation and menstrual function in women with autoimmune POI,
NCT01486745,Urine Metabolomics and Colorectal Cancer Screening,,Colorectal Cancer,whether urine metabolomics can play a role in the screening of colorectal cancer (CRC),,
NCT06238245,Combination of ATG-based Conditioning Regimen and PTCy for GVHD Prevention in Allo-HSCT After PD-1 Blockade,PHASE2,Graft-versus-host Disease,"of this study is to evaluate the efficacy and safety of anti-thymocyte globulin combined with PTCy (post-HSCT cyclophosphamide, PTCy) in preventing graft-versus-host disease (GVHD) in allo-HSCT patients after anti-PD-1(anti-programmed cell death protein 1) antibody treatment","the efficacy and safety of anti-thymocyte globulin combined with PTCy (post-HSCT cyclophosphamide, PTCy) in preventing graft-versus-host disease (GVHD) in allo-HSCT patients after anti-PD-1(anti-programmed cell death protein 1) antibody treatment",
NCT05408845,"Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers",PHASE2,Metastatic Salivary Gland Carcinoma,,,
NCT00610272,Optimization of Radiotherapy in Treatment of Painful Bone Metastasis,PHASE3,Pain,,,
NCT03455595,CONECCT (Colorectal Neoplasia Endoscopic Classification To Chose the Endoscopic Treatment),,Digestive System Disease,CONECCT score to determine both histological tissue and therapeutic choice,both histological tissue and therapeutic choice,
NCT00348595,Study of 2 Different Doses of Revlimid in Biochemically Relapse Prostate Cancer,PHASE1,Prostate Cancer,the rate of PSA (prostatic specific antigen) progression at 6 months after treatment with 5mg/day and 25mg/day of Revlimid (CC-5013) in patients with evidence of biochemical relapse after local therapy,"feasibility, safety and tolerance of 6 months administration of Revlimid at 5mg/day and 25mg/day, given orally in subjects with prostate cancer with evidence of biochemical relapse (M0) following local treatment (i",
